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Double antibody radioimmunoassays for thyroxine (T4) and triiodothyronine
(T3) were optimised and validated for use in cats. Serum total T4 concentrations
of 318 and total T3 concentrations of 299 healthy cats were measured. In both
sexes, T4 concentrations tended to decrease until five years of age and then rise
again. For any given age, females and neutered females tended to have
significantly higher T4 values than males and neutered males. Pedigree animals
tended to have higher concentrations of T3 at any given age than cross-bred cats.
Animals living in the same environment had significantly similar T4 and T3
concentrations respectively which, for T3 only, appeared to be due to a definite
genetic component.
There was no obvious difference in the results of the T4 uptake test
between euthyroid, hyperthyroid and hypothyroid cats. In normal feline serum,
after agarose gel electrophoresis with tris-maleate buffer at pH 7.4, T4 was
bound only to albumin and alpha-globulin, and feline T3 mainly to alpha-2-
globulin and beta-globulin. In thyrotoxicosis, the percentages of T4 bound to
albumin and alpha-globulin were decreased and increased respectively. These
changes were not the result of hyperthyroxinaemia per se, nor to interference
of T4 binding to albumin by non-esterified fatty acids. Changes in iodothyronine
binding were seen in two euthyroid cats with elevated serum T3 and/or T4
concentrations, in two cats with euthyroid diseases, but not in two experimental
hypothyroid animals.
The historical, clinical and diagnostic features of 74 hyperthyroid cats are
presented. Approximately 70 per cent of cases had unilateral goitre. Surgical
treatment for both unilateral and bilateral lobe involvement was effective but
post-operative hypocalcaemia was common in the latter group.
Hypothyroidism was induced in two cats using and the resultant state
monitored for 91 weeks. Both cats developed sub-normal rectal temperatures,
reduced heart rates and bilaterally symmetrical alopecia and hyperpigmentation of
the distal pinnae. Hyperkeratosis, myxoedema and apocrine gland changes were
found in skin biopsies. Serum gamma-globulin concentrations increased
progressively after thyroid ablation.
The historical and clinical features of 26 cases of feline endocrine alopecia
(FEA) are described. A raised blood eosinophil count was highly reliable in
distinguishing between FEA and physically similar conditions. Seventy-three per
cent of cases responded totally to treatment with T3.
The thyroid stimulating hormone (TSH) stimulation test was optimised for
cats. Six hours after TSH administration, cats with FEA had significantly lower,
and absolute increases in, T4 concentrations than healthy cats. The serum T4
and T3 concentrations of the experimental hypothyroid cats failed to increase
after TSH but a single hyperthyroid cat responded normally.
Thyroid and antinuclear antibodies were demonstrated in serum from ten and
four of 29 hyperthyroid cats respectively, using the indirect immunofluorescence
test with normal cat thyroid as substrate. Fifteen healthy control cats were
negative for autoantibodies. Animals with strong positive results for thyroid
antibodies were significantly more likely to have bilateral goitre with
lymphocytic infiltrations than other thyrotoxic cats.
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1. SUMMARY
The work described in this thesis is a study of a number of
aspects of thyroid function in the domestic cat.
Chapter 2 provides an introduction to the subject and Chapter 3
reviews the literature on feline thyroid function.
DEVELOPMENT OF RADIOIMMUNOASSAYS FOR THYROID HORMONES IN FELINE
SERUM (CHAPTERS 4-6)
In order to develop assays applicable to cats, conditions were
first established for preparation of a "hormone-free" serum matrix.
Endogenous thyroxine (T4) and triiodothyronine (T3) were
successfully removed from normal cat serum by means of an anion
exchange resin, and this serum was used as a base for the
preparation of standards.
Radioimmunoassay (RIA) methods, using either solid phase
antibodies or liquid phase double antibodies, were developed and
optimised. However, the solid phase methods were found to be
insufficiently sensitive, particularly for T3 and were not applied
further.
SERUM THYROID HORMONE CONCENTRATIONS IN HEALTHY CATS (CHAPTER 7)
Serum total T4 and total T3 concentrations were measured in 318
and 299 healthy cats respectively, aged from four months to 13 years.
Mean +_ sd concentrations were 26.1 + 10.1 nmol/1 for T4 and 0.69
+ 0.29 nmol/1 for T3. Serum T4 and T3 concentrations of
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individual animals were highly correlated. In both sexes, T4
concentrations tended to decrease until approximately five years of
age and then rise again. A similar but less pronounced effect was
found for T3. For any given age, females and neutered females
tended to have significantly higher T4 values than males and
neutered males, but these effects were not significant for T3. When
other effects were accounted for, the effects of neutering were not
significant for concentrations of either hormone. Pedigree animals
tended to have higher concentrations of T3 at any given age than non-
pedigree cats. Animals living in the same environment had
significantly similar T4 and T3 concentrations. For T3, this
appeared to be due to a definite genetic component but it was not
possible to differentiate between environmental and genetic effects
for T4. During this part of the study, two euthyroid cats with
grossly elevated serum thyroid hormone concentrations were
identified.
TRANSPORT OF THYROID HORMONES IN HEALTHY FELINE SERA (CHAPTER 8)
Techniques were developed to investigate the serum protein
binding of T4 and T3 in healthy cats.
Initial studies with unfractionated sera using the T3 and T4
uptake tests showed less avid binding of both T3 and T4 in cats
compared with man. Subsequently, agarose gel electrophoresis with
tris-maleate buffer at physiological pH was used to define, more
specifically, the nature of the serum iodothyronine binding in
healthy cats. Feline T4 was bound to albumin (40.2 +_ 6.7 per
cent) and a protein with a mobility in the alpha-l/alpha-2-globulin
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area (50.2 +_ 6.5 per cent). Feline T3 was bound mainly in the
alpha-2-globulin (37.1 +8.6 per cent) and beta-globulin (32.5 +_
6.3 per cent) zones, with smaller proportions being present in
albumin and al pha-l-globul in (figures are mean val ues +_ sds). T3
was also present in the gamma-globulin zone but the technique did
not prove whether or not this was protein bound. There were major
differences in T4 and T3 binding between cats and humans.
TRANSPORT OF THYROID HORMONES IN FELINE SERA WITH ABNORMAL TOTAL
THYROXINE AND TRIIODOTHYRONINE CONCENTRATIONS (CHAPTER 9)
The same techniques were used to investigate serum thyroid
hormone protein binding in cats with abnormal total T4 and T3
concentrations.
The T4 uptake test was unchanged in feline hyperthyroidism and
hypothyroidism and is therefore of no value in the diagnosis of
these conditions. In thyrotoxicosis, the percentage of T4 bound to
albumin was decreased and the percentage bound to alpha-globulin,
increased. These changes were not the result of hyperthyroxinaemia
per se, nor, in the small number of cases studied, were they due
to blockage of binding of T4 to albumin by non-esterified fatty
acids. In hyperthyroid cats, there were also small but significant
percentage decreases of T3 bound to albumin and alpha-l-globulin.
After successful treatment of the condition, T4 and T3 binding tended
to revert to that seen in euthyroid animals. Two cats in which
hypothyroidism had been induced using radioiodine showed no
abnormalities of thyroid hormone binding. However, there were T3
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and/or T4 binding changes in two euthyroid cats with
hypertriiodothyroninaemia and/or hyperthyroxinaemia and in two cats
with euthyroid diseases.
FELINE HYPERTHYROIDISM (CHAPTER 10)
A series of 74 hyperthyroid cats is described.
The historical and clinical features and the results of
investigative procedures (radiography, electrocardiography,
haematology and biochemistry) agreed closely with other series. Pre-
surgical treatment using propranolol and potassium iodide was
effective in reducing elevated heart rates and technical problems at
surgery but not in producing a return to the euthyroid state pre¬
operative^. Seventy per cent of cases were judged clinically to
have unilateral thyroid lobe disease. Both unilateral and bilateral
cases responded well to surgery but post-operative hypocalcaemia was
common in the latter group.
EXPERIMENTALLY-INDUCED FELINE HYPOTHYROIDISM (CHAPTER 11)
Because a case of naturally-occurring, acquired, feline
hypothyroidism has never been confirmed, the condition was induced
experimentally and the resultant clinical and laboratory changes
monitored over a 91 week period.
After radioisotope administration, the serum T4 and T3
concentrations of both animals were consistently below the detection
limits of the respective assays and both animals had sub-normal
rectal temperatures and reduced heart rates. Widespread hair loss
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did not develop but an unusual dermatosis, characterised by alopecia
and hyperkeratosis, occurred over the distal halves of the pinnae.
Hyperkeratosis, myxoedema and reduced numbers of apocrine glands
were found histologically in skin biopsies from these and other
sites. Serum cholesterol concentrations remained in the normal
range but there was a progressive increase in serum gamma-globulin
and total protein concentrations.
THYROID FUNCTION IN FELINE ENDOCRINE ALOPECIA (CHAPTER 12)
A series of 26 cases of feline endocrine alopecia (FEA) is
described.
The diagnosis was made on the history, results of physical
examination, negative laboratory findings for diseases with similar
presenting signs and failure to respond to flea control measures. A
raised eosinophil count was highly reliable in distinguishing
between FEA and physically similar conditions. Although clinical
and basal laboratory data did not suggest hypothyroidism as the
cause of FEA, 73 per cent of cases responded totally to treatment
with liothyronine sodium.
THE THYROID STIMULATING HORMONE STIMULATION TEST IN THE ASSESSMENT
OF FELINE THYROID FUNCTION (CHAPTER 13)
The optimisation of the thyroid stimulating hormone (TSH)
stimulation test in healthy cats is described.
Cats with FEA had lower total T4 concentrations and absolute
increases in T4 concentrations six hours after TSH administration
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than did healthy cats but these values were not significantly
different for T3. Some cases of FEA may be a manifestation of low
thyroid reserve. The two hypothyroid cats failed to show any
increase in serum T4 or T3 concentrations after administration of
TSH but a single case of hyperthyroidism responded normally.
AUTOANTIBODY STUDIES IN FELINE NATURALLY-OCCURRING HYPERTHYROIDISM
AND RAD 10IODINE-INDUCED HYPOTHYROIDISM (CHAPTER 14)
Indirect immunofluorescence studies were carried out in cases
of feline thyrotoxicosis and experimental hypothyroidism.
Thyroid autoantibodies were demonstrated in sera from ten of 29
hyperthyroid cats and antinuclear antibody was found in a further
four cases. Of the five sera showing a strong reaction for
autoantibodies, four had bilateral goitre and lymphocytic
infiltrates were found in four excised thyroid glands. During
follow-up periods of three to 40 months, three cats developed
recurrent hyperthyroidism. Two cats had high titres of thyroid
antibodies and bilateral goitre with lymphocytic infiltrates, while
the remaining case was antinuclear antibody positive and had
unilateral goitre with lymphocytes. Autoantibodies were not
demonstrated in the two cases of experimental hypothyroidism.
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2. INTRODUCTION
Although details of feline thyroid anatomy date from the end of
the last century, until recently, comparatively little was known
about feline thyroid physiology. This may have resulted, in part,
from an apparent lack of thyroid-related diseases in cats. Thus,
the earliest investigations into normal feline thyroid function,
measuring protein-bound iodine, were actually carried out by medical
research workers who required control values to compare with results
obtained after the experimental production of feline hyper and
hypothyroidism. As other techniques were developed for use in
human medicine, occasional reports of their use in cats appeared in
the literature. However, these often involved very small numbers of
animals and were undertaken simply to contrast with values obtained
in other species.
The possible repercussions of changes in serum protein binding
of thyroxine (T4) and triiodothyronine (T3) were quickly recognised
in human medicine, and medical endocrinologists carried out the
earliest studies into iodothyronine transport in cats for
comparative purposes. Although there were qualitative and
quantitative differences in binding, a protein comparable with human
thyroxine binding globulin (TBG) appeared to be present in feline
serum. However, while some veterinary research workers subsequently
came to similar conclusions, others failed to identify a feline
TBG. The nature of thyroid hormone protein binding in the species
has never been properly addressed and consequently, conditions of
abnormal iodothyronine transport, so wel1-documented in man, have
never been recorded in cats.
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The first disease of cats to be linked with abnormalities of
thyroid function was feline endocrine alopecia (FEA). A number of
authors have reported that the condition responds to thyroid hormone
supplementation but others have stated that affected cats are not
hypothyroid, although only one paper has included supportive data.
While attempts have been made to induce hypothyroidism
experimentally in cats, modern tests of thyroid function were not
used to confirm the condition and clinical changes were poorly
recorded. A case of naturally-occurring, acquired, feline
hypothyroidism has never been definitively diagnosed.
The first detailed reports of feline hyperthyroidism were
published in 1980, after the present study had begun. In fact, two
short reports of cases had been published in 1979 in North American
conference proceedings but these were not readily available in the
U.K. It quickly became obvious that hyperthyroidism was a common
disease of older cats and this provided the incentive for further
investigations into normal feline thyroid physiology. However,
subsequent reports of plasma T4 and T3 concentrations in healthy
cats have merely provided details of ranges without studying the
possible effects of a number of variables.
It was against this background that the present study was
begun. Its aims were to:
(i) develop RIAs for T4 and T3 which would accurately and
precisely measure these analytes in feline serum.
(ii) use these assays to determine the normal ranges for T4 and
T3 and to identify any effects of breed, sex, age,
environment or heredity.
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(ill) develop techniques to determine the normal mechanisms of
T4 and T3 transport in feline serum.
(iv) identify whether hyperthyroidism and hypothyroidism
occurred naturally in cats by using the developed
techniques to investigate clinically suggestive cases,
(v) induce hypothyroidism experimentally in cats and monitor
its progression by modern clinical and laboratory methods.
(vi) determine whether FEA might be a manifestation of
hypothyroidism.
(vii) optimise the thyroid stimulating hormone stimulation test
for use in cats and to determine its value in the
investigation of possible feline thyroid diseases.
(viii) conduct such other studies as might be indicated in the
light of observations made during these investigations.
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3. THYROID FUNCTION IN THE CAT - REVIEW OF THE LITERATURE
3-1 HISTORICAL ASPECTS
Excellent accounts of the history pertaining to the thyroid
gland of man and animals have been given by Rolleston (1936) and
Werner (1978a), whose summaries form the basis of this review.
The thyroid was described by Galen in his De Voce some time
between A.D. 130 and 200. He considered that it provided a
lubricating fluid to the larynx and its cartilages to facilitate
speech. Vesalius (1543) was the first to provide a fuller account
of the gland. Eustachius (1520-1575, cited 1714) called it the
"glandula laryngea" and applied the term "isthmus" to the part
connecting the two lobes. However, it was not until 1656 that
Wharton named the organ "the thyroid" on the basis of shape, from the
Greek "thyreos" meaning "an oblong shield" plus "eidos" meaning
"form". He wrote: "It contributes much to the rotundity and beauty
of the neck, filling up the vacant spaces round the larynx and
making its protruberant parts almost to subside, and become smooth,
particularly in females which renders their necks more even and
beautiful".
Cowper (1698) concluded that the thyroid had the same function
as the thymus which he regarded as a lymphatic gland for the upper
part of the body. Vercellone (1711) thought that the thyroid was a
bag of worms, the ova of which mixed with the chyle and passed by
ducts into the oesophagus. Parry (1825) felt that the thyroid was a
"vascular shunt" cushioning the brain against sudden increases in
blood flow.
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By means of experimental surgical thyroidectomy, Cooper (1827)
studied the relationship between the thyroid and various body
functions and subsequently King (1836) reported that the gland had
an internal secretory function. Reverdin and Reverdin (1883)
associated naturally-occurring myxoedema with the state post-
thyroidectomy, but it required Semon (cited by Rolleston, 1936) and
Horsley (1885) to confirm the connection. Because the parathyroids
were only recognised by Gley in 1891, death usually followed
thyroidectomy and it was not until 1896 that Vassale and Generali
separated myxoedema following thyroidectomy from hypocalcaemic
tetany. The specific role of the parathyroids was confirmed in 1898
when Welsh carried out parathyroidectomy without thyroidectomy in
the cat and in 1909, McCallum and Voegtlin demonstrated that
hypocalcaemia followed parathyroidectomy.
Baumann (1895) made the association between iodine and thyroid
function when he discovered a high concentration within the gland
and Oswald (1899) confirmed this with his work on thyroglobulin. In
1900, Gley and Bourcet identified the presence of organic iodine in
plasma in combination with plasma proteins. In 1915, Kendall
1 1
isolated L-3,5,3 ,5 -tetraiodothyronine (L-thyroxine, T4)
from thyroid tissue and its chemical structure was identified by
Harington (1926) and Harington and Barger (1927). Thyroid
stimulating hormone, thyrotropin (TSH) was discovered by Smith and
Smith (1922) who found that extracts of fresh bovine pituitary
glands would reactivate the atrophied thyroid glands of
hypophysectomised tadpoles.
A further major discovery was made with the identification of
an iodine-containing substance other than T4 in animal plasma
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(Gross and Leblond, 1951 a and b) and in human plasma (Gross and Pitt-
Rivers, 1951). This was shown to be L-3,5,3*-triiodothyronine
(T3) by Gross and Pitt-Rivers (1952). This compound proved to be
more potent and rapid in onset than T4 and these workers speculated
that T4 was the form in which thyroid hormone was secreted while T3
was the form that was active in tissues. In 1952, Gordon, Gross,
O'Connor and Pitt-Rivers reported that plasma T4 was largely
associated with a single protein constituent, thyroxine binding
globulin (TBG).
L-3,3*^-triiodothyronine (reverse T3, rT3) was
identified in the blood and thyroglobulin of the rat by Roche,
Michael and Nunez in 1956.
The hypothalamic-pituitary regulation of thyroid hormone
production has been extensively reviewed by Burger and Patel
(1977). The identification of a hypothalamic TSH-releasing factor
was claimed by Shibusawa, Saito, Nishi, Yamamoto, Tomizawa and Abe
(1956) but this work did not receive wide acceptance. The first
incontrovertible evidence for the existence and purification of
thyrotropin releasing hormone (TRH) was published by Guillemin,
Yamazaki, Jutisz and Sakiz in 1962 and its chemical structure was
determined by Schally, Arimura, Bowers, Wakabayashi, Kastin,
Redding, Mittler, Nair, Pizzolato and Segal (1970).
Baber (1876) in his work with dogs was the first researcher to
note two kinds of thyroid cells. Copp, Davidson and Cheney (1961)
and Copp, Cameron, Cheney, Davidson and Henze (1962) reported their
discovery of calcitonin and subsequently Foster, Maclntyre and
Pearse (1964) proposed that this compound was produced by one of the
types of thyroid cells. In 1965, Gudmundsson, Maclntyre and Soliman
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synthesised calcitonin. The cells that produced it endogenously
were named C cells by Pearse in 1966.
3.2 EMBRYOLOGICAL DEVELOPMENT OF THE THYROPARATHYROID APPARATUS
Few studies have been carried out on the embryological development
of the feline thyroid. Thomas and Nathanielsz (1980) stated that
the process is essentially the same in all mammalian species. Thus,
the thyroid glandular epithelium arises from the entodermal lining
of the foregut at the level of the first pair of pharyngeal pouches.
The gland first appears as a distinct entodermal pocket, the
thyroid diverticulum. This ventral outgrowth from the middle of the
foregut remains, for some time, attached by a narrow neck, the
thyroglossal duct. As development proceeds, this duct becomes a
solid stalk of cells and eventually breaks off, leaving only a surface
indentation on the back of the tongue, the foramen caecum. The
thyroid soon becomes a bilobed, solid mass of cells when set free
from the atrophied stalk. The connective tissue capsule and
vascular interstitial tissue are derived from surrounding mesenchyme
(Venzke, 1975).
Winiwarter (1935) noted changes in the pace of feline foetal
thyroid development. During the first half of gestation, until the
first vesicles of colloid appeared, growth was slow ("embryonic")
but there was then a rapid multiplication of follicles and a phase
of activity, followed by an almost complete resting phase until
after birth.
Ramsay (1938) carried out an extensive study of the development
of feline thyroid parenchyma using the entire Cornell collection of
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cat embryos stained with either Mayer's HC1 carmine or with
haematoxylin and eosin, and a graded series of foetuses stained with
haematoxylin and eosin. He divided the process arbitrarily into
five: the plate stage, diverticulum formation, cavity formation, the
prefol1icular stage and the follicular stage.
In the plate stage, the youngest embryo (11 somites) showed no
definite area for thyroid formation, the future thyroid plate being
discernible only by its position and the absence of mesenchyme
between it and the underlying aortic sac. The first indication of a
delimitation in the thyroid area occurred at the 16 to 18 somite stage
with a slight depression in the pharyngeal floor immediately over
the aortic sac and between the ventral grooves of the first pair of
pharyngeal pouches. Embryos of 22 and 23 somites possessed easily
recognised thyroid plates showing both thyroid pits and a massive
increase in mitotic figures. This active growth phase initiated
diverticulum formation and tended to fill up the thyroid pit. At
the same time, the mesenchyme below the floor of the pharynx
increased and migrated between the plate and the aortic sac. The
thickened plate was countersunk by the continued growth of the
mesenchyme and its area of attachment to the pharyngeal epithelium
was markedly constricted, thus changing the plate into a
diverticulurn.
There was considerable variation between embryos but newly
formed diverticula were usually saccular. Due to growth of the
thyroid epithelium, the walls of the diverticulum became evaginated,
producing secondary diverticula (primitive thyroid follicles) as
well as solid buds and sprouts of cells from the original saccular
an!age. This was the initial stage of cavity formation. Crowding
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and sloughing of cells caused the cavities of the hollow buds thus
formed to lose their connection with the main cavity very rapidly.
The residual lumen was lost by the production of a massive portion
of thyroid cells in the midline. To establish a more extensive
contact with the surrounding vascular mesenchymal bed, the thyroid
cells of 6mm to 8mm embryos separated to form tiny intercellular
clefts (the intraglandular clefts of Nlorris). These opened at the
outside of the anlage and were invaded by mesenchyme which
ultimately reduced the central massed region of the thyroid to
plates and bands two cells in thickness.
In the prefollicular stage, Complex IV fused with the thyroid
anlage (12mm to 13mm embryonic length). Primitive follicles occurred
most numerously in the lateral lobes while the central region
(isthmus) contained few. The walls of the primitive follicles
thickened but only the single layer of cells around the lumen showed
any definite arrangement. By the 40mm stage, the gland was composed
of irregularly branching bands and buds of compact, highly
vascularised thyroid parenchyma and numerous primitive follicles.
The follicular stage was marked by the appearance of a highly
refractile, acid-staining substance in the primitive follicles (40mm
to 41mm foetal length). By 50mm, this colloid had increased in
amount and these structures were termed "primary thyroid follicles".
Initially, the cells surrounding the colloid had no orientation but
as the globules increased in size, the adjacent cells became
typically arranged and the characteristic picture of adult thyroid
parenchyma emerged. Secondary follicles were formed by constriction
or division of primitive and primary follicles and by direct hollow
outgrowths from existing follicles followed by constriction.
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However, some of the thyroid parenchyma retained a marked tendency
for growth and continued to add thyroid material for some time
following birth.
The authors drew particular attention to two features
described. Firstly, the development of primitive follicles directly
from the open thyroid diverticula appeared to be a process peculiar
to the cat. Secondly, primary feline thyroid follicles produced
colloid before they possessed lumina, whereas the reverse occurred
in man (Kingsbury, 1915; Morris, 1916).
Latimer (1939a) weighed the thyroids of 229 foetal cats. The
glands were relatively heaviest in the smallest foetuses, decreasing
rapidly in percentage weight at first, and then more slowly to
birth.
The early growth and development of the thyroid does not appear
to be TSH dependent since histological development, colloid
formation and storage can occur in the absence of a pituitary
(Thomas and Nathaniel sz, 1980).
In the cat, as in other species, a portion of the thyroglossal
duct may persist post-natally and form a cyst due to proteinaceous
material secreted by the lining epithelium (Martin and Capen, 1983).
The parathyroids develop separately from the dorsal diverticula
of the third and fourth branchial pouches. Each diverticulum forms
into a solid mass of cells of entodermal origin, to become
differentiated into two pairs of globular glands which become
detached from the pharyngeal mucosa. The pair derived from the
third branchial pouch are termed parathyroids III or the cranial or
external glands and those derived from the fourth branchial pouch,
parathyroids IV or the caudal or internal parathyroids (Kohn, 1895).
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3.3 ANATOMY OF THE THYROPARATHYROID APPARATUS
Gross anatomy
Kohn (1895) was the first person to detail the anatomy of the
thyroid of the cat, since when there have been numerous descriptions
published. It is generally regarded by anatomists to be a single
gland consisting of two lobes (Holzworth, Theran, Carpenter,
Harpster and Todoroff, 1980). Embryologically, the
lobes are connected by an isthmus but this is not usually present
in adults (Nicholas and Swingle, 1924a; Andrew, 1959; Lucke, 1964;
Walker, 1967; McDonald, 1975, 1980; Schaer, 1981), although a large
lymph channel marks its foetal location (Ramsay and Bennett, 1943).
However, Nickel, Schummer and Seiferle (1975) state that the lobes
are usually joined by a 1mm to 2mm wide isthmus. When present, the
isthmus may be glandular (Lucke, 1964) or fibrous (Holzworth et
al., 1980) connecting the lobes ventrally across the trachea (Field
and Taylor, 1969; Kaneko, 1970, 1980a) by their inferior poles
(Nicholas and Swingle, 1924a). The lobes are flattened, long
ellipses, generally with rounded anterior and pointed posterior
edges (Lucke, 1964), although a thin, tongue shape has also been
described (Winiwarter, 1935).
Carlson (1914) was of the opinion that normal cats' thyroids
were constant in size. Bustad and Fuller (1970), however, writing
of mammals generally (in which they included the cat), commented
that thyroid size fluctuated markedly with advancing age, changes in
physiological state such as pregnancy and lactation, and in response
to environmental factors such as stress, temperature and diet
(particularly iodine content). Clark and Meier (1958) agreed that
adult feline thyroid size depended upon age. In mature animals,
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each lobe is approximately 2cm long, 0.5 to 0.6cm deep and 0.3cm
wide (Daniel, Gale and Pratt, 1962; Lucke, 1964) with a colour
variably described as pale to medium mahogany (Lucke, 1964), yellow
or red-brown (Holzworth et al., 1980), light brownish-yellow (Black
and Peterson, 1983) and tan (Peterson, Birchard and Mehlhaff, 1984).
The thyroid lobes lie within the cervical fascia, between the
sternothyroideus muscles and the trachea, with their anterior poles
just below the cricoid cartilage and extending downwards over the
first five to six tracheal rings (Nicholas and Swingle, 1924a;
Lucke, 1964; Crouch, 1969; Bustad and Fuller, 1970; Martin and
Capen, 1983; Birchard, Peterson and Jacobson, 1984; Peterson,
Birchard and Mehlhaff, 1984). Contrary to all other authors,
Nickel, Schummer and Seiferle (1975) described the lobes as lying in
the area of the seventh to tenth tracheal rings. Dorsally, the
lobes are in close proximity to the carotid sheath and the vago¬
sympathetic trunk. The right recurrent laryngeal nerve is medial to
the gland and courses along the trachea's right dorsolateral
surface. The left recurrent laryngeal nerve lies between the
trachea and the oesophagus (Black and Peterson, 1983). A thick,
firm, fibrous capsule surrounds each lobe (Ramsay and Bennett, 1943;
Soderberg, 1958; Black and Peterson, 1983). Fibro-elastic
connective tissue septa extend from the capsule into the glandular
parenchyma providing an internal support, transporting blood
vessels, lymphatics and nerves and separating the gland into
indistinct lobules. There are fewer connections between the
parenchyma and the capsule in young animals, the increase with age
possibly being due to secondary adhesion formation (Ramsay and
Bennett, 1943).
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Brody and Kibler (1941) noted that, in general, in mature
domestic animals (in which they included the cat), the thyroid gland
represented lOOmg/kg of bodyweight and proportionately more in the
young. Carlson (1914) examined 20 healthy, pregnant queens with a
mean bodyweight of 3.0kg (range 2.81kg to 4.6kg) and found their mean
thyroid weight to be 0.25g (range 0.2g to 0.3g) thus giving a mean
bodyweight/thyroid weight ratio of 12,000:1 (range 8,800:1 to
16,200:1). Eighty-five kittens taken from these queens either
before term or at birth had a mean bodyweight of 80g (range 41g to
125g), a mean thyroid weight of 0.017g (range 0.012g to 0.022g) with
a resultant mean ratio of 4,705:1 (range 4,500:1 to 7,300:1). There
was no evidence that thyroid weight increased or decreased
proportionately with a gain or loss of body fat.
Latimer (1939a) examined the thyroid glands of 35 newborn
kittens and 104 adult cats. At birth, the gland represented 0.02
per cent of bodyweight but this fell to 0.0084 per cent in mature
animals. In adults, there was no significant sex difference in
either absolute or percentage weight, with mean weight for males
being 0.235g and for females 0.218g (Latimer, 1939b).
Knigge (1961) examined the thyroids of ten healthy cats and
reported that the two lobes may vary in weight from 0 to 29.6 per cent
(mean j^sd was 12.3 _+ 6.5 per cent) with neither lobe consistently
weighing more than the other. The mean weight of the two lobes of a
further 65 cats was 248mg + 24mg (range lOlmg to 398mg) with a mean
relationship to bodyweight of 75.9 _+ 6.2mg/kg. Daniel, Gale and
Pratt (1962) reported that each feline thyroid lobe weighed 0.2g to
0.5g, whereas Nickel, Schummer and Seiferle (1975) stated that the
absolute weight of the whole gland varied between 0.19 and 1.45g but
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in neither case were further details given. None of these workers
apparently removed parathyroid tissue from the excised glands and
thus the above figures presumably indicate combined
thyroid/parathyroid weights.
Kohn (1895) gave the first description of the cat's parathyroid
glands. One external (cranial) and internal (caudal) gland is
normally associated with each thyroid lobe. However, the number of
each is variable, particularly in the case of the caudal glands
(Nicholas and Swingle, 1924a).
The external parathyroids are usually located near the cranial
pole of each lobe in fascia external to the thyroid capsule
(Nicholas and Swingle, 1924b; Black and Peterson, 1983; Martin and
Capen, 1983; Birchard, Peterson and Jacobson, 1984; Peterson,
Birchard and Mehlhaff, 1984). Their position is not, however,
constant and they may be found in practically any site on the
anterior or ventral surfaces of the glands (Nicholas and Swingle,
1924a; Holzworth et al., 1980). They are spherical, 2mm to 7mm in
diameter (Nicholas and Swingle, 1924a; Holzworth et al., 1980; Black
and Peterson, 1983) and tan (Holzworth et al., 1980) or pink (Black
and Peterson, 1983) in colour.
The internal glands are more variable in position than the
externals and although they commonly lie within the thyroid
parenchyma at the caudal pole of each lobe (Nicholas and Swingle,
1924a; Holzworth et al., 1980; Black and Peterson, 1983; Birchard,
Peterson and Jacobson, 1984; Peterson, Birchard and Mehlhaff 1984),
they may be found anywhere on the tracheal surface of the lobe
(Nicholas and Swingle, 1924a) or within the thyroid capsule (Martin
and Capen, 1983). The internal glands are smaller than the
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externals and spherical, although a star shape has also been
described (Winiwarter, 1935).
Walker (1967) stated that "two pairs of parathyroid glands are
embedded in the dorsomedial surface of the thyroid but cannot be
seen grossly". In their description of the feline parathyroid
glands, Field and Taylor (1969) stated that they "are located on the
dorsal side of the thyroid gland near its anterior end". They were
presumably referring to the external glands and made no mention of
the internals.
There is an intimate relationship between the thymus and the
thyroid gland of the cat. In many cases, a portion of the cervical
thymus is found attached to, or even partially embedded in, the
thyroid lobes. In adults, the cervical thymus tissue may be lacking
or replaced by fat but in younger animals, some thymus is generally
present in close connection with the thyroid and external
parathyroids (Kohn, 1895).
Vascularisation
According to McDonald (1975, 1980), the vascular supply to the
(vertebrate) thyroid fluctuates considerably depending on the
activity of the gland. Considering its size, it receives one of the
richest supplies of blood of any organ with the exception of the
adrenal. Soderberg (1958) was able to show the rapid, short-term
changes in blood flow from the feline thyroid in response to a
number of nervous, hormonal and chemical stimuli.
Nicholas and Swingle (1924a) carried out an extensive
investigation into the vascularisation of the cat's thyroparathyroid
apparatus using one of two methods. In some animals, chrome yellow
was injected through the femoral artery immediately after death, to
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delineate the main arterial circulation. In others, ammoniacal
carmine solution was injected into the inferior vena cava of
anaesthetised animals. The abdominal aorta was then severed and
clamped to permit a slight blood flow from the proximal end and when
the heart action ceased, pressure was applied by syringe. The
thyroparathyroid apparatus was then placed in a mixture of ten per
cent formalin and five per cent acetic acid and cleared in
Spal tehol tz1s fluid (50 per cent benzol benzoate and 50 per cent
methyl salicylate). This technique reveals the thyroid tissue as
pink, the parathyroids white and the vasculature red. The authors
found that the arterial supply enters each thyroid lobe at its cranial
pole and corresponds to the cranial or superior thyroid artery of
other species. Immediately after entering the thyroid, it gives off
several small branches, which supply the gland plus both
parathyroids. The cranial thyroid arteries branch from the common
carotid artery opposite the larynx, from where they run caudally to
each thyroid lobe (Schaer, 1981; Birchard, Peterson and Jacobson,
1984; Peterson, Birchard and Mehlhaff, 1984). The caudal or
inferior thyroid artery is not present in most cats (Nicholas and
Swingle, 1924a).
Venous drainage from the thyroid and parathyroid glands is
usually described as being via the cranial and caudal thyroid veins
(Black and Peterson, 1983; Birchard, Peterson and Jacobson, 1984;
Peterson, Birchard and Mehlhaff, 1984), the latter corresponding to
the v. thyroidea media as described by Schummer, Wilkens,
Vollmerhaus and Habermehl (1981a). Whatever the terminology, most
of the venous outflow follows these caudal veins which leave the
caudal border of each lobe (Soderberg, 1958; Schaer, 1981). Thence,
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there is acknowledged to be some variation, with some authors
stating that these vessels form a single vein in most cats which
runs down the ventral surface of the trachea, emptying into the
right or left jugular vein (Nicholas and Swingle, 1924a; Soderberg,
1958), while others describe the caudal veins continuing to run
separately, eventually joining the respective internal jugular veins
(Schaer, 1981). The cranial vein is a small vessel which arises
near the cranial pole of each thyroid lobe and drains into the
internal jugular vein at that position (Schaer, 1981; Schummer et
al ., 1981a).
Schummer et al. (1981b) alone describe a vessel they term the
v. thyroidea caudal is which is not the counterpart of the caudal
thyroid vein described above. This unpaired structure arises from
the cranial thyroid vein usually draining only the left thyroid lobe
together with the trachea and the sternohyoid and sternothyroid
muscles. It runs ventrally along the neck between these muscle
groups and enters the left, or rarely the right, brachiocephalic
vein.
Lymphatic drainage
Ramsay (1938) reported that the mature cat's thyroid possessed
an almost complete lymph sac surrounding the entire thyroid except
at the point of entrance and exit of blood vessels. The lymphatic
endothelium penetrated the lobules to such an extent that each
follicle was in close contact with it. He also made brief comments
about the chief lymph drainage.
In a slightly later communication, Ramsay and Bennett (1943)
studied the thyroid lymphatics in more detail by subcapsular
injection of diluted Indian ink in anaesthetised animals. When the
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injection was made into one lobe, the ink spread immediately through
the lymph sac of that lobe and then across to the other lobe by a
"bold" channel which marked the region of the isthmus, whether a
parenchymatous isthmus was present or not. Smaller, additional
isthmic vessels were also usually present. Two main groups of
lymphatics drained the thyroid. The superior or cranial group,
consisting of two to nine vessels, arose at the cranial pole of each
lateral lobe and drained to a large, deep, cervical lymph node
located dorsolaterally to each lobe. The inferior or caudal group
arose at the caudal pole of each lateral lobe and drained caudal ly
or caudolaterally into the tracheal nodes on the lateral or ventral
trachea, to small nodes located in the superior mediastinum and to
jugular nodes of varying size close to the jugular-subclavian venous
junction.
In 18 of 32 animals, it was possible to identify thyroid
lymphatics passing directly to veins without first passing through
lymph nodes. These emptied either at the junctions of the internal
or external jugular or the subclavian and jugular veins. In
addition to these lymphatics, in many cases, other lymph vessels
passed laterally or caudolaterally to empty directly into the
cervical lymphatic trunks on either the right or left sides and in
two animals into both. These "direct" vessels, which usually arose
at the caudal poles of the glands whether they went to veins or to
the cervical lymphatic trunks, were never the only draining vessels
but were supported by the more usual type.
Schummer et al. (1981c) gave a detailed account of the lymphatic
drainage of the cat's thyroid which differed to some extent from the
above both factually and in terminology. They stated that the
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thyroid was drained by two of the three groups of the deep lymph
vessels of the neck (the lymphocentrum cervicale profundum), namely
the cervicales profundi medii and caudales. The middle group is
small and may be absent altogether whereas the caudal group is
constant and particularly large.
The cervicales profundus medius is a small, round node of 1mm
to 4.5mm diameter which is present in only one in four cats and then
only unilaterally. It is situated against the cervical trachea and
the internal jugular vein approximately halfway along the neck. It
drains the thyroid and the cervical trachea and oesophagus, together
with secondary lymph from the medial retropharyngeal node, its
efferent route being to the jugular trunk. The cervicales profundi
caudales (presumably corresponding to Ramsay and Bennett's inferior
group) consists of one to six (usually two to four) round to
elliptical nodes, 1mm to 3mm in diameter, located on the ventral
surface of the trachea near the thoracic inlet at the bifurcation of
the brachiocephalic veins. It drains the thyroid, the trachea and
the oesophagus, with secondary lymph from nodes of the mediastinal,
bronchial and ventral thoracic lymphocentres and from the middle
deep cervical node. Secondary branches of the terminal part of the
jugular trunk also enter these nodes. The efferent route is to the
point of confluence of the external and internal jugular veins (the
"venous angle") or, if only one of these veins is present, to its
junction with the ipselateral subclavian vein.
In a paper describing investigations on cats, rabbits and
sheep, Daniel, Excell , Gale and Pratt (1962) stated simply that ten
to 15 lymphatic trunks carried away thyroid lymph. In a further
contribution, dealing with cats, rabbits, rats and monkeys, Daniel,
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Gale and Pratt (1963) remarked that the thyroid was richly supplied
with lymphatics which lay closely adjacent to the parenchymal cells.
In both papers, these statements referred generally to the species
mentioned.
Innervation
While detailed descriptions of the innervation of the
thyroparathyroid apparatus of man date from the early part of this
century (e.g. Rhinehart, 1912), specific information on the subject
in cats is sparse. Nicholas and Swingle (1924a), while admitting
they had made no special study of the subject, reported that the
nerve supply to the feline parathyroids consisted entirely of
sympathetic fibres from the perivascular plexuses. Soderberg (1958)
stated that the main innervation of the cat and rabbit thyroids
consisted of relatively large fibres from the vagus running chiefly
in the superior and the recurrent laryngeal nerves. The recurrent
nerve followed the caudal thyroid vein on each side of the trachea.
Fibres from the cervical portion of the sympathetic trunk followed
the cranial thyroid arteries but also joined both the superior and
the recurrent laryngeal nerves.
McDonald (1975, 1980), discussing vertebrates in general,
similarly reported that the thyroid had a rich supply of
sympathetic nerves which entered the gland in association with the
blood vessels. These nerves were thought to regulate only the blood
supply to the organ, since transplantation did not affect thyroid
function.
Schaer (1981) stated that the principle nerve supply to the
feline thyroid was derived from the cranial cervical ganglion and
the cranial laryngeal nerve. Sympathetic nerve innervation also
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came from the cranial cervical ganglion. Thyroidal sympathetic
adrenergic nerve terminals around vessels and follicles were rare.
3.4 ACCESSORY THYROID AND PARATHYROID TISSUE
Although Huguenin (1926) reported that he was unable to find
"ectopic" (meaning accessory) thyroid tissue in 50 cats which he
examined in detail, it is generally accepted that such tissue is not
uncommon in practically any position between the tongue and the
heart (Nicholas and Swingle, 1924a; Winiwarter, 1935; Schaer, 1981;
Noxon, Thornburg, Dillender and Jones, 1983). In man, it results
from the dislodging of primordial thyroid cells during the embryonic
migration of the thyroid (Arey, 1966; Rogers, 1971) and it is
believed that the situation is probably similar in the cat although
experimental data have not been reported (01 sen, 1982; Noxon
et al., 1983). The latter drew attention to the difference between
ectopic and accessory thyroid tissue. Ectopic tissue results from
premature or late separation of normal thyroid tissue from the
embryonic heart as it migrates caudally. In this situation, the
corresponding gland is missing from its normal position. Despite
the variations in terminology, ("ectopic", "secondary" or
"accessory") the descriptions here refer to true accessory tissue.
Vincent and Jolly (1906) sectioned the neck and mediastinal
tissue of seven cats and found an accessory thyroid in one animal
close to one of the thyroid lobes. Tehver (1940) described the
presence of a poorly encapsulated "secondary" thyroid measuring 3mm
by 1.5mm by 1.5mm within the tongue muscle of a cat.
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Nicholas and Swingle (1924a) defined accessory parathyroid
glands as "aggregations of parathyroid tissue other than the usual four
glands, which have no intimate anatomical relation to the thyroid
lobes". They found that what they described as "supernumerary" glands
occurred fairly frequently in close proximity to the usual four
parathyroids. However, their work involved the study of surgically-
induced feline hypoparathyroidism and because these supernumerary
glands were removed routinely during thyroidectomy, they did not
consider them to be truly "accessory".
Despite Vincent and Jolly's report (1906) that they were unable
to find accessory parathyroid tissue in the neck and mediastinal
tissue of any of seven cats examined in detail, other authors almost
unanimously agree on its existence, although its derivation is
disputed. Harvier and Morel (1909) felt that it resulted from the
origin of the third and fourth branchial clefts and their intimate
developmental association with the thymus anlage, together with the
shifting and migration of tissue which occurs in the cervical region
during embryological development. Winiwarter (1935), however,
believed that it did not result from parathyroid fragmentation but
from tissue mutation of the thyroid and thymus. He found that
although such tissue was invisible macroscopically, it could usually
be detected microscopically between the thymus and the thyroid, in
the larynx or towards the base of the heart. The number of
accessory glands varied between five and eight.
There is considerable disagreement about the frequency with
which accessory parathyroid tissue occurs in cats. Harvier and
Morel (1909) identified it in the cervical thymus of 50 per cent of
"less than five cats". Farner and Klinger (1920) believed that
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such tissue was practically universally present in cats because 20
per cent of animals which they experimentally parathyroidectomised
failed to show evidence of tetany. Shapiro and Jaffe (1923)
reported that 12 per cent of cats which they examined had accessory
parathyroids in their thoracic thymus. Nicholas and Swingle (1924a
and b) disputed Harvier and Morel's figures and pointed to the small
number of cats they had examined, but reported accessory
parathyroids in 35 per cent of 107 animals.
3.5 HISTOLOGY
Although there are numerous accounts of the microscopic anatomy
of the thyroid gland of the domestic animals generally, there are
few specific descriptions of feline thyroid histology. The
following account is taken from general veterinary histology works
with specific details about the cat being added where such
information is available.
The thyroid capsule (referred to previously) gives off septa or
trabeculae of varying thickness to the interior of the gland. These
are continuous with sparse, loose, interstitial connective tissue
which divides the lobes into interconnected lobules (Trautman and
Fiebiger, 1952). The feline thyroid has a relatively homogeneous
structure, consisting of numerous follicles (also termed auri or
vesicles) ranging from lOu to 15u interior diameter. Large follicles
(up to lOOu diameter) are rare but occur more frequently on the
periphery. The central and peripheral zones are relatively
indistinct from one another (Radacot, 1957). In young animals, the
follicles often retain their embryonic continuity and are usually
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smaller than in adults (Trautman and Fiebiger, 1952). The follicles
are usually filled with colloid which may appear homogeneous or
finely granular, and is usually acidophilic although it may show
degrees of basophilia. It stains red with azocarmine, blue with
aniline blue and is periodic acid-Schiff (PAS) positive due to its
content of glycoprotein (Dellman, 1971; Dellman and Brown, 1981).
The follicles are completely closed and are surrounded by a network
of delicate reticular fibres which are continuous with the capsular
trabeculae (Trautman and Fiebiger, 1952). They are lined with a
single layer of cells with a secretory polarity directed towards the
follicular lumen. In the resting state, the cells are low cuboidal
or even squamous. In the cat they average between 8u and 12u in
height and have dense colloid (Radacot, 1957). When stimulated,
the cells become cuboidal or columnar and the colloid is
dissolved. The cells are joined to each other by terminal bars
(Trautman and Fiebiger, 1952). The epithelium is surrounded by a
basement membrane, sparse connective tissue, a dense network of
capillaries possessing fenestrated endothelium similar to that in
other endocrine glands, and lymph vessels (Dellman, 1971; Dellman
and Brown, 1981).
The number and extent of the various cytoplasmic organelles
vary according to the degree of activity of the cells. The round
nucleus is in the basal portion of the cell and is surrounded by
rough-surfaced endoplasmic reticulum. Mitochondria, ribosomes and
polysomes are distributed throughout the cytoplasm. The Golgi
apparatus lies between the nucleus and the apical cell surface which
bears microvilli extending into the colloid. The apical cytoplasm
also contains two types of vesicle. Apical vesicles originate from
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the Golgi complex and contain thyroglobulin which is secreted by
exocytosis into the follicular lumen. Large, membrane-bounded,
colloid droplets arise by absorption into the follicular cells and
merge with lysosomes, forming phagolysosomes in which thyroglobulin
is broken down (Dellman and Brown, 1981; Schaer, 1981).
Parafol1icular cells (light cells or C cells) are considered to
be the source of calcitonin. In the cat, they are round or oval and
lie singly or in small groups evenly distributed throughout the
gland (Mietkiewski, Zabel and Linke, 1974). These authors found the
reactions for alpha-glycerophosphate dehydrogenase and
cholinesterase to be particularly good markers for these cells.
They contain a well-developed Golgi apparatus and a large number of
membrane-bounded granules and mitochondria (Dellman, 1971).
Tehver (1940) reported on the histological structure of the
accessory thyroid tissue he identified in a cat's tongue. Only the
larger follicles lying close to the periphery contained colloid but
otherwise the tissue corresponded generally to that of normal
thyroid gland.
Winiwarter (1935) reported that accessory parathyroid tissue
was structurally identical to normal parathyroid tissue.
Both physiological and experimental situations may affect the
morphology of the thyroid gland. Trautman and Fiebiger (1952),
commenting generally about domestic animals, stated that thyroid
histology changes with advancing age. The epithelium becomes
flatter and there is an increase of fat and pigment granules in the
cells. Pflugfelder (1955) found little change in thyroids of cats less
than 16 years of age, but in a single 20-year-old animal, there was
marked hyperplasia and formation of large follicles centrally,
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although normal follicles were found at the periphery. Hurtrel
(1974), in a quantitative study of the C cells of the left thyroid
of 11 cats, identified a regression in cell density with advancing
age but the small number of animals studied did not permit any
general conclusions to be drawn.
Lowe (1930), in a study of the thyroid glands of four lactating
cats, found no obvious differences between them and controls.
Radacot (1957) examined the thyroid glands of 33 cats which were
either pregnant (15 animals) or lactating (24 hours to six weeks
post-partum, 12 animals) and compared them with six controls. He
found little difference between the glands of non-pregnant and
pregnant individuals. However, marked changes occurred at the
beginning of lactation, with complete colloid resorption and the
disappearance of large and medium sized follicles and their
replacement with small follicles up to 5u internal diameter which
were devoid of colloid. These were produced either by the regrouping
of cells surrounding empty follicles or the proliferation of large
acidophilic cells. The follicular epithelium was increased in
height. Animals which had undergone parturition but not lactation
showed thyroid histology similar to controls, confirming that the
changes resulted from lactation and not simply from giving birth.
After six weeks of lactation, there was a reaccumulation of colloid
within the follicles which remained smaller than controls.
Sarrat (1966a and b) deprived cats of food and water and found
their thyroids to be in a "regressive" state. He described large
cells within the follicles and claimed that they were secretory and
not simply desquamated. However, after subjecting 20 cats to hunger
and thirst for 21 days, Vazquez (1974) claimed that the thyroids
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were hyperactive in all animals. They consisted of many small
follicles with barely perceptible lumina. The epithelium changed
from cuboidal to columnar and, within the majority of cells, there
were periodic acid Schiff (PAS) positive colloidal droplets,
particularly at the apices.
3.6 THYROID PHYSIOLOGY
Introduction
There have been relatively few studies directed specifically
at thyroid function in the cat. However, reactions leading to the
formation of iodotyrosines and T4 are well-established biochemical
processes in animals; all vertebrates that metabolise iodine into an
organic form produce T4 and variable relative proportions of a
triiodinated form of the thyronine molecule, and iodination of
tyrosine molecules always takes place in a characteristic protein
which in the mammalian thyroid is known as thyroglobulin (Gorbman,
1978). Thus, in the absence of information specifically to the
contrary, feline thyroid physiology might reasonably be considered
to be similar to that of man and the dog. The following account has
been compiled from a large number of publications but, in
particular, from those by Werner and Ingbar (1978) (discussing man)
and Rosychuk (1982), Belshaw (1983) and Ferguson (1984) (discussing
the dog), with specific details on the cat being added where such
are available.
The metabolically active thyroid hormones are the
iodothyronines, L-thyroxine and L-triiodothyronine and both have
been repeatedly identified in feline serum (reviewed by Thoday, Seth
and Elton, 1984). T4 is the main secretory product of the thyroid.
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However, T3, the most active thyroid hormone, as well as smaller
amounts of rT3, an inactive product, and subsequent de-iodination
products 3,3^-diiodothyronine (3,3^--T2) and
diiodothyronine (3^,51-T2) have been found in venous
effluent from canine thyroids (Laurberg, 1978, 1980 a and b, 1981).
The structural formulae of these compounds are shown in Fig. 3.1.
Hormone synthesis and secretion
The thyroid gland is unique among the endocrine glands in that
an integral part of its hormones is a micronutrient, iodine, which
is available to the animal in only limited amounts. The daily
maintenance iodine requirement for adult cats varies depending on
the nature of the food. On purified diets, thyroid status remains
normal with a daily dietary intake of approximately 70ug (Scott,
1965). However, the high-protein diet needed by cats imposes a
relatively high iodine requirement because there appears to be a
synergistic relationship between the requirements of iodine and
calcium and the calcium content of meat is low (Roberts and Scott,
1961).
On high-protein diets, the daily iodine requirement for adult
cats has been variably quoted as 150ug (Scott, 1965), 150 to 400ug
(Scott, 1966, 1975a), lOOug/kg (Kallfelz, 1975) and 200 to 400ug (P.P.
Scott, 1984). There are additional requirements during lactation
as iodine passes into the milk in considerable quantities and
additional T4 is necessary for milk production. Fish and fish
products, including cod-liver oil, are excellent sources of iodine:
cats on a fish diet take in 400 to 500ug iodine daily.
Experimentally, 5mg to lOmg potassium iodide daily are tolerated by
normal cats which excrete the excess in urine (Scott, 1965, 1966,
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1975a). Daily iodine requirements for growing kittens have been
reported as 100 to 150ug on a high-protein diet (Greaves, Scott and
Scott, 1959) and 0.01 to 0.02mg on a dry diet (Scott, 1965).
Knigge (1961) measured the stable iodine I) concentration
of the thyroids of 40 cats by an unspecified method. The cats were
fed on the same commercial (unspecified) cat food. There was
considerable variation, the mean +_ sd being 67.5 _+ 9.6ug per
lOOmg.
Most iodine in the diet is reduced to iodide in the gastro¬
intestinal tract and absorption of iodide begins immediately
(Belshaw, Cooper and Becker, 1975).
Inorganic iodide enters the thyroid follicular cells and is
transformed through a series of metabolic steps into T4 and T3.
Hormone synthesis involves (i) active transport of iodide, (ii)
iodination of tyrosyl residues of thyroglobulin, (iii) coupling of
iodotyrosine residues within thyroglobulin to form T4 and T3, (iv)
proteolysis of thyroglobulin with release of free iodotyrosines and
iodothyronines and secretion of iodothyronines into the blood, and
(v) reutilisation of the liberated iodide (Taurog, 1978).
(i) Active transport of iodide. Iodide is concentrated from
the extracellular fluid against a concentration gradient by a
mechanism variably referred to as the iodide transport mechanism,
the iodide concentrating mechanism, the iodide pump or the iodide
trap, by an active transport system in the basal membrane of the
thyroid follicular cell (Andros and Wollman, 1967). Cellular
integrity is required for this transport (Wolff, 1964). Once inside
the cell, iodide diffuses down a concentration gradient to reach the
apical membrane and thus into the follicular lumen (Werner, 1982).
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Gastric mucosa, salivary glands, mammary glands, choroid plexus,
placenta and the skin also concentrate iodide in man (Taurog, 1978).
(ii) Iodination of tyrosyl residues of thyroglobulin.
Thyroglobulin, a large, iodinated glycoprotein with a molecular
weight of 670,000 and a sedimentation coefficient of 19S, is
produced within the thyroid cell. After synthesis on the rough
endoplasmic reticulum, non-iodinated thyroglobulin migrates to the
Golgi apparatus and, during this time, glycosylation occurs.
Cytoplasmic vesicles containing thyroglobulin fuse with the apical
membrane and are released by exocytosis into the follicular lumen.
Iodide present there is inserted in the 3, or 3,5 positions of
tyrosine residues on the thyroglobulin, forming monoiodotyrosine
(MIT) and diiodotyrosine (DIT), processes catalysed by a peroxidase
(Ferguson, 1984).
(iii) Coupling of iodotyrosine residues within thyroglobul in
to form T4 or T3. Two DIT residues couple via an ether linkage to
form T4; one molecule of MIT and one of DIT couple to form T3.
(iv) Proteolysis of thyroglobulin with release of
iodotyrosines and iodothyronines and secretion of iodothyronines
into the blood. Secretion begins by the ingestion of
thyroglobulin into the follicular cell in the form of colloid
droplets. Ingestion occurs either by micropinocytosis (possibly the
most important mechanism in basal secretion) or by pseudopod
formation from the surface of the follicular cell (seen particularly
after pharmacologic doses of TSH but not in resting glands). The
colloid droplets acquire proteolytic enzymes from lysosomes,
probably at the time of formation (Nunez, Bel shaw and Gershon, 1972)
and then migrate to the base of the cell. The iodothyronines
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diffuse from the lysosomes and then from the cell into the
extracellular space, from which they enter the adjacent capillary.
Both Ramsay (1938) and Ramsay and Bennett (1943) drew attention
to the extensive lymphatic spaces of the cat's thyroid and suggested
that they played an important role in the passage of secretion from
the gland. Evidence consistent with this was presented by Daniel et
al., (1962). Two to four days after injecting subcutaneously
into cats, they collected thyroid gland lymph and thyroid venous
blood before and after the administration via an unspecified route
of an unspecified dose of TSH. They considered the count rate per
unit weight of sample measured in a scintillation counter to be an
indication of thyroid hormone concentration, which, it must be said,
is both crude and inaccurate. Eighty-eight to 99 per cent of the
radioactivity in the lymph was protein bound. They subsequently
calculated the ratio (R) of count rate per unit weight of the
thyroid lymph or thyroid venous blood relative to that in systemic
blood. R was always considerably greater for thyroid lymph than for
thyroid venous blood. After the administration of TSH, there was a
rise in R in both calculated values. They concluded that the high
count found in lymph must mean that a significant proportion of the
thyroid hormone was carried away via lymphatics.
In a further experiment on ten cats, Daniel, Gale and Pratt,
(1963) found that after TSH administration, R for thyroid lymph
compared to thyroid venous plasma ranged from 25.8 to 59.3. Using
the same technique, Daniel, Gale, Plaskett and Pratt (1963)
chromatographed the thyroid lymph of cats one to two hours after
giving TSH. Although they expected to identify mainly T4, 70 to
90 per cent of the total radioactivity behaved like an iodoprotein
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resembling thyroglobulin and failed to migrate. Most of the
remainder was T4 and inorganic iodide. They eliminated
experimentally the possibilities that this high concentration of
thyroglobulin was due to manipulation of, or radiation damage to,
the gland. This work throws some doubt on the group's initial
conclusions about the importance of lymphatic drainage of secreted
T4.
Taurog, Porter and Thio (1964) carried out a series of
experiments in which they studied the compounds present in feline
thyroid venous plasma after previous injection with Forty
minutes to two hours after the administration of liu or 1.4iu
TSH, the T4 concentration increased approximately seven times but T3
or rT3 could not be demonstrated. In a further experiment, they
injected two cats with lOuCi of daily for 13 days and then
collected thyroid venous plasma before and after injection with
liu TSH. No MIT and DIT could be demonstrated despite an
increase in T4 of five times the basal value. In one cat which
received 200uCi of ^I, DIT was not present in the pre-TSH
sample but was found after the administration of 1.4iu of TSH.
(v) De-iodination of iodotyrosines within the thyroid and
conservation of the liberated iodide. Uncoupled MIT and DIT in
thyrogl obul in are also released during proteolysis of colloid
droplets. In man, they are efficiently de-iodinated within the
follicular cell and most of the iodide generated is re-used. In the
dog, most of the iodotyrosine is released back into the circulation
(Belshaw, 1983).
Taurog, Porter and Thio (1964) administered lOuCi of ^I
to cats for seven days and 2iu TSH 110 minutes before
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thyroidectomy. Large MIT and DIT, T4 and iodine peaks were found in
chromatographed thyroid digests. A small T3 peak was also
identified but there were no unequivocal rT3 or T2 peaks. Because
there was no demonstrable MIT and DIT in the circulation but high
levels in the thyroids, the authors concluded that de-iodination of
iodotyrosines in the feline thyroid must be very efficient.
Thyroid hormone transport and metabolism
All body T4 is initially secreted by the thyroid. In contrast,
T3 production in the euthyroid state is variably a result of
extrathyroidal conversion of T4 to T3 by de-iodination of its outer
ring (5l-de-iodination). In man, approximately 80 per cent of T3
is produced in this way (Braverman and Vagenakis, 1979), whereas in
dogs the figure ranges from 37 to 60 per cent (Belshaw et al.,
1974). Most tissues can convert T4 to T3 but the liver and
kidney are the most active in this respect. T4 may also be de-
iodi nated in its inner ring (5-de-iodination) to produce the
metabolically inactive rT3. In man, rT3 is almost entirely derived
from extrathyroidal de-iodination of T4 (Chopra, 1978) with the
corresponding figure in the dog being approximately 90 per cent
(Laurberg, 1978). rT3 has not been described in the cat.
Thyroid hormones are carried in blood, bound to plasma
proteins. In man, under normal physiological conditions, the
majority of T4 is bound to an inter-alpha-globulin, thyroxine
binding globulin (TBG), and to a lesser degree to a thyroxine
binding prealbumin (TBPA) with a small proportion being bound to
albumin. T3 is also predominantly bound to TBG and to a small
extent to albumin but not to TBPA (Micoloff, 1978). In the dog, T4
is bound to albumin and three globulin fractions and T3 to albumin
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and one globulin (Refetoff, Robin and Fang, 1970). The overall
binding affinity of plasma proteins for T4 is lower in dogs than in
man due to the absence of a globulin comparable to TBG (Belshaw,
1983).
A small amount of data is available on feline T4 binding
proteins. Robbins, Apter and Rail (1957) and Robbins and Rail
(1960) made brief reference to T4 serum binding in an unspecified
number of cats. After adding variable amounts (0.008 to 2ug per ml)
131
I-T4 to serum, they carried out conventional and reverse flow
electrophoresis on paper in barbital, pH 8.6. This latter method
was employed to overcome the artefacts arising from absorption by
the paper of the albumin-bound T4 in the globulin region. The
results by the conventional technique were not reported, but by
reverse flow, the fastest of the major components (thought to be
albumin) contained a large radioactive peak. There was a second,
poorly separated peak immediately behind the first.
Farer, Robbins, Blumberg and Rail (1962) gave further details
of this technique and discussed the results more fully. Using
autoradiography or Geiger counting with subsequent staining of the
proteins with bromphenol blue, the second peak was found to contain
substantial quantities of radioactive T4. It corresponded in
position to the alpha-globulin (and, therefore, TBG) region of human
serum.
Tanabe, Ishii and Tamaki (1969) performed reverse flow cellulose
acetate electrophoresis with 0.07M barbital buffer, pH 8.6, on an
unspecified number of cat plasma samples, each containing 5ug per
100ml 131i_t4. Protein zones were stained with Ponceau 3R and bound
T4 was demonstrated by autoradiography or by cutting the gel and
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counting in a scintillation counter. Most of the T4 appeared
bound to albumin and postalbumin and no radioactivity was found in
the alpha-globulin zone. When increments of 20 to 295ug T4 per
100ml of plasma were added, the radioactivity in the postalbumin
band did not disappear or decrease. As TBG is characterised by
saturability at relatively low T4 concentrations compared to other
T4-binding proteins, the authors argued that the alpha-globulin
band of Farer et al. (1962) was probably postalbumin and not
comparable with human TBG.
Scherzinger, Guzy and Lorcher (1972) carried out conventional
cellulose acetate electrophoresis with 0.04M sodium veronal buffer on
an unspecified (between four and ten) number of cat sera containing
0.08ug per ml ^^I-T4. The resulting trace was stained with
Ponceau S and the distribution of the radioactivity determined with
a radioactivity scanner. T4 appeared bound to the anodal edge of
the albumin band with "sliding" into the globulin region, and the
authors speculated that there were two T4 binding fractions lying
close together. There was no noticeable change in the percentage
distribution of radioactivity after the addition of exogenous T4 and
they suggested that feline TBG had only a low capacity with most T4
being bound to albumin at normal concentrations.
Bigler (1976a) used immunoelectrophoresis to identify the T4
binding proteins of four healthy cats. After incubating with 2.5ug
125
I-T4 per ml serum, agarose electrophoresis was carried out in 0.1M
glycine acetate buffer, pH 8.6. Following immune precipitation with
anti-cat serum, the proteins were stained with Ponceau S and
subsequently autoradiographed for eight weeks. T4 binding to
albumin was demonstrated but the authors failed to identify a T4
binding globulin.
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Investigations into feline T3 serum protein binding have not
been reported.
In man, the kinetic consequences of the interaction between T4
and binding proteins are dramatic. T4 is a small molecule with a
molecular weight of only 700 and would be expected to diffuse
rapidly into interstitial fluid. However, because it is avidly
bound to plasma proteins, its diffusion through the capillary
barrier to target organs and tissues is retarded.
Even from the early studies of compartmental kinetics in man,
it became clear that the extrathyroidal T4 pool was not homogeneous
but should be considered as having functionally separate
compartments. From work in sheep (Irvine, 1969) and its
subsequent application to man, two different kinetic compartments
have been identified. The rapidly equilibrating compartment is made
up of the liver and kidney and the slowly equilibrating compartment
of muscle, skin, brain, fat and other tissues (Nicoloff, 1978). The
differences between the two probably arise because of variations in
the permeability of their capillary walls to T4.
Compartmental kinetics are not as well defined for T3 but are
probably similar. However, because T3 is less firmly bound to
carrier proteins, it equilibrates much faster than T4 in each
compartment.
In man, approximately 50 per cent of body T4 and 15 per cent
of body T3 is found in the interstitial fluid and plasma
compartments. Approximately 55 per cent of intracellular T4 but only
five per cent of intracellular T3 is present in the rapidly
equilibrating tissues. Some 80 per cent of all extrathyroidal T3 but
only 22 per cent of extrathyroidal T4 is located in the slowly
equilibrating tissues (Nicoloff, 1978).
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In the dog, about 40 per cent of the extrathyroidal T4 is in
plasma and most of the remainder is taken up by the liver. The
total plasma-equivalent space of distribution is 12 per cent.
Because T3 is less avidly bound to plasma proteins, it enters
peripheral cells more readily and reaches a total distribution
volume equal to 65 per cent of bodyweight (Belshaw, 1983).
Most studies suggest that only free (unbound) hormone is
metabolically active, the bound fraction acting as a reservoir in
situations of rapid increase or decrease of hormone supply to
tissues. In dogs, estimates of plasma free T4 (FT4) have varied
from 0.103 to 0.189 per cent (Furth, Becker, Nunez and Reid, 1968),
to 0.155 to 0.303 per cent (Refetoff, Robin and Fang, 1970) of the
total plasma concentration. Thus, some 99.7 to 99.9 per cent of
circulating T4 in dogs is bound to plasma proteins. Because of the
presence of the high affinity binding protein TBG, the FT4
concentration of human plasma is approximately one third to one
fifth of the dog i.e. 0.03 to 0.05 per cent of total plasma T4.
However, the dog's total T4 concentration is proportionately lower
making its FT4 concentration very similar to that of man.
The proportion of free hormone is a primary determinant of the
rate of fractional turnover. The T4 plasma half-life, therefore, is
considerably shorter in the dog than in man and has been variably
reported as 10.3 hours (Furth et al., 1968) and 15.9 hours
(Kallfelz and Erali, 1973), whereas in man it is approximately seven
days (Nicol off, 1978). The half-life of T3 has been estimated to
be five to six hours in the dog (Fox and Nachreiner, 1981) and 24
hours in man (Nicol off, 1978).
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T4 and T3 may be sequentially de-iodinated to produce the
simple thyronine nucleus (TO). The resultant metabolites are not
thought to have metabolic activity but complete de-iodination
preserves iodine. Fifteen per cent to 20 per cent of the total
daily disposal of T4 and T3 in man is conjugated to soluble
glucuronides and sulphates (Nicoloff, 1978) and a much smaller
amount is degradated by oxidative deamination and cleavage of the
ether linkage. The conjugates may be excreted in bile or in urine.
Those passed into the gut are hydrolysed back to T4 and reabsorbed,
this entero-hepatic circulation being of importance in the
preservation of total body T4.
In the dog, approximately 45 per cent of T4 turnover is via de-
iodi nation with 55 per cent being by faecal secretion (biliary
clearance of T4 being very much higher in the dog than in man).
Seventy per cent of T3 turnover is via subsequent de-iodination and
30 per cent is secreted in the faeces (Furth et al., 1968; Belshaw,
Barandes, Becker and Berman, 1974). Less than 15 per cent of T4 is
reabsorbed in the dog (Furth et al., 1968) compared with 70 per cent
of T4 and 100 per cent of T3 in man.
Sites and mechanism of action of thyroid hormones
T4 has been described by many workers as a prohormone with its
activity being dependent on its mono-de-iodination to T3. While
this conversion is responsible for approximately 85 per cent of its
activity, T4, like T3 does have intrinsic thyromimetic actions,
although studies in man and the rat have established that T3 is
three to five times more potent (Ferguson, 1984).
Specific nuclear T3 receptors were described by Oppenheimer,
Koerner, Schwartz and Surks (1972) and mediate effects dependent on
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protein synthesis, possibly as a result of augmented transcription
of DNA or modulation of RNA. The responsiveness of a tissue to
thyroid hormone is dependent to some extent on the numbers of
nuclear receptors it possesses. Thyroid responsive tissues such as
liver and kidney contain high numbers of receptors whereas thyroid
non-responsive tissues such as spleen and testis possess few.
Specific T3 binding to plasma membranes and mitochondria has also
been demonstrated. These effects are much more rapid than those
evoked by binding to nuclear receptors. Effects of thyroid hormone
on membrane-bound Na+K+ATPase, amino acid transport and
mitochondrial oxygen consumption have been demonstrated minutes to
hours after administration. Additionally, the numbers of beta-
adrenergic receptors and/or the activity of plasma membrane
adenylate cyclase may be increased by T3 administration (Werner,
1982).
The cellular role of T4 appears to be of major importance in
the regulation of CNS and pituitary function (Larsen, Silva and
Kaplan, 1981).
Control of thyroid function
The hypothalamic-pituitary-thyroid-extrathyroidal
axis. Detailed information about this axis in the cat is
unavailable. In man, peptidergic neurones in the thyrotropic area of
the hypothalamus secrete the tripeptide amide, L-pyroglutamyl-L-
histidyl-L- prolineamide, thyrotropin releasing hormone (TRH) into
the hypophyseal portal system. TRH acts on the thyrotrope cells of
the anterior pituitary by binding to specific receptors that
activate an adenylate cyclase-cyclic adenosine monophosphate (c-AMP)
system. The effect of TRH on TSH secretion is not dependent on the
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synthesis of protein and is extremely rapid, measurable increases in
plasma TSH concentrations occurring within one to two minutes in
both man and animals (Reichlin, 1978).
The thyroid is under the direct control of TSH. This is a
glycoprotein of molecular weight in the range of 28,000-30,000,
consisting of two peptide chains. The alpha chain is common to TSH,
luteinising hormone (LH) and follicle stimulating hormone (FSH)
within a species, whereas the beta chain has a different amino acid
sequence depending on the hormonal activity to be expressed (Pierce,
1971). TSH attaches to receptors on the cells of the thyroid
follicles, activates adenylate cyclase and enhances c-AMP
production. It is likely, although not yet proven in all instances,
that c-AMP mediates the effects of TSH on follicular cell growth,
iodination and thyroid hormone synthesis and thyroid hormone
secretion (Van Herle, Vassart and Dumont, 1979). Within minutes of
TSH administration, there is enhancement of iodide binding to
protein, iodothyronine synthesis, thyroglobulin secretion into the
follicular lumen and ingestion of colloid via pseudopod formation.
Increased trapping of iodide follows after several hours (Belshaw,
1983). TSH also increases the secretion of the de-iodination
products, suggesting that significant T4 de-iodination occurs during
secretion.
Knigge and Joseph (1971) reported the concentrations of TSH in
the pituitary glands of normal cats. However, they used a
modification of a human TSH assay and as TSH is species specific,
the validity of the values obtained is debatable.
Recently, Lothrop, Tamas and Fadok (1984) described increases
in serum T4 after intravenous TRH administration in six cats,
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indicating a functional pituitary-thyroid axis with endogenous
production of TSH by the pituitary gland and subsequent thyroid
stimulation.
Inhibition of thyroid hormone production is achieved via a
negative feedback system whereby plasma FT4 and free T3 (FT3) act
directly on the pituitary. This feedback appears to involve both
the production of an inhibitory protein that blocks TSH release and
a decrease in the number of TRH receptors on the pituitary thyrotrope
cells (Hinkle, Perrone and Schonbrunn, 1981). Thus, these effects
take several hours. The pituitary rapidly de-iodinates T4 to T3
and thyrotrope nuclear T3 receptor occupancy is inversely
proportional to TSH secretion. Despite T3 being the active
intracellular hormone for TSH suppression, T4 is the less variable
source of pituitary nuclear T3, and T4 elevation produces a more
prolonged suppression of TSH release (Morley, 1981; Werner, 1982).
However, it must be possible for T4 to affect TSH independently of
plasma T3, or else the pituitary could not increase TSH with
resultant goitre in iodine deficiency when plasma T3 is maintained
at the expense of T4 (Larsen, Silva and Kaplan, 1981).
Small doses of thyroid hormones suppress and large doses
completely abolish the TRH-induced release of TSH.
Knigge and Joseph (1971), in experiments with normal cats and
cats in which the basal hypothalamus had been de-afferented,
concluded that an inhibitory pathway from the preoptic area to some
region close to the median eminence was involved in the negative
feedback action of T4. Joseph and Knigge (1972) concluded that
there was a similar pathway in kittens.
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The hypothalamic hormone, somatostatin, has an inhibitory action
on TSH release in man and the rat but its role in tonic regulation
is still unknown. Its inhibitory action appears to be additive to
that of T4 and T3 (Reichlin, 1978).
Extrathyroidal thyroid hormone metabolism may also act as a
regulator of thyroid function by de-iodination of T4 to either T3 or
the metabolically inactive rT3. Recently, it has been suggested
that extrathyroidal de-iodination may be autoregulated (Lum, Nicoloff
and Spencer, 1983).
Other mechanisms affecting thyroid hormone production
Iodine intake. Thyroglobulin stored within thyroid follicles
allows for continued hormone secretion during iodine deficiency.
During such time, there may be preferential T3 secretion relative to
T4 because of increased formation of MIT relative to DIT (Belshaw et
al., 1974; Werner, 1982). Because T3 is more potent than T4, this
mechanism serves to maintain euthyroidism despite iodine deficiency.
A gradual increase in iodide intake, with a consequent increase
in thyroidal iodide levels, results in increased stores of thyroid
hormones. Beyond a certain level, excess iodide administration has
an antithyroid effect as iodide binding to thyroglobulin is
progressively inhibited. This is the Wolff-Chaikoff effect (Wolff
and Chaikoff, 1948). The mechanism of this effect is unknown but
Raben (1949) demonstrated that it depended on a critical level of
iodide being reached in the thyroid rather than the circulation.
However, the inhibition of thyroid hormone synthesis is followed by
an "escape" phenomenon due to autoregulation of thyroid iodide
transport. These autoregulatory phenomena are protective
mechanisms, preventing massive thyroid hormone release after an
iodide overload.
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Sherwin (1982) investigated the ability of foetal, neonatal
and adult cat thyroid glands to respond to excess iodide in
vitro. He concluded that the autoregulatory effect of iodide
transport develops at a later gestational time than the action on
TSH-stimulated c-AMP formation.
Inherent rhythms. A number of factors have been
suggested as producing an inherent rhythm in feline thyroid
activity. Lowe (1930) thought that there was an annual thyroid
cycle which could be overridden by physiological influences such as
gestation.
Knigge (1961) identified differences in the plasma protein-
bound iodine (PBI) concentrations of 40 normal cats between winter
and summer, but the results were not statistically significant.
Randall and Littschwager (1967), Randall and Parsons (1970) and
Rogers and Randall (1972) assessed seasonal variation in feline
thyroid function by measuring ^1 or retention and excretion
after the administration of Na^I or Na^I. A three to four
month rhythm was identified with maximal activity occurring in
autumn and minimal activity in spring. Using the same technique,
Randall (1970) found that the thyroid function of ten normal cats
was significantly correlated with the percentage sunshine, maximal
activity lagging approximately one month behind times of maximal
sunshine. He concluded that the behaviour of clouds correlated
with feline thyroid function. Rogers and Randall (1972) even
correlated the position of the planet Mercury with the thyroid
activity of cats, although they remarked on the uncertainty of the
relevance of this observation!
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Woods, Wayt and Baker (1966) examined the radioactivity of the
thyroids of 12 adult cats after intravenous or subcutaneous ^lj
administration. Peak radioactivity occurred in the morning (mean
time 07.14 hours) with minimum activity in the evening (mean time
19.42 hours). The cycles persisted in animals in which the thyroids
had been transplanted to the tail region and in others after
division of the spinal cord in the lower cervical region. No cycles
occurred in two decerebrate animals, indicating the role of the CNS in
the rhythm.
Nelson, Wolfangel and Stara (1966) assessed radioactivity in
"blood" samples from 12 cats taken morning and evening for four days
after Na^I had been administered intravenously. In all cases,
morning samples had a much higher concentration of radioiodine than
the previous afternoon's specimens, suggesting possible diurnal
cycling. Hoenig and Ferguson (1983) collected blood samples at two-
hourly intervals over a 24 hour period from six cats and failed to
find any diurnal variation in serum T4 concentration as assessed by
double antibody radioimmunoassay. However, as thyroid
activity, blood activity and serum T4 concentration are not
measurements of the same functions, these results are not
necessarily contradictory.
Donne and Wildgoose (1984) collected blood samples from two
Devon Rex cats every two hours between 08.00 hours and 18.00 hours,
and measured total serum T4 and T3 by solid phase, magnetic antibody
immunoassay. T4 concentration rose minimally from 08.00 hours until
10.00 hours and then remained constant. T3 concentrations rose
gradually but steadily from 08.00 hours to 16.00 hours and then
decreased. Because only two animals were used and samples were
taken over a ten hour period little can be deduced from this study.
50
In man, there is a minor nyctohemeral rhythm in TSH secretion
(Van Haelst, Van Cauter, Deguate and Golstein, 1972), with peak
secretion between midnight and 04.00 hours and a fall after 06.00 to
08.00 hours but the physiological significance of this is unknown.
It seems likely that the circadian rhythms of TSH and of Cortisol
and, by extension, of adrenocorticotrophic hormone (ACTH) are
independently controlled by the CNS and are not reciprocally related
(Van Cauter, Leclerq, Van Haelst and Golstein, 1974). No data have
been published on feline plasma TSH concentrations, a consequence of
the lack of suitable bioassay or radioimmunoassay methods for feline
Factors affecting extrathyroidal metabolism of thyroid hormones
Effects of disease and malnutrition. The euthyroid sick
syndrome. In man, a number of conditions (diabetes mellitus,
hepatic and renal conditions, other chronic disease states, surgery,
starvation, malnutrition) are associated with reduced
extrathyroidal T4 to T3 conversion and, except in chronic renal
failure, increased plasma rT3. This decrease in circulating T3 is
probably a mechanism to conserve protein during illness and has
been termed the "low T3" or "euthyroid sick" syndrome. The
specific mechanism is not clear but it is speculated that there is
inhibition of the 5^-de-iodinase enzyme which de-iodinates T4 to T3
and rT3 to 3, 3^-T2. This results in reduced T3 production and
decreased rT3 clearance (Ferguson, 1984).
The total serum T4 concentration may also be reduced in the
euthyroid sick syndrome and is termed specifically the "low T4 state
of medical illness". It is usually associated with acute, severe
conditions (Slag, Morley, El son, Crowson, Nuttal and Shafer, 1981;
TSH
Kaplan, Larsen, Crantz, Dzau, Rossing and Haddow, 1982). Suggested
mechanisms for this change include inhibition of plasma T4 binding,
possibly by blocking of binding sites by immunoglobulin M (IgM) or
immunoglobulin G (IgG) immune complexes (Chopra, Chua Teco, Nguyen
and Solomon, 1979), decreases in plasma binding protein
concentrations (Woeber and Maddux, 1981) and alterations in tissue
T4 binding (Kaptein, Robinson, Grieb and Nicoloff, 1982). The free
T4 concentration remains the same and patients are euthyroid.
The euthyroid sick syndrome is also believed to occur in the
dog. However, in chronic renal disease, dogs have elevated plasma
rT3. In a group of dogs with a variety of medical conditions in an
intensive care unit, all had sub-normal T4 concentrations (Ferguson,
1984). The euthyroid sick syndrome has not been investigated in the
cat.
Effect of drugs. A number of drugs have been shown to
alter plasma thyroid hormone concentrations, either by changes in
peripheral metabolism or in plasma or cellular binding (Kaplan,
1981; Wenzel, 1981). In dogs, plasma T4 concentration may be
moderately to severely depressed by, for example, diphenylhydantoin,
phenobarbital, phenylbutazone, o,p^DDD and glucocorticoids
(Belshaw, 1983). Plasma T3 concentration is lowered by prednisone
(Woltz, Thompson, Kemppainen, Munnell and Lorenz, 1983). In man,
diphenylhydantoin interferes with the binding of T4 to plasma
proteins and increases T4 to T3 conversion. Phenobarbital increases
biliary excretion of T4 and possibly T4 de-iodination.
Phenylbutazone and o,p^DDD interfere with T4 binding to plasma
proteins. Glucocorticoids, both exogenous and when produced in
excess endogenously, decrease the release of TRH, the TRH-induced
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release of TSH and the T4 binding capacity of TBG. Dogs maintained
for long periods on these drugs do not develop signs of
hypothyroidism, euthyroidism probably being maintained by adequate
levels of free T4 and T3. There have been no detailed studies of
the exact mechanism by which each of these drugs affects total
plasma T4 concentration in the dog.
In man, androgens decrease the concentration of thyroid hormone
binding proteins and oestrogens increase them (Wenzel, 1981).
Similar studies have not been carried out in dogs but pregnant
bitches have been reported to have higher protein-bound (mostiy
T4) concentrations (Monty, Wilson and Stone, 1979). However, dogs
with hyperoestrogenism have normal T4 and T3 concentrations but
depressed responses to TSH (Gosselin, Capen, Martin and Targowski,
1980).
Effect of obesity. Overeating results in increased T3
production in man (Danforth, 1981) but the TSH response to TRH is
not blunted and such people are euthyroid (Utiger, 1982). The total
serum T3 and T4 concentrations of obese dogs are elevated (Gosselin
et al., 1980). Similar investigations have not been carried out in
the cat.
3.7 METHODS USED TO ASSESS NORMAL FELIME THYROID FUNCTION -
MEASUREMENT OF CIRCULATING HORMONES UNDER BASAL CONDITIONS
Introduction
Despite the cat's popularity both as a pet and as a laboratory
animal, its thyroid function has been little studied by comparison
with that of the dog. This may have resulted, in part, from an
apparent lack of thyroid-related disease in the former. The
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following account reviews those tests which have been used to assess
the thyroid function of healthy cats.
Protein-bound iodine (PBI)
Method principle. This test was one of the first in
vitro techniques used to study human and animal thyroid function
(e.g. Trevorrow, 1939; Riggs and Man, 1940). It measures chemically
the amount of iodine that is co-precipi table with serum proteins.
While no figures are available for the cat, at least 99.8 per cent
of canine and 99.95 per cent of human T4 is bound to plasma
proteins and 65 per cent of the T4 molecule is iodine (Lorenz and
Cornelius, 1976). Thus, the PBI is a reflection of the serum T4
concentration, but will also reflect changes in the thyroid hormone
transport proteins. Other non-hormonal iodoproteins that may be
present will also be included.
In man, the diagnostic efficiency of the PBI was originally
reported as being satisfactory for both hypothyroidism (e.g. Salter,
1947) and hyperthyroidism (e.g. Starr, Petit, Chancy, Roll man,
Aiken, Jamieson and Kling, 1950). A number of early workers (e.g.
Meier and Clark, 1958; Wilson, Dickson and Frost, 1961) also
considered that the technique was suitable for measuring canine
thyroid function. However, the inorganic iodine content of human
serum is usually negligible (de Mowbray and Tickner, 1952), whereas
canine serum contains high concentrations of inorganic iodides which
may falsely elevate the PBI (Lorenz and Cornelius, 1976). Canine
serum may also contain variable amounts of non-hormonal iodoproteins
(Siegel, 1977). Thus it rapidly became clear that PBI was
inadequate for diagnostic purposes in the dog.
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Other sources of error in the use of the technique in both
human and veterinary medicine include contamination by iodine in
glassware (de Mowbray and Tickner, 1952), iodine administration to
the patient in the form of drugs such as the anthelmintic DNP
(Thompson and Michael son, 1967), expectorants (Lorenz and Cornelius,
1976), iodised vitamins (Kaneko, 1980a), iodine containing
radiographic contrast media (reviewed by de Mowbray and Tickner,
1952 and Kaneko, 1980a), and topically applied, iodine-containing
antiseptics (Lorenz and Cornelius, 1976). Any drug which affects
the concentrations of thyroid hormone binding proteins will also
alter the PBI concentration (reviewed by Kaneko, 1980a). The
mercury content of some diuretics can cause an artificial decrease
in the PBI level by interfering with the chemical estimation of PBI
(Siegel, 1977).
Because of these problems and the advent of more convenient and
specific radioimmunoassay methods, the PBI is now obsolete in human
medicine (Toft, Campbell and Seth, 1981) and is no longer considered
a reliable test of thyroid function in dogs (Siegel, 1977).
Clinical studies. There are no critical reviews of the
value of PBI concentrations in the assessment of feline thyroid
function other than reports consisting simply of statements of
ranges in veterinary texts or in medical research papers. These are
summarised in Table 3.1.
Although the higher values reported in the earlier studies do
not appear to have been confirmed, there is reasonable agreement
that the mean PBI in normal cats is approximately 230nmol/l (which
is equivalent to 57nmol/l T4).
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In vitro radio!abel1ed triiodothyronine uptake tests
Method principle. As previously discussed, thyroid hormones
are carried in blood, bound to plasma proteins. In man, TBG has a
high affinity for, and binds the majority of, T4. T3 is also
predominantly bound to TBG but less avidly than T4 which it cannot
displace from binding sites on TBG (Luick, 1971). Thus, for a
constant TBG concentration, the thyroid hormone concentration is
inversely proportional to the number of unoccupied binding sites.
The erythrocyte appears to be a secondary binding site for
circulating thyroid hormones. Using ^lj labelled T4 and T3,
Crispell, Kahana and Hyer (1956) showed in vitro that the uptake
by human red blood cells (RBCs) was consistently greater for T3 than
for T4 and that the presence of plasma markedly decreased T4, and to
a lesser extent, T3 erythrocyte binding. As thyroid hormone
concentrations rise, the degree of saturation of the plasma protein
binding sites by T4 decreases their availability for T3 and the
surplus is bound to the red cell surface. This is the basis of the
erythrocyte or red cell T3 uptake test (RBC T3 uptake test).
This test was devised by Hamolsky, Stein and Freedberg (1957)
who estimated thyroid function based on the in vitro uptake by the
erythrocytes of 1^I-T3 added to a sample of human whole blood.
After separating and washing the RBCs, they counted their
radioactivity and expressed it as a percentage of the total blood
radioactivity, corrected to a haematocrit reading of 100. In 231
determinations on 209 euthyroid subjects, the values for the
corrected erythrocyte uptakes ranged from 10.3 per cent to 17 per
cent with a mean of 13.9 per cent, levels rising in hyperthyroidism
and falling in hypothyroidism.
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In 1961, Sterling and Tabachnik reported a modification of the
technique using the patient's serum instead of whole blood and an
anion exchange resin in place of erythrocytes (T3 uptake test). The
resin's avidity for was less than TBG so the test worked in
the same way as the RBC T3 uptake test. The advantages of the
method were that it excluded complications due to haemolysis and did
not require the use of a haematocrit correction factor. Thereafter,
a number of other absorbents were used, e.g. incorporating the resin
into a sponge or using charcoal, haemoglobin saturated charcoal,
silicate or Sephadex and a number of kits were produced
commercially. The normal range for the resin sponge uptake in man
is 23.2 per cent to 32.6 per cent uptake (Goo!den, Gartside and
Orsorio, 1965).
The T3 uptake tests found widespread use as thyroid function
tests in man because of their simplicity and convenience. Non-
thyroidal organic iodides did not interfere with, or caused only a
slight increase in, uptake (Hamolsky, Stein and Freedberg, 1957).
Currently, they are also useful during pregnancy and as an adjunct to
other tests (see later). However, a necessary prerequisite for the
diagnostic use of the test is a high affinity thyroid hormone plasma
binding protein. There is considerable debate as to whether such a
protein occurs in cat plasma.
Clinical studies. The results from these are summarised
in Table 3.2.
Wilson, Dickson and Frost (1961) are the only workers to have
used the RBC T3 uptake test to assess feline thyroid function.
Unfortunately, animals studied were clinical patients in the
authors' veterinary hospital or from experimental projects at their
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College of Veterinary Medicine and so could not be classed as
"healthy". They used the same procedure as Hamolsky, Stein and
Freedberg (1957), but corrected to a standard packed cell volume
(PCV) of 40. The mean value for the cat was the highest of all the
species studied (horse, cow, pig, sheep, dog).
Tanabe, Ishii and Tamaki (1969) measured the ^^I-T3 uptake
on acetalised polyvinyl alcohol sponges in a number of species by a
method originally described by Inagaki (1965). Only one cat was
tested but its uptake was the highest of all the mammalian species
studied (man, cow, sheep, goat, rabbit, guinea-pig and mouse) with
the exception of the latter.
Kallfelz and Eral i (1973) used a commercially available resin
sponge uptake test (Triosorb-125, Abbott Radiopharmaceuticals) to
assess thyroid function in 14 cats of varying ages. No details of
technique were given. The mean uptake of 57.2 per cent was more
than ten per cent higher than any other species studied (dog, pig,
cow, goat, sheep and horse) and compared with a value for man of
approximately 30 per cent. They concluded that the concentration of
T4 binding proteins or their affinity for T4 must be different in
animals from man.
Ling, Lowenstine and Kaneko (1974) evaluated a commercial kit
method of T3 uptake using silicate particle adsorption (Tri-Tab,
Nuclear Medical Laboratories) in cats presented for sterilisation.
The mean uptake in 39 cats was almost identical to that found by
Kallfelz and Eral i (1973).
Lorenz and Cornelius (1976) reported the T3 resin sponge uptake
values of an unspecified number of cats by an unspecified method.
Their normal range was identical to that given by Ling, Lowenstine
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and Kaneko (1974). However, the last named authors described their
technique as silicate particle adsorption.
With the advent of commercially available, highly specific
antibodies against T3, Anderson and Brown (1979) reported T3 uptake
values utilising them as the uptake medium. In their technique,
serum and buffer containing were incubated in plastic tubes
coated with a T3 antibody (Immunotubes, Smith Kline). Competition
for the ^2^I-T3 was between the antibody and the unsaturated binding
sites of what the authors called "TBG" in the serum. The bound and
free ^2^I-T3 were separated by decanting. Ninety-two healthy cats of
several breeds and a wide age range were studied.
Because neither naturally-occurring hypo or hyperthyroidism
had been documented in cats at the time of these studies, it was not
possible for these workers to make any comment about the specific
value of these tests in assessing feline thyroid function. However,
both Anderson and Dorner (1971) and Kallfelz (1973), in work with
thyroidectomised dogs, documented the insensitivity of the T3 uptake
tests in detecting changes in canine thyroid gland function. They
commented that this resulted from differences in binding affinity
between the plasma proteins of the dog and man, with the consequence
that the test did not alter significantly even with marked changes
in thyroid activity. Such differences could also be a consequence
of smaller concentrations of binding proteins with the same binding
affinity. Neither Scherzinger, Guzy and Lorcher (1972) nor Bigler
(1976a) were able to identify the presence of a high-affinity
thyroxine binding alpha-globulin in cat serum, although the first
named authors felt that this might be due to inadequate separation
techniques being employed. Both reports stated that the T3 uptake
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test was consequently not suitable for assessing thyroid function
in cats.
In general, the T3 resin uptake and Immunotube techniques in
cats show satisfactory agreement but give different results from the
initial method using RBCs. T3 uptake tests have played a diminishing
role as a test of thyroid function in man, and their use is now
essentially limited to the estimation of the concentration of
unoccupied TBG sites for the purpose of calculating the "free
thyroxine index".
Competitive protein binding (CPB) methods
Method principle. This approach provided the first
direct measurement of thyroid hormone concentrations in the cat.
The procedure is similar to the radioimmunoassay (RIA) methods that
were introduced later but differs in the important respect that TBG
is used as the binding reagent rather than an anti-T4 antibody.
The procedure involves the extraction of T4 from patient serum
and its subsequent incubation with a fixed amount of human TBG in
the presence of ^^I-T4. The ^^I-T4 is displaced from the TBG
by the patient T4 in an amount proportional to the amount of patient
IOC
T4. The displaced I-T4 is then removed from solution by an anion
IOC
exchange resin or by silicate particles. The I-T4 on the
adsorbent or, alternatively remaining in solution on the TBG, may
then be counted and from standards treated in the same way, the
total serum T4 of the patient can be interpolated from the standard
curve.
This test was first described by Ekins (1960) and later was
developed and simplified by Murphy (1964) and Murphy and Pattee
(1964) using ^1I-T4 and Sephadex columns. Murphy and Jachan (1965)
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further modified the method by using ion-exchange resin and
dispensing with the Sephadex columns. Subsequently, the test was
modified by others and became commercially available in a number of
kit forms.
The T4 CPB test is a direct indicator of T4 concentration.
Unlike the PBI, it is not affected by iodides (Kaneko, 1970, 1980a)
and the most commonly-occurring sources of interference are
medications which alter the TBG concentration (e.g. oestrogens) or
compounds which compete with T4 for binding sites on the binding
proteins. Only diphenylhydantoin and salicylates compete when given
in large amounts, but in small doses even this interference is
negligible (Sparagana, Phillips and Kucera, 1969). These studies
indicated that T4 CPB was a major improvement over earlier methods
of thyroid function testing.
Clinical studies. Table 3.3 summarises data on CPB
measurements of T4 in healthy cats.
Scherzinger, Guzy and Lorcher (1972) were the first people to
use the test in the cat. They estimated the T4 concentration of a
sample of pooled normal cat serum, using ^I-T4, human TBG and
an anion exchange resin as described by Murphy and Jachan (1965).
They reported a value which was in good agreement with later results
from Scherzinger and Grosser (1972) who used the same method on
samples from five cats.
Kallfelz and Erali (1973) evaluated a commercially available
kit designed for use in man (Tetrasorb-125, Abbott
Radiopharmaceuticals). This technique initially involved alcoholic
extraction of T4 from the test serum. As not all of the T4 was
extractable in this way, recovery of T4 on extraction had to be
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separately estimated in each experimental run. The radioactive
label was ^^I-T4 which was added bound to TBG, with the adsorption
medium being a resin sponge. These authors' values appeared somewhat
lower than those recorded in previous studies, but similar results were
later recorded by Scott (1975b), using the same kit.
Bigler (1976b) also used the Tetrasorb-125 kit in measuring the
total serum T4 concentration of 110 healthy cats of both sexes and
varying ages. Unmodified, the kit gives optimum results between
51.5nmol/l and 205.9nmol/l. Because of the low concentrations of T4
found in cat serum, he modified the technique by using three times
the volume of alcohol-extracted T4. His results were lower than
those previously reported by Kallfelz and Erali (1973) using the
same method without modifications.
Ling, Lowenstine and Kaneko (1974) used an alternative
commercial method of T4-CPB (Tetra-Tab, Nuclear-Medical
Laboratories) with cat serum. This technique employs 12^I-T4, human
TBG and inorganic silicate particles as the adsorbent. The mean T4
concentration of 40 healthy cats of a number of breeds, both sexes
and varying ages was 12.3nmol/l with a range of 1.3nmol/l to
32.2nmol/l. While they included two additional standards of
19.3nmol/l and 38.6nmol/l to allow for the low T4 concentrations
found in cat serum, the difficulties in quantitating low T4
concentrations in an assay designed for the higher normal values
in humans raise some doubts concerning the reliability of the lower
limit of their reference range.
Kaneko (1980a) also used CPB to measure T4 ranges in the cat
but did not specify the particular method.
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Overall, the data in Table 3.3 show that there is no clear
agreement on normal T4 concentrations in the cat as measured by CPB,
although the initial estimates appear, in retrospect, to have been
too high. The best estimate of the normal mean appears to be in the
range 10nmol/l to 30nmol/l.
Most workers consider T4 CPB to be less specific than T4
determinations by radioimmunoassay (T4 RIA) because, in addition to
the total T4, CPB measures approximately 35 per cent of the total
serum T3 (Scherzinger, Guzy and Lorcher, 1972). However, Kaneko,
Baker and Mills (1975) found no difference in statistical
comparisons of T4 CPB with T4 RIA. This may have resulted from low
values due to under-recovery on extraction, being compensated for by
some degree of non-specificity in the assay.
Radioimmunoassay of thyroxine and triiodothyronine
Method principle. The principle of RIA was first
described by Yalow and Berson (1960) in their now classic paper on
the measurement of insulin using specific insulin antibodies. The
method offers a unique combination of specificity, sensitivity,
precision and practicality and its application to the measurement of
other hormones has revolutionised endocrinology.
There are three requirements for successful RIA: (i) an
antibody which has high affinity and specificity for the analyte (or
antigen) to be measured, (ii) a radio!abelled form of the analyte,
and (iii) a suitable method for separating in solution, the antibody-
bound and "free" forms of the labelled analyte.
The analyte reacts with the specific antibody, which is present
at low but constant concentration, in the presence of
radio!abel1ed analyte. The proportion of the total analyte which is
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antibody-bound decreases as the amount of added analyte increases.
The labelled analyte (usually, though not necessarily, the same as
the substance being measured) is distributed between the antibody-
bound and free forms in the same way as the non-labelled analyte.
This partitioning of labelled analyte can be measured using one of a
variety of methods that exploit differences in molecular size or
charge, adsorption or immunological or solubility properties between
antibody-bound and free moietes. Following this separation, the
radioactivity in the antibody-bound or free fraction is measured and
by comparison with an appropriate standard curve, the concentration
of the test antigen can be interpolated.
The extension of the RIA technique from protein analytes to
include low molecular weight analytes (haptens) that are not in
themselves antigenic was a major step forward.
In 1972, Chopra described the first RIA for T4, (T4RIA), a
double antibody method, which allowed its measurement in unextracted
serum. The procedure used a first antibody produced in rabbits by
immunisation with human thyroglobulin and a second antibody of goat
anti-rabbit gamma-globulin. The assay was set up in the presence of
8-anilino-l-napthalene-sulphonic acid (ANS) to mobilise T4 from its
binding with TBG, and barbital buffer to inhibit binding of T4 to
TBPA. Since then a number of different methods have been applied to
the RIA of human T4.
In 1970, Brown, Ekins, Ellis and Reith reported the production
of specific T3 antibodies and subsequently, the first sensitive and
precise RIA for T3 (T3RIA) in serum extracts was developed by Brown,
Ekins, Ellis and Williams (1971). Eastman, Corcoran, Ekins,
Williams and Nabarro (1975) reviewed the literature on the
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development of methods for assaying T3 in man. They concluded that
T3RIA had proved to be a precise and reliable method for the
detection of thyroid dysfunction.
Clinical studies. Techniques for RIA of T4 and T3 are
applicable to the cat provided the methods are modified to allow for
the much lower concentrations of circulating total T4 and T3 in this
species compared with man. Data on studies in the literature are
summarised in Table 3.4.
Reap, Cass and Hightower (1978) were the first workers to
report details of total T4 and T3 concentrations by RIA in "normal"
cats in a study of ten animals (further details unspecified).
Anderson and Brown (1979) reported a study of the total T4
concentrations of 92 healthy animals. Both groups used commercially
produced RIA kits (Tetra-Tab RIA, Nuclear Medical Laboratories and
125
I-T3 RIA kit, Diagnostic Products Corporation; Immunotube,
Smith Kline, respectively), which were designed for use with human
serum. Both groups recognised the particular problems in applying
these kits to assay the low levels of thyroid hormones in cats and
attempted to circumvent them by doubling the volume of serum used.
None of the assays was optimised for the cat and standards were
prepared in buffer.
Reimers, Cowan, Davidson and Colby (1981), reporting on
commercially available coated-tube RIAs for T4 and T3 (Autopak,
Micromedic Systems), produced for use with human plasma, described
their validation for canine, feline and equine serum. Standards
were lyophilised in human plasma, beginning at 0 and 12.9 nmol/1 for
T4 and 0 and 0.77nmol/l for T3 and continuing in doubling
concentrations to 510nmol/l and 9.24nmol/l respectively. To
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increase the assay sensitivities, additional low standards
(4.3nmol/l for T4 and 0.26nmol/l for T3) were produced by diluting
the lowest standards supplied, 1:2 with buffer. Specificity of both
assays was indicated by: (i) sample results falling in parallel with
the standard curve on sample dilution, (ii) a lack of cross-
reactivity for other iodothyronines tested, and (iii) appropriate
biological responses in sera from seven cats stimulated with TSH,
and several animals monitored post-thyroidectomy. Satisfactory
accuracy was indicated by quantitative recovery of added analyte,
for T4 using canine and equine but not feline serum, and for T3
using feline serum. Human and canine but no feline quality control
samples were included in each assay. Sensitivity was evaluated by
determining the intercept of the standard curves with the lower 95
per cent confidence limit of percentage of binding by the Bo
standards, the mean of ten assays being 2.2nmol/l for T4 and
0.22nmol/l for T3. Within and between-assay precision figures were
published for both T4 and T3 for canine and human, but not for
feline, pools.
The authors did not report normal ranges for T4 or T3
concentrations for cats in this paper but values were subsequently
published by Reimers (1982) and Reimers (cited by Randolph and
Jorgensen, 1984). No further details were given but presumably
these ranges were derived from the assays described above.
Hoenig, Goldschmidt, Ferguson, Koch and Eymontt (1982), using
unspecified modifications of the double antibody RIA of Chopra
(1972), reported the mean total T4 concentration of 51 healthy cats.
Using unspecified modifications of the double antibody RIA of
Lieblich and Utiger (1972), the same authors reported the total T3
concentration of 44 healthy animals.
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Peterson, Keene, Ferguson and Pipers (1982) employed double
antibody techniques for T4 and T3 modified by using charcoal -
extracted, pooled serum from normal cats to produce T4 and T3
depleted serum for addition to control and standard tubes. The T4
and T3 ranges of an unspecified number of cats were reported but no
further details were given. Peterson, Kintzer, Cavanagh, Fox,
Ferguson, Johnson and Becker (1983b) used the same techniques in 67
animals and reported reference ranges.
Hoenig and Ferguson (1983) gave further details of their
modification of Chopra's double antibody RIA for T4 and reported the
normal range for 67 animals. The first antibody had a cross-
reactivity of 0.3 per cent for T3 and two per cent for rT3. They also
included activated charcoal hormone-depleted serum in standard tubes
in an attempt to equalise protein concentrations with samples.
Dilutions of hyperthyroid cat sera to 75 per cent, 50 per cent and
25 per cent using hormone-depleted serum gave concentrations of 77.7
+_ 2.2 per cent, 56.1 +_ 1.9 per cent and 23.7 +_ 1.3 per cent
respectively (n=6) of the undiluted sera. Low, medium and high
concentration recovery experiments gave results of 107.6 _+ 6.0
per cent, 104.2 _+ 5.1 per cent and 86.3 _+ 5.4 per cent (n=8)
respectively. The within-assay variation was 6.8 per cent. The
working range of the assay was 2.6 to 644nmol/l but standard values
were not stated.
Peterson et al. (1983b) used commercial solid phase
techniques (Micromedic T4 and T3 RIA Kits, Micromedic Systems) and
evaluated the serum total T4 and T3 concentrations of 135 normal
cats but assay methodologies were not reported.
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Donne and Wildgoose (1984) investigated commercially available,
solid phase, magnetic antibody RIA (T4 and T3 MAIA Kits, Serono
Diagnostics), designed for the assay of T4 and T3 in human plasma
but modified for use with cat serum. The original standards were
supplied in human serum and for T4 ranged from 0 and 25.7nmol/l to
411.8nmol/l and for T3 from 0 and 0.39nmol/l to 12.32nmol/l. In an
attempt to obtain greater accuracy for the low serum T4
concentrations found in the cat, an extra standard of 12.9nmol/l was
prepared and the highest standard reduced to 51.5nmol/l. In an
investigation of 40 normal cats, the T4 range was quoted as 19.7
nmol/1 to 68.3nmol/l. The authors did not explain how they were
able to read values above the highest standard. No modifications
were made to the T3 assay, the range being 0.46 to 1.71nmol/l.
Data on validation of the assay were presented in detail. Cross-
reactivity of T4 antibody for T3 in extracted cat serum was 6.2 per
cent, with that of T3 antibody for T4 being 0.28 per cent.
Specificity was investigated by parallelism, dilutions of feline
sera resulting in linear decreases in T4 and T3 concentrations.
Accuracy was evaluated by assessing the percentage recovery of known
amounts of T4 and T3 which had been added to feline serum, the range
for T4 being 93 to 107 per cent and ranges for different concentrations
of T3 being 98 to 110 per cent and 99 to 107 per cent. Within-assay
precision expressed as mean +_ sd was 24.5 _+ 0.9nmol/l for T4
(coefficient of variation (cv) was 3.4 per cent, n=20) and 1.60 +_
0.06nmol/l for T3 (cv was 3.8 per cent, n=22). Between-assay
precision also expressed as mean _+ sd was 23.7 _+ 1.8nmol/l for
T4 (cv was 7.4 per cent) and 1.66 +_ 0.9nmol/l for T3 (cv was 5.2
per cent, n was not specified). The detection limits of the assays
were found to be 2.6nmol/l for T4 and 0.15nmol/l for T3.
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Kemppainen, Mansfield and Sartin (1984) used a commercially
available T4 RIA kit (Canine Thyroxine, Diagnostic Products
Corporation), validated for use with cat serum, to measure the total
T4 concentrations of 12 healthy cats. Although few details were
reported, they stated that inhibition curves produced by serial
dilutions of cat plasma were parallel with the respective standards,
that when "varying" amounts of T4 were added to a cat plasma pool an
average of 96 per cent was recovered, and that the sensitivity of the
T4 assay was 1.9nmol/l.
The only other reports of total T4 or T3 concentrations using
RIA methods in healthy cats have referred to normal ranges without
data on the numbers of animals studied, in clinical papers on feline
hyperthyroidism or in review articles. These publications and the
values reported are presented in Table 3.4.
Generally, there is good agreement for feline T4 RIA values in
the literature, with an approximate mean of 30nmol/l. This is
perhaps surprising in view of the variety of techniques used and the
number of centres from which they have been reported. The values
for T3 are more variable and fall into two groups with ranges of
approximately 0.8 to 3.0nmol/l and 0.23 to 1.60nmol/l. For T3,
there is a trend for lower values to be reported in later studies.
Effects of anticoagulants, haemolysis, storage, freezing
and thawing and anaesthesia on thyroxine and triiodothyronine
radioimmunoassay. Kubasik and Sine (1978) compared the T4
and T3 concentrations of human heparinised plasma and serum using a
number of commercially available RIA kits and found significant
differences between the results obtained by some of the techniques.
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Reimers, McCann, Cowan and Concannon (1982) investigated the
effects of storage, haemolysis and freezing and thawing on T4
concentrations of five canine blood samples as measured by a
commercially available, solid phase RIA (Autopak, Micromedic
Systems). They also compared T4 concentrations in
ethylenediaminetetraacetic acid (EDTA) - treated and heparinised
blood and serum. Concentrations of T4 did not change in whole or
clotted blood stored for 72 hours at 4°C or room temperature (22°C
to 26°C) and in serum stored for eight days at -20°C, 4°C or room
temperature. Repeated freezing and thawing of serum and haemolysis
also did not significantly affect the T4 concentration. The overall
mean concentration of T4 of plasma from heparinised blood was lower
(P < 0.05; mean +_ sd = 61.3 _+ 8.0nmol/l) than that in EDTA-
treated plasma (66.9 _+ 9.lnmol/I) and serum (67.2 +_ 8.6nmol /I).
Donne and Wildgoose (1984) carried out similar investigations
into T4 and T3 concentrations of an unspecified number of feline
blood samples using a commercially available solid phase, magnetic
antibody RIA (MAIA kits, Serono Diagnostics). They compared the T4
and T3 concentrations of heparinised plasma and serum. The effect
of haemolysis was examined by the addition of packed red cells to
serum samples to simulate mild, moderate and severe red cell
breakdown. Storage effects were evaluated by assay of samples
stored at 8°C and -20°C. After collection, samples were aliquoted,
with one being stored at 8°C and assayed within eight hours and
the second stored at -20°C and assayed after 48 hours. None of
these variables produced significant differences in T4 and T3
concentrations.
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In the same report, the effects of the steroid anaesthetic
mixture of alphaxalone and alphadalone acetate (Saffan, Glaxovet) on
serum T4 and T3 concentrations were evaluated. Blood samples were
collected from an unspecified number of cats before, and at intervals
of from two to 60 minutes after, anaesthesia. There were slight
increases in post-anaesthetic T4 and T3 concentrations but these
were not statistically significant.
Total serum thyroxine and triiodothyronine concentrations
in healthy cats by unspecified methods
Data from studies in which methodological details were not
given are shown in Table 3.5. In some instances, the number of cats
investigated was also not stated. The values of T4 reported are in
the region of the highest concentrations reported by RIA, while the
single mean T3 appears substantially higher than other reported
values.
Free thyroxine index (FT4I)
Method principle. As stated previously, it is the free
or unbound fraction of the plasma T4 which is able to leave the
intravascular space, and take part in the production of metabolic
effects at the tissue level. It follows, therefore, that FT4
is a more accurate indicator of thyroid status than total T4.
The very low FT4 concentrations, are, however, technically difficult
to measure. Although simple kit methods have recently become
commercially available for FT4 in humans, the FT4 concentration in
cats has not been reported.
In human medicine, a widely used solution to this problem has
been to calculate a plasma free thyroxine index (FT4I) which is
proportional to the FT4 concentration. The FT4I is a product of the
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total T4 concentration and the T3 uptake. In effect, the total T4
is corrected for the number of unsaturated TBG binding sites, the
latter being measured as the T3 uptake. In man, the FT4I is
valuable in patients with acquired TBG excess e.g. in pregnancy or
on oestrogen treatments. However, the test is of less use in
patients with non-thyroidal illness or hereditary TBG excess or
deficiency and adds little diagnostically to the majority of
patients with normal TBG levels (Toft, Campbell and Seth, 1981).
Clinical study. Kallfelz and Era!i (1973) are the only
workers to have reported FT4I values in cats. Their data are
presented in Table 3.6. They measured both the total serum CPBT4
concentration and the T3 uptake by commercially available kit
methods (Tetrasorb-125 and Triosorb-125, respectively, Abbott
Radiopharmaceuticals). The mean FT4I of 14 healthy cats derived
from the product of total T4 in ug/lOOml and T3 uptake expressed as
a decimal, was 1.36. They commented that as the T3 uptake test did
not seem responsive to changes in thyroid gland status in the dog,
the FT4I in this species only reflected alterations occurring in the
serum T4 concentration. They made no comment about cats. However,
if cats do not possess a high affinity thyroid hormone binding
protein comparable to human TBG, the situation is likely to be
similar.
Assay of thyroid stimulating hormone
In human medicine, the major value of plasma basal TSH
measurements is in the investigation of suspected primary
hypothyroidism. Here, the test is a very sensitive indicator of
thyroid failure, the TSH concentration commonly being elevated some
two to three months before total T4 levels are depressed. Partial
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thyroid failure can also result in an elevated basal TSH which
serves to maintain normal plasma thyroid hormone concentrations and
euthyroid status (Toft, Campbell and Seth, 1981). In secondary and
tertiary hypothyroidism, the TSH concentration is low to normal.
TSH measured by RIA is undetectable in the plasma of more than
90 per cent of hyperthyroid patients but the same is true of 20 per
cent of euthyroid humans. Thus, it is not possible to differentiate
between these states using plasma basal TSH measurements (Toft,
Campbell and Seth, 1981).
TSH is a species specific polypeptide. Attempts to measure
canine TSH using a human TSH RIA were unsuccessful (Chastain, 1978).
However, Nachreiner (1981a) reported that an RIA kit for measuring
human TSH gave reliable values in dogs. Quinlan and Michael son
(1981) reported on an homologous, double antibody RIA for canine TSH
which showed slight cross-reactivity with ovine, but not with human,
bovine or rat TSH. It is, therefore, rather surprising that an
earlier reference (Knigge and Joseph, 1971) reported assaying TSH
extracted from cats' pituitary glands by modifying the method of
McKenzie (1958) used to measure human TSH. In 19 normal cats, the
mean pituitary TSH concentration was 13.4mu/mg.
Because of the lack of cross-reactivity between feline TSH and
that from other species, and the lack of pure feline TSH for
preparation of antisera and radiolabel for use in RIA, the levels
of TSH in feline plasma have not been reported.
3.8 METHODS USED TO ASSESS NORMAL FELINE THYROID FUNCTION
- RADIONUCLIDE STUDIES
Introduction
The ability of the thyroid gland to concentrate and organify
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iodide and subsequently release iodothyronines established an important
role for radionuclide studies in the investigation and management of
thyroid disease. Some techniques have been applied to the cat.
Early tests were confined to research into thyroidal iodide uptake
and conversion ratio, but with the recent identification of feline
hyperthyroidism, more detailed investigations into radioiodide
uptake, gamma camera imaging and rectilinear scanning have been
carried out in normal cats for the purpose of comparison with
thyrotoxic individuals.
Radioactive iodide (131 j, 125j or 123j) ^ -j^g stable iodine
(1^1), is trapped and concentrated in the thyroid follicular cells
by the iodide pump. It is subsequently incorporated into
thyroglobulin which is stored in the follicular colloid, T4 and T3
being released by proteolysis. Daniel, Gale and Pratt (1962) discussed
the advantages of using ^5j over 131j for radionuclide studies
in cats. They presented data which showed that the low energy
radiations of made possible sensitive quantitative assessment
at a relatively low radiation dose in vitro. However, in vivo
counting of was less convenient. The longer half-life (27
1 pr -I 01
days for I compared with 8.1 days for I) is a
disadvantage for clinical work although it may be helpful in non¬
survival experiments.
99m-Pertechnetate (99mTc04), a radioisotope derived
from molybdenum, is trapped and concentrated like iodide within
thyroid follicular cells. However, it is neither incorporated in
thyroglobulin nor stored in the thyroid (Pineda, Clauria, Rocha and
Harbert, 1979) and thus reflects only the trapping mechanism of the
thyroid gland. Its rapid uptake and short isotopic half-life (6.0
hours) give it considerable advantage for scinticism work.
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Thyroidal radioiodine uptake (Thyroidal RIU)
Method principle. The test uses the principle that the
administered radionuclide is concentrated by the thyroid in a
similar way to dietary iodide. The RIU therefore directly assesses
the functional status of the thyroid. Generally, the higher the
RIU, the more active is the thyroid (Peterson, 1984). Because
99mTC0^ is not concentrated by the thyroid and because
125 1?-}I has the disadvantage of a longer half-life, i':jI or
131
I are commonly used. RIU is usually expressed as a
percentage of the administered dose.
Although the estimation of thyroidal RIU is usually made 24
hours after the oral administration of radioiodine (Luick, 1971),
the time of maximum uptake of 13^I in the cat has been variably
reported as 72 hours (Knigge, 1961) and 96 hours (Bard and Woods,
1960).
Clinical studies. Reports of the use of this test in healthy
cats are summarised in Table 3.7.
Knigge (1961) determined both the in vivo and the excised
thyroid RIU in 40 normal cats, 72 hours after the intraperitoneal
administration of 25uCi of carrier-free ^I. At this time, animals
were anaesthetised and the right thyroid removed surgically. The
excised thyroid RIU was determined using a lead-shielded
scintillation crystal. Immediately after hemi-thyroidectomy, the
in vivo uptake of the intact lobe was also determined. The mean
value +_ sd of the latter was 6.6 +_ 2.0 per cent of the
administered dose. This was a mean +_ sd of 13.0 _+ 0.5 per cent
less than the excised uptake value.
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The only other reports of thyroid RIU in normal cats have been
for comparison purposes with hyperthyroid individuals. Peterson,
Becker and Hurley (1980), Peterson, Becker, Hurley and Ferguson
(1981), Peterson et al. (1982) and Peterson and Becker (1983) gave
no further information as to techniques or numbers of animals
studied.
Hoenig et al. (1982) and Peterson et al. (1983b) described the
equipment they used to carry out RIU. Both assessed RIU at 24 hours
but the former group also compared this to uptake at six hours.
Overall, the studies using 131 j sh0VJ g00c| agreement for uptake
at 24 hours. The study by Hoenig et al. (1982) using 123j shows
higher values but the reasons for this are not clear.
Radioiodine retention and excretion
The metabolism of radioiodine has been investigated by
measuring its retention in the body or in the blood, or by
monitoring its urinary excretion. These are very crude techniques
but were used in early investigations to give some measure of feline
thyroid function.
Nelson, Wolfangel and Stara (1966) administered aqueous Na 131i
intravenously to 12 cats and assayed radioactivity in the
whole body and blood samples "regularly". Whole blood displayed the
same general downward trend as exhibited by the whole body retention
curves. The cat appeared to retain a high proportion (80 per cent)
1 Ol
of the initial I dose at 24 hours. Further details were not
given.
Randall and Littschwager (1967) determined the percentage
urinary excretion of 1311 -}n ten healthy cats at monthly intervals
for 20 months. One to 3 uCi of Na 1311 was injected
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intramuscularly into each animal, and an identical volume was
retained for comparison purposes. The urine of each cat was
collected for five days, individually pooled, aliquoted and counted
in a scintillation gamma counter. Identical volumes of the solution
retained for comparison were also counted. After calculating the
percentage of the injected dose of Na ^lj that was -jn the total
volume of urine, the percentage ^1 retention was determined by
subtraction from 100. The values varied between individuals and
on the time of year, results being from -2.4 per cent to 58 per cent.
This remarkable variation and the fact that the authors appeared to
make no allowance for radioiodine loss in the faeces meant that
little could be deduced from the data.
Protein-bound radioiodine and the conversion ratio
Method principle. The rate at which radioiodine-label1ed
thyroid hormone is secreted into the circulation after the
administration of a tracer dose of radioiodine (e.g. ^I) is related
to the functional state of the gland. In order to estimate the
amount of labelled hormone in the plasma in the presence of
inorganic radioiodide, use is made of the strong binding of T4 to
plasma proteins. The hormonally active iodine is precipitated with
plasma proteins using, for example, trichloracetic acid, and is
101 1 01
termed the plasma protein-bound I (PB I). The inorganic
iodide can be removed from plasma using an anion exchange
resin (Zieve, Vogel and Schultz, 1956) which does not absorb the
1 Q1
protein-bound forms. Thus, the radioactivity of the PB I and of
the inorganic iodide may be evaluated separately.
Clark, Moe and Adams (1949) introduced the term 'conversion
ratio' (PB l^I-CR) for a given quantity of plasma, which was defined
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by the equation: Conversion ratio (per cent) =
Plasma protein radioactivity xlOO = PB xiqO
Total plasma radioactivity PB 131I + 131j
In human hyperthyroids, a greater amount of labelled hormone is
found in the plasma after 24 hours than in euthyroids (Luick, 1971)
and the conversion ratio rises.
Clinical study. Knigge (1961) reported the thyroid
conversion ratio of 40 normal cats, 24 hours after the
intraperitoneal injection of 25u Ci of carrier-free 1311, to be a
mean +_ sd of 27.6 +_ 7.3 per cent. This test has not been
evaluated in feline hyperthyroidism.
Estimate of the rate of release of radio!abel1ed thyroid
hormones
Randall and Littschwager (1967) attempted to measure the rate
of release of radiolabeled T4 in 15 healthy cats. Beginning seven
days after the intramuscular injection of one to three uCi Na
131
I to each cat, daily determinations of the radioactivity in
the neck region were made for three weeks, or until the counts fell
to approximately ten times the background. To determine what they
called "an estimate of the average daily release of thyroxin from
the thyroid gland" the three largest intervals were selected for
evaluation, e.g. in 21 days, three 18 day intervals would be
available (one to 18, two to 20 and three to 21). After corrections
for background and decay, the rates of gamma irradiation on days one
and 19 were used to obtain the constant a in the equation:
1°9l0 Nt = - at + c
where N^. -js the rate of gamma irradiation on day t. The average
daily release (i) was then calculated from:
i = l-10"a
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The mean daily release was thus calculated for each of the 18 day
intervals. The mean of the three scores (i) was an estimate of the
percentage of the organically bound existing on any one day
that was absent 24 hours later.
This value is clearly not an estimate of the release of T4 as
it makes no allowance for T3 or other radiolabel1ed iodothyronines.
The values they obtained varied from 1.4 per cent to 9.1 per cent
per animal for each period tested.
This test should not be confused with the thyroxine secretion
rate which has usually been determined in domestic species by
the amount of exogenous L-T4 necessary to inhibit the release of
111
I by the thyroid i.e. by T4 substitution (Kaneko, 1980a).
Thyroid imaging
Method principle. Scanning the thyroid with a highly
collimated camera after administration of a suitable radionuclide
serves to delineate areas with relatively high or low uptake. The
thyroid scan is useful in hyperthyroidism to determine unilateral or
bilateral lobe involvement, abnormal thyroid lobe position or
metastasis. The radionuclides most commonly used for thyroid imaging
are isotopes of iodine (^1 and and technetium-99m as
pertechnetate (99m Tco^). Similar images are produced by
each. However, in the cat, as in man, there are several advantages
of using 99ffl TCO^ instead of radioiodine (Peterson and
Becker, 1984).
Because of the rapid uptake of 99mTC0^} the imaging
procedure can begin only 20 minutes after administration, as opposed
to four and 24 hours for -^I and respectively.
131
I has a long physical half-life (8.1 days) and emits high-
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energy gamma rays (364 keV) which are inefficiently collimated by
the scintillation camera. Also, ^1 emits beta particles that
are not detected by the camera but increase total body and thyroid
radiation exposure (Johnson, 1978). In contrast to ^lj,
123
I has a short physical half-life (13.3 hours), emits low-
energy gamma rays (159 keV) well-suited for scanning and has no beta
emission (Pineda et al., 1979). Regrettably, it is very expensive.
Pertechnetate has a short physical half-life (six hours), emits low-
energy gamma rays (140 keV), has no beta emission and gives the
lowest radiation dose to the thyroid gland (Dos Remedios, Weber and
Jasko, 1971). Thus, higher doses of 99mTC0^ may be given to
patients than of radioiodine and thyroid imaging may be completed
more rapidly.
Clinical studies. Hoenig et al., (1982) carried out
rectilinear thyroid scanning of five normal cats after the oral
administration of 100 uCi ^1. Animals were premedicated with
atropine and sedated with ketamine. A five inch rectilinear scanner
with a fine focus collimator was employed, using a 140 to 180 keV
window. The resulting scan revealed homogenous uptake of
radioiodide by both lobes.
Peterson et al., (1983b) performed thyroid scans on 13
clinically normal cats. Twenty minutes after the intravenous
administration of 0.5mCi 99mTc04, the cats were sedated
with ketamine and scanned, using a scintillation gamma camera with a
pinhole collimator. The thyroid glands showed uniform distribution
of radioactivity throughout both lobes. The lobes were symmetrical
in position and size and an isthmus was not visible.
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Peterson and Becker (1984) compared the results of radionuclide
imaging using either 99mTc04 0r as described above, in
13 normal cats. Imaging (16,000 counts, 140 keV setting) was
carried out with a scintillation gamma camera and a 5mm pinhole
collimator. Scans were also performed 24 hours after intravenous
administration of 10 uCi to 25 uCi of 131i. Here, 8,000 counts
were imaged at the 1311 pea|< setting (364 keV) with the same
scintillation camera and pinhole collimator. All cats showed
uniform distribution of radioactivity throughout both lobes in
images obtained with both radionuclides. As described previously,
the lobes were symmetrical in position and size and no isthmus was
visible. The quality of the scans obtained with 99mTcO^ was
consistently equal or superior to that of those obtained with 1311.
These results were also summarised by Peterson (1984).
3.9 METHODS USED TO ASSESS NORMAL FELINE THYROID FUNCTION
- DYNAMIC FUNCTION TESTS
The thyroid stimulating hormone stimulation test
Introduction. Administration of exogenous (usually bovine)
TSH followed by the measurement of some parameter of thyroid function
provides important information about thyroid status. In veterinary
medicine, the test has been most widely applied to the diagnosis of
primary hypothyroidism in dogs (Belshaw, 1983). In such cases, there
is no significant increase in serum T4 concentration after TSH
administration. The test will differentiate hypothyroxinaemia due
to non-thyroidal illness or drug administration (responses similar
to normal) from primary hypothyroidism (Belshaw, 1983). It may also
be used to differentiate secondary and tertiary hypothyroidism from
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the primary form of the disease (Chastain, Riedesel and Graham,
1979). In secondary and tertiary hypothyroidism, one dose of TSH
usually leads to serum increases of T4 similar to those seen in non-
thyroidal illness or as a result of drug administration. A small
percentage of cases may require repeated administration of TSH for
three consecutive days before a significant increase is seen
(Ferguson, 1984), as prolonged TSH deficiency may lead to glandular
atrophy, limiting the thyroid's ability to respond to exogenous TSH
(Rijnberk, 1971).
Method principle. As discussed in Section 3.6, TSH
stimulates a number of steps in thyroid hormone synthesis. Clinical
application of the test relies on the measurement of one of these
physiological alterations.
In human medicine, the response to TSH has been gauged by
increases in basal metabolic rate (Thompson, Taylor, Thompson,
Nadler and Dickie, 1936; Querido and Stanbury, 1950), thyroidal
131
I uptake at various times after radioiodine adrnimstrati on
(Perloff, Levy and Despopoulos, 1951; Schneeberg, Perloff and Levy,
1954; Burke, 1968), serum PB1 or PB^I concentrations
(Jefferies, Levy, Palmer, Storaasli and Kelly, 1953; Einhorn and
1
Larsson, 1959), urinary excretion of I (Querido and Stanbury,
1950), and by the use of scintigraphy (Dos Remedios, Weber and
Jasko, 1971). The technique used to be of diagnostic value in
differentiating between primary and secondary hypothyroidism (Toft,
Campbell and Seth, 1981) and in delineating the state of low thyroid
reserve (Jefferies, Kelly, Levy, Cooper and Prouty, 1956). However,
a single basal plasma TSH concentration provides the same
information and the TSH stimulation test is now obsolete in human
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medicine (Toft, Campbell and Seth, 1981). In the absence of assays
for canine TSH, however, the technique is still regarded by many
veterinary endocrinologists and dermatologists as the most
convenient method for the definitive diagnosis of canine
hypothyroidism (Oliver and Waldrop, 1983). The test is usually used
in conjunction with the measurement of T4 by RIA. Because the
majority of T3 is produced by mono-de-iodination of T4, serum T3
determination after TSH stimulation is diagnostically unreliable.
(Nesbitt, 1983).
In cats, the TSH stimulation test has been used in conjunction
with chromatography of radiolabelled serum, the T3 uptake test and
T4 determination by CPB or RIA.
Clinical studies. Literature reports of the TSH stimulation
test in healthy cats are presented in Table 3.8.
The earliest studies (Daniel, Excell, Gale and Pratt, 1962;
Taurog, Porter and Thio, 1964) were physiological rather than
clinical and have been discussed in detail in Section 3.6.
Ling, Lowenstine and Kaneko (1974) gave the first report of the
use of TSH stimulation with biochemical tests of thyroid function in
ten female cats, none of which was older than two years. There was
no significant difference in the T3 uptake test before and after
administration of TSH but T4 concentrations by CPB were
significantly elevated post-stimulation.
Hoenig and Ferguson (1983) reported the results of a detailed
investigation into thyroid functional reserve in 19 healthy cats as
determined by response to TSH. Nine cats were male, ten female, 12
were American short-hairs and seven were Siamese. Details of the T4
RIA used are discussed in Sections 3.7, 4.1 and 4.7. Doses of TSH
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used varied from 0.05 to 1.00 iu/kg and animals were sampled before
and two, four, six, eight, ten, 12, 24, and 48 hours after
administration. Greatest stimulation was seen with the highest TSH
dose used. With all TSH doses, the peak serum T4 concentration
was found at six hours except with 0.05 iu/kg which gave a peak at
four hours. There was a linear correlation between the T4
concentration at six hours post-TSH and the logarithm of the TSH
dose (P<0.001), and between the absolute increase in serum T4 after
TSH administration and the logarithm of the TSH dose (P<0.001).
The ratio of post-TSH T4 concentration divided by the pre-TSH T4
concentration, the most commonly used index of TSH stimulation in
dogs, correlated less well with the logarithm of the TSH dose
(P<0.01). The authors concluded that in euthyroid cats, intravenous
administration of 1 iu/kg TSH should lead to a T4 concentration of
greater than 51.5 nmol/1 at six hours after administration, or to an
increment in the serum T4 of at least 32.3 nmol/1.
Kemppainen, Mansfield and Sartin (1984) carried out
investigations into the serum T4 response to bovine TSH in 12
healthy cats (five neutered females and seven neutered males). The
cats were divided randomly into three groups of four. After blood
sampling, TSH was administered intramuscularly at a dose of 2.5
iu/cat (0.55 to 0.69 iu/kg) to one group, and 0.1 iu/kg (0.38 to 0.45
iu per cat) to a second group. Cats in the third group were
administered the vehicle only and acted as controls. Further blood
samples were collected four, eight, 12 and 24 hours later. T4
samples were determined by RIA as discussed in detail in Section
3.7. The response of serum T4 to 0.1 iu/kg TSH was not
significantly different from controls. However, the authors
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concluded that an intramuscular dose of 2.5 iu TSH per cat would
more than double the serum basal T4 and give a concentration of
greater than 38.6 nmol/1 at eight and/or 12 hours after
administration.
The other reports of the use of the TSH stimulation test in
healthy cats either have given only brief details of regimes and
results for comparison with those found in specific disease
entities (FEA and hyperthyroidism), or been in review papers.
Information from these publications is presented in Table 3.8.
Generally there is good agreement for feline T4 responses to
TSH, with most authors citing an increase to at least twice the basal
concentration. This is perhaps surprising in view of the variety of
doses of TSH and routes of administration used.
The thyrotropin releasing hormone response test
Method principle. TRH, released by the hypothalamic neurones,
stimulates synthesis and release of TSH by the thyrotrophs of the
anterior pituitary. TSH subsequently stimulates production of T4
and T3 by the thyroid. Elevations of plasma T4 and T3 after TRH
administration indicate a functionally intact pituitary-thyroid axis.
In human medicine, measurements of plasma TSH before and after
the intravenous injection of TRH have proved to be extremely valuable
in the investigation of patients with suspected hyperthyroidism. In
normal subjects, there is a marked increase in plasma TSH
concentration after TRH, whereas in hyperthyroidism, due to suppression
of the thyrotrophs, there is no significant rise (Toft, Campbell
and Seth, 1981). In primary hypothyroid!'sm, the basal plasma TSH
concentration is raised and no additional information is gained by
performing a TRH test. However the test is of value in
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differentiating between pituitary and the rare hypothalamic forms
of hypothyroidism. In pituitary hypothyroidism, there is little or
no TSH response whereas in the hypothalamic form of the disease,
there may be a delayed (compared to euthyroid individuals) TSH
response (Toft, Campbell and Seth, 1981).
Because TSH assays are not available for cats, the response to
TRH must be determined by assaying T4 and T3.
Clinical study. Lothrop, Tamas and Fadok (1984) are the only
workers to have reported the use of the TRH response test in cats
(Table 3.9). A doubling of serum basal T4 concentrations was seen
at four hours after stimulation with all doses of TRH used. There
was no change in the size of the T4 response as the dose of TRH
increased from 0.02 mg/kg to 10 mg/kg. Side effects of TRH
administration were observed at doses above 0.02 mg/kg and included
salivation, urination, defaecation, vomition, pupillary
constriction, tachycardia and tachypnoea. These result from the
central cholinergic properties of TRH (Yarborough, 1983). By
withholding food for three to six hours before TRH administration,
vomition was prevented in most cats.
The authors concluded that the TRH stimulation test might be
valuable in evaluating pituitary, as well as thyroid-based,
dysfunctions of the feline thyroid gland. They recommended a test
procedure of serum total T4 determination before, and six hours after,
the intravenous administration of 0.1 mg/kg TSH (although this dose
of TRH was not used in cats in their study).
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3.10 EFFECTS OF AGE, SEX AND BREED ON THYROID FUNCTION OF
HEALTHY CATS.
Introduction
Little has been published on the effects of age, sex and
breed on the thyroid function of healthy cats. Details of the
methodologies and results of the reports here discussed are
presented in Section 3.7 and in Tables 3.2, 3.3, 3.4 and 3.6.
Effects of age
Wilson, Dickson and Frost (1961) reported no age-related
differences in the RBC T3 uptake test in cats but studied only five
animals.
Kallfelz and Erali (1973) investigated the effects of age using
the T3 uptake test, T4CPB and the FT4I in five cats aged ten weeks,
four aged one year and five that were more than one year old. There
was a trend towards decreasing concentrations of T4 with increasing
age but this was not statistically significant.
Ling, Lowenstine and Kaneko (1974) evaluated the T3 uptake test
in 39 and the T4CPB in 40 healthy cats. Sixteen animals were less
than one year old, 17 were from one to two years and five (T3 uptake)
and six (T4CPB) were older than two years of age. No animal
examined was more than five years old. There were no significant
age effects for either of the tests.
Using the T3 uptake test and T4 RIA, Anderson and Brown (1979)
found no effects of age on thyroid function of 92 healthy cats
varying between five months and 15 years but the actual numbers in
each group were not stated.




Wilson, Dickson and Frost (1961) found no significant
difference in the RBC T3 uptake test according to sex of only five
animals, but did not present data.
Using CPB, Ling, Lowenstine and Kaneko (1974) studied the T4
concentration of 31 female and nine male healthy cats. There was no
significant sex difference in total T4 concentration.
Bigler (1976b) found that the T4 concentration, as determined
by CPB, of 55 female cats (one of which was ovariohysterectomised)
was significantly higher (P<0.01) than that of 55 male cats (seven
of which were castrated). The effects of neutering were not
reported.
Using RIA, Reap, Cass and Hightower (1978) failed to identify
any sex differences in total T4 and T3 concentrations of ten healthy
cats but they did not state whether any animals had been neutered
and detailed data were not presented.
Anderson and Brown (1979), also using RIA, failed to identify
any significant difference between the total T4 concentrations of 52
male cats (28 entire and 24 castrated) and 40 female cats (23 entire
and 17 ovariohysterectomised). However, they reported that "a
significant difference was found for serum T4 values of intact
females and those of altered females" but they presented no
statistical evidence for this assertion. Moreover, the large sds
associated with the ranges lead to some doubts about the validity of
their conclusions (Table 3.10).
Donne and Wildgoose (1984) presented numerical data on the
total T4 and T3 concentrations of 40 "mixed" cats (15 male and 25
female) as measured by solid phase, magnetic antibody immunoassay
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(Table 3.10). Female cats had a slightly higher mean T4 and a
slightly lower mean T3 but the authors did not further analyse these
data according to sex.
The findings from these reports are contradictory, with only
one (Bigler, 1976b) describing a difference for T4 concentrations
between male and female animals. These discrepancies may result
from the small number of observations in some of the studies.
Effects of breed
Wilson, Dickson and Frost (1961) reported no differences in
the RBC T3 uptake test according to breed of five cats but they
presented no data.
Ling, Lowenstine and Kaneko (1974) found no significant
difference for the T3 uptake test between 17 domestic short-haired,
seven domestic long-haired and 11 Siamese cats (Table 3.2). Using
CPB, however, they found a significantly higher concentration of
total T4 in Siamese (n = 11) compared with domestic long-haired cats
(n = seven) but no difference between T4 in either of these breeds
and domestic short-haired cats (n = ten) (Table 3.3).
3.11 FELINE HYPERTHYROIDISM
Introduction
Feline hyperthyroidism (thyrotoxicosis) is a multisystemic
disorder resulting from excessive circulating concentrations of T4
and T3. Although reports of suspected cases appeared sporadically
in the early veterinary literature, the first cases were only
confirmed in 1979 by Cotter and by Peterson, Johnson and Andrews.
Feline hyperthyroidism has also been produced experimentally.
This section reviews these reports.
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Naturally-occurring cases of feline hyperthyroidism
Causes. Benign thyroid tumours are the commonest cause of
feline hyperthyroidism (Peterson, 1984). However, there is
considerable uncertainty about the classification of such tumours in
cats and Lucke (1964) was doubtful whether a true distinction should
be made between what she termed "nodular (adenomatous) goitre" and
single or multiple adenomas, except on the basis of size. Thus,
while some authors have attempted to make the distinction (eg.
Theran and Holzworth, 1980; McMillan and Scherding, 1981; Theran,
1981; Martin and Capen, 1983; Turrel, Feldman, Hays and Hornof,
1984), many workers have reported the pathological changes simply as
"thyroid adenomas (adenomatous hyperplasia )" (Peterson et al.,
1982; Peterson et al., 1983b; Birchard, Peterson and Jacobson, 1984;
Bond and Fox, 1984; Peterson, 1984; Peterson and Becker, 1984).
While early reports of small numbers of cases suggested that
unilateral thyroid enlargements were more common (Cotter, 1979;
Peterson, Johnson and Andrews, 1979), later studies in which
thyroid scans were performed, confirmed bilateral hyperfunction in
between 71 per cent and 79 per cent of affected animals (Hoenig et
al., 1982; Peterson et al., 1983b).
Thyroid carcinoma, the primary cause of hyperthyroidism in the
dog, rarely causes hyperthyroidism in the cat (Peterson, Becker and
Hurley, 1980; Peterson, 1981; Peterson et al., 1981; Theran, 1981;
Hoenig et al., 1982; Cotter, 1983; Fox, 1983).
Accessory or ectopic thyroid tissue may occasionally be
involved in the production of hyperthyroidism (Noxon et al., 1983;
01 sen, 1983).
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Incidence and prevalence. Until recently, feline thyroid
lesions were considered to produce no clinical signs and to be
incidental findings at post-mortem examination (Brodey, 1970;
Capen, 1978). However, with the increased availability of thyroid
hormone RIA, hyperthyroidism is now thought to be one of the most
common feline endocrine disorders, with Peterson (1984) reporting the
diagnosis in approximately one of every 300 cats examined at the
Animal Medical Center, New York, USA. Between 98 per cent and 99
per cent of cases are caused by thyroid adenomas (adenomatous
hyperplasia). The prevalence of functional thyroid carcinoma is
approximately one to two per cent (Peterson et al., 1983b).
Unsubstantiated reports. Prior to T4 and T3 assay
procedures being available to veterinary clinicians, a number of
suspected cases of feline hyperthyroidism were reported.
Holzworth, Husted and Wind (1955) reported a case of arterial
thrombosis and thyroid carcinoma in a domestic short-haired cat
(discussed in detail in Section 3.12). Their initial diagnosis was
hypothyroidism but retrospectively they considered the animal might
have actually been hyperthyroid.
Meier and Clark (1958) diagnosed a single case of feline
hyperthyroidism "according to the presence or lack of functional
disturbances associated with thyroid changes" together with a low
serum cholesterol concentration. Further details were not reported.
Lucke (1964) described a 14-year-old, neutered female cat which
presented with weight loss, vomiting and panting. At post-mortem
examination there was adenomatous goitre, left and right
ventricular hypertrophy of the heart and metastatic calcification of
the lungs, the superior mesenteric artery and the kidneys, suggesting
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hyperthyroidism. A second cat also showed marked ventricular
hypertrophy in association with adenomatous goitre, but thyroid
function tests were not carried out in either case.
Leav, Schiller, Rijnberk, Legg and der Kinderen (1976) reported
that, retrospectively, "some" of 52 cats with thyroid tumours had
clinical signs which might have reflected an altered hormonal status.
The PBI of one animal was elevated suggesting possible thyrotoxicosis
but further details were not available.
Flecknell, Gruffydd-Jones, Brown and Kelly (1979) reported the
ECG findings in a seven-year-old, neutered male, Russian blue cat.
There was evidence of ventricular pre-excitation, and the authors
suggested that this was similar to that found in the Lown-Ganong-
Levene syndrome of man. At post-mortem examination, a thyroid
adenoma was identified but the authors felt that this was a
coincidental lesion. Thyroid hormone determinations were not carried
out but it is likely that the arrhythmia present in this cat was
secondary to hyperthyroidism.
O'Brien, Riley and Hagemoser (1980) reported details of an aged
cat which showed clinical signs of hyperthyroidism and at post¬
mortem examination an atypical thyroid adenoma was identified.
Serum thyroid hormone concentrations were not determined.
Thus, a number of cats with clinical features similar to
hyperthyroidism have been described in the veterinary literature.
The frequency with which the disease has been identified




Breed, sex and age predispositions. There is no breed
predisposition for feline hyperthyroidism (Peterson, 1982, 1984).
While the majority of cases have been reported in domestic short and
long-haired cats, cases have also occurred in Siamese and Persians
(Hoenig et al., 1982; Peterson et al., 1982; Peterson et al.,
1983b) and a Russian blue (Peterson et al., 1983b). Similarly,
there is no sex predisposition (Peterson, 1982; Hoenig, 1983). In
a series of 135 affected animals, 68 were male and 67 were female
(Peterson and Becker, 1984).
Hyperthyroidism is a disease of middle-aged to old cats
(Peterson, 1982). The youngest yet recorded age at onset has been
six years (Hoenig et al., 1982; Peterson et al., 1983b) and the
oldest, 22 years (Theran and Holzworth, 1980; Theran, 1981).
Hoenig et al. (1982) reported a mean age at onset of 11.8 years in
a series of 24 cases and Peterson et al. (1983b) a mean age of 12.8
years in a series of 131 cases.
Historical and clinical features. The signs exhibited by
cats with hyperthyroidism vary from mild to severe and are modified
by the duration of the condition, the presence of concomitant
abnormalities in other organ systems and the inability of a body
system to meet the demands imposed by thyroid hormone excess
(Peterson, 1984). Most affected individuals show evidence of
dysfunction of a number of systems but occasionally disturbances in
one predominate.
Table 3.11 lists the historical and clinical findings reported
in the three, major, published, independent series of feline
hyperthyroidism. They are largely in agreement with one another and
with other smaller series and single case reports.
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Physical appearance. Most hyperthyroid cats exhibit mild
to severe weight loss. Skin changes consisting of mats, greasy
seborrhoea (Holzworth et al., 1980), excessive shedding of hair
(Peterson, 1984) and varying degrees of alopecia (Holzworth et al.,
1980; Hoenig et al., 1982; Peterson et al., 1983b) are common.
Changes in coat colour from black to rust-brown were recorded in one
case (Jones and Johnstone, 1981). Affected cats may show an
anxious, frantic, facial expression (Peterson, 1984).
Gastrointestinal signs. All authors agree that polyphagia
is one of the most frequently seen symptoms of feline
hyperthyroidism. However, although the cause is unknown,
approximately 20 per cent of affected cats show short periods of
decreased appetite which alternate with longer intervals of
polyphagia (Peterson, 1982; Peterson et al., 1983b; Peterson,
1984). Other common gastrointestinal signs include vomition,
increased frequency of defaecation, diarrhoea and voluminous faeces
(Peterson, 1982) and excessive flatus (Theran and Hoizworth,1980).
Steatorrhoea may also be present (Peterson, Becker and Hurley, 1980;
Peterson et al., 1981).
Nervous and muscular signs. Central nervous system
abnormalities in hyperthyroid cats are evidenced by increased
activity, restlessness, nervousness, irritability, pacing and
excessive grooming (Holzworth et al., 1980; Hoenig et al., 1982;
Peterson et al., 1983b). Muscular weakness is usually accompanied
by severe muscle wasting (Peterson, 1984).
Cardiovascular signs. Numerous cardiovascular abnormalities
have been recorded in hyperthyroid cats. Tachycardia with or
without premature beats is common (Holzworth et al., 1980) with
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rates up to 320 beats per minute (Liu, Peterson and Fox, 1984).
There may be a prominent precordial impulse, apical systolic or
holosystolic murmurs (Holzworth et al., 1980), gallop rhythm,
cardiomegaly and congestive cardiac failure (Keene and Peterson,
1980; Peterson et al., 1982; Liu, Peterson and Fox, 1984). Three of
ten cases had hyperaemia of the mucous membranes and the skin of
the ears suggesting possible hypertension (Holzworth et al., 1980).
Apathetic hyperthyroidism. A form of the disease
comparable with apathetic (masked) hyperthyroidism of man (Thomas,
Mazzaferri and Skillman, 1970) occurs in approximately ten per cent
of affected animals (Peterson et al., 1983b). These cases are
depressed and weak and inappetant or anorexic rather than
hyperactive and polyphagic. They may show ventral neck flexion.
Severe cardiac abnormalities (arrhythmia, congestive cardiac failure)
are common (Peterson, 1984).
Thyroid gland. Enlargement of one or both thyroid lobes is
detectable by careful palpation in between 85 per cent (Peterson,
1984) and 100 per cent (Holzworth et al., 1980) of hyperthyroid cats.
Affected glands are freely mobile and may become retro-tracheal
(Holzworth et al., 1980; Theran and Holzworth, 1980) or intra¬
thoracic (Peterson et al., 1983b; Peterson and Yoshioka, 1983;
Peterson and Becker, 1984). Anterior migration of intra-thoracic
masses for diagnostic purposes may be made possible by holding
sedated or anaesthetised animals by the hind limbs with the head
pointing downwards (Peterson and Yoshioka, 1983).
Investigative procedures. A large number of diagnostic
tests have been applied to the investigation of feline
hyperthyroidism. These are described below. The pathomechanisms
behind the changes are discussed in Chapter 10.
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Radiology. Although Fox (1983) reported that thoracic
radiographs of hyperthyroid cats were generally unremarkable, Bond
and Fox (1984) commented that varying degrees of cardiomegaly may be
present. In a number of series of cases, cardiomegaly has been
reported in 25 per cent (Hoenig et al., 1982; Hoenig, 1983), 40 per
cent (Peterson et al., 1983b), 45 per cent (Liu, Peterson and Fox,
1984) and 50 per cent (Holzworth et al., 1980) of animals
radiographed. When the change is severe, there may be evidence of
extracardiac abnormalities associated with heart failure such as
pulmonary oedema, pleural effusion or both (Peterson et al., 1983b;
Liu, Peterson and Fox, 1984; Cowell and Cowell, 1985). Fox (1983)
reported that angiocardiography may fail to display abnormalities or
may show mild to moderate hypertrophy of the left ventricular
posterior wal 1.
Signs of pulmonic hyperinflation were evident in six of 24
cases (Hoenig et al., 1982) and moderate hepatomegaly in two of 10
others (Holzworth et al., 1980).
Electrocardiography. Electrocardiographic disturbances are
common in hyperthyroid cats (Peterson et al., 1982). The most
frequent changes are sinus tachycardia (rate greater than 240 beats
per minute) and an increase in R wave amplitude in lead II (greater
than 0.9 mV) suggestive of left ventricular enlargement (Peterson,
Johnson and Andrews, 1979; Kruth, 1980; Peterson, Becker and
Hurley, 1980; Peterson et al., 1981; Hoenig et al., 1982; 01 sen,
1982; Peterson, 1982; Peterson et al., 1982; Bond, Fox and
Peterson, 1983a; Fox, 1983; Fox, Tilley and Liu, 1983; Hoenig,
1983; Martin and Capen, 1983; 01 sen, 1983; Peterson, 1983;
Peterson et al., 1983b; Rochlitz, 1983; Bond and Fox, 1984;
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Peterson, 1984). In the largest series (131 cases) of ECGs from
hyperthyroid cats yet reported (Peterson et al., 1983b), 66 per cent
showed tachycardia and 29 per cent increased R wave amplitude.
However, numerous other changes were recorded including prolonged
QRS duration (18 per cent), short Q-T interval (ten per cent),
atrial premature complexes (seven per cent), left anterior
fascicular block (six per cent), ventricular premature complexes,
right bundle-branch block, first-degree atrioventricular block and
second-degree atrioventricular block with ventricular escape
complexes (two per cent each) and atrial tachycardia, ventricular
tachycardia and bigeminy and ventricular pre-excitation (one per cent
each). Almost all of these changes have been recorded variously by
the authors cited elsewhere in this section and in small series or
single cases reported by Holzworth et al., 1980; Keene and Peterson,
1980; McMillan and Scherding, 1981; Webb and Atwell, 1981; Noxon
et al., 1983 and Peterson and Yoshioka, 1983.
Liu, Peterson and Fox (1984) reported on the
electrocardiographic findings in 23 cats with hyperthyroid-
associated hypertrophic cardiomyopathy. Seventy per cent showed
tachycardia, 22 per cent left ventricular enlargement pattern, 13
per cent atrial premature complexes, nine per cent ventricular
premature complexes and nine per cent left anterior fascicular
block.
Echocardiography. Echocardiography abnormalities are
common in hyperthyroid cats, with Bond, Fox and Peterson (1983b)
reporting changes in 29 of 30 animals examined. Because of
hyperactivity, Bond, Fox and Peterson (1983a) administered ketamine
hydrochloride prior to carrying out the procedure. Optimum M-mode
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echocardiograms were obtained by placing the cats in left lateral
recumbency, and pointing the transducer immediately off the right
sternal border in the third to fourth rib interspace.
In these and other contributions (Fox, 1983; Bond and Fox,
1984), the most common abnormalities reported were left ventricular
hypertrophy, aortic root and left atrial enlargement and increased
parameters of contractibility (increased shortening fraction and
velocity of circumferential fibre shortening).
Serum thyroid hormone concentrations. Resting serum total
concentrations of both T4 and T3 are elevated above the normal range
in most hyperthyroid cats (Peterson, 1982; Peterson et al., 1982;
Peterson, 1983). The T4 concentration may be up to 14 times the
upper limit of the reference range with a concentration of 696
nmol/1 having been recorded (Peterson et al., 1983b; Peterson and
Becker, 1984). The T3 concentration may be up to 17 times the upper
limit of the reference range with a concentration of 15.40 nmol/1
having been recorded (Peterson et al., 1983b; Peterson and Becker,
1984).
In a series of 131 cases, the T4 concentrations were elevated
in all, whereas the T3 concentrations were in the normal range in
four cases (three per cent) (Peterson et al., 1983b). These four
cats showed only mild symptoms and signs of hyperthyroidism and had
a mean T4 concentration of only 86.2 nmol/1 (normal range was 10.3
nmol/1 to 48.9 nmol/1). Other investigators have also reported
normal concentrations of T3 in cats with hyperthyroidism (Holzworth
et al., 1980; McMillan and Scherding, 1981). It is likely that
these normal T3 concentrations would increase into the thyrotoxic
range if the disorder were allowed to progress untreated (Peterson,
1982, 1983; Peterson et al., 1983b; Peterson, 1984).
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Turrel et al. (1984) have suggested that concentrations of T4
and T3 should exceed three sds from the mean to confirm a diagnosis
of hyperthyroidism in cases where these values are only marginally
elevated.
Hoenig (1983) found that the ratio of total T3 concentration
to total T4 concentration was increased in hyperthyroid cats.
Peterson (1982), Peterson et al. (1983b) and Peterson (1984)
reported that most hyperthyroid cats have little or no increase in
basal serum T4 concentrations following exogenous TSH
administration. They suggested that this test may be of value in
the diagnosis of feline hyperthyroidism when basal thyroid hormone
concentrations are borderline or only slightly elevated. These
reports are discussed in more detail in Section 13.9.
Other biochemical changes. Although some early case
reports and reviews of feline hyperthyroidism stated that serum
biochemical tests were of no diagnostic value (Peterson, Johnson and
Andrews, 1979; Peterson, Becker and Hurley, 1980; Peterson et al .,
1981; Fox, 1983; Hoenig, 1983), most authors report changes in
many biochemical parameters in the disease.
The most commonly found abnormalities are mild to moderate
elevations in one or more of the following enzymes: serum alkaline
phosphatase (AP), alanine aminotransferase (ALT) and aspartate
aminotransferase (AST) (Holzworth et al., 1980; Kruth, 1980;
Theran and Holzworth, 1980; Jones and Johnstone, 1981; McMillan
and Scherding, 1981; Hoenig et al., 1982; Olsen, 1982; Fox,
Tilley and Liu, 1983; Martin and Capen, 1983; Noxon et al., 1983;
Peterson and Yoshioka, 1983; Rochlitz, 1983; Harari, MacCoy,
Johnson and Tranquil!i, 1984; Cowell and Cowell, 1985). Peterson
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(1982, 1983, 1984) stated that such changes were seen in between
50 per cent and 75 per cent of cases. Peterson et al., (1983b)
reported that 127 of 131 cases of feline hyperthyroidism had
elevations of at least one of AP, ALT, AST or lactate dehydrogenase
(LDH).
Mild to moderate azotaemia was found in "approximately" 25 per
cent of 131 hyperthyroid cats (Peterson et al., 1983b). However,
while other authors have reported elevations of blood urea nitrogen
in single cases (Noxon et al., 1983; Harari et al., 1984), Holzworth
et al . (1980) failed to find azotaemia in any of ten cases and Hoenig
et al. (1982) found an elevated serum creatinine concentration in
only one of 24 affected cats.
Mild to moderate hyperphosphataemia was seen in "approximately"
20 per cent of hyperthyroid cats in the absence of renal
insufficiency (Peterson, 1982, 1984).
The serum cholesterol concentration of hyperthyroid cats is
rarely subnormal. Holzworth et al. (1980) reported this change in
only two of ten and Peterson et al. (1983b) in none of 131 cases.
Haematological changes. A number of authors have reported
that routine haematological examinations are of no diagnostic value
in feline hyperthyroidism (Peterson, Johnson and Andrews, 1979;
Kruth, 1980; Peterson, Becker and Hurley, 1980; Jones and
Johnstone, 1981; McMillan and Scherding, 1981; Peterson et al.,
1981; Webb and Atwell , 1981; Fox, 1983; Hoenig, 1983).
Peterson (1982) reported that mature leukocytosis
and eosinopenia are common in feline hyperthyroidism and Cowell and
Cowell (1985) made this observation in a single case report.
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Peterson et al. (1983b) carried out complete blood counts in
131 cases of feline hyperthyroidism. The PCV and the mean
corpuscular volume were increased in 45 per cent of cases. In 14
per cent, the RBC count and the haemoglobin concentration were also
increased. The finding of macrocytosis explained why some cats had
high PCVs but normal RBC counts and haemoglobin concentrations. A
"small number" of cats, however, developed mild anaemia in
association with the hyperthyroid state.
Peterson (1983, 1984) presented reviews of these findings.
Urine analysis. Examination of urine in feline
hyperthyroidism is non-contributory (Peterson, Johnson and Andrews,
1979; Kruth, 1980; Peterson, Becker and Hurley, 1980; Peterson et
al., 1981; Webb and Atwell, 1981; Hoenig, 1983; Noxon et al.,
1983). Proteinuria and haematuria were described in two separate
case reports (Jones and Johnstone, 1981; Watson, Church, Middleton
and Rothwell, 1981), and Peterson et al. (1983b) reported that three
cats had glycosuria in association with elevated serum glucose
concentrations.
Hyperthyroid cats are able to concentrate urine (Cotter,
1983). Impaired kidney function, as evidenced by low urine specific
gravity (less than 1.015) was found in only one of a series of ten
(Holzworth et al., 1980) and two of a series of 57 (Peterson et al.,
1983b) cases. Such low figures are surprising for groups of aged
cats.
Faeces examination. Despite the clinical observation of
steatorrhoea in some hyperthyroid cats, Peterson, Johnson and Andrews
(1979) reported that faecal fat analyses were normal in five cats.
Subsequently, however, Peterson, Becker and Hurley (1980) and
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Peterson et al. (1981) reported that 48-hour faecal fat analysis of
28 and 16 cases respectively, revealed marked steatorrhoea with a
range of 5.5 to 35.3 g fat (normal is less than 3.5 g). Watson et
al. (1981) found split but not unsplit fat in two of three faecal
samples from a single hyperthyroid cat.
Peterson et al. (1983b) described more detailed findings on
the faecal fat content of five cases of feline hyperthyroidism. The
mean daily faecal fat excretion was significantly (P <0.01) greater
than normal with a daily excretion of two to 15 times the upper
limit of normal. The mean percentage fat digestibility (calculated
as the difference between the amount of fat ingested and excreted,
divided by the amount ingested) was reduced significantly from
normal (P <0.01). The serum T4 concentrations of these animals
correlated significantly with the weight of fat excreted and the
percentage fat digestibility (P <0.05 in each case).
Peterson (1984) has also reviewed his reports of steatorrhoea
in hyperthyroid cats.
Radionuclide studies
Thyroidal radioiodine uptake. Most hyperthyroid cats have
increased thyroid RIU when determined 24 hours after administration
of the radionuclide (Peterson, 1984).
Peterson, Johnson and Andrews (1979) found the range of
thyroid RIU to be 32 per cent to 58 per cent, 24 hours after the
administration of an unspecified radioisotope by an unspecified
route. Normal values were not cited. Peterson, Becker and Hurley
(1980), Peterson et al. (1981), Peterson et al. (1982), Peterson
and Becker (1983), Peterson et al. (1983b) and Peterson (1984)
found the range in hyperthyroid cats to be 19 per cent to 58 per
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cent in 28, 16, 31, 35, 32 and 51 cases respectively, 24 hours after
the intravenous administration of 25 uCi of 1311. The mean
value in 32 cases was 39.1 _+ 2.1 (sd) which was significantly
higher (P <0.001) than the mean value in healthy cats (Peterson et
al. 1983b).
Hoenig et al. (1982), using 100 uCi of 1^1 by mouth,
measured the thyroidal RIU at six hours in ten and at 24 hours in
eight hyperthyroid cats. The mean uptake at six hours was 54.2 per
cent (range 11 per cent to 81 per cent) and at 24 hours was 57.8
per cent (range 40 per cent to 97 per cent).
The details of the procedures and the reference ranges for
the above reports have been previously discussed in Section 3.8 and
summarised in Table 3.7.
Because many factors, including high dietary iodine intake,
renal disease and numerous drugs, may decrease thyroidal RIU, such
measurements can be a relatively insensitive test for
hyperthyroidism in man (Mckenzie, Zakarija and Bonnyns, 1979; Ingbar
and Woeber, 1981). Thyroidal RIU is, therefore, most useful in
determining the 1311 dose for the treatment of hyperthyroidism
and for research studies. For the former purpose, Turrel et al.
(1984) measured the thyroidal RIU in eight hyperthyroid cats at 12-
hourly intervals over three to five days, after the intravenous
administration of 100 uCi to 300 uCi of 1311. The mean peak
uptake was 24.3 _+ 9.2 per cent (sd) with a range of 10.0 per cent
to 37.9 per cent. Normal values were not reported.
Thyroidal kinetic studies. Peterson, Becker and Hurley
(1980) and Peterson et al. (1981) reported a rapid turnover of
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I in five of 16 and four of six hyperthyroid cats studied.
No further details were presented.
103
According to thyroidal kinetic studies of 30 cases, Peterson
and Becker (1983) defined two groups of hyperthyroid cats. Thirteen
animals with a rapid turnover of 1^1 (mean 49.8 hours "*)
had earlier (six compared with 24 hours) and higher (56.8 per cent
compared with 34.2 per cent) mean peak thyroidal RIU relative to 17
cats with slower 1^1 turnover (mean 148.1 hours "■*■)• The mean
T4 and T3 concentrations in the rapid turnover group were 324.3
nmol/1 and 7.76 nmol/1 respectively. These compared with mean T4
and T3 concentrations of 135.1 nmol/1 and 3.39 nmol/1 respectively
for the slower turnover group. These values were significantly
different (P <0.002 in each case).
Peterson, Becker and Hurley (1980) studied the disposition
kinetics of an unspecified dose of 1^1I in four hyperthyroid
cats. Urinary excretion predominated over faecal loss, but
approximately 25 per cent of administered ^1 remained
unaccounted for, suggesting either vapour loss or a slow releasing
compartment.
Thyroid imaging. In feline hyperthyroidism, thyroid
imaging is a very useful procedure to determine unilateral or
bilateral lobe involvement, alterations in position of the thyroid
lobes, the site of hyperfunctioning accessory/ectopic thyroid tissue
and the presence of regional or distant metastasis from a
functioning thyroid carcinoma.
Radioactive iodine (^1 and *^I) an(j technetium -99m as
pertechnetate (^m TcO^) have been used for thyroid imaging in
hyperthyroid cats. In a comparison between scans produced with
99m i
TcO^ and 1 in hyperthyroid cats, the radionuclide
images with both were similar. However, the quality of the
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TcO^ scans was usually better than that of the
scans (Peterson and Becker, 1984). Unless otherwise stated, the
techniques used in the following contributions have been discussed in
Section 3.8.
The earliest reports of thyroid imaging of hyperthyroid cats
used radioiodine and unilateral lobe involvement was most frequently
diagnosed. Thus, Peterson, Johnson and Andrews (1979), Keene and
Peterson (1980), Peterson, Becker and Hurley (1980) and Peterson et
al . (1981) reported unilateral involvement in 100 per cent of five
cases, 1 case only, 71 per cent of 28 cases and 94 per cent of 16
cases respectively. Thyroid uptake varied from a discreet nodule of
radionuclide (Peterson, Johnson and Andrews, 1979) to diffuse uptake
throughout the lobe(s) (Peterson, Becker and Hurley, 1980). The
reasons for the high incidence of unilateral involvement in these
early studies compared with a lower incidence in later studies are
unclear. Certainly, it was not a result of using radioiodine rather
than technetium, as when Peterson and Becker (1984) used each in 32
cases of feline hyperthyroidism, they found 100 per cent agreement
between the scans obtained with the two radioisotopes.
Hoenig et al. (1982) first reported the use of ^9m jco^
in thyroid imaging of six hyperthyroid cats. The animals were
premedicated with atropine and sedated with ketamine. Subsequently,
1 mCi to 2 mCi of the radioisotope were administered intravenously and
the animals scanned with a gamma camera from the cricoid arch to the
heart base 30 minutes later. No difficulty was encountered in
recognising functional thyroid tissue.
Peterson et al. (1982) carried out scintiscan evaluations of 45
hyperthyroid cats. In all cases, there was evidence of increased
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radionuclide uptake in one or both thyroid lobes consistent with the
presence of hyperfunctional tumours. In a study of 11 hyperthyroid
cats using the same technique, Peterson et al. (1983a) found
bilateral thyroid lobe enlargement in nine (82 per cent) and
unilateral lobe enlargement in two (18 per cent).
Peterson et al. (1983b) used ^mTcO^ for thyroid imaging
of 126 hyperthyroid cats. Enlargement and increased radionuclide
accumulation was found unilaterally in 36 cases (29 per cent) and
bilaterally in 90 cases (71 per cent). In all cats with unilateral
involvement, the contralateral lobe was suppressed completely and
could not be visualised. The left lobe was affected in 21 cases (58
per cent) and the right in 15 cases (42 per cent). Where there was
bilateral involvement, both lobes were of similar size in 31 cases
(34 per cent) and of unequal size in 59 (66 per cent). In 16 cats
(13 per cent), there was no palpable goitre and in these, scans
revealed that the affected lobes had descended into the thoracic
cavity. Thyroid imaging showed extension of neck swellings into the
thoracic cavity in two cats (1.6 per cent). Biopsies from these
subsequently confirmed adenocarcinoma formation. This study was
subsequently extended to 135 cases (Peterson and Becker, 1984).
They commented that although radionuclide uptake was fairly uniform
in distribution in all cats with unilateral lobe involvement,
heterogeneous accumulation of radioisotope occurred in 27 per cent of
cases with bilateral involvement. Summaries of these studies were
also published by Peterson (1982, 1983, 1984).
Peterson and Yoshioka (1983) used thyroid imaging to identify
the site of hyperfunctional thyroid tissue which was not palpable
on physical examination of a single hyperthyroid cat. After
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premedication with atropine and tranquillising with ketamine, 1.8
mCi 99 yco^ was administered intravenously. Ten minutes
later, with the patient in dorsal recumbency, 150,000 gamma camera
scintiplates were obtained using a low energy, all-purpose
collimator. Three small foci on the right side of the neck and
one large intense focus of activity on the left side of the neck
were identified.
Turrel et al. (1984) performed thyroid imaging on 11 cats,
some of which had been previously treated unsuccessfully for
hyperthyroidism by surgery (two cases) and propylthiouracil (seven
cases), prior to subsequent thyroid ablation by *31I. images
were obtained on a large field of view gamma camera utilising a
converging collimator, 20 minutes after the intravenous injection of
"approximately" 1 mCi 99m TcO^.
Rectilinear scanning has also been employed for thyroid
imaging in hyperthyroid cats. Hoenig et al. (1982) carried out the
technique using as described in Section 3.8 in 18 animals.
Resolution by this technique was usually inadequate to permit
differentiation between unilateral and bilateral involvement of the
thyroid. A summary of this work was published by Hoenig (1983).
Noxon et al. (1983) used rectilinear scanning to identify the
site of hyperfunctional "ectopic" thyroid tissue at the thoracic
QQm
inlet of a 13-year-old, domestic short-haired cat. 5.7 mCi Tc
pertechnetate was administered intravenously and, three hours later,
the cat was anaesthetised with halothane, placed in dorsal
recumbency and imaging carried out with a Picker Magna V rectilinear
scanner. The procedure contributed to successful surgical removal
of the thyroid mass. It is possible that the thyroid tissue
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identified was not truly ectopic but a hyperfunctional lobe which
had subsequently moved from its original site through the thoracic
inlet.
The main value of thyroid imaging in a cat with confirmed
hyperthyroidism is to indicate whether one or both lobes are
abnormal and thus, whether unilateral or bilateral thyroidectomy is
required. Where these facilities are not available, the clinician
can only make this decision on gross appearance of the lobe at
time of surgery or as a result of thyroid biopsy.
Thyroid biopsy. Thyroid biopsy may be used to confirm that
a cervical mass is of thyroidal origin and to identify the specific
histological abnormality. In hyperthyroid cats, the technique is
most frequently used to sample a lobe which is equivocally abnormal
in size, colour or location at the time of unilateral thyroidectomy,
thus indicating whether further surgery may be required. Because
biopsy results may demonstrate absence of pathological change, the
procedure may prevent the lifelong administration of thyroid hormone
replacement therapy or reduce the incidence of hypoparathyroidism
(Black and Peterson, 1983).
Thyroid biopsy may be carried out by closed or open techniques
but, for the reasons outlined above, the former is rarely indicated
in cats. Black and Peterson (1983) described two methods of
carrying out open thyroid biopsies in cats. In both, the surgical
approach to the gland is as described subsequently, and the biopsy
specimen is taken from the caudal aspect of the gland which is the
least vascular and which ensures preservation of the external
parathyroid.
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One technique involves using a suture of polyglycolic acid or
silk to amputate the caudal tip of the gland after ligation of the
caudal vasculature. If this is unsuccessful a wedge biopsy of the
same area can be performed, controlling haemorrhage with digital
pressure or with a deep, horizontal mattress suture.
Post-mortem examination. The results of a small number of
post-mortem examinations of hyperthyroid cats have been published.
Jones and Johnstone (1981) commented on the emaciated
appearance of one case. Liu, Peterson and Fox (1984) reported that
the mean bodyweight of 23 cases examined post-mortem was
significantly (P <0.001) less than that of clinically normal cats.
Hypertrophic cardiomyopathy is commonly found at post-mortem
examination of hyperthyroid cats. Harari et al . (1984) examined a
cat which was euthanased because of a recurrent peripheral
arteriovenous fistula at the left elbow, an infiltrative sublingual
squamous cell carcinoma and hyperthyroidism. The heart was globoid,
the apex rounded and the left ventricular wall was moderately
thickened.
Liu, Peterson and Fox (1984) found hypertrophic
cardiomyopathy in 100 per cent of 23 hyperthyroid cats examined post¬
mortem. The ratio of heart weight to bodyweight was significantly
greater (P < 0.001) in these animals than in normal cats and cats
with primary cardiomyopathy. Twenty animals (87 per cent) had
symmetrical hypertrophy of the ventricular septum and the left
ventricular free wall, whereas the remaining three had
disproportionate thickening of the ventricular septum compared with
the free wall, similar to that which is found in cats with
asymmetric hypertrophic cardiomyopathy. Histological cardiac
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abnormalities included large hyperchromatic nuclei, interstitial
fibrosis, endocardial fibroplasia, fibrosis of the
atrioventricular node and marked disorganisation of cardiac muscle
cells. Myocardial fibrosis was also reported in a single case by
Watson et al. (1981).
Cowell and Cowell (1985) reported a single case of feline
hyperthyroidism which was associated with a pseudochylous thoracic
effusion. The heart showed mild degenerative changes and it was
postulated that these were secondary to hyperthyroidism, with the
cardiomyopathy precipitating the effusion.
Hepatic changes in feline hyperthyroidism include marked
hyperaemia (Cowell and Cowell, 1985), diffuse atrophy of hepatic
cell plates (Jones and Johnstone, 1981), fatty change (Jones and
Johnstone, 1981; Liu, Peterson and Fox , 1984), bile pigment
accumulation (Jones and Johnstone, 1981) and partial fibrosis
(Watson et al., 1981).
Thirteen of 23 cats examined showed considerable engorgement
and tortuosity of alveolar capillaries (Liu, Fox and Peterson, 1984).
Transmural thickening of the pulmonary arteries, multifocal areas of
atelectasis and occasional pleural thickenings were observed in a
single case (Cowell and Cowell, 1985).
Liu, Fox and Peterson (1984) reported that eight of 23
hyperthyroid cats showed nodular hyperplasia of the zonae
glomerulosa and fasciculata of the adrenal glands. Three cases
had diffuse hyperplasia of cells of the zona glomerulosa.
Jones and Johnstone (1981) reported dermatohistopathology
consisting of mild hyperkeratosis, severe atrophy of adnexal
structures and hypertrophy of piloerector muscles in a single case
of feline hyperthyroidism.
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Mild to extensive amyloidosis has been reported in a small
number of thyrotoxic cats. Jones and Johnstone (1981) described
mild to moderate amyloid deposition in the perivascular connective
tissue of lung, lymph nodes, skin, adrenals, thyroid, liver and
spleen of a single case. Watson et al. (1981) found extensive
amyloid deposition in the glomeruli and between the medullary
tubules, and in the adrenal and thyroid glands of a hyperthyroid
cat. In both of these reports, it was suggested that the amyloid
may have been a coincidental finding. However, localised thyroid
amyloidosis has been reported previously in association with feline
thyroid tumours (Lucke, 1964; Leav et al., 1976).
Treatment. Spontaneous remission of feline hyperthyroidism
does not occur (Peterson, 1984). The disease may be treated in
three ways: by surgery, with radioactive iodine (1^1) 0r by
long-term use of an antithyroid drug.
The treatment adopted will depend on several factors
including the presence or absence of major medical disorders, the
availability of an experienced surgeon or nuclear medicine
department and the wishes of the owner (Peterson, 1984).
Surgery. Surgical thyroidectomy is the treatment of choice
for most thyrotoxic cats (Black and Peterson, 1983; Birchard,
Peterson and Jacobson, 1984). The surgical procedure is relatively
simple (Peterson, 1984) and safe (Peterson, Birchard and Mehlhaff,
1984). However, because hyperthyroidism affects many organ systems,
the anaesthetic and surgical risks in affected cats are increased
(Peterson et al., 1983b). While some authors (e.g. Theran and
Holzworth, 1980) felt that pre-operative treatment of hyperthyroid
cats did not affect the outcome of surgery, Birchard, Peterson and
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Jacobson (1984) reported that six of eight cats which died during or
immediately after thyroidectomy had not received such treatment.
Pre-operative treatment. Antithyroid drugs, and potassium
iodine alone or in combination with propranolol have been used for
pre-operative treatment of hyperthyroid cats.
Peterson (1981) felt that antithyroid drugs were the method
of choice for this procedure. The two most widely used drugs are
the thiocarbamide derivatives propylthiouracil (PTU) and methimazole
(MMI). They act mainly by blocking incorporation of iodine into the
tyrosyl groups in thyroglobulin and by preventing the coupling of
MIT and DIT (Green, 1978). In addition, PTU inhibits conversion of
T4 and T3 in peripheral tissue (Larsen, 1978).
Recommended initial daily doses of PTU and MMI are 150 mg and
15 mg per cat respectively. Although single daily doses have been
reported to be adequate in some cats, three times daily
administration appears to provide a more reliable response (Peterson,
1984).
The length of time needed for either drug to return T4 and T3
concentrations to normal is determined by the initial degree of
hyperthyroidism, the amount of thyroid hormones stored in the gland
and the extent to which thyroid hormone synthesis is inhibited
(Peterson, 1984). Most hyperthyroid cats treated with the above
regime become euthyroid within one to three weeks (Black and
Peterson, 1983; Hoenig, 1983), or two to three weeks (Peterson,
1981), although Bradley and Feldman (1982) reported that five of 13
cases continued to have elevated serum thyroid hormone concentrations
after 21 days' treatment with PTU by this regime. Dosages of 200 mg
to 300 mg PTU per day have been used if there is no decrease in
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serum thyroid hormone concentrations by this time (Peterson, 1981,
1982).
Side effects of antithyroid drug therapy are common
(Peterson, 1981, 1982) and occur more frequently with PTU than MMI.
These reactions are usually mild but serious immune-mediated drug
reactions have also been recorded (Peterson, Cavanagh and Hurvitz,
1983; Peterson, Hurvitz, Lieb, Cavanagh and Dutton, 1984) and are
described subsequently.
Propranolol, a beta-adrenergic receptor antagonist, does not
lower elevated serum thyroid hormone concentrations but prevents
many of the cardiovascular and neuromuscular effects of excess
thyroid hormones and controls the tachycardia and hyperexcitability
associated with feline hyperthyroidism (Peterson, 1982; Hoenig,
1983; Peterson, 1983; Birchard, Peterson and Jacobson, 1984).
Commonly recommended dosages for cats are 2.5 mg three times daily
(Black and Peterson, 1983) or 2.5 to 5.0 mg three times daily
(Peterson, 1982, 1983; Birchard, Peterson and Jacobson, 1984;
Peterson, 1984) for seven to 14 days before surgery. Birchard,
Peterson and Jacobson (1984) and Peterson, Birchard and Mehlhaff
(1984) used propranolol alone as pre-operative treatment for feline
hyperthyroidism but it has also been combined with potassium iodide
therapy.
Large doses of stable iodine are reported to block T4 and T3
release from the human thyroid gland and to lower serum thyroid
hormone concentrations (Mckenzie, Zakarija and Bonnyns, 1979; Ingbar
and Woeber, 1981). Thus, Hoenig (1983) recommended three to five
drops of saturated potassium iodide solution daily to render cats
euthyroid prior to thyroidectomy and to prevent complications such
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as cardiac arrhythmias during surgery, or post-operative "thyroid
storm" (hyperthermia, disorientation, disturbed cardiac function).
However, iodine alone is reported to have major limitations as
antithyroid therapy. Serum T4 and T3 concentrations may never
return to the euthyroid range and the drug may lose its antithyroid
effect within a few weeks (Peterson, 1982). Thus, the combined use
of potassium iodide and propranolol has been recommended as being
equally effective as PTU or MMI for the pre-surgical treatment of
feline hyperthyroidism (Black and Peterson, 1983), or as an
alternative in affected cats that cannot tolerate PTU (Peterson,
1981, 1983, 1984). Recommended doses of potassium iodide, when used
together with propranolol, in hyperthyroid cats, have been 50 mg to
100 mg daily (Peterson, 1982, 1983, 1984) and two to three drops of
the saturated solution daily for seven to 14 days before surgery
(Black and Peterson, 1983). Potassium iodide is said to have a
brassy taste and to cause excessive salivation and partial to
complete anorexia in some cats (Black and Peterson, 1983).
Anaesthesia and management during surgery. Anaesthesia of
the hyperthyroid cat requires a regime which minimises the risk of
death from cardiac arrhythmia. Premedication with acepromazine,
administered intramuscularly, has proved effective as it reduces the
autonomic manifestations of hyperthyroidism and causes sedation
(Black and Peterson, 1983; Birchard, Peterson and Jacobson, 1984).
Anticholinergic agents such as atropine are not usually used because
they cause sinus tachycardia and are known to enhance anaesthetic-
induced cardiac arrhythmias (Black and Peterson, 1983). If required,
glycopyrrolate is the anticholinergic of choice (Peterson, Birchard
and Mehlhaff, 1984) since it has minimal effects on cardiac rate and
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rhythm (Short and Miller, 1978). Thiamylal sodium or ketamine are
suitable agents for induction of anaesthesia (Birchard, Peterson and
Jacobson, 1984). Nitrous oxide alone (Black and Peterson, 1983), or
in combination with halothane or methoxyflurane (Peterson, Birchard
and Mehlhaff, 1984) may be used to maintain anaesthesia.
Nine of a series of 85 hyperthyroid cats developed atrial or
ventricular arrhythmias during surgery. These were successfully
controlled using 0.1 mg to 0.2 mg intravenous propranolol (Birchard,
Peterson and Jacobson, 1984).
Surgical technique. The surgical approach to the thyroid
gland has been described by Black and Peterson (1983), Birchard,
Peterson and Jacobson (1984) and Peterson, Birchard and Mehlhaff
(1984). The cat is positioned in dorsal recumbency with the
forelimbs pulled caudally and the neck slightly hyperextended. A
ventral, midline skin incision is made from the larynx to the
manubrium. The sternohyoideus and sternothyroideus muscles are then
separated by blunt dissection in the midline and retracted to reveal
the thyroid lobes.
In the case of unilateral lobe pathology, Black and Peterson
(1983) recommended unilateral extracapsular thyroidectomy and
parathyroidectomy. The cranial and caudal thyroid vessels are
ligated and transected and dissection of the loose cervical fascia
surrounding the gland allows its removal. However, subsequently,
Birchard, Peterson and Jacobson (1984) and Peterson, Birchard and
Mehlhaff (1984) recommended that intracapsular thyroidectomy should
be carried out so as to preserve both external parathyroid glands,
in cases of both unilateral and bilateral thyroid enlargement. The
internal parathyroids are embedded in the substance of the thyroid
and cannot be preserved (see Section 3.3).
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To carry out intracapsular thyroidectomy, the caudal thyroid
vein is ligated and transected. A nick incision is then made in an
avascular area of the thyroid capsule on the caudal aspect of the
gland. This incision is then extended cranially with scissors
until the entire capsule is opened. The thyroid parenchyma is then
bluntly removed from the capsule using sterile cotton-buds leaving
the thyroid capsule and the external parathyroid gland intact. The
cranial thyroid vessels should not be disturbed, because transient
or permanent ischaemia of the parathyroid gland may result. If
thyroid tissue fragments during separation from the capsule, all
pieces must be removed even if portions of capsule are removed with
them. If there is bilateral lobe involvement, the procedure is
repeated for the opposite lobe.
In man, even if the parathyroid glands are successfully
preserved, their function may be impaired by oedema and scarring
(Freeman, 1970). The incidence of permanent hypoparathyroidism was
decreased dramatically with routine autotransplantation into the
forearm musculature, of any parathyroid tissue which became
devascularised (Paloyan, Lawrence and Paloyan, 1977). Thus,
Peterson, Birchard and Mehlhaff (1984) have recommended the same
procedure in cats. However, Theran and Holzworth (1980) reported
that accessory parathyroid tissue is usually present in sufficient
amounts in cats to maintain function or to restore it within a few
days, even after total parathyroidectomy.
The surgical field is carefully examined for haemostasis
before closing the incision routinely.
Post-operative complications. Reported post-operative
complications include hypoparathyroidism, Horner's syndrome and voice
changes.
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Hypoparathyroidism may occur after the parathyroid glands are
injured, devascularised or inadvertently removed in the course of
surgery (Peterson, 1982, 1983). This results in hypocalcaemia which
may be manifested as heightened neuromuscular irritability with
muscle tremors, tetany and generalised convulsions. As only one
(Peterson, 1984) or one to two (Birchard, Peterson and Jacobson,
1984) parathyroid glands are required to maintain normocalcaemia,
hypoparathyroidism only occurs as a sequel to bilateral
thyroidectomy.
Hoenig et al. (1982) reported that six of 19 hyperthyroid
cats treated by bilateral thyroidectomy became hypocalcaemic despite
preserving at least one parathyroid in all but two cases. In four,
the hypocalcaemia was evident within eight hours of surgery but not
until four to five days later in the remainder. Birchard, Peterson
and Jacobson (1984) reported that eight of 53 hyperthyroid cats
(15 per cent) treated by bilateral thyroidectomy had low serum
calcium concentrations when tested one to four days after surgery.
However, only four animals showed signs and were treated. Peterson
(1982, 1983) also reported that it is not necessary to treat
hypocalcaemia in the absence of clinical signs. However, Martin and
Capen (1983) stated that treatment should be given routinely to any
cat in which the serum calcium concentration falls below 2 mmol/1.
Because of the possibility of post-surgical hypoparathyroidism,
serum calcium determinations should be carried out within eight
hours of bilateral thyroidectomy (Hoenig, 1983), daily for at least
two days following surgery (Peterson, 1982, 1983), and daily until
it has stabilised within the normal range (Peterson, 1984).
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Treatment of hypoparathyroidism involves the use of calcium
with or without vitamin D. Black and Peterson (1983) recommended
beginning treatment of the acute stage with 1.5 ml/kg of ten per
cent calcium gluconate by slow intravenous injection. Subsequently,
calcium may be administered orally. Hoenig et al. (1982) reported
that the daily dose of calcium gluconate required to maintain
normocalcaemia in affected cats post-surgery was 0.6g to 4g and that
there was no correlation with the initial serum calcium
concentration.
Vitamin D may be administered together with calcium as soon
as signs of hypocalcaemia are detected (Holzworth et al., 1980;
Theran and Holzworth, 1980; Hoenig et al., 1982; Martin and Capen,
1983) or used if oral calcium alone is not sufficient to maintain
normal serum calcium concentrations (Black and Peterson, 1983).
However, vitamin D therapy must be used cautiously in cats as
overdosing may result in hypercalcaemia and secondary renal damage
(Theran and Holzworth, 1980).
Unspecified dosages of vitamin D2 (Holzworth et al.,
1980), and 50,000 iu (Hoenig et al., 1982) and loading
dosages of 0.6 g to 0.8 g with subsequent daily maintenance dosages
of 0.2 g of dihydrotachysterol (Hoenig et al., 1982) have been
recommended for cats. Hoenig (1983) commented that
dihydrotachysterol has the advantage over other vitamin D analogues
because it does not require parathyroid hormone-mediated activation
by the kidney. It is activated by the liver and is non-cumulative
(Harrison, Lifshitz and Blizzard, 1967).
In most cases, iatrogenic hypocalcaemia in cats resolves
spontaneously, weeks to months after surgery (Peterson, 1982, 1983).
118
Birchard, Peterson and Jacobson (1984) reported that treatment of all
four of their cases was discontinued after two to six months
without recurrence of hypocalcaemia. In such cases, the
hypocalcaemia probably results from reversible parathyroid damage
and ischaemia incurred during surgery, or accessory parathyroid
tissue may become functional (Peterson, 1984).
Horner's syndrome may occur as a sequel to thyroidectomy in
cats (Peterson, 1982, 1983) and arises due to injury to the cervical
sympathetic trunk (Hoenig, 1983). One of 85 cats treated by
Birchard, Peterson and Jacobson (1984) developed Horner's syndrome.
Damage to the recurrent laryngeal nerves may occur during
thyroidectomy in cats because they lie close to the thyroid lobes
and are less than 1 mm in diameter. Resultant signs include altered
voice, cough and harsh respiratory sounds (01 sen, 1982). Holzworth
et al. (1980) and Birchard, Peterson and Jacobson (1984) reported
that one of ten and one of 85 hyperthyroid cats respectively,
developed such changes after surgical treatment.
Long-term management. Following thyroidectomy for
hyperthyroidism, serum thyroid hormone concentrations become normal
or subnormal within 24 to 48 hours (Peterson, Becker and Hurley,
1980; Peterson, 1982, 1983; Birchard, Peterson and Jacobson, 1984).
After hemithyroidectomy for unilateral lobe involvement, T4 and T3
concentrations are usually subnormal for six weeks (Hoenig, 1983)
or two to three months post-operatively (Peterson, 1982; Black and
Peterson, 1983; Peterson, 1983) but T4 supplementation is rarely
required during this period (Theran and Holzworth, 1980; Peterson,
1984).
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Some authors state that bilateral thyroidectomy in
hyperthyroid cats results in permanent hypothyroidism (Theran and
Holzworth, 1980; 01 sen, 1982; Martin and Capen, 1983). Other
workers have reported that serum T4 and T3 concentrations in such
cases return to normal within six weeks (Hoenig et al., 1982) or
three to six months (Birchard, Peterson and Jacobson, 1984) of
surgery. The source of thyroid hormones after bilateral
thyroidectomy may be ectopic thyroid tissue (Hoenig et al., 1982) or
regeneration of small remnants of thyroid tissue which remain
attached to the capsule (Peterson, 1984). Most authors recommend
beginning T4 supplementation within 24 to 48 hours of surgery.
Subsequently, T4 administration may be for life (Theran and
Holzworth, 1980; Martin and Capen, 1983) or simply until endogenous
hormone is once again produced at normal concentrations (Peterson,
1984). Replacement dosages of thyroid hormones for hypothyroid cats
are reviewed in Section 3.12.
After successful surgery, the signs of hyperthyroidism
rapidly disappear. Hoenig et al. (1982) described marked clinical
improvement with weight gain and evidence of regrowth of hair within
two weeks and Peterson et al. (1982) reported that ECG abnormalities
and associated cardiovascular signs resolved in most cases.
Peterson (1982) commented that relapse rarely, if ever,
occurred after thyroidectomy for hyperthyroidism when the condition
was due to unilateral lobe changes. Birchard, Peterson and Jacobson
(1984) reported that four of 53 hyperthyroid cats developed
recurrence of hyperthyroidism within eight to 44 months of bilateral
thyroidectomy. They felt that this was due to regrowth of
adenomatous thyroid tissue attached to the thyroid capsule.
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Recurrence may also result from failure to remove totally thyroidal
adenocarcinomas (Hoenig et al., 1982). Thus, Peterson, Birchard and
Mehlhaff (1984) recommended that all hyperthyroid cats treated by
surgical thyroidectomy should have their serum thyroid hormone
concentrations monitored at six to 12 month intervals to ensure that
relapse does not occur.
Radioactive iodine. In human medicine, radioactive iodine
(131i) provides a simple, effective and safe treatment for
hyperthyroidism (Peterson et al., 1983a). Radioactive iodine is
concentrated within the thyroid gland and selectively irradiates and
destroys functioning thyroid tissue (McKenzie, Zakarija and Bonnyns,
1979; Ingbar and Woeber, 1981). Dosages should, however, be
carefully calculated as persistent or recurrent hyperthyroidism may
result from inadequate therapy and hypothyroidism results from
overdosage. 131 j has also been used to treat feline
hyperthyroidism.
In an early contribution, Peterson, Becker and Hurley (1980)
commented that they had successfully treated one hyperthyroid cat
with 131i. Mo further details were given.
Peterson and Becker (1983) gave brief details of 15 cases
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which were treated with between 1 mCi and 5 mCi -LJ-LI. Serum T4
and T3 concentrations returned to the respective reference ranges
within two to nine days with a mean of 4.1 days. Hypothyroidism
developed in two cats while two relapsed needing retreatment.
Both Peterson et al. (1983a) and Turrel et al. (1984)
attempted to individualise doses of 1311 by carrying out
radioactive iodine tracer studies to determine peak RIU and
biological half-lives. Subsequently, the administered dose was
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calculated on the basis of these results and the estimated thyroid
gland weight.
Peterson et al. (1983a) attempted to deliver 15,000 rad to
the thyroid gland in each of 11 cases. The serum T4 concentration
decreased to the normal range in one to nine days with a mean of
4.1 + 0.7 days. No serious side-effects were noted. Signs
consistent with hypothyroidism developed in one cat and its serum
T4 concentration was found to be subnormal, requiring thyroid
hormone supplementation. One cat relapsed after 18 months but
responded to further ^lj therapy. The remaining nine cats
remained euthyroid in follow-up periods of one to 26 months.
Turrel et al. (1984) treated 11 hyperthyroid cats with
131
I, seven of which had been previously treated unsuccessfully
with PTU and two by hemithyroidectomy. Their treatment goal was to
deliver 20,000 rad to hyperactive thyroid tissue using doses of 1.0
mCi to 5.9 mCi However, retrospective calculations showed
that radiation doses actually ranged from 7,100 rad to 64,900 rad.
Adverse effects of 1^1 therapy such as radiation thyroiditis
or "thyroid storm" were not observed. A transient change in voice
was noted in one cat. Six hyperthyroid cats became euthyroid after
a single treatment while one required retreating after six months.
Clinical improvement was noticeable and serum T4 concentrations were
in the reference range within one month of therapy. Two cats had
1 ^1
partial responses to I therapy but remained clinically and
biochemically hyperthyroid. Two cats became hypothyroid. The
relationship between the theoretically required ^lj dose and
the ultimate thyroid status appeared to be affected by: (i) the
initial T4 concentrations, with animals having high concentrations
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responding less well, (ii) previous PTU therapy, there being some
evidence of this drug increasing radioresistance, (iii) the size of
the gland, with larger glands responding less well.
The use of radioactive iodine to treat feline hyperthyroidism
has also been reviewed by Peterson (1982, 1983, 1984).
While radioactive iodine therapy is an effective treatment for
feline hyperthyroidism, the lack of suitable facilities for this
type of treatment in animals severely limits its usefulness in
veterinary practice.
Long-term antithyroid drug therapy. This therapeutic
approach has been suggested for the management of feline
hyperthyroidism where unrelated medical conditions increase the
surgical risk, owners refuse surgical treatment and therapy
is unavailable (Peterson, 1981, 1982). Both PTU and MMI have been
used in hyperthyroid cats but no detailed studies of results with
the latter drug have been published. Unless otherwise specified,
the following comments refer to PTU therapy.
As discussed previously with respect to pre-operative
treatment, most workers report that initial daily doses of 150 mg
PTU or 15 mg MMI will reduce the serum T4 and T3 concentrations in
most hyperthyroid cats to the normal range within one to three
weeks. However, there are a number of disadvantages to long-term
antithyroid drug therapy, in particular with regard to maintenance
of the euthyroid state and the development of drug side-effects.
Because these drugs do not remove the underlying thyroid
lesion, if they are discontinued or given irregularly (as may result
from poor owner compliance), the serum thyroid hormone
concentrations increase again (Peterson, 1982, 1984). It may also
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be difficult to maintain the euthyroid state without regular changes
in the dosages of the drug. Thus, Peterson (1981) reported that the
majority of hyperthyroid cats treated long-term with 150 mg PTU daily
developed subnormal thyroid hormone concentrations and showed signs
of hypothyroidism. However, in further contributions, the same
author (Peterson, 1982, 1983, 1984) commented that relapse into the
thyrotoxic state usually occurs in due course if the dosage is
reduced below 150 mg PTU daily. In addition, hyperthyroid cats may
become "resistant" to the effects of antithyroid drugs and
subsequently require an increased dose to maintain normal serum
thyroid hormone concentrations.
Holzworth et al. (1980) were the first workers to report the
use of PTU in the management of feline hyperthyroidism. At 150 mg PTU
daily, four of six cases continued to eat ravenously but stopped
losing weight. The remaining two became anorexic immediately and
PTU therapy was ceased.
McMillan and Scherding (1981) used 50 mg PTU twice daily to
treat a single case of feline hyperthyroidism. The cat died four
months after the diagnosis was made, showing difficulty in eating
and swallowing.
Bradley and Feldman (1982) treated 13 cats with long-term
PTU. Eleven cats subjectively were improved according to their
owners and ten cats gained weight.
Minor adverse reactions to PTU therapy in cats are common
and include lethargy, vomiting (Peterson, 1981; Hoenig, 1983),
decreased appetite, facial swelling and pruritus (Peterson, 1981).
However, in an early contribution, Peterson (1981) commented that
more serious side-effects (hepatopathy and immune-mediated
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haemolytic anaemia) developed in two of 16 hyperthyroid cats treated
with PTU and subsequently other complications were noted.
Peterson and Becker (1983) briefly commented on serious drug
reactions which occurred in six of 20 hyperthyroid cats (30 per
cent) treated solely with PTU. These included anaemia,
thrombocytopenia and a lupus-like reaction. Peterson, Cavanagh and
Hurvitz (1983) gave further information about these animals and
subsequently Peterson et al. (1984) extended the series to report
on adverse reactions of PTU therapy in nine of 105 cats.
Clinical signs developed after 19 to 37 days (with a mean of
24.8 days), and included lethargy (nine cats), weakness (seven),
anorexia (six), bruising (four), oral haemorrhage (three), aural
haemorrhage (two), and haematemesis (one). Physical examination
revealed pale mucous membranes (nine cats), petechial and ecchymotic
haemorrhages of the skin and oral cavity (seven), fundic haemorrhage
(one) and icterus (one). In all nine cats, routine haematological
tests showed severe anaemia and thrombocytopenia. Granulocytopenia,
the most frequent haematological reaction to PTU therapy in man
(Parker, 1980), was not observed but has been recorded in cats taking
MMI (Peterson, 1984). A bone marrow biopsy in two cats showed
erythroid and megakaryocyte hyperplasia. The direct antiglobulin
(Coombs') test was positive in all seven cats evaluated and the
serum antinuclear antibody (ANA) titre was greater than 1:10 in five
of eight cats tested. All cats were negative for feline leukaemia
virus antigen.
Five cats were euthanased. The remaining four responded to
cessation of PTU, whole blood transfusions and oral prednisone. Two
cats also received cytotoxic therapy (vincristine and
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cyclophosphamide). In these, the anaemia and thrombocytopenia
resolved and the Coombs' and ANA tests became negative within two
weeks.
Cats that have developed a serious toxic reaction to one of
the antithyroid drugs should not be treated with the other since
cross-sensitivity may occur (Peterson, 1984).
Thus, to maintain normal circulating thyroid hormone
concentrations and to monitor for serious adverse reactions to long-
term drug therapy, a physical examination, complete blood count and
serum T4 and T3 determinations should be carried out, initially at
weekly intervals, especially between the second and sixth week of
PTU therapy when most serious adverse reactions occur (Peterson et
al., 1984). Subsequently, monitoring at monthly intervals is
probably satisfactory (Peterson, 1984).
Various clinical aspects of naturally-occurring, confirmed
cases of feline hyperthyroidism have also been reviewed by Schaer
(1981), Legendre (1983), Moore (1983), Oliver and Greene (1983),
Scherding (1983) and Tilley, Liu and Fox (1983).
Experimentally-induced cases of feline hyperthyroidism
Experimental hyperthyroidism has been induced in kittens by
dietary means and in adult cats by the administration of thyroid
extract or T4.
Roberts and Scott (1961) and Scott, Greaves and Scott (1961)
reported that kittens fed on diets with fluctuating iodine content,
(such as when a fish diet rich in iodine was replaced for several
weeks by a meat diet low in iodine), had thyroid glands which were
hyperplastic. They felt that these animals might have been thyrotoxic
but on histological and other evidence available, they were not able
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to be certain whether this was the case, or whether the thyroid was
showing compensatory hypertrophy due to iodine deficiency or the
presence of a goitrogen in meat. However, Scott (1966, 1975a),
citing this work, reported that these animals were hyperthyroid.
The cats were hyperexcitable and very active for brief periods,
after which they became exhausted and tachypnoeic. Laboratory
studies to confirm the hyperthyroid state were not carried out and
it is unlikely that these animals were actually thyrotoxic.
Hyperthyroidism has been induced experimentally in cats by a
number of medical research groups. Details of the regimes employed
and biochemical changes reported are given in Table 3.12.
Buccino, Spann, Pool, Sonnenblick and Braunwald (1967) induced
hyperthyroidism in 13 cats. The serum PBI and cholesterol
concentrations of 12 animals studied were significantly elevated and
reduced respectively (P <0.01 in each case) but the heart rate was
not significantly different, as compared to euthyroid animals. In
hyperthyroid cats, the cardiac index, the mean systolic ejection
rate and the total oxygen consumption were all significantly
elevated above normal. The authors concluded that the thyroid state
profoundly affects the intrinsic contractile state of cardiac
muscle, primarily by altering the speed of shortening of contractile
elements, and that the cardiovascular dynamic changes in
hyperthyroidism result in part from the effects of thyroid
hormones or something produced in response to thyroid hormones.
Aliev and Gaidina (1973) showed that the administration of
excess thyroid hormones to cats changed the modulatory effect of
supraspinal structures on spinal reflex activity.
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In the course of experimental studies on contractile function
of the heart, Skelton and Sonnenblick (1974) induced acute and
chronic hyperthyroidism in cats. Short-term administration of T4 did
not result in alterations in ventricular size, while prolonged T4
administration resulted in massive biventricular hypertrophy. When
T4 administration was stopped, both ventricle sizes regressed to
normal within 12 months.
Strauer and Scherpe (1975) reported that cats with experimental
thyrotoxicosis showed an increased responsiveness of the ventricular
myocardium to the negative inotropic effect of propranolol.
Other studies involving the experimental induction of
thyrotoxicosis in cats include those by Sobel, Dempsey and Cooper
(1969) and Gol'ber, Gaidina and Ignatkov (1971).
3.12 FELINE HYPOTHYROIDISM
Introduction
Hypothyroidism (Gull's disease) is a multisystemic disorder
associated with a deficiency of thyroid hormone activity. Despite
numerous anecdotal reports of the condition in cats, a case of
naturally-occurring, acquired, feline hypothyroidism has never been
definitively diagnosed, although a case of primary hypothyroid!" sm-
associated dwarfism in a kitten has been described (Arnold, Opitz,
Grosser, Bader and Eigenmann, 1984). This section reviews these
reports and those in which hypothyroidism was experimentally or
therapeutically induced.
Naturally-occurring cases of feline hypothyroidism
In 1914, Carlson reported that goitre in cats was endemic in
the Chicago and Great Lakes region of the USA. The mean ratio of
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thyroid weight to bodyweight in six affected queens was 1:6,400
(normal 1:12,000) and in 27 kittens born to them, 1:2,424 (normal
1:4,705). The adult hyperplastic thyroids showed decreased acini
and colloid, columnar instead of cuboidal cells and a marked
increase in interacinar cells. Thyroid glands from affected
kittens were enlarged with retarded formation of acini. The author
concluded that "the goitre of the newborn is due to some
pathological condition of the maternal blood".
Bourgeois (1933) reported that the "great majority" of cats in
Bern had goitre by comparison with animals from Paris or Hanover.
The degree of goitre was independent of age and no cause was
suggested. It is likely that the goitres reported in these early
contributions were due to local iodine deficiency.
Holzworth, Husted and Wind (1955) gave details of an obese,
15-year-old, neutered male, domestic short-haired cat which
presented with a left fore-leg lameness. It had sparse, brittle
hair over the flanks, atonic muscles and was weak, anxious and
restless. There was tachycardia and subsequently tachypnoea and
polydipsia. Although thyroid function tests were not carried out, a
tentative diagnosis of hypothyroidism was made. At post-mortem
examination, bilateral thyroid adenocarcinoma with arterial
thrombosis were found. Retrospectively, the authors considered that
the cat might have been hyper rather than hypothyroid. The
historical and clinical features of anxiety, hyperactivity,
tachycardia, tachypnoea and polydipsia suggest that the cat was,
indeed, probably hyperthyroid.
Meier and Clark (1958) diagnosed hypothyroidism in five cats,
"on the presence or lack of functional disturbances associated with
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thyroid changes" but, in apparent contradiction, went on to report
that, "In cats, clinical hypothyroidism practically does not exist,
there being no symptoms specifically referrable to decreased
function".
Lucke (1964) studied the thyroid glands obtained from 75
consecutive feline post-mortem examinations. The histological
appearance of one case resembled the involutionary stage of iodine
deficiency goitre.
Joshua (1965, 1971, 1979) diagnosed hypothyroidism clinically
in association with a decrease in quantity and quality of the coat,
excessive sluggishness, a reluctance to jump without evidence of a
painful focus and a slow pulse rate.
Conroy (1968) reported that hypothyroidism, sometimes
associated with widespread diffuse alopecia, occurred infrequently
in cats. He cited a plasma cholesterol concentration of greater
than 3.9 mmol/1 as being suggestive of the diagnosis.
Baker (1970), reviewing the causes of feline alopecia, felt
that feline hypothyroidism was uncommon and should be diagnosed on
the basis of low serum PBI and hypercholesterolaemia.
Berry and Mosier (1971) reported that the aetiology of feline
hypothyroidism was either thyroid atrophy or iodine deficiency.
Clinical signs included bilaterally symmetrical alopecia of the
lateral neck, thorax and abdomen, the remaining hair being dry
and lustreless, and the skin dry and scaly. Like Conroy (1968),
they also based their diagnosis on a plasma cholesterol of more than
3.9 mmol/1.
Doering (1974) felt that the serum cholesterol concentration
was not useful as an indicator of hypothyroidism as it could be
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affected by a number of disorders. In a subsequent report (Doering,
1976), he commented that, "A T4-thyroxin level of less than 12.9
nmol/1 might be significant for consideration of hypothyroidism in
cats", but no data were presented.
Austin (1975), without citing references, reported that feline
hypothyroidism was not common but had been diagnosed. Clinical
signs included obesity, lethargy, poor appetite, a tendency to seek
warm areas and bilaterally symmetrical alopecia with or without
hyperpigmentation. The serum T4 concentration was considered to be
a better diagnostic test than the PBI concentration. The
recommended therapy was dessicated thyroid or sodium laevothyroxine
(doses not specified) but even if this was otherwise successful, the
skin lesions might not completely resolve. The disease entity
described by this author does not correspond to any definitively
described elsewhere in the literature.
Scott (1975b) reported that hypothyroidism results from thyroid
aplasia. The presenting signs were the same as those of
experimental iodine deficiency but specific case details were not
presented.
Lorenz and Cornelius (1976) did not describe the physical signs
of feline hypothyroidism but stated that T4CPB before and after an
unspecified dose of TSH by an unspecified route was the preferred
method of confirming the diagnosis. Non-specific tests such as a
complete blood count and serum cholesterol concentration should be
used only as indicators of the hypothyroid state and not as
confirmatory tests.
Martin and Capen (1983) agreed with other authors that feline
hypothyroidism was uncommon. They presented photographic evidence
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of what they termed, "hypothyroidism in a cat", which was accompanied
by obesity and failure to groom and in which the serum T4 and T3
concentrations were "markedly reduced". No further details of this
case were given but serum T4 and T3 concentrations of below 12.9
nmol/1 and 0.92 nmol/1 respectively were said to support a diagnosis
of hypothyroidism. However, in other species, a number of non-
thyroidal states may reduce the total serum thyroid hormone
concentrations (see Section 3.6), and in the absence of other
diagnostic tests, subnormal values fail to confirm hypothyroidism.
Sousa and Ihrke (1983), while commenting that a well-documented
case of feline hypothyroidism had not been reported, stated that
suspected cases were obese and lethargic with a poor haircoat. They
recommended basing the diagnosis on the history, physical
examination, serum T4 and T3 concentrations before and after TSH
stimulation, and characteristic skin histology.
The only confirmed case of feline hypothyroidism was reported
by Arnold et al. in 1984 in a 14-week-old, entire female, "European"
short-haired cat presented to them because of constipation. The
kitten was stunted with short legs and an enlarged head. The tongue
was large and sometimes protruded from the oral cavity and the
teeth were underdeveloped. The haircoat was present all over the
body but consisted mainly of undercoat with primary hairs being
scattered throughout. The cat did not move spontaneously, refused
to play with other kittens and appeared dull. The body temperature
was normal but there was a marked bradycardia (88 beats per
minute). Radiographic investigation revealed almost complete
absence of ossification centres of the long bones, there was a mild
anaemia and the serum T4 was undetectable before and after three
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daily injections of TSH. Post-mortem examination revealed thyroid
lobes measuring 15 mm by 4 mm by 4 mm. Histological examination of
the thyroid showed the presence of few follicles, little colloid,
and tall epithelial cells containing slightly irregularly-shaped
nuclei characteristic of a TSH-stimulated gland. The liver
contained large amounts of glycogen. The authors attributed the
condition to a congenital defect in thyroid hormone biosynthesis.
There have been two general reports on feline secondary
hypothyroidism. Austin (1975) commented that if hyperpigmentation
is present with other signs of hypothyroidism, pituitary dysfunction
may be the initiating factor. Martin and Capen (1983) stated that
secondary signs of hypothyroidism might result from pituitary
tumours but could be alleviated with oral T4. None of these authors
gave specific case details in these contributions.
The literature on feline hypothyroidism has also been reviewed
by Scott (1980), Randolph and Jorgensen (1984) and Wilkinson
(1984).
With the exception of the report by Arnold et al. (1984), the
other descriptions of naturally-occurring "hypothyroidism" appear to
have been based on supposition and have assumed that the clinical
condition in cats must resemble that in dogs and man. Where
laboratory tests have been carried out, they have not been
sufficiently specific to confirm the diagnosis, leaving a case of
naturally-occurring, acquired, feline hypothyroidism yet to be
described.
Experimentally and therapeutically-induced cases of feline
hypothyroidism
Feline hypothyroidism has been induced experimentally by
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feeding diets deficient in iodine and by the administration of
or methylthiouracil, and as a consequence of the treatment of feline
hyperthyroidism.
Scott and her co-workers reported extensively on the effects of
feeding raw or cooked bovine heart exclusively or with various
supplements. The heart contained low quantities of iodine (lOug to
80ug per lOOg dry weight) and vitamin A and had a low calcium:
phosphorous ratio of approximately 0.05 (Scott, Greaves and Scott,
1961).
After feeding heart to ten to 14-week-old kittens for eight
weeks, the thyroids became hyperaemic, hypertrophied and
hyperplastic (Greaves, Scott and Scott, 1959). Histologically, the
thyroids of kittens receiving heart alone had reduced or absent
colloid, uniformly small follicles with one or more layers of
columnar cells and numerous dilated interfollicular capillaries
(Greaves, Scott and Scott, 1959). The condition was progressive,
the severity depending on the length of time on the diet. After 30
weeks, little colloid remained and the thyroids began to show
atrophic, fibrotic changes in place of hyperplasia (Scott and Scott,
1960). Supplementation of the diet with sufficient calcium, as
gluconate or carbonate, to give a calcium: phosphorous ratio of 1.0
reduced the degree of thyroid hyperplasia that developed, even after
eight months on the diet. Supplementation with 50 ug iodine daily
(as potassium iodide) prevented gross enlargement of the thyroid and
100 ug daily completely prevented the hyperplastic changes (Scott,
Greaves and Scott, 1961). When the diet was supplemented with
iodine, the urinary and faecal losses of calcium were reduced,
suggesting there may be a synergistic relationship between the
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requirement for iodine and calcium in the cat (Roberts and Scott,
1961).
Clinical signs of hypothyroidism due to iodine deficiency were
cessation of growth, sparse, short haircoat, thickened skin and
broadening of the head due to oedema. Affected cats moved slowly
and were affectionate and gentle (Scott, 1966, 1975a). The signs
reported are very similar to those of a single case of goitrous
hypothyroidism and dwarfism described by Arnold et al. (1984).
Although many animals showed no sexual activity, females on the
borderline of deficiency could conceive and carry foetuses to
term or beyond. Subsequently, parturition was difficult and the
kittens tended to have congenital defects such as open eyes and
cleft palates (Scott, 1966, 1975a). No tests were carried out to
confirm the hypothyroid state in these cases.
The clinical signs of hypothyroid!'sm due to iodine deficiency
were reviewed by Wilkinson (1984).
Dohan and Lukens (1938), in their investigations into feline
diabetes, surgically thyroidectomised 19 cats. Wortis and Wortis
(1938) experimentally thyroidectomised an unspecified number of cats
by an unspecified (possibly surgical) technique. Neither group
carried out tests to confirm hypothyroidism.
There are a number of reports of the induction of
hypothyroidism in healthy cats using ^1 (Table 3.13). Crawford
(1961) administered two doses of this radioisotope. He reported that
attempts to collect blood prior to treatment were so difficult, even
with the help of pentobarbitone anaesthesia, that they had to be
abandoned. However, he succeeded in collecting blood at the time of
sacrifice. Treated cats showed few signs. Their coats were ruffled
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and poorly groomed and the cats spent more time sitting in their
1itter trays.
At post-mortem examination, three cats appeared to be totally
thyroidectomised while three had residual thyroid tissue which was
abnormal macroscopically, but appeared histologically to be
functional in two.
The results of blood examinations were compared to untreated
control cats. Unfortunately, these so called "controls" were
maintained under the same conditions as the test cats for only two
weeks. The total red and total white blood cell counts of the
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I treated animals were lower than controls. The mean
haemoglobin concentration of the experimental group was also
marginally, although probably not significantly, lower than the
controls. The PBI and cholesterol concentrations of the two groups
were not statistically compared.
Buccino et al., (1967) induced hypothyroidism in cats using a
single dose of 1-^1. The heart rates and serum PBI
concentrations of treated animals were significantly different
(P <0.05 and <0.01 respectively) but the serum cholesterol
concentrations were not significantly different, between the treated
and the euthyroid groups.
Randall and Parsons (1970) ablated the thyroid glands of six
adult male cats using AJ1I. The hypothyroid state was not
confirmed by standard laboratory techniques. The cats showed skin
changes (alopecia, dry or greasy seborrhoea, hyperpigmentation of
the dorsal surface of the nose), abnormal grooming behaviour,
hoarseness of the voice and abdominal swelling.
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Pascalov-Stoenescu and Sterescu (1971) treated 17 cats orally
with 25 mg/kg methylthiouracil for ten to 14 days. They assumed that
they were subsequently hypothyroid but no clinical or laboratory
data were reported.
In a novel approach to the induction of feline hypothyroidism,
Randall and Littschwager (1967) induced surgically, stereotaxic
lesions of the brainstem of six cats. They assessed thyroid
function by determining the percentage urinary excretion of an
injected dose of ^ll. The inaccuracies of this thyroid
function test have been discussed in Section 3.8.
The most frequently reported cause of feline hypothyroidism
has been as a result of the treatment of feline hyperthyroidism due
to bilateral (or rarely unilateral) surgical thyroidectomy
(Holzworth et al. 1980; Theran and Holzworth, 1980; McMillan and
Scherding, 1981; Theran, 1981; Hoenig et al., 1982; Olsen, 1982;
Peterson, 1982; Black and Peterson, 1983; Hoenig, 1983), 131i
thyroid ablation (Peterson and Becker, 1983; Peterson et al., 1983a;
Peterson, 1984; Turrel et al., 1984) or by overdosage of
propylthiouracil (Peterson, 1981, 1984). Despite this large number
of references, clinical details of the induced hypothyroid state are
almost completely lacking. Black and Peterson (1983) mentioned the
occasional development of lethargy, anorexia and weakness lasting
two to three months after unilateral surgical thyroidectomy and
Turrel et al. (1984) commented that one of 11 cats treated with
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I subsequently became lethargic and obese. These references
are reviewed in detail in Section 3.11.
Hypothyroidism and feline endocrine alopecia
The aetiology of feline endocrine alopecia is unknown (Scott,
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1980). However, Martin and Capen (1975) equated the condition to
hypothyroidism, Doering and Jensen (1973) and Breen and Reedy (1975)
felt that it might involve thyroid hypofunction and Thornton (1963),
Anon. (1966), Wilkinson (1966), Muller and Kirk (1969), Austin
(1975), Muller and Kirk (1976), Thoday (1981), Muller, Kirk and
Scott (1983), Sousa and Ihrke (1983), Kunkle (1984), Thoday, Seth and
Elton (1984) and Thoday (1985) have reported that the condition may
respond to treatment with thyroid hormones. These references are
reviewed in Section 3.13.
Treatment of feline hypothyroidism
Dessicated thyroid, L-thyroxine (laevothyroxine sodium, T4),
L-triiodothyronine (1iothyronine sodium, T3) and combinations of T4
and T3 have all been used to treat naturally-occurring or induced
cases of feline hypothyroidism. Experimental iodine deficiency has
been treated with potassium iodide.
Naturally-occurring cases. Alleged cases of hypothyroidism
have been reported to respond to dessicated thyroid at doses of 33 mg
to 65 mg/day (Scott, 1980), 30 mg to 120 mg/day (Joshua, 1971), 60
mg to 120 mg/day (Joshua, 1965, 1979) and 2g/day (Berry and Mosier,
1971). Joshua (1971) commented that the drug was wel1-tolerated by
cats and resulted in increased energy and improvement in coat
quality. Tachycardia was an indication for withdrawing therapy.
Most authors report that once-daily therapy with T4 is
satisfactory, recommended daily doses being 10 ug to 30 ug (Muller,
cited by Doering, 1974), 50 ug to 100 ug (Martin and Capen, 1983),
100 ug to 300 ug (Scott, 1980), and 22 ug/kg (Rosychuk, 1982).
Doering (1974) reported that the half-life of T4 in cats was 12
hours and therefore he recommended twice-daily therapy with a dose
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of 1.1 ug to 2.2 ug/kg. No experimental data were reported. He
also suggested, in the absence of cardiac insufficiency, what he
termed "therapeutic diagnostics": the diagnosis of hypothyroidism by
response to T4 therapy. Such approaches have no basis in science
and little to commend them.
Scott (1980) reported a dose of 5 ug to 10 ug T3 to be
satisfactory replacement therapy for feline hypothyroidism.
Induced cases. Scott (1965, 1966, 1975a) stated that 5 mg
to 10 mg potassium iodide were wel 1-tolerated by normal cats which
excreted the excess in urine. However, cats made hypothyroid by
experimental dietary iodine deficiency showed toxic side-effects of
anorexia, fever, weight loss, a rapid pulse and tachypnoea when
treated with the same dose. She therefore recommended treating such
cases "cautiously".
Crawford (1961) treated his experimental hypothyroid cats with
either 7 mg, 16 mg or 33 mg dessicated thyroid. No signs of toxicity
appeared, even after prolonged periods of treatment with what the
author thought were doses which were large by human standards.
However, he did not state whether his treatment was successful.
Randall and Parsons (1970) used a daily intramuscular dose of
0.04 mg of a mixture of T4 and T3 in a ratio of three to two, to
treat experimental hypothyroidism. They determined the "correct"
dose by treating euthyroid cats with the preparation until they
began to lose weight and then marginally reduced the dose so that
normal weight was maintained.
T4 has been used by a number of different regimes to prevent or
treat hypothyroidism arising from the treatment of feline
hyperthyroidism. Peterson and Yoshioka (1983) recommended a daily
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dose of 50 ug T4. Holzworth et al. (1980), Theran (1981) and 01 sen
(1982, 1983) used 50 ug to 100 ug T4 per day. The currently accepted
standard replacement therapy is 100 ug T4 per cat once daily
(McMillan and Scherding, 1981; Peterson, 1982; Birchard, Peterson and
Jacobson, 1983; Peterson, 1983, 1984; Peterson, Birchard and Mehlhaff,
1984), although other authors have recommended twice-daily dosage of
100 ug (Theran and Holzworth, 1980; Hoenig et al., 1982; Black and
Peterson, 1983) or 22 ug/kg (Hoenig, 1983).
Holzworth et al. (1980) have suggested that where plasma T3
concentrations remain low despite adequate T4 concentrations, 30 ug
T3 three times daily or an unspecified combination dose of T4 and T3
may be used.
Despite these numerous reports, no carefully controlled studies
of thyroidal kinetics in normal or hypothyroid cats have been
published. Until such work is carried out, the correct thyroid
hormone dosages for the treatment of feline hypothyroidism remain
a subject of conjecture.
3.13 FELINE ENDOCRINE ALOPECIA
Feline endocrine alopecia (FEA) has also been termed sexual
alopecia (Joshua, 1958, 1965, 1971, 1979; Baker, 1974b; Scott,
1980, 1981), hormonal alopecia (Wilkinson, 1966), hypoandrogenism
(Conroy, 1968), castrate or castration alopecia (Baker, 1970;
Daykin, 1971; Austin, 1975; Scott, 1975b, 1980, 1981; Keep, 1981),
gonadal alopecia (Berry and Mosier, 1971; Scott, 1975b, 1980, 1981;
Keep, 1981), senile alopecia (Daykin, 1971; Scott, 1975b, 1980,
1981); perineal hair loss (Chesney, 1976), and endocrine dermatitis
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(Keep, 1981). FEA is the currently preferred term for the
condition.
With the exception of the report on FEA by Scott (1975b), all
other descriptions of the condition have appeared in review articles
and have been unsupported by detailed data. This has led to
conflicting claims about aetiology, predispositions and therapy of
this condition.
The prevalence of the condition is disputed, with Scott (1980)
regarding it as one of the more frequently seen dermatoses of
cats and Sousa and Ihrke (1983) reporting it to be uncommon.
Wilkinson (1981) reported geographical differences in prevalence.
Conroy (1964) reported that FEA was most common in Siamese
cats. However, with the exception of one other case in a Siamese
(Kirk, 1980) all other reports of FEA have been in non-pedigree
animals or occasional pedigree crosses (Scott, 1975b, 1981; Thoday,
1981, 1985).
Breed, sex and age predispositions
The majority of authors report that the condition is confined
to neutered individuals (Dall, 1958; Joshua, 1958, 1965; Anon.,
1966; Wilkinson, 1966; Conroy, 1968; Muller and Kirk, 1969;
Baker, 1970; Berry and Mosier, 1971; Daykin, 1971; Joshua, 1971;
Doering, 1972, 1973; Doering and Jensen, 1973; Scott, 1975b;
Muller and Kirk, 1976; Joshua, 1979; Scott, 1980, 1981). However,
other workers have reported that entire cats are occasionally
affected (Baker, 1974c; Austin, 1975; Thoday, 1981), and Kirk
(1980), in a series of 34 cases, showed a "relatively even
distribution" between entire and neutered individuals. Because the
majority of mature cats seen at veterinary clinics are neutered, the
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proposed predisposition of neutered animals in most reports may be
apparent rather than real .
Similar confusion exists in the literature as to a sex
predisposition for the disease. Anon. (1949), Joshua (1958, 1965),
Wilkinson (1966), Berry and Mosier (1971), Joshua (1971), Doering
and Jensen (1973), Baker (1974b and c), Austin (1975), Joshua
(1979) and Thoday (1981, 1985), reported no sex predisposition.
However, Scott (1975b, 1980) and Muller, Kirk and Scott (1983)
reported that 90 per cent of their cases were neutered males. Other
authors (Comben, 1953; Conroy , 1968; Muller and Kirk, 1969;
Daykin, 1971; Doering, 1973) agreed that neutered males were
more commonly affected but did not present data.
The age range of affected animals has been reported as two to
ten years, with a mean of six years (Scott, 1975b); two to 12
years, with a mean of six years (Scott, 1980; Muller, Kirk and Scott,
1983), "more than two or three years" (Kirk, 1980), any age (Scott,
1981), and old cats (Thornton, 1963; Anon., 1966; Daykin, 1966;
Joshua, 1979).
Aetiol ogy
Despite the many endocrine synonyms for the disease, FEA is, in
fact, a disease of unknown aetiology (Scott, 1980), but is presumed
to result from hormonal changes because it usually responds well
to a number of hormonal therapies (Thoday, 1981). Proposed causes
include biotin deficiency (Anon., 1949), neutering at a premature age
(six to 12 months) (Krai, 1959; Krai and Schwartzman, 1964; Scott,
1980, 1981), "endocrine changes" (Thornton, 1963; Keep, 1981),
insufficiency of androgens in neutered males (Conroy, 1968; Doering,
1972, 1973; Austin, 1975) or oestrogens in neutered females (Conroy,
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1968), unspecified sex hormone deficiencies (Joshua, 1971; Breen and
Reedy, 1975; Doering, 1976; Scott, 1980; Sousa and Ihrke, 1983;
Wilkinson, 1984), sex hormone imbalances (Baker, 1974c; Scott, 1980;
Muller, Kirk and Scott, 1983; Sousa and Ihrke, 1983; Wilkinson,
1984), hypothyroidism (Martin and Capen, 1975), deficiencies of both
sex and thyroid hormones (Doering and Jensen, 1973; Breen and Reedy,
1975) and the feeding of certain diets (Wilkinson, 1981).
Chesney (1976) proposed that FEA, miliary eczema,
neurodermatitis and eosinophilic granuloma might all be forms of the
same disease because they responded to megestrol acetate, and that
the underlying cause was a hypersensitivity response, probably to
fleas.
Recently, Ihrke (1982) and Sousa and Ihrke (1983) have also
questioned the existence of FEA as a separate disease entity
suggesting it was a manifestation of psychogenic alopecia and
dermatitis. Kunkle (1984) agreed and felt that because the
wide variety of drugs used to treat the condition all had mood-
altering capabilities and some had anti-inflammatory actions, a
favourable response did not necessarily prove an endocrine
deficiency.
Krai (1959) and Krai and Schwartzman (1964) suggested that the
reason only certain prematurely neutered cats developed FEA was
deficient adrenocortical production of androgens and/or oestrogens.
The interval between neutering and development of the condition is
very variable (Thoday, 1981, 1985). Austin (1975) quoted a period
of "a year or so" with respect to castrated males, while Scott
(1975b) reported a range of one to nine years (mean five years) in a
series of 20 cases.
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Clinical features
Despite the considerable dispute about the aetiology of FEA,
all authors are agreed on its clinical signs and the nature of the
condition's progression. FEA is characterised by bilaterally
symmetrical alopecia which usually begins over the perineum, the
genital area, the ventral tail-base, the posterior or medial thighs
or the ventral abdomen. In addition, the fore-legs (elbow to
carpus) are commonly affected, sometimes early in the condition.
There is diffuse thinning of hair, rather than complete alopecia.
In long-standing cases, hair may be lost over the ventral two-thirds
of the lateral abdomen and, less commonly, the thorax, but the
dorsum is always spared. The division between affected and non-
affected areas may be very well demarcated. Remaining hairs in
affected areas are easily epilated and microscopically show no
evidence of the free end of the shaft being broken, as may happen in
self-inflicted alopecia. In most cases, the skin is otherwise
macroscopically normal and there is no pruritus, but a very
occasional case may show areas of erythema and mild to moderate
irritation. Kunkle (1984) reported that grooming of telogen hairs
may result in hairballs and gastrointestinal upsets in FEA.
Investigative procedures
Currently the diagnosis of FEA is based on the history,
physical examination, elimination of other, clinically similar
conditions, and response to therapy. Histopathological examination
of affected skin reveals that most hair follicles are in the telogen
phase and often devoid of hairs (Scott, 1980). However, such
changes are non-specific as Kunkle (1984) reported that, in a study
of three healthy cats over a six month period, the percentage of
primary hairs in telogen was as high as 96 per cent.
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Kirk (1980) reported that one male castrate had a markedly
elevated serum progesterone concentration, and serum oestradiol
concentrations above that of eight healthy male castrates. The
serum testosterone concentration was normal for male castrates.
Three affected neutered females had slightly increased serum
oestradiol concentrations but normal serum progesterone and
testosterone concentrations compared with five healthy spayed
females. As the author commented, these results are most surprising
in view of the favourable response of some cases of FEA to
progestogens and testosterone. No other reports of sex hormone
assays in the condition have been published.
Treatment
A large number of hormonal and some non-hormonal treatments
have been recommended for the treatment of FEA.
Testosterone implants of 25 mg to 50 mg per cat have been
reported to be effective in neutered males (Dal 1 , 1958; Daykin,
1971) and both sexes (Joshua, 1965; Anon., 1966; Wilkinson, 1966;
Baker, 1970; Joshua, 1971; Baker, 1974b; Keep, 1981; Thoday, 1981;
Wilkinson, 1981, 1984; Thoday, 1985, 1986). Joshua (1965, 1971)
found that oral administration or injection of androgens was
ineffective in most cases but other authors disagreed. Oral
methyl testosterone at dosages (per cat) of 1 mg to 2 mg daily (Anon.,
1966), 5 mg daily (Wilkinson, 1966) and 0.5 mg to 1 mg daily
(Muller and Kirk, 1976), and depot-injectable testosterone at doses
of 0.5 mg/kg (Berry and Mosier, 1971) or 5 mg to 10 mg per cat
(Kirk, 1980) have been recommended. Oral or depot-injectable
testosterone therapy at unspecified dosages has also been used by
Thornton (1963), Baker (1970), Daykin (1971), Whitehead (1971),
Austin, (1975) and Breen and Reedy (1975).
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In affected female cats, oral stilboestrol has been recommended
at dosages (per cat) of 0.25 grains every third day for three weeks
(Dall, 1958), 0.25 mg to 0.5 mg every other day (Anon., 1966), 1 mg
twice weekly (Berry and Mosier, 1971), 0.1 mg daily reducing to once
or twice weekly (Breen and Reedy, 1975) and unspecified dosages
(Thornton, 1963; Whitehead, 1971). 0.25 mg to 0.5 mg stilboestrol
may also be used to treat affected male cats (Anon., 1966).
Repositol injections of 0.25 mg/kg diethylsti1boestrol have been
recommended by Berry and Mosier (1971). All authors agree that
stilboestrol implants should be avoided as female cats subsequently
show persistent oestrus (Dall, 1958; Joshua, 1965; Anon., 1966).
Wilkinson (1966) warned against the use of stilboestrol by any route
because of possible fatal hepato-biliary disease.
While Wilkinson (1981) reported that he had had no therapeutic
success using megestrol acetate, most other authors have found
progestational compounds to be particularly useful in the treatment
of FEA. Megestrol acetate at initial dosages per cat of 2.5 mg
daily (Sousa and Ihrke, 1983), 2.5 mg to 5 mg daily (Wilkinson,
1984) or every other day (Scott, 1980, 1981), 5 mg daily (Kirk,
1980) or every second or third day (Thoday, 1985, 1986) or
unspecified dosage (Austin, 1979), has been recommended until hair
growth is complete.
Other progestational compounds that have been used successfully
include depot injections of progesterone at an unspecified dose
(Daykin, 1971), 2 mg to 4 mg/kg (Kirk, 1980) and 2.2 mg to 22 mg/kg
(Scott, 1980, 1981), and medroxyprogesterone acetate at doses of 20
mg/kg (Scott, 1979), 25 mg to 90 mg/kg (Keep, 1981), or 50 mg to 175
mg/lb (Muller, Kirk and Scott, 1983). In all instances, animals are
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re-examined after six weeks and the administration repeated if
required. Progesterone implants (dose unspecified) have also been
recommended by Daykin (1971).
Mixtures of various sex hormones have been employed to treat
FEA. Doering and Jensen (1973) and Doering (1976) recommended a
depot combination of 0.1 mg to 0.5 mg oestradiol and 2.5 mg to
12.5mg testosterone to either sex, with a second administration
after three weeks. Scott (1975b) reported that 18 of 20 affected
cats responded to depot combination injections of 12.5 mg
testosterone and 0.625 mg stilboestrol. The remaining two cats
required a second administration after six weeks. Similar regimes
have also been recommended by Austin (1979), Scott (1980, 1981),
Kirk (1980), Keep (1981) and Muller, Kirk and Scott (1983).
Although Scott (1975b) reported that FEA cats were not
hypothyroid, some authors have shown that cases respond well to
thyroid hormones. Thyroid extract at daily dosages of 0.5 grain/cat
and 1 grain/4.6kg was recommended by Wilkinson (1966) and Anon.
(1966) respectively. L-thyroxine sodium has also been found to be
effective. Muller, cited by Muller and Kirk (1976) administered 300
ug T4 daily for three months and subsequently once weekly. Keep
(1981) used the same initial dosage but a maintenance dosage of 10 ug
to 30 ug/day. Thornton (1963) and Austin (1979) recommended thyroid
hormone replacement therapy but further details were not given.
Combinations of sex hormones and thyroid hormones have also
been used to treat FEA. Muller and Kirk (1969) used a combination
of either 2 grain dessicated thyroid or 100 ug to 300 ug L-thyroxine
sodium daily for three to six months, together with 2 mg oral
testosterone to neutered male or 0.1 mg oral stilboestrol to
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neutered female cats daily. The sex hormones were discontinued
temporarily if males began to spray urine or females showed signs of
oestrus. Berry and Mosier (1971), Doering (1972, 1973) and Breen
and Reedy (1975) reported similar treatment regimes. However, the
report from Doering contradicts others from the same author (Doering
and Jensen, 1973; Doering, 1976) which stated that thyroid replacement
had not been attempted. Baker (1974b) successfully used a
combination of 1 mg/kg thyroid extract daily for "several months"
together with a 25 mg subcutaneous implant of testosterone.
Whichever hormone or combination is used, all authors agree
that continuous low dosage or intermittent high dosage is
required in most cases to maintain normality.
Other recommended regimes have included biotin and other
vitamin or mineral supplements (Anon., 1949; Anon., 1966; Wilkinson,
1966), Whitfield's ointment (Anon., 1949), colloidal iodine oil and
glucocorticoids (Wilkinson, 1966).
3.14 AUTOANTIBODIES IN FELINE NATURALLY-OCCURRING HYPERTHYROIDISM
AND RAD 10IODINE-INDUCED HYPOTHYROIDISM
Naturally-occurring hyperthyroidism
Human hyperthyroidism is most commonly due either to Graves'
disease or to toxic nodular goitre (Toft, Campbell and Seth, 1981).
Graves' disease is characterised by diffuse hyperplasia of the
thyroid gland whereas toxic nodular goitre results from one or more
hyperfunctioning, adenomatous thyroid nodules (Peterson, 1984). A
Graves-like condition with associatedophthalmopathy has not been
recorded in cats (Peterson, 1983, 1984). The thyroid changes
occurring in most cases of feline hyperthyroidism resemble human
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toxic nodular goitre, for which it has been suggested as an animal
model (Peterson, Becker and Hurley, 1980; Peterson and Becker,
1983; Peterson, 1984).
Graves' disease is a well-characterised autoimmune disorder in
which antibodies to the TSH receptor (Manley, Bourke and Hawker,
1974; Petersen, Smith and Hall, 1976) and changes in lymphocyte
subsets with a relative deficiency of suppressor cells (Thielmans,
Van Haelst, de Waele, Jonckheer and Van Camp, 1981; Sridama, Pacini
and DeGroot, 1982) are recognised. In common with many other
autoimmune diseases, it is associated with HLA DR3 (Farid and Bear,
1981). Toxic nodular goitre, however, has no particular HLA
association and the role of autoimmunity in the condition is
unclear. Thyroid specific antibodies may occur (Codaccioni,
Depieds, Jean, Henry and Lebreuil, 1971) and TSH receptor antibodies
can be detected using sensitive cytochemical bioassays (Smyth,
Neylan and 0'Donovan 1983). Changes in immunoglobulin
concentrations and an abnormal response to thyroid antigen in the
lymphocyte migration test have been described (Kiy, Rezkallah-
Iwasso, Peracoli and Mota, 1982).
Immunological studies have not been carried out in untreated
cases of feline hyperthyroidism. As discussed in Section 3.11,
positive serum ANA titres have been reported in small numbers of
hyperthyroid cats showing serious drug reactions to PTU. In a brief
contribution, Peterson, Cavanagh and Hurvitz (1983) reported ANA
titres of 1:20 to 1:40 in serum samples from four of six affected
cats tested by an unspecified method. Subsequently, Peterson et al.
(1984) identified serum ANA by indirect immunofluorescence using
HeLa cells as the substrate and fluorescein-conjugated IgG as the
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developing antiserum. Titres of greater than 1:10 were reported for
five of the eight affected cats tested. None of the cats was tested
for ANA before drug therapy and cessation of treatment and
supportive therapy resulted in negative titres within two weeks.
Radioiodine-induced hypothyroid!'sm
While there have been previous accounts of the ablation of the
feline thyroid using radioiodine (see Section 3.12) there are no
reports as to whether this procedure may induce circulating thyroid
antibodies.
In man, thyroid microsomal and thyroglobulin antibodies may be
induced in euthyroid subjects as a result of 1^1 therapy
(Einhorn, Fagraeus and Jonsson, 1966).
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4- STANDARDISATION OF RADIOIMMUNOASSAYS FOR THYROXINE
AND TRIIODOTHYRONINE IN FELINE SERUM
4.1 INTRODUCTION
Standards prepared in buffer or serum of another species may
result in inaccuracies in RIA procedures because of the absence of,
or differences in, protein effects in standards compared with test
samples. Ideally, therefore, standards for thyroid hormone assay
should be prepared in T4 and T3-free serum of the same species as
the test samples. This not only attempts to equalise protein
concentrations in standard and sample tubes but compensates for
residual protein interference not eliminated by barbiturate buffer
and ANS.
Thyroid hormones may be removed from serum in a number of ways
e.g. by using activated charcoal (Peterson et al., 1982; Hoenig and
Ferguson, 1983; Donne and Wildgoose, 1984), agarose-covered charcoal
(Stockhill, 1979) or anion exchange resin (Salter, 1979). The
latter technique is currently recommended by the UK External
Quality Assessment Scheme for T4 and T3.
4.2 REAGENTS
Anion exchange resin
Strongly basic anion exchange resin was obtained in the
chloride form as Dowex 2X8, dry mesh 100-200, from the Sigma
Chemical Company, Poole, Dorset, England.
151
Protein standard and protein control serum
The protein standard used in estimating serum protein
concentrations was prepared from Pentex bovine albumin (ten per
cent) crystalline solution, obtained from Miles Laboratories, Stoke
Poges, Buckinghamshire, England. The protein control serum was
Seronorm, obtained from BDH Chemicals, Poole, Dorset, England.
Thyroxine and triiodothyronine
T4 sodium salt pentahydrate (per cent purity unstated)
and T3 free acid (95 to 98 per cent pure) for use as standards were
obtained from the Sigma Chemical Company.
4.3 EQUIPMENT
Filter papers
Glass microfibre filter papers (coarse filter, GF/D;
fine filter, GF/F) were obtained from Whatman, England.
Electrophoresis system
Serum protein electrophoresis was carried out using
the Corning AC1 film/cassette electrophoresis system. Films were
scanned by a Beckman R112 scanning densitometer.
Spectrophotometers
A Cecil CE 292 UV/visible range digital spectrophotometer
was used for determining total serum protein concentrations. The
concentrations of the T4 and T3 standard solutions were measured
using a Pye Unicam SP-8-100 ultraviolet spectrophotometer.
4.4 PREPARATION OF "HORMONE-FREE" FELINE SERUM
Collection of normal serum
Blood was collected from a number of cats which were
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considered to be healthy on the basis of a physical examination, and
prior laboratory screening by means of a complete blood count and
serum urea, AP, ALT and cholesterol estimations. Anaesthesia was
induced and maintained using halothane (Fluothane, Imperial Chemical
Industries), initially via an open mask and subsequently by cuffed
endotracheal tube. The animals were then bled out from the carotid
arteries via polythene tubing which had previously been flushed with
heparin solution, 1,000 units/ml (Heparin Injection B.P., Paines
and Byrne).
The blood was collected and allowed to stand at room
temperature until clot retraction had occurred. Serum was harvested
by centrifugation and subsequently transferred to universal
containers for storage at -40°C.
Procedure for removal of endogenous thyroxine and
triiodothyronine
Endogenous T4 and T3 were extracted from pooled serum using an
anion exchange resin (Salter, 1979). The pooled serum was allowed
to come to room temperature and a sample taken for determination of
the protein content. In order to monitor the efficiency of hormone
removal, or 125j_j3 was added to give approximately
10,000 counts/minute/ml. The resultant mixture was incubated
overnight to ensure binding of the radiolabel1ed hormones to serum
proteins.
The serum was then stirred magnetically with 300mg/ml of
the anion exchange resin in an incubator at 37°C for three hours.
Although the original method recommends decanting the serum at this
stage, it was found that the final yield could be increased by
filtration through a series of glass microfibre papers on a Buchner
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funnel using first a coarse filter, followed by a double layer of a
fine filter. Further resin was added in the same proportions and
the stirring and filtration stages repeated. A sample of the serum
was then counted and the per cent removal of radiolabeled hormones
determined. A sample was retained for further protein
electrophoresis. Sodium azide (0.01 per cent) as a bacteriostat was
added to the extracted serum which was stored in aliquots at -40°C.
Optimisation of procedures for removal of thyroxine and
triiodothyronine
In the trial stages of the technique, effects of (i) time
of pre-incubation of radiolabel with serum, (ii) temperature of resin
extraction, and (iii) a third extraction stage on the efficiency of
the process were evaluated.
(i) Effect of time of ^^I-T4 pre-incubation. This was
compared between two samples of the same serum. One was incubated
with ^I-T4 at 4°C overnight and one for 15 minutes only. The
resin extraction process was then run in parallel.
The percentage ^I-T4 removed from serum by resin extraction
after only 15 minutes' incubation with tracer was consistently but
only marginally higher than that removed after overnight incubation
(Table 4.1, samples A and B). Nevertheless, as a precautionary
measure, it was decided to use overnight incubation as a routine
measure.
Effect of temperature. Two samples of serum were resin
extracted at room temperature instead of 37°C. The results showed
no significant difference in the amount of T4 removed at the two
temperatures (Table 4.1, samples A and C). This indicated that there
was considerable latitude in the temperature required but as the
154
original method specified that it be carried out at a constant 37°C,
this was the condition routinely used.
Effect of an additional resin extraction stage. In
three studies, a third resin extraction stage was added in order to
investigate whether additional, significant quantities of T4 could be
removed.
The mean ^^I-T4 removed after two stages was 98.23 per cent.
Only a mean 0.56 per cent of radiolabel was removed in the third
stage (Table 4.1). It was not felt that this small increase in
extraction efficiency would add to the resultant assay accuracy.
Efficiency of resin extraction
The results of six hormone extraction studies for T4
and seven for T3 are presented in Table 4.2. Experiments 1 to 4
were pilot experiments and on a small scale. Serum from experiments
5 and 6 and 5 to 8 was used for the production of T4 and T3
standards respectively. The procedure was efficient at removing
added (and, therefore, presumably endogenous) T4 and T3, with mean
_+ sd values of 98.84 +_ 0.54 per cent and 99.45 _+ 0.35 per
cent respectively. The percentage 125j_j3 removec| Was
consistently greater than 125j_ y^ y^ y-jgu 0y serum was
approximately 70 per cent by volume.
Effect of resin extraction on serum protein
concentrations
Methods. Serum protein values of samples taken
before and after the resin extraction procedure were determined and
the paired samples compared with each other and with normal values
published from this School (Keay, 1982).
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Total protein was determined by the biuret method of Henry,
Sobel and Berkman (1957) using crystalline bovine albumin as standard.
The final absorbances of the protein/biuret complexes were read
spectrophotometrically in 1 cm plastic cuvettes against a reagent
blank at 545nm. Seronorm samples were used for quality control.
Agarose electrophoresis of serum proteins was carried out
according to the procedure described by the manufacturer (Corning
AC1 Film/Cassette Electrophoresis System-applications Manual). 0.8ul
of each serum sample was located into preformed, numbered sample
wells on the film. Each film could accommodate eight serum samples.
The films were electrophoresed for 35 minutes at a constant 90
volts with fresh, refrigerated 0.05mol/l barbital/EDTA buffer, pH
8.6. After electrophoresis, the films were simultaneously fixed and
stained in an acetic acid/ami do black solution for 15 minutes at
37°C. After destaining in acetic acid and drying completely, the
films were scanned densitometrically at 600nm.
Results. Fig. 4.1 shows the mean and sd of a number of
batches of sera in which protein concentrations were checked before
and after the resin extraction process. The number of batches varies
because while the technique was being developed, normal serum
samples were divided and extracted on different occasions. In
addition, it was not always possible to separate the beta-globulin
component into two groups electrophoretically and such samples have
not been included.
Resin extraction resulted in a slight loss in most protein
fractions, but the effects were not statistically significant as
assessed by Student's paired t test (t = 1.46, 5d.f; P > 0.2).
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4.5 PREPARATION AND CALIBRATION OF STOCK SOLUTIONS OF
THYROXINE AND TRIIODOTHYRONINE
Thyroxine standard
L-Thyroxine sodium salt pentahydrate (87mg) was weighed at
room temperature and transferred quantitatively to a 100ml volumetric
flask. The solvent used was propylene glycol:water (1:1 by volume)
adjusted to pH 9.0 by the dropwise addition of sodium hydroxide
(1.0mmol/l). The solution was agitated gently until all the sodium
salt had dissolved, then made up to the mark. The concentration of
this stock solution was nominally 1.0mmol/l.
The concentration of the solution in 0.1mol/l sodium hydroxide
was checked spectrophotometrically from the absorbance at 325nm
assuming an absorbance coefficient of 6200 1 mol~^cm~^.
Triiodothyronine standard
L-Triiodothyronine free acid (65.1mg) was weighed and
made up to 1.0mmol/l as above. The concentration of the solution
in 0.1mol/l sodium hydroxide was checked spectrophotometrically
from the absorbance at 320nm, assuming an absorbance coefficient of
4660 1 mol~lcm"l.
4.6 PREPARATION OF WORKING STANDARDS
In order to conserve extracted serum, initial dilutions of
stock iodothyronine solutions were made in assay buffer using a
pipette checked for accuracy prior to use, to produce an intermediate
stock solution of lumol/1. Subsequent dilutions were made into
extracted cat serum in two stages to produce standards of 0, 5, 10,
20, 40, 60, 80, 120, 160, and 200 nmol/1 for T4, and 0, 0.125, 0.25,
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0.5, 1, 1.5, 2, 3, 4, 5 and 10 nmol/1 for T3. The standards were
stored in aliquots in polystyrene tubes at -40°C.
Reproducibility of standard preparation
Sufficient T4 working standards were prepared to complete
the studies described here but additional T3 standards had to be
produced. The second set of T3 standards was prepared from the same
stock standard using a different batch of "hormone-free" serum.
Standard curves with the new and old standards were virtually
superimposable, the slight difference being reflected in the pool
values (Table 4.3).
4.7 DISCUSSION
Correct standardisation of RIA is essential and for this
reason, standards for these assays were prepared in resin extracted
cat serum. The extraction method adopted has been recommended for
use with human serum as it does not affect the major thyroid hormone
binding proteins (C.R. Salter, personal communication), whereas
charcoal extraction as used with cat serum by Peterson et al.
(1982), Hoenig and Ferguson (1983) and Donne and Wildgoose (1984)
tends to remove a proportion of such proteins. The charcoal
extraction technique also requires the use of an ultra-centrifuge to
remove charcoal fines.
When used with cat serum, the technique showed no serious
effects on protein concentrations. Albumin concentrations were
sometimes lowered but alpha-1 and alpha-2-globulin levels showed
little change (the major human thyroid hormone binding protein, TBG
migrates in the inter-alpha-l/alpha-2 zone on electrophoresis). In
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fact, the alpha-l-globulin component in nine studies and the beta-1-
globulin component in five studies showed mean increases of 0.25g/l
and 0.24g/l respectively. The cause of these increases is unknown.
It is possible that they may fall within the experimental error
limits for the method. An alternative explanation is that during
the extraction process, there was some fluid component loss, in
which case the protein levels post-extraction in all components are
artificially elevated. A third possible explanation is that some
denaturing of other protein components occurred during resin
extraction so that they migrated electrophoretically in different
groups.
Prior to resin extraction, the total protein concentration and
the concentration of albumin were marginally below the normal
respective ranges as evaluated as two sds from the mean from data
published from this School by Keay (1982). Such a range includes 95
per cent of the population and inevitably there will be some healthy
animals which will have protein concentrations outside this range.
It might have been expected that pooled serum from a number of
healthy animals would come within the 95 per cent confidence
limits. However, the serum was collected from arterial blood
whereas Keay's samples were obtained from venous blood and this may
explain the differences.
The efficiency of resin extraction of thyroid hormones is
monitored by the percentage removal of radiolabeled T4 and T3 and
it is assumed that endogenous T4 and T3 behave in a similar fashion.
The percentage of -^^5j-T4 removed by the technique was only
marginally greater after 15 minutes' incubation with the radiolabel
than if they were incubated together overnight, indicating that the
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binding of T4 to serum proteins in the cat, as in man, is an
extremely rapid process (Robbins and Rail, 1957).
Several modifications of the original resin extraction method
were investigated. There was no significant difference in the
percentage ^^I-T4 removed at room temperature compared with 37°C.
An additional resin stage removed a mean of only 0.56 per cent more
radiolabel. Because of the possibility of protein denaturation by
these altered conditions, it was felt to be inadvisable and
unnecessary to employ them. T3 is less avidly bound to human serum
proteins than T4, and is more easily removed by resin extraction. A
similar situation is likely in feline serum and it was found that in
each paired study, a greater percentage of ^^I-T3 was removed from
the serum than Thus, trials with a third resin extraction
stage were not repeated for T3.
After four pilot experiments for T4 and three for T3, a
minimum of 98.5 per cent T4 and 99.1 per cent T3 had been removed
from the serum. It is generally accepted in human medicine that
serum is satisfactory for standard production if greater than 95
per cent of these iodothyronines have been removed. In fact, in full-
scale studies to produce serum in bulk for standard production,
means of 99.45 per cent T4 and 99.70 per cent T3 were removed.
This is superior to the best results obtained by the U.K. External
Quality Assessment Scheme for T4 and T3 in studies on human serum
(C. R. Salter, personal communication) and may reflect less avid
protein binding of these hormones in cats than in man.
By counting samples of serum after the first and second resin
extraction stages, it was shown that means of 96.76 per cent T4 and
98.46 per cent T3 were removed initially, leaving means of only 1.61
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per cent and 0.72 per cent respectively to be removed by the second
stage. By filtering rather than decanting the serum at each stage,
the yields could be increased. It is obviously essential to
maximise such yields when working with animals with relatively small
blood volumes such as the cat.
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5. DEVELOPMENT OF RADIOIMMUNOASSAYS FOR TOTAL THYROXINE
AND TOTAL TRIIODOTHYRONINE IN FELINE SERUM
5.1 INTRODUCTION
A RIA is defined by three components: the radiolabeled
species, the antiserum and the separation system. In these
studies, 125l-T4 0r ^^I-T3 and sheep anti-T4 or anti-T3
defined the first two components. An important task, therefore, was
to define the separation system.
The important requirements of a separation system are that it
should:
(i) completely separate the antibody-bound and free forms of
the labelled analyte (i.e. low misclassification error).
(ii) give a low "non-specific" binding (i.e. binding in the
absence of the primary antiserum).
(iii) show minimum drift with exposure of incubates to
separation reagents (i.e. reach equilibrium and not cause disruption
of the antigen-antibody complex).
(iv) be rapid and convenient.
Many methods have been described but they fall into the broad
categories of:
(i) Solvent precipitation: e.g. polyethylene glycol (PEG) which
precipitates IgG.
(ii) Absorption: e.g. activated charcoal which absorbs the free
analyte.
(iii) Molecular sieving: on sephadex gels, either
chromatographically or in batch mode.
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(iv) Immunology: using a second antibody directed against
the IgG of the species in which the first antibody was raised (the
double antibody technique).
(v) Solid phase methods: in which either the first or second
antibody is conjugated to an insoluble support.
In these studies, both solid phase first antibody and double
antibody techniques were investigated.
All RIAs require optimisation to ensure an assay response
which is appropriate to the type of sample and the concentration
range of interest, and a consistent response in the face of possible
variations in reagent concentration. After optimisation, it is
necessary to validate each assay by demonstrating satisfactory
accuracy, precision and sensitivity.
This chapter describes the investigation of two RIAs, using
different separation systems, for the measurement of feline total
serum T4 and T3. The difficulties encountered with the solid phase
system are detailed and subsequently the optimisation of the double
antibody RIA methods selected for routine use are described in
detail. The methods chosen and their validation are described in
Chapter 6.
5.2 REAGENTS
Anti-thyroxine and anti-triiodothyronine sera
Sheep anti-T4 and sheep anti-T3 sera were obtained from the
Scottish Antibody Production Unit (SAPU), Carluke, Lanarkshire,
Scotland. These antisera were pools of selected bleeds from sheep
immunised with T4 and T3 respectively which had been conjugated to
human serum albumin by the carbodiimide method. Cross-reactivities
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on a molar basis were 2.5 per cent for T3 with the anti-T4 serum
and 0.25 per cent for T4 with the anti-T3 serum. The lyophilised
antisera were reconstituted with distilled water and allowed to
stand at room temperature for one hour. The resulting solutions
were stored in aliquots at -20°C until required.
Cellulose-linked anti-thyroxine and anti-
triiodothyronine
Microcrystal1ine cellulose was obtained from E. Merck
(Darmstadt, Germany), activated with cyanogen bromide and covalently
coupled with anti-T4 or anti-T3 serum according to the method of
Seth, Rutherford and Mckenzie (1975). The stock preparation was
stored at 4°C.
Donkey anti-sheep serum and non-immune sheep serum
Donkey anti-sheep serum (DAS), for use as a precipitating
antiserum, and non-immune sheep serum (NSS) for use as a "carrier"
were supplied in liquid phase by SAPU and stored in aliquots at
-20°C. The DAS was a pool of selected donations from donkeys
immunised with a mixture of purified normal sheep IgG.
Radiolabeled thyroxine and triiodothyronine
125
I-labelled T4 of specific activity greater than 34.5
MBq/nmol, and ^I-labelled T3, of specific activity greater than
28.9 MBq/nmol were obtained from the Radiochemical Centre, Amersham,
Buckinghamshire, England. These reagents were in ethanol/water
(3:1) solution.
8-anilino-l-napthalene-sulphonic acid (ANS) ANS was obtained
from the Sigma Chemical Company.
Assay diluents
Solid phase techniques. The assay diluent was 0.1mol/l
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sodium glycinate buffer, pH 10.5 containing 0.2 per cent gelatine
and 0.01 per cent thiomersal. The stock solution was stored at 4°C.
Double antibody techniques. The assay diluent was 0.05mol/l
sodium barbiturate buffer, pH 8.6, containing 0.01 per cent sodium
azide as a bacteriostat. The stock solution was stored at 4°C. In
order to prevent adsorption of thyroid hormones to equipment
surfaces, 0.1 per cent bovine serum albumin (Miles Laboratories) was
added immediately before use.
5.3 EQUIPMENT
Assay tubes
All RIAs were performed in duplicate in 12 x 75mm
polystyrene tubes (Sarstedt, Beaumont Leys, Leicester, England).
Pipettes
Sampling of serum and dispensing of reagents was carried out
using a Giford Automatic Pipetter/Diluter and a Hamilton Microlab M
automatic pipette.
Centrifuge
The separation of free and antibody-bound activity was
performed on a Heraeus Christ 6.4 refrigerated centrifuge. A
multiheaded carrier was used, giving a centrifugal force of 3,000g
at 3,000 revolutions per minute (rpm).
Gamma counter
A Nuclear Enterprise NE 1600 was used. The background count
(1^1 channel) was less then 50 cpm, and regular checks were
performed to ensure equivalence between channels.
Computer facilities
Data on the paper tape output from the NE1600 was entered
via a Hewlett Packard paper tape reader (Model 9833A) and a Hewlett
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Packard desk-top calculator (Model 9821A) for calculation of RIA
results. This was done using a four parameter logit-log fit for the
standard curve (courtesy of Dr. A. Smith).
5.4 INVESTIGATION OF SOLID PHASE METHODS FOR THYROXINE AND
TRIIODOTHYRONINE RADIOIMMUNOASSAY
Introduction
The assay design was similar for both T4 and T3 and was based
on the methods described by Seth, Toft and Irving (1976). In these
techniques, the antibody is made insoluble by covalent coupling
with microcrystalline cellulose. Use of antibodies in this form
permits antibody-bound and unbound radiolabel1ed T4 and T3 to be
easily separated by centrifugation. Although theoretically robust
and giving high precision, the solid phase T3 assay proved to be
unsuitable and only brief details of the techniques are given here.
Methods and results
Optimisation of anti-thyroxine antibody dilution. The
concentrations of other reagents and reaction conditions were
initially based on those used in the assay of human T4 and were as
follows: ^I-T4, 35,000cpm; ANS, 250ug per tube; 0 or 80nmol/l
standards, 25ul; final reaction volume, 725ul.
Suspensions of stock solid coupled T4 antibody were prepared in
assay diluent in doubling dilutions such that the final dilution in
the incubates would range from 1:145 to 1:74,250. Titre curves were
set up using 0 and 80nmol/l standards. (The anticipated normal
feline serum T4 concentration was up to 80nmol/l). After incubation
at 4°C for 36 hours, pre-wash solution (0.1nmol/l saline containing
0.06 per cent Brij) was added to all tubes which were then
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centrifuged at l,500g for 15 minutes. After decanting the
supernatant to waste, the antibody-bound ^^I-T4 was counted.
Graphs of per cent ^J>I-T4 bound were plotted against antibody
dilution. The optimum antibody dilution was subsequently
interpolated as the largest difference in per cent ^I-T4 bound
between the two sera at any antibody dilution. This was found to be
1:8,700 final dilution (1:6,000 initial dilution).
Optimisation of anti-triiodothyronine antibody dilution.
This was performed as above with the following modifications:
The initial concentration of the other reagents was ^I-T3,
30,000 cpm; ANS, 250ug per tube; 0 and 2.0nmol/l standards, 50ul,
(the anticipated normal feline serum T3 concentration was up to
2.0nmol/l); final reaction volume, 750ul. T3 antibody final
dilutions tested ranged from 1:150 to 1:77,000.
The optimum T3 antibody dilution was interpolated from graphs
at 1:7,500 final dilution (1:5,000 initial dilution).
Optimisation of ANS concentrations for the
solid phase thyroxine and triiodothyronine
radioimmunoassays. ANS concentrations for the T4 and T3
assays were optimised using the method described by Seth, Rutherford
and McKenzie (1975). This method is described in detail for the
double antibody RIA in Section 5.6. ANS concentrations tested
ranged from 2,000ug per tube in doubling dilutions to Oug per tube.
The concentration of other reagents and reaction conditions were as
described previously.
The optimum ANS concentrations were found to be T4, 300ug per
tube; T3, 200ug per tube.
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The solid phase radioimmunoassay methods for
total thyroxine and total triiodothyronine in
feline serum
The optimised reagent concentrations and the assay method
are presented in Table 5.1.
Validation of solid phase radioimmunoassays
for total thyroxine and total triiodothyronine in
feline serum. Accuracy of the solid phase RIAs was assessed
by determining the recovery of known amounts of T4 or T3 added to
"hormone-free" serum as described in detail in Section 6.3, to give
concentrations in the range of 18.1 to 55.7nmol/l for T4 and 0.70 to
2.71nmol/l for T3. For 12 observations for T4, mean recovery +_ sd
was 118 +_ 16.9 per cent (range 91 per cent to 147 per cent). For
13 observations for T3, mean recovery _+ sd was 120.5 +_ 25.9 per
cent (range 73 per cent to 162 per cent).
Low, medium and high pools were included in each assay,
prepared as described in detail in Section 6.3. Within-assay
precision as judged from the high proportion of discrepant replicates
was unsatisfactory.
During the validation experiments, it was found that the per
cent ^I-T4 and *^I-T3 bound to their respective antibodies at
any standard concentration varied markedly between assays. This was
considered to be a possible cause of poor precision. This
variability in binding was not due to leakage of antibody from the
solid phase, as demonstrated by the lack of increase in binding on
pre-washing antibody in buffer. It was not due to insufficient
mixing of the solid phase antibody in the incubates, as standard
curves obtained on shaking incubates for 16 or 24 hours at room
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temperature were superimposable, but showed lower binding than the
curves routinely obtained after a 36 hour incubation at 4°C.
Pi scussion
In solid phase RIA, the antiserum is attached to a solid
support medium either by adsorption or covalent conjugation. A
number of techniques have been described.
The coated tube method relies on the adsorption of the anti¬
serum to the assay tubes (usually made of polystyrene). Separation
of the bound and free antigen is simply achieved by decanting the
free to waste while the bound remains attached to the tube walls and
is counted directly. This simple method, while superficially having
much to commend it, suffers from poorer sensitivity and precision
than some other systems.
With covalent conjugation, the antibody is linked to a solid
phase support medium (such as cellulose, Sephadex or Sepharose) and
is added as a suspension to the assay tubes. Separation of the
bound component is easily achieved by centrifugation. A
modification of this technique is the magnetic antibody immunoassay
in which the antibody is covalently coupled to magnetic particles.
Separation of the bound from the free fractions is achieved using a
magnetic separator.
Optimisation of the assays for both T4 and T3 was readily
achieved but both accuracy and precision were poor, particularly
with the T3 RIA. This may have resulted, in part, from fluctuations
in the per cent antibody bound in the 0 standard (Bo) between
assays, the cause of which was not identified. Two possible causes
for this were investigated. Detachment of the antibody from the
support medium was ruled out by replacing supernatant fluid by assay
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buffer. In addition, studies examining the possibility that the
assay reactions were not proceeding to completion, by comparing
shaking and room temperature incubation with static incubation at
4°C showed, contrary to expectations, reduced binding in the former.
Precision tends to decline with decreasing concentrations of
analyte. Thus, poor precision in similar assays for T3 in human
serum have been observed (G. J. Beckett, personal communication).
As it was clearly desirable to use the same techniques for both T4
and T3, the use of double antibody methods was investigated.
5.5 OPTIMISATION OF SECOND ANTIBODY METHODS FOR THYROXINE
AND TRIIODOTHYRONINE RADIOIMMUNOASSAY
Introduction
In view of the unsatisfactory precision and sensitivity of
the solid phase T3 RIA, liquid phase methods were investigated. The
assay design was similar for both T4 and T3 and was based on the
double antibody methods described by Ratcliffe, Challand and
Ratcliffe (1974) but optimised for use with feline serum.
Optimisation requires determining:
(i) the optimum second antibody separating conditions (that is
the concentrations of DAS and NSS).
(ii) the required amount of ANS per tube.
(iii) the optimum first antibody dilution for the required
sensitivity of the assay.
Methods
Thyroxine assay. Concentrations of DAS and NSS were
optimised by the procedures of Hunter (1978). The concentration of
the reagents and reaction conditions were initially based on those
used in the assay of human T4 and were as follows: Anti-T4 serum,
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final dilution 1:13,500; ^^^I-T4, 35,000 cpm; ANS, 325ug per
tube; "hormone-free" feline serum, 25ul; final reaction volume,
825ul.
Initial dilutions of DAS and NSS were prepared in assay diluent
so that the final dilutions would range from 1:10 to 1:330 and 1:560
to 1:22,440 respectively. Each DAS dilution was tested against each
NSS dilution in the form of a matrix according to the stated assay
procedure. After incubation for 36 hours at 4°C, the tubes were
centrifuged, the supernatant decanted to waste, the tube tops
blotted dry on absorbent paper and the antibody-bound radioactivity
counted.
Triiodothyronine assay. This was performed as above,
with the following modifications:
The initial concentration of other reagents was: anti-T3
serum, final dilution 1:25,000; ^5I_T3j 30,000 cpm; ANS, 90ug
per tube; "hormone-free" feline serum, 50ul; final reaction volume
1,050ul.
DAS and NSS were tested in all combinations from 1:10 to 1:160
and 1:500 to 1:10,000 respectively.
Results
Thyroxine radioimmunoassay. The results of this study
are presented in Fig. 5.1.
The curves show excellent plateau regions and a number of DAS
and NSS concentrations could have been selected. The conditions
chosen were: DAS final dilution 1:96 (initial dilution 1:73) and NSS
final dilution 1:5,610 (initial dilution 1:1,360).
Triiodothyronine radioimmunoassay. The results of this study
are presented in Fig. 5.2.
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As in the corresponding T4 study, the curves show excellent
plateau regions, the conditions chosen being DAS final dilution
1:76 (initial dilution 1:29) and NSS 1:3,000 (initial dilution
1:1,680).
Piscussion
The double antibody separation method relies on the
finding that on antibodies, antigenic sites (Fc fragment) and
antibody sites (Fab fragment) are separate. An antibody molecule may,
therefore, form a complex with its antigen and then be complexed to a
second antibody. In RIA, the primary antigen-antibody complex is too
dilute to be precipitated. If, however, a carrier non-immune serum
is added and this is followed by an antiserum raised in a second
species to the gamma-globulin of the first antibody, a much larger
lattice can be established and all, including the labelled antigen
bound to the first antibody, can be precipitated. Separation of the
bound component is achieved by centrifugation. The method gives
excellent separation (e.g. one to three per cent bound in the
absence of first antibody and greater than 95 per cent bound in the
presence of excess antibody (Hunter, 1978)). A single experiment
is sufficient to optimise a system, although this must be repeated
each time a new batch of second antibody is used.
Because of the good "plateau" regions in the plotted results,
various combinations of DAS and NSS concentrations could have been
selected for routine assay use. DAS is relatively expensive and
generally cannot be used in high dilution. Thus, without
compromising maximum efficiency and reproducibility, it is usual to
select the greatest dilutions of DAS and NSS compatible with maximum
binding. Selection of DAS and NSS concentrations giving a "plateau"
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in binding ensures that minor deviations from the concentrations
chosen, due to, for example, pipetting errors or errors in reagent
dilution, do not adversely affect the assay. The lower binding of
labelled hormone at dilutions higher and lower than the optimum
reflect conditions of antibody excess and deficiency.
During optimisation of these RIAs, it was helpful that similar
assays were in routine diagnostic use with human sera locally. This
provided initial information on criteria such as reagent volumes,
first antibody and ANS concentrations, reaction times and
temperature, and centrifugation times. These were subsequently
optimised specifically for feline serum.
5.6 OPTIMISATION OF ANS CONCENTRATIONS USING "HORMONIE-FREE" SERUM
Introduction
ANS is usually included in the RIA incubate in the
measurement of thyroid hormone concentrations in human serum. It
binds to the hydrophobic sites of serum proteins displacing T4 and
T3 and makes them available for reaction with their respective
antibodies, and minimises serum protein binding of radioactive T4
and T3. The mass per tube must be carefully optimised.
The object of these experiments was to determine the optimum
concentration of ANS for the determination of T4 and T3 in feline
serum.
Method
Thyroxine radioimmunoassay. Doubling dilutions of ANS
were prepared in assay diluent so that the final mass per assay tube
ranged from l,500ug to Oug. The final dilution of anti-T4 was
1:13,500 with those of DAS and NSS being as determined previously.
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At each concentration of ANS, triplicate incubates were prepared
with the addition of either "hormone-free" feline serum (25ul) or
diluent (25ul). After incubation, centrifugation and counting,
graphs were plotted of per cent 125j_y4 bound against mass of ANS
per incubate.
Triiodothyronine radioimmunoassay. The same technique
was used as above, varying the amount of ANS from 800ug per assay
tube in doubling dilutions to Oug per tube, with the final dilution
of anti-T3 serum being 1:25,000 and DAS and NSS concentrations as
determined previously.
Resul ts
Thyroxine radioimmunoassay. The results of this study
are presented in Fig. 5.3.
As the concentration of ANS per tube increases, the per cent
125
I-T4 bound to the T4 antibody increases as the binding to serum
proteins is inhibited. The concentration of ANS required to
block serum protein binding maximally is shown by the greatest
possible binding in the presence of extracted serum. If the
concentration of ANS is further increased, antibody binding of T4 is
progressively inhibited. To allow a safety margin, the optimum ANS
used per tube is slightly greater than that required to block serum
protein binding maximally, that is 290ug per tube (Fig. 5.3). The
difference in per cent •^I-T4 bound in the tubes containing diluent
or extracted serum represents the residual effect of serum proteins
that is not inhibited by ANS.
Triiodothyronine radioimmunoassay. The results of this
study are presented in Fig. 5.4.
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There is no increase in the per cent ^^I-T3 bound to the T3
antibody as the mass of ANS per tube increases, suggesting that ANS
has no effect in this assay. When the mass of ANS is increased
above 50ug per tube, blocking of radiolabelled T3 to T3 antibody
begins to occur as shown by the parallel fall in the per cent 125I-
T3 bound in both diluent and extracted serum tubes.
Piscussion
ANS has the property of binding to hydrophobic sites on protein
molecules, and in doing so, appears to displace T4 and T3. The
inclusion of ANS in the incubates, therefore, reduces competition
from the serum proteins for binding of thyroid hormones, and is
essential if accurate results are to be obtained. The weight per
tube must be carefully optimised. If there is insufficient ANS, its
effects as described are reduced. If present in excess, the
antibody binding itself may be lowered.
The mass of ANS required in the T4 assay was 290ug per tube
compared with 325ug in a comparable assay for human serum. It is
perhaps surprising that there is so little difference in the
requirements of ANS between assays for the two species when human
serum is known to contain TBG, and a comparable high-affinity thyroid
hormone binding protein in feline serum could not be demonstrated
(Tanabe, Ischii and Tamaki, 1969; Bigler, 1976a).
The conclusion that ANS did not appear to be necessary in the
T3 assay was surprising but may reflect these reports, although other
authors have described the presence of a feline TBG (Farer et al.,
1962) but of low binding capacity (Scherzinger, Guzy and Lorcher,
1972). It is possible that barbiturate, also known to inhibit
protein binding, might have provided sufficient inhibition in this
assay.
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In order to confirm whether or not ANS could be omitted from
the T3 assay, an additional experiment using normal feline sera (as
opposed to the "hormone-free" serum used here) was performed.
5.7 OPTIMISATION OF ANS CONCENTRATION IN THE TRIIODOTHYRONINE
RADIOIMMUNOASSAY USING NORMAL SERA
Introduction
In the absence of ANS in the RIA of T3 in human serum, the
protein binding sites for T3 are not blocked and bind more of the
125
I-T3 than when ANS is present. This results in reduced
antibody binding of radiolabel and a higher value for the T3
concentration. This study investigates whether such an effect
occurs in feline serum and compares the results to those seen in
samples of human serum of known thyroid hormone concentration.
Method
T3 assays were set up with and without ANS (90ug per
tube). Each assay included a standard curve, the same samples
of normal feline sera of unknown concentration, and human sera of
known concentration from hypothyroid, hyperthyroid and euthyroid
patients.
Assay conditions were: anti-T3 serum, 1:13,500 final dilution;
125
I-T3, approximately 30,000 cpm per tube; DAS, 1:76 final
dilution; NSS 1:3,150 final dilution; final incubation volume
l,050ul. Incubation was carried out at 4°C for 36 hours, and the
antibody-bound fraction separated by centrifugation and counted as
before.
Results
These are presented in Table 5.2.
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With human sera, the results were as anticipated with
higher T3 values being recorded in the absence of ANS. These
differences were highly significant as assessed by Student's paired
t test (t = 8.65, 8d.f; P < 0.001). These effects appeared more
obvious at low T3 concentrations. However, with cat serum, the
reverse effect was found, with T3 concentrations being consistently
lower in the absence of ANS than when it was included. These
differences were also highly significant as assessed by Student's
paired t test (t = 7.78, 9 d.f; P < 0.001). This effect was
unexpected. It may have been due to the ANS depressing binding in
the standard tubes (containing extracted serum) more than in the
sample tubes.
The values for T3 concentrations of human sera read against
both human and feline standards were also compared using Student's
paired t test. The differences were highly significant (t = 9.00,
9 d.f; P < 0.001).
As ANS did not adversely affect the T3 assay, it was decided,
as a safety measure, to include it in the incubate. The mass
required per tube was evaluated from Fig. 5.4 as that which reduced
the antibody-binding to just below the maximum obtainable in the
study (90ug per tube).
Piscussion
The inclusion of the protein-binding inhibitor ANS in the
incubates was found to be necessary despite reports in the
literature that high affinity binding proteins for thyroid hormones
could not be demonstrated in cat serum (Tanabe, Ishii and Tamaki,
1969; Bigler, 1976a). As barbiturate contributes to the blocking of
the binding of thyroid hormones to their carrier proteins, it was
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thought that it might be possible to omit ANS from the incubate,
particularly in the T3 assay. Indeed, optimisation in the presence
of "hormone-free" serum suggested that ANS had no effect in the
assay. However, in the absence of ANS, T3 concentrations were
consistently a mean of 16.4 per cent lower and ANS was therefore
included in both assays.
The explanation for the apparent discrepancy between the
effects of T3 in the optimisation experiment using "hormone-free"
serum and normal feline serum may lie in the binding properties of
the extracted and sample sera. Clearly, the extracted serum can only
approximate the composition of normal sample sera and is not
identical with it. In view of the small but significant difference
in results with feline sera, it was considered prudent to include
ANS in the incubates for the T3 RIA. The observation that omission
of ANS had a much greater effect in the assay of human, than in the
assay of feline, samples provided confirmatory evidence of the
relatively minor effect of ANS in the assay of T3 in feline serum.
There was a highly significant difference in T3 concentrations
of human sera when determined in assays standardised and optimised
for the cat and man respectively. Thus, the use of commercial human
RIA kits or testing services offered by human reference laboratories
should be discouraged unless the assays have been validated
adequately for cats.
5.8 OPTIMISATION OF FIRST ANTIBODY DILUTIONS
Introduction
Optimisation of first antibody dilutions is necessary in
order that the maximum change in signal (per cent radiolabel bound)
occurs over the ranges of clinical interest.
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Method
Thyroxine radioimmunoassay. Solutions of T4 antibody
were prepared in assay diluent such that the final dilution in the
incubates would be 1:10,300, 1:13,600, 1:20,600 and 1:28,000.
Standard curves were then set up using these dilutions of first
antibody and concentrations of reagents as previously determined.
Triiodothyronine radioimmunoassay. The T3 antibody
dilution was optimised in the same way as for the T4 RIA using final
dilutions of anti-T3 of 1:15,000, 1:20,000 and 1:25,000 and other
conditions as previously determined.
All incubations were carried out for 36 hours at 4°C with
separation by centrifugation.
Results
Thyroxine radioimmunoassay. The results of this study
are presented in Fig. 5.5.
The best compromise for the first antibody dilution covering
the anticipated hypothyroid, euthyroid and hyperthyroid ranges was a
final dilution of 1:20,000 (initial dilution, 1:4,700).
Triiodothyronine radioimmunoassay. The results of this
study are presented in Fig. 5.6.
The optimum first antibody concentration was evaluated as for
T4 at 1:15,000 final dilution (1:8,400 initial dilution).
Piscussion
The specificity of any RIA rests on the ability of the
first antibody to recognise the antigen under test, and that antigen
alone (any deviations from this being described as per cent cross
reactivity). The interaction between antibody and antigen involves
numerous weak bonds present only between closely fitting parts of
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the molecules. It is the so-called N terminal of the immunoglobulin
which is responsible for the binding of antigen.
Antibodies are almost bound to be heterogeneous because the
antigenic response brings responses from immunoglobulins of all
types. There may also be variability within the same antibodies
raised against the same determinant, brought about by differences in
degree of fit and area of the antigen molecule with which they
combine. An antiserum with antibodies which combine closely with
only a few determinants of the antigen is likely to be more specific
but less tightly bound than one with a greater variety of
antibodies combining with more determinants and with a wider range
of fit.
The optimum first antibody dilution is that which gives the
maximum change in signal over the ranges of clinical interest. These
assays were directed at a clinical situation for the recognition of
possible hypo and hyperthyroidism. Thus it was necessary to select
the best compromise in first antibody dilutions over a wide range of
T4 and T3 concentrations.
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6. THE RADIOIMMUNOASSAY METHODS FOR TOTAL THYROXINE
AND TOTAL TRIIODOTHYRONINE IN FELINE SERUM
6.1 TOTAL THYROXINE
Working reagents and standards
The following reagents were freshly prepared in assay
diluent (0.05mol/l barbiturate containing O.Ol per cent azide and
0.1 per cent bovine serum albumin, the latter added immediately
before use) for each assay.
Reagent 1. ^^I-T4 (157ul) was diluted to 231ml in assay
diluent and donkey anti-sheep serum (DAS, 3.2ml) added to give a
working dilution of 1:73.
Reagent 2. 8-anilino-l-napthalene sulphonic acid (ANS)
(llOmg) was diluted to 80ml in assay diluent and sheep anti-T4
(17ul) and non-immune sheep serum (NSS, 59ul) added to give working
dilutions of 1:4710 and 1:1,360 respectively.
These volumes were sufficient for 360 assay tubes.
Thyroxine standards. T4 working standards in "hormone-
free" feline serum were prepared and stored as described in Chapter
4.
The reagents, samples and standards were allowed to come to
room temperature and each was mixed well before use.
Method
(1) All standards, samples and controls are assayed in
duplicate.
(2) The assay is arranged with tubes 1-20 for standards,
with pools of low, medium and high concentrations
at the beginning and end of the block of samples. A
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maximum of 80 samples and pools is assayed against
each standard curve.
(3) Using an automatic diluter, pick up standard (25ul)
or sample (25ul) and dispense together with reagent
1 (600ul). Dispense reagent 2 (200ul). Vortex mix.
(4) Incubate for 36 hours at 4°C.
(5) Centrifuge at 3,000 rpm for 30 minutes at 4°C.
(6) Decant supernatant to waste. Blot tube tops dry
on absorbent paper.
(7) Determine antibody-bound in tubes by counting
in a gamma counter.
(8) Enter count results on paper tape via Hewlett Packard
tape reader (Model 9883A) and calculator (Model 9821A)
into computer (Hewlett Packard 9871A) for calculation
of results using four parameter logit-log model for
the standard curve.
A summary of the composition of the assay incubate is given in
Table 6.1.
6.2 TOTAL TRIIODOTHYRONINE
Working reagents and standards
The following reagents were freshly prepared in assay
diluent (0.05mol/l barbiturate buffer containing 0.01 per cent
azide and 0.1 per cent bovine serum albumin, the latter added
immediately before use) for each assay.
Reagent 1. ^^I-T3 (300ul) was diluted to 135ml in assay
diluent and DAS (4.8ml) added to give a working dilution of 1:29.
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Reagent 2. ANS (34mg) was diluted to 210ml in assay diluent
and sheep anti-T3 (25ul) and NSS (125ul) added to give working
dilutions of 1:8,400 and 1:1,680 respectively.
These volumes were sufficient for 300 assay tubes.
Triiodothyronine standards. T3 working standards in
"hormone-free" feline serum were prepared and stored as described in
Chapter 4.
The reagents, samples and standards were allowed to come to
room temperature and each was mixed well before use.
Method
(1) All standards, samples and controls are assayed in
duplicate.
(2) The assay is arranged with tubes 1-22 for standards,
with pools of low, medium and high concentrations at
the beginning and end of the block of samples. A
maximum of 80 samples and pools is assayed against each
standard curve.
(3) Using an automatic diluter, pick up standard (50ul)
or sample (50ul) and dispense together with reagent 1
(400ul). Dispense reagent 2 (560ul). Vortex mix.
(4) Incubate for 36 hours at 4°C.
(5) Centrifuge at 3,000 rpm for 30 minutes at 4°C.
(6) Decant supernatant to waste. Blot tube tops dry on
absorbent paper.
(7) Determine antibody-bound in tubes by counting
in a gamma counter.
(8) Enter count results on paper tape via Hewlett Packard
tape reader (Model 9883A) and calculator (Model 9821A)
183
into computer (Hewlett Packard 9871A) for calculation
of results using four parameter logit-log model for the
standard curve.
A summary of the composition of the assay incubate is given in
Table 6.1.
6.3 VALIDATION OF ASSAYS FOR TOTAL THYROXINE AND TOTAL
TRIIODOTHYRONINE IN FELINE SERUM
Introduction
Once a RIA system has been optimised it must be
validated to determine its reliability. The criteria of assay
validity are specificity, accuracy, precision and sensitivity.
Specificity is the extent of freedom from interference by
substances other than the one intended to be measured (Midgley,
Niswender and Rebar, 1969). Accuracy is the extent to which the
measurement of an antigen in a sample agrees with the "correct"
amount that is present (Midgley, Niswender and Rebar, 1969).
Precision is a measure of the scatter of the individual estimates
around their mean value. Sensitivity (detection limit) is the
smallest amount of antigen that can be distinguished from no
antigen.
Specificity
Method. Specificity may be evaluated by the extent of
cross-reactivity of antibodies to chemically similar substances.
Results. For these assays, cross-reactivities on a
molar basis were provided by the manufacturers of the antibodies and
were 2.5 per cent for T3 with the anti-T4 serum, and 0.25 per cent
for T4 with the anti-T3 serum.
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Accuracy
Method. Accuracy was assessed by determining the
recovery of known amounts of T4 or T3 added to "hormone-free" or
normal feline sera to give concentrations in the range of 18.1 to
69.0nmol/l for T4 and 1.0 to 2.0nmol/l for T3. The T4 and T3 was
added as a 2.0ul volume to a 1.0ml volume of serum, the T4
(940nmol/l) and T3 (36.6nmol/l) being prepared in diluent.
The per cent thyroid hormone recovery was calculated from the
equation:
Per cent hormone recovery = (Concentration of hormone found-
Endogenous hormone concentration) xlOO
Concentration of hormone added
Results. The results of the recovery experiments for T4 and
T3 are presented in Tables 6.2 and 6.3 respectively. In both assays,
recovery was excellent, mean _+ sd (number of observations) being
106 _+ 5.9 per cent (n=ll) for T4 and 104.4 +_ 8.5 per cent (n=9)
for T3.
Precision and drift
Method. Low, medium and high pools were included in
each assay. The medium pool was prepared from normal feline serum
and the low and high pools from this by dilution with "hormone-free"
cat serum, and by the addition of known amounts of T4 and T3 in
assay buffer respectively. At least one pool was included at least
twice in each assay so that evidence of drift and within-assay
precision could be evaluated. Between-assay precision was also
studied.
Results. Data on T4 and T3 pools from which results on
precision and drift were derived are given in Tables 6.4 and 6.5
respectively.
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Within-assay coefficients of variation (cv) for low, medium and
high pools respectively were five per cent, four per cent and two per
cent for T4, and 12 per cent, five per cent and five per cent for T3.
There was no evidence of drift in either assay as assessed by
Student's paired t test on pools placed at the beginning and end of
the assays (T4:t=0.03, 16d.f; T3:t=0.50, 25d.f.).
Data on between-assay precision for low, medium and high T4 and
T3 pools are presented in Table 6.6. The mean cvs for the T4 and T3
assays were 6.6 per cent and 12.1 per cent respectively.
Sensitivity (detection limit)
Method. Assay detection limits can be estimated as the
concentration of hormone required to give a statistically
significant signal in the assay. The detection limit may be
calculated as the concentration of analyte which corresponds to
twice the sd of the zero standard binding.
Results. Detection limits so calculated were
approximately 1.3nmol/l for T4 and 0.1nmol/l for T3. In practice, a
more conservative and simple approach was adopted, by taking the
lowest standard (5 nmol/1 and 0.13nmol/l respectively for T4 and T3)
as the detection limits.
Piscussion
Data on specificity, accuracy, precision and sensitivity
are necessary if RIA is to be considered reliable.
Specificity may be evaluated quantitatively by the comparison
of inhibition curves produced by standards and serial dilutions of
normal sera, and by the extent of cross-reactivity of antibodies to
chemically similar substances, and qualitatively by reproducing and
measuring known biological responses in vivo (Reimers et al.,
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1981). In these assays, cross-reactivities for the anti-T4 and anti-
T3 sera were provided by the manufacturers (see Chapter 5).
Accuracy is ideally assessed by comparison of assay results
with measurements made by a definitive "reference" method. Gas-
chromatography - mass spectrometry is used to assess accuracy of
some RIAs for haptens, although this technique is not yet available
for iodothyronines.
A simpler, if less complete, approach is to measure recovery of
added analyte, although it is important to appreciate that
quantitative recovery does not ensure accuracy. Recovery
experiments will reveal errors in standardisation, but not
background interference if this contributes both to the spiked and
unspiked samples.
By this technique, accuracy was found to be excellent with
means of 106.0 per cent for the T4 and 104.4 per cent for the T3
assays.
Quality control samples of low, medium and high concentrations
should be included in all RIAs to allow the calculation of within
and between-assay precision. Within-assay and between-assay
precision are determined by calculating the cv of a number of
measurements of the same sample within one or in a number of assays
respectively. Reimers et al. (1981), Hoenig and Ferguson (1983),
Donne and Wildgoose (1984) and Kemppainen, Mansfield and Sartin
(1984) are the only workers to have reported such data for feline T4
and T3 RIA. Hunter (1978), referring to human RIAs in general,
stated that, "the precision of determination of antigen in
physiological fluids is generally of the order of +_ five to ten
per cent for within-assay duplication and + eight to 15 per cent
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for between-assay replication as determined from quality control
samples". In the present study, within and between-assay precision
for T4 and T3 was excellent and fell easily into Hunter's criteria.
The single exception was between-assay precision for the low T3 pool
but this compared well with that of similar assays and reflected the
low concentrations being measured.
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7. CLINICAL STUDIES OF THYROID HORMONE CONCENTRATIONS IN
HEALTHY CATS
7.1 INTRODUCTION
While there are a small number of reports of T4 and T3
concentrations by RIA in healthy cats, no detailed investigations
have been carried out into the effects of such variables as age,
sex, breed, heredity and environment. The aim of this study was to
establish the normal range of feline T4 and T3 and to investigate
the influence of such variables on these ranges.
7.2 METHODS
Clinical material
Blood was obtained from 319 cats (122 males, 141 females, 35
neutered males and 21 neutered females) aged between four months and
13 years. All were classified as healthy on the basis of a detailed
history and physical examination. Pregnancy checks were carried out
on all entire females by ballottement and those considered to be
positive were excluded from the study. The majority of the animals
were either domestic short or long-haired, but 23 pedigree animals
of several breeds were also represented.
Sample collection and preservation
Samples were collected from conscious animals by venepuncture,
usually from the jugular vein but also from the cephalic vein. After
clot retraction, blood was centrifuged and the serum transferred to
a clean tube for storage at -40°C. Where the volume of sample
allowed, T4 and T3 were assayed on each specimen giving 298 paired
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observations. Twenty samples were assayed for T4 alone and one for
T3 alone.
RIAs were performed as detailed in Sections 6.1 and 6.2.
7.3 RESULTS
Distribution of values in the healthy population (all ages
and both sexes)
T4 and T3 values were found to fit a normal distribution (chi-
squared goodness-of-fit tests on grouped data were not significant).
Figs. 7.1 and 7.2 are histograms of the total T4 and T3
concentrations respectively in the healthy population and show how
the normal distribution closely describes the observed values.
Table 7.1 summarises the data in terms of mean, sd, range and 95
per cent range (2.5 per cent and 97.5 per cent sample percentiles).
Three of the T4 and ten of the T3 estimations gave values that
were less than the working detection limits of the assays. In each
case, however, the paired T3 and T4 concentration was within the 95
per cent reference range. Data on these animals are presented in
Table 7.2.
Relationship between total thyroxine and triiodothyronine
concentrations (all ages and both sexes)
Individual T4 and T3 values were highly significantly
correlated (r = 0.46, P <0.001). This relationship is shown in
Fig. 7.3.
Effects of age, sex and breed on hormone concentrations
Multiple regression was used to investigate the relationship
of T4 and T3 concentrations to age, sex and breed. This method
tests whether or not mean hormone concentrations are significantly
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affected by each factor when the effect of all the others is taken
into account. A quadratic term for age was included to test whether
any relationship with age was linear. In view of the small numbers
of pedigree cats, the analysis compared all pedigree to all domestic
breeds. The former comprised ten Siamese, seven Burmese, three
British blues, two Devon rex and one Persian, while there were 254
domestic short-haired and 24 domestic long-haired cats.
For descriptive purposes, animals were divided into five age
groups to allow, as far as was possible, for different life stages:
Group 1: 4-6 months (pre-puberty)
Group 2: >6 - 12 months (pubertal growing animals)
Group 3: >12 - 60 months (young adulthood)
Group 4: >60 - 108 months (maturity)
Group 5: >108 months (elderly)
However, multiple regression testing analyses the data according to
specific age and not on arbitrary groupings.
Data on effects of sex, age and breed on total T4 and T3
concentrations are presented in Tables 7.3 and 7.4. The results of
the analyses as applied separately to T4 and T3 are summarised in
Table 7.5. In the case of T4, both the linear and quadratic effects
of age were highly significant and there was also a significant
difference in T4 concentrations between the original sexes. Fig.
7.4 illustrates mean values (+_ SEM) for T4 for each sex in the
five age groups, and shows that T4 concentrations in both sexes
tended to decrease with age up to approximately five years and then
to rise again. Female cats of a given age tended to have higher T4
values than male cats. The effects of neutering and breed were not
significant for a given age and original sex.
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For T3, a similar, though less pronounced age effect was found,
with the initial decrease with age being followed by a levelling out
rather than an appreciable rise. The effects of original sex and
neutering on T3 were not significant, but pedigree cats tended to
have higher concentrations of the hormone at any given age than
domestic cats (Tables 7.4 and 7.5). Fig. 7.5 illustrates the
differences in mean serum T3 concentrations of pedigree and
domestic cats according to age. In neither case did Siamese cats
considered separately from other pedigree cats differ significantly
from domestic long-haired cats for given levels of the other
significant factors.
Fitted multiple regression of significant factors for T4 and T3
was:
T4 = 27.1 + 2.94 (if originally female) - 0.224 x age +
0.0019 x age^
T3 = 0.77 + 0.09 (if not domestic breeds) - 0.068 x age +
0.00004 x age^
Influence of heredity and environment on hormone
concentrations
If environmental effects influence T4 and T3 concentrations, it
would be expected that cats reared in the same environment would
show less variation in hormone concentrations than those reared in
different environments. Similarly, a genetic component to hormone
concentrations would lead to related cats varying less than
unrelated ones. To examine these possibilities, hormone
concentrations were measured in 12 unrelated cats grouped in five
environments (Table 7.6) and in 18 related cats grouped in nine
environments (Table 7.7). Nested random-effect analysis of
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covariance was used to test for significance between environment and
between-family effects, while correcting for the previously
established effect of age on T4 and T3 concentrations.
The results of these analyses are shown in Table 7.8 together
with their interpretation. The significant excess variation between
environmental groups for the related cats suggests that hereditary
and/or environmental influences exist on both T4 and T3, but it is
not clear which component predominates for T4. For T3, there appears
to be a definite hereditary component.
Apparent euthyroidism with elevated thyroid hormone
concentrations
Data on these cases are presented in Table 7.9.
One healthy cat (FT/NC/9/82) was found to have grossly elevated
T4 and T3 concentrations. The sample was taken prior to routine
dentistry and before premedicants were given. Another cat
(FT/NC/3/82) had normal T4 but grossly elevated T3 concentrations.
This cat had been involved in a road traffic accident three weeks
before, resulting in separation of the mandibular symphysis. This
was repaired immediately with wire around the lower canines, no
drugs had been administered post-operatively and, according to the
owner, the cat had been clinically normal for two weeks. The sample
was taken prior to removing the wire, before premedication.
Because these values were grossly elevated, they were excluded
from calculations of normal ranges.
7.4 DISCUSSION
Many of the reported early studies of feline thyroid function
used methods which have been superseded in studies on humans
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because of poor specificity, sensitivity or both. RIA is now firmly
established for the investigation of thyroid disease in man.
Similar techniques are applicable to the cat provided the methods
are modified to allow for the much lower concentrations of
circulating T4 and T3 in this species, and the different sample
matrix presented by cat serum.
When this study was initiated, Reap, Cass and Hightower (1978)
and Anderson and Brown (1979) were the only workers to have reported
details of the RIA methods they used to determine plasma total T4
and T3 concentrations in normal cats. Following the recognition in
1979 of feline hyperthyroidism by Cotter and by Peterson, Johnson and
Andrews, and its further definition as an important entity in older
cats (Holzworth et al., 1980), there has been considerable interest
in the biochemical investigation of this disease. There have been
several subsequent reports on total T4 and T3 concentrations in
normal cats but most have been simple statements of reference ranges
for comparison with hyperthyroid individuals (see Table 3.4).
While others have modified RIAs for use in cats, this work
describes the first RIA specifically designed for measuring thyroid
hormones in cat serum. Although Donne and Wildgoose (1984) reported
no significant differences for feline T4 and T3 concentrations
between heparinised plasma and serum, and no effects of freezing and
thawing and steroid anaesthesia, in this study, blood samples were
taken from conscious animals without prior use of sedation. Only
serum was used and this was separated from cells as soon as clot
retraction had occurred and stored at -40°C. Standards and pools
were also stored aliquoted at -40°C to avoid repeated thawing and
freezing.
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This study, based on 318 T4 estimations and 299 T3 estimations,
is more comprehensive than any previously described (Table 3.4). The
values reported here can be considered reliable as they were
obtained with wel1-validated methods on a large population. The
reference ranges from different laboratories usually vary as a result
of differences in methodology and it can be confusing and hazardous
to compare them. Although the mean T4 and T3 concentrations found
here are in good general agreement with previously reported values,
it is evident that some euthyroid concentrations in other series
would be in the hyperthyroid ranges on the basis of the present data.
These high values have largely been described in the earlier studies.
As assay reagents become more specific for the analyte and
procedures more refined, there is a tendency for reference ranges to
become lower.
0.94 per cent of the determined T4 values and 3.35 per cent of
the T3 values were less than the working detection limits of the
assays. In each case, however, the paired T3 or T4 concentration
was within the 95 per cent confidence limits for the respective
assay. The assays were designed so that both thyroid hypo and
hyperfunction as well as the normal ranges could be evaluated and
inevitably there will be some animals which will have hormone
concentrations outside the 95 per cent normal range. To have re-
optimised the assays to measure the lowest concentrations of T4 and
T3 found would have meant a loss in working range, at the higher
concentrations. In addition, the value of the 2.5 per cent sample
percentile was greater than the lowest standard, for each assay.
In this study, the serum total T3 concentration was found to be
highly significantly related to the serum total T4 concentration.
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While the methods of T3 production in the cat have not been
established, such a relationship would be expected if its
derivation were similar to that in man, where only a small proportion
of circulating T3 is secreted by the thyroid, approximately 80 per
cent of it being produced from extra-thyroidal mono-de-iodination
of T4 (Braverman and Vagenakis, 1979).
Effect of age
Variations in thyroid hormone concentrations with age have not
been reported previously in cats. In this study, total T4
concentrations were found to vary highly significantly with age in a
non-linear manner, mean concentrations decreasing in both males and
females until greater than 12 to 60 months and increasing thereafter.
T3 concentrations also showed this non-linear decrease with age but
tended to level out rather than increase at very high ages. It would
be expected that T3 changes would parallel those of T4 in view of
the findings that T4 and T3 concentrations were highly correlated.
In man, thyroid hormone concentrations decrease with increasing age in
hospital patients but not in the healthy elderly; that is, the
decrease appears to be a consequence of illness rather than age
per se (01 sen, Laurberg and Weike, 1978). Cats for inclusion in
this study were taken from a healthy rather than a hospital population
but, nevertheless, the rise of total serum T4 concentrations in older
animals was not expected.
Effect of sex
Literature reports of the variation of thyroid hormone
concentrations in cats according to sex are contradictory. Most
studies failed to find any difference but Bigler (1976b) reported
higher concentrations in females than in males, with Anderson and
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Brown (1979) finding higher concentrations in entire compared to
ovariohysterectomised animals. In man, thyroid hormone
concentrations have been reported to be slightly higher in females
than in males, but there is no universal agreement on this. Indeed,
the tendency to higher concentrations in females may have been due
to the inadvertent inclusion of some pregnant women in the series
(Robbins and Rail, 1979).
In this study, an attempt was made to exclude pregnant animals
by physical examination. For any given age, female and neutered
female cats taken as one group tended to have significantly
higher T4 concentrations than males and neutered males. No such
effect was identified for T3. When age was accounted for, the
effects of castration or ovariohysterectomy were not significant for
either T4 or T3.
Effect of breed
In the only report on the relationship between breed and
thyroid hormone concentrations, Ling, Lowenstine and Kaneko (1974)
found a significantly higher concentration of total T4 in Siamese
than in domestic long-haired cats. Because the present study only
included 23 pure-bred cats, data were pooled and compared with those
for domestic short and long-haired animals taken together. No
significant differences in T4 concentrations were found but the
total T3 concentrations were significantly higher for any given age
in the pedigree breeds. When the Siamese breed was compared
separately with domestic long-haired cats, T4 and T3 concentrations
did not differ significantly.
Effects of heredity and environment
Of particular interest was the similarity between T4
concentrations of animals kept in the same environment. T3
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concentrations also showed a close similarity within a single
environment, and these similarities were demonstrated
statistically. However, when the animals were separated into
related and non-related groups, it was not possible to show which
component predominated for T4. For T3 there appeared to be a
definite genetic component. Such findings have not been reported
previously but they require further studies on larger numbers of
animals.
Euthyroid animals with raised thyroxine or triiodothyronine
concentrations
Euthyroid hyperthyroxinaemia is a well-documented syndrome in
man (reviewed by Borst, Eil and Burman, 1983). The commonest cause
is acquired TBG excess as a result of pregnancy (due to oestrogen-
induced TBG production by the liver), non-thyroidal illness
(hepatic disease with TBG leakage into the circulation, porphyria,
oestrogen-producing tumours, hydatidiform mole and lymphosarcoma),
and drug induction (oestrogen, narcotics, 5-fluorouracil and
clofibrate).
Inherited thyroxine-binding abnormalities (increased TBG,
excess albumin binding and increased TBPA) have also been described
in man. In increased TBG concentrations, both total T4 and T3 are
elevated, whereas in excess albumin binding and increased TBPA, total
T3 concentrations are normal.
Other causes of euthyroid hyperthyroxinaemia in man include
peripheral resistance to thyroid hormones, acute non-thyroidal
illness, acute psychiatric illness and drug administration.
Peripheral resistance to thyroid hormones is an inherited
condition and is associated with elevated total T3 and free T4 and
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T3 concentrations. Transient hyperthyroxinaemia of acute
non-thyroidal illness results from a combination of decreased protein
binding and decreased extra-thyroidal T4 metabolism and shows normal
to low T3 concentrations. Transient hyperthyroxinaemia of acute
psychiatric illness is associated with binding abnormalities in 50
per cent of patients. The aetiology in the remainder is unknown but
may be the result of amphetamine abuse or the endogenous production
of an amphetamine-like substance such as beta-phenethylamine. The
condition is associated with normal to low T3 concentrations. Drug-
induced hyperthyroxinaemia may occur due to the administration of the
contrast agents iopanoic acid and ipodate and the antiarrhythmic
agent amiodarone and results in decreased total T3 concentrations.
The only recorded cause of elevated T4 and T3 concentrations in
the cat is hyperthyroidism and thus the two cases described in
association with apparent euthyroidism are of particular interest.
It is possible that both animals may have been hyperthyroid. However,
neither showed clinical abnormalities nor had palpable thyroid
masses and both are alive and healthy after a follow-up period of
three years. This diagnosis is particularly unlikely in case
FT/NC/3/82 which had normal T4 and elevated T3 concentrations. This
animal was only three and a half years old when sampled and the
youngest age for a case of feline hyperthyroidism yet recorded
is six years (Peterson et al., 1983b). In addition, while T3
toxicosis has been recorded in man (Sterling, Refetoff and Selenkow,
1970; Hollander, Shenkman, Mitsuma, Blum, Kastin and Anderson, 1971;
Hollander, Mitsuma, Nihei, Shenkman, Burday and Blum, 1972) and in
the dog (Chastain, Hill and Nichols, 1972) it has not been recorded
in cats.
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Of the documented causes of elevations of both T4 and T3
concentrations in euthyroid humans, the most likely cause for the
case described (FT/NC/9/82) is an inherited thyroxine-binding
abnormality. It is more difficult to hypothesise about case number
FT/NC/3/82 as this animal had a normal T4 with an elevated T3
concentration. This finding has not been recorded in man but could
result from a variant of binding protein with increased affinity for
T3 and not T4 or T3 antibody formation. The cat was also involved
in a road traffic accident three weeks before sampling which further
complicated the situation, but it is difficult to see how this might
have influenced the abnormal results. The assay of further samples
from each animal would have been desirable but neither owner would
agree to this.
Studies were subsequently carried out on the serum thyroid
hormone binding proteins of both of these cases, together with
samples taken from other animals with selected disease conditions
which had abnormal T4 and T3 concentrations. These results are
reported in Chapter 9.
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8. INVESTIGATIONS OF THYROID HORMONE BINDING BY SERUM PROTEINS
IN NORMAL CATS
8.1 GENERAL INTRODUCTION
The strong association of thyroid hormones with macro-
molecules in serum has, retrospectively, been clear from early
experiments which demonstrated that human serum iodine failed to
dialyse (Gley and Bourcet, 1900) or to pass on ultrafilter
(Trevorrow, 1939). However, thyroxine could readily be removed from
these macro-molecules by organic solvents (Trevorrow, 1939).
Early attempts to identify proteins responsible for thyroxine
binding in man by iodine analyses of plasma protein fractions
(Taurog and Chaikoff, 1948) implicated most of the serum proteins
except gamma-globulins. The presence of a specific thyroxine
binding globulin (TBG) was not appreciated until Gordon et al.
(1952) used the technique of zone electrophoresis and subsequent
studies identified that T4 was also carried by TBPA, and to a
lesser extent, by albumin. T3 is bound only to TBG and albumin
(Nicoloff, 1978).
There are major differences in thyroid hormone protein binding
between species (Robbins and Rail, 1960). As previously discussed,
the few reports on feline thyroid hormone binding are contradictory
and a corresponding protein to human TBG has not been identified
conclusively.
This chapter describes studies of thyroid hormone binding to
serum proteins in normal cats. Section 8.2 reports on the binding
of T4 and T3 in unfractionated feline and human sera. Sections 8.3
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to 8.6 detail experiments performed to establish and validate the
conditions for electrophoresis of thyroid hormone binding proteins
in feline serum. Section 8.7 describes the qualitative and
quantitative features of the binding of T4 and T3 to serum proteins
in normal cats and compares these with the corresponding data for
normal humans. Chapter 9 subsequently describes protein binding
studies in animals with physiological or pathological variations of
T4 and T3 concentrations.
8.2 BINDING OF THYROXINE AND TRIIODOTHYRONINE TO PROTEINS IN
UNFRACTIQNATED FELINE AND HUMAN SERA
Introduction
As an initial step in investigating the binding of T4 and T3
by serum proteins in the cat, the T3 serum uptake test (Section 3.7)
and the T4 serum uptake test were performed on feline and human
serum from healthy individuals. These tests would indicate
differences in the overall binding of the labelled iodothyronines to
serum proteins without distinguishing between the relative
concentrations of individual proteins.
Reagents
i or
Radiolabelled thyroxine and triiodothyronine. A"I-T4
was as described in Section 5.2. ^^I-T3 (1 MBq/nmol to 1.4
MBq/nmol) was obtained from the same source.
Absorbent. Sephadex G-25 (fine) was obtained from
Pharmacia, Mi 1ton-Keynes, Buckinghamshire, England.
Buffer. The buffer used was 0.02 mol/1 sodium phosphate,
pH 7.2 containing 0.2 per cent (w/v) gelatine and 0.01 per cent (w/v)
sodium azide as bacteriostat. The stock solution was stored at 4°C.
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Reference and quality control sera. The reference serum
was Wellcomtrol 1 (Wellcome Ltd., Berkhamsted, Hertfordshire,
England). Quality control sera for the T3 uptake test were Riatrac
1, 2 and 3 obtained from Beckton-Dixon Immunodiagnostics, Orangeburg,
New York, USA.
Equipment. All equipment was as described in Section 5.3
with the exception of:
Assay tubes. All reactions were carried out in duplicate
in round-bottom polystyrene tubes of 8.5 ml capacity obtained from
W. Sarstedt Ltd. (address as in Section 5.3).
Method
The reagents and samples were allowed to come to room
temperature and each was mixed well before use.
Triiodothyronine uptake tests. A working solution of
125
I-T3 was prepared by adding 15 ul of the stock radiolabel
to 75 ml buffer. The reference serum, quality controls and samples
(three sera from healthy cats and three from healthy humans, the
latter kindly supplied by Dr. G.J. Beckett), together with a sample
of assay diluent were tested in duplicate.
Sephadex G-25 (400 mg) was delivered to each assay tube by
means of a pre-cal ibrated scoop. 2.5 ml ■'•^^I-T3 working
solution was added to each assay tube using an automatic diluter.
25 ul of sample, quality control serum or reference serum was then
added to the respective tubes by means of an adjustable pipette.
After mixing in a multi-tube vortex mixer for 15 minutes,
the tubes were then centrifuged at room temperature for 15 minutes
at 3,000 rpm. 0.5 ml of supernatant was then transferred to clean
12 x 75 mm tubes and counted in a gamma counter.
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Thyroxine uptake test. A working solution of ^^I-T4
was prepared by adding 60 ul ^^I-T4 to 75 ml buffer.
The T4 uptake test was performed as the T3 uptake test, us
the same samples and quality controls and buffer alone.
Results
Table 8.1 shows the number of counts per minute per 0.5 ml
of supernatant fluid (i.e. bound to serum proteins) for each of the
test samples, together with the group mean values and the value for
buffer alone.
Triiodothyronine uptake test. The T3 serum uptake, with a
correction for the particular reference serum used, is given by the
equation:
T3 serum uptake = counts for test serum x Value of
mean counts for reference serum reference serum
The results for the quality controls for the T3 uptake test were
satisfactory and are presented in Table 8.2.
The mean number of counts in the supernatant was 2.3 times
that of buffer for feline serum and 5.9 times that of buffer for
human serum. A mean of 2.5 times the mass of radiolabel was bound
by human compared with feline serum.
Thyroxine uptake tests. Values for the quality controls
were not available for the T4 uptake test.
The mean number of counts in the supernatant was 3.6 times
that of buffer with feline serum and 4.9 times that of buffer for
human serum. Human serum bound a mean 1.4 times that of the same
volume of cat serum.
Piscussion
The T3 uptake test has been widely employed as a test of
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thyroid function in man and its use with healthy cat sera has also
been reported (see Section 3.7). As carried out here, the amount
of radiolabel1ed iodothyronine in the supernatant reflects the
concentrations of unsaturated thyroid hormone binding proteins,
which in turn depend upon the serum T4 and the total concentration
of the thyroid hormone transport proteins.
Results of the quality controls for the T3 uptake test were
expressed relative to a reference serum so as to avoid changes that
would otherwise occur if the absolute uptake were used, owing to
slight changes in assay conditions and reagents. The quality
control samples gave satisfactory results at all levels in the T3
uptake test. It was not possible to evaluate quality control
results for the T4 uptake test since target values for the controls
were unavailable. However, the same distribution of counts was
obtained with the three control samples in both the T4 and T3 tests,
suggesting that the results were of the correct order.
T3 appeared to be poorly bound in cat sera compared to human
sera. In this study, human serum bound a mean of 2.7 times the
125
I-T3 than an equal volume of cat serum. Other workers who
have used the T3 uptake test in cats have reported similar results.
Tanabe, Ishii and Tamaki (1969) and Kallfelz and Erali (1973) found
a T3 uptake (determined as radioactivity bound to the absorbent, and
therefore the inverse of the results expressed above) which was
higher than any other mammalian species studied with the exception
of the mouse.
T4 was also more avidly bound in human compared with cat
serum, but in contrast to T3, the difference was less marked,
human serum binding only 1.4 times the ^-25j_-p4 0f feq ine serum.
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It is probable that this reflects more avid binding of T4 than T3 by
feline serum proteins, but confirmation of this hypothesis would
require equilibrium dialysis studies to determine the relative
percentages of free T4 and T3. The reduced degree of T3 and T4
binding in feline compared to human serum may be explained by
reduced capacity or affinity of the binding proteins, or higher
concentrations of iodothyronines by comparison with human serum.
The latter possibility can be discounted as serum T4 and T3
concentrations are considerably lower in cats than in man. The
present study does not give specific information about the capacity
or affinity of feline binding proteins. By means of electrophoresis
and autoradiography of feline serum labelled with 1^1j_j4#
Tanabe, Ishii and Tamaki (1969) found that the radioactivity of
what they termed the "post-albumin" band did not disappear when
increments of T4 were added. They argued that this zone could not
be TBG which in man is characterised by saturability at low T4
concentrations. Scherzinger, Guzy and Lorcher (1972) made similar
observations, but felt that the zone did correspond to human TBG
but was of lower capacity, with most T4 being bound to albumin at
normal concentrations.
The following sections of this chapter attempt to define
more specifically the nature of the binding of iodothyronines in the
cat by means of the fractionation by electrophoresis of serum
proteins previously labelled with ^J>I-T4 or 125j_j3<
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8.3 METHODOLOGICAL STUDIES OF IODOTHYRONINE BINDING TO PROTEINS
IN FELINE SERUM, (i) PRELIMINARY INVESTIGATIONS USING
AGAROSE GEL ELECTROPHORESIS
Introduction
Preliminary studies of serum T4 and T3 binding were carried out
with a commercially available agarose gel electrophoresis system.
Such gels are easily managed and preserved. Diethylbarbiturate
buffer, pH 8.6 is recommended for use with this system. However,
barbiturate has been shown to inhibit T4 binding to prealbumin in
human plasma (Ingbar, 1958; Farer et al., 1962). In addition, Tata
(1959) showed that T4 binding to human albumin varied between
physiological pH and pH 8.6. In order to avoid these problems,
initial studies were carried out with an alternative buffer at
physiological pH.
Reagents
Radiolabel1ed thyroxine and triiodothyronine. ^5j_j4
and ^I-T3 were as described in Section 5.2.
Support medium. The support medium was a commercially
available agarose gel containing arabic acid, and sodium azide as a
bacteriostat, and diethylbarbiturate buffer as described below
(Beckman SPE Gels, Beckman Instruments Inc., Fullerton, California,
USA).
Buffer. The buffer was 0.05 mol/1 tris-maleate
containing 0.05 mol/1 tris (hydroxymethyl) methyl amine and 0.05
mol/1 maleic acid, the pH being adjusted to 7.4 by the addition of
1.0 mol/1 sodium hydroxide. The stock solution was stored at 4°C.
Acid-alcohol solution. Washing and destaining of the
gels was carried out in acid-alcohol solution comprising six parts
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of 100 per cent ethyl alcohol, one part of glacial acetic acid and
three parts of deionised water. This solution was stored at room
temperature in a closed container.
Acetic acid solution. The fixative was five per cent
aqueous acetic acid solution. The solution was stored at room
temperature.
Protein stain. The protein pattern was visualised by
staining with Paragon blue (disodium salt of disulphonic acid),
obtained from Beckman Instruments and dissolved in five per cent
aqueous acetic acid solution according to the manufacturer's
instructions.
Film. Autoradiography was carried out using Fuji RX
(Safety) 4 X-ray film (Fuji Photo Film Company (UK) Ltd., Cresta
House, 125 Finchley Road, London, England).
Equipment
Reaction tubes. Serum samples were incubated with
125 nc
I-T4 or -l"I-T3 in 12 mm x 75 mm glass tubes (Corning
Pyrex Borosilicate Culture Tubes, Corning Glass Works, Corning, New
York, 14830, USA).
Pipettes. Serum samples were applied to the gels using
an automatic pipette (Beckman Paragon Applicator 656030), with
disposable pipette tips.
Electrophoresis system. Electrophoresis was carried out
using the Beckman Paragon Electrophoresis System comprising the
Paragon Cells (number 655802) assembled into the Paragon Power
Supply (number 655803). Drying took place in the Paragon Dryer
(number 655805) and fixing, staining and destaining in the Paragon
Wet Processor (number 655809). Electrophoresis and X-ray films were
scanned by a Beckman R112 Scanning Densitometer.
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Gamma counter. A Nuclear Enterprise NE 1600 was used
and maintained as in Section 5.3.
X-ray film processor. X-ray films of autoradiographs
were processed automatically in a Fuji X-Ray Processor, RGII at a
developer temperature of 32°C and a dryer temperature of 30°C.
Methods
Thyroxine binding to serum proteins. From previous
studies, a mean T4 concentration for feline serum of 30 nrnol/1 was
assumed. It was also assumed that the same concentration of
105
I-T4 could be added without disturbing the equilibrium. The
tracer used had a specific activity of InCi/pg T4 and binding of the
radiolabel would be detected radiographically by a 48-hour exposure.
Gels were soaked overnight at room temperature in tris-
maleate buffer to replace contained diethylbarbiturate buffer. The
reagents and samples were allowed to come to room temperature and
each was mixed well before use.
Twenty ul 12^I-T4 was added to each sample tube and the
ethanol:water evaporated by nitrogen. Fifty ul of test serum was
added to each tube and allowed to equilibrate for one hour at room
temperature. During development of the technique, buffer replaced
serum in one tube so that the position of the electrophoresed,
unbound X"I-T4 could be determined. Samples were vortex-mixed
before, during and after equilibration.
Gels were blotted gently with the gel blotter provided.
Electrophoresis runs were arranged with test samples in positions
one to three inclusive, with duplicate samples containing radiolabel
in positions six, eight and ten. Positions four, five, seven and
nine were not used, to facilitate cutting. Five ul samples were
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placed onto the gel via the sample template provided and allowed to
diffuse into the gel for five minutes. Excess sample was removed
by blotting with the template blotter provided and the template
removed.
Gels were electrophoresed at a constant 100 volts for 25
minutes. The gel was then cut to separate the radiolabeled and non-
radiolabelled parts. The non-radiolabel1ed part of the gel was
placed in acid-alcohol solution for five minutes and then into the
drying oven for a minimum of ten minutes. When completely dry, it
was stained with Paragon blue solution for three to five minutes.
It was then immersed sequentially for two-minute intervals in acetic
acid solution, acid-alcohol solution and acetic acid solution.
After drying, the films were scanned densitometrically at 600 nm to
determine serum protein concentrations.
The radiolabeled part of the gel was rapidly dried by hot
air, and covered in thin, transparent kitchen film to prevent the
gel adhering to the X-ray film. The gel, in contact with the X-ray
film, was then clamped between glass plates for 48 hours. The film
was processed and the subsequent autoradiograph scanned
densitometrically as above. By comparison with the stained
electrophoretogram, the corresponding radiolabelled film was cut
according to its protein fractions and the radioactivity of each was
counted in a gamma counter.
125
I-T4 in buffer was electrophoresed as above and the
resultant gels cut by comparison to stained electrophoretograms of
normal so ta diiu counted in a gamma counter.
Background counts were deducted from all observations
prior to percentage binding evaluation.
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Triiodothyronine binding to serum proteins. This was
investigated as above with the following modifications: From
previous studies, a mean T3 concentration for feline serum of 1
nmol/1 was assumed. It was also assumed that the same concentration
of 125j_j3 couid be added without disturbing the physiological
equilibrium. The tracer used had a specific activity of InCi/pg
T3. While this was sufficient for detecting ^^5j-T3
distribution by cutting and gamma counting the gels, it was unlikely
that suitable autoradiographs would be obtained except with very
long exposures, but initially a five-day exposure was investigated.
Ten ul of ^5j_j3 per sanip-|e was used.
Results
Initial pilot experiments using four sera from healthy cats
together with two buffer studies were carried out for both T4 and
T3.
Serum protein separation. This technique readily
separated the serum proteins into five fractions (Fig. 8.1). From
the fastest migrating component, these were: albumin, alpha-1-
globulin, alpha-2-globulin, beta-globulin and gamma-globulin. The
alpha and beta-2-globulins could generally be sub-divided into
alpha-la, alpha-lb, alpha-2a, alpha-2b, beta-2a and beta-2b
fractions. However, such separation was not possible in all samples
and the beta-1 and gamma-globulin fractions generally could not be
subdivided. A prealbumin fraction was not demonstrable.
Thyroxine binding to serum proteins. Autoradiographs
showed two bands of radioactivity in all sera tested. When compared
to the stained electrophoretogram, the first band corresponded to
the albumin zone. The second band began at the leading edge of the
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alpha-l-globulin and blurred into the alpha-2-globulin area (Fig.
8.1).
Autoradiographs of the radiolabel electrophoresed in
buffer only showed non-protein bound T4 to be distributed towards
the trailing edge of the alpha-l-globulin extending into the alpha-
2-globulin, i.e. it had slower mobility than the non-albumin bound
label in serum (Fig. 8.2).
Superimposition of the densitometer scans of the
electrophoretograms and the autoradiographs confirmed qualitatively
the distribution of the radiolabel in the serum samples (Fig. 8.3).
The results of quantitative assessment of ^^I-T4
distribution in normal feline sera and unbound in buffer are
presented in Table 8.3. There was good agreement between the
cutting and counting and scanning densitometry techniques with no
significant difference being demonstrated by Student's paired t test
(t=0.05, 24 d.f; P>0.9). The major part of the ^5j_j4 was
present in the albumin and alpha-l-globulin fractions with a smaller
percentage in the alpha-2-globulin fraction. Negligible amounts
were present in the beta and gamma-globulin fractions.
The distribution of radiolabel in the two samples of
125
I-T4 electrophoresed in buffer only showed good agreement.
Here, only a small percentage of the radiolabel was carried
in the position corresponding to albumin. The major carriage
was in a position corresponding to the alpha-globulin zone although
the percentage distribution in the alpha-1 and alpha-2 components
was marginally decreased and markedly increased respectively by
comparison with electrophoresed serum samples.
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Triiodothyronine binding to serum proteins. Auto-
radiographs were not obtained after a five-day film exposure and
125
I-T3 distribution was therefore evaluated by cutting and
counting the gels by comparison with the corresponding stained
electrophoretogram.
The results of this study are shown in Table 8.4. Apart
from the albumin zone where negligible amounts of radioactivity were
present, ^-^5j_X3 was demonstrated in the four other main protein
fractions, the major percentages being in the alpha-2 and the beta-
2-globulin zones. Relatively small percentages were found in the
alpha-1 and the gamma-globulin fractions. This distribution of
radio!abel was clearly different from that in buffer where the
majority of the radioactivity was present in the gamma-globulin
fraction.
Piscussion
The principles of electrophoresis are based on the fact that
a charged particle placed in an electric field will migrate towards
the oppositely charged electrode at a rate depending upon the
electrical charge of the particle, the strength of the electrical
field and the nature of the support medium.
Amino acids and therefore proteins themselves are
amphoteric, that is, they exist as positive ions in acidic solution
and negative ions in basic solutions. Both amino acids and proteins
possess an isoelectric point, the pH value at which the number of
positive and negative charges on the molecule balance each other.
In a solution with a pH of its isoelectric point, a protein has a
neutral charge and does not migrate if a direct current potential is
applied to the solution. The higher the pH value above the
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isoelectric point, the greater is the negative charge, and the
farther the protein will migrate towards the positive electrode when
placed in an electric field. Conversely, the lower the pH value
below the isoelectric point, the greater will be the positive
charge, and the farther the protein will migrate toward the negative
electrode when electrophoresed. Agarose gel electrophoresis, as
used in this study, separates proteins according to charge. Some
other support media separate molecules according to size (discussed
1ater).
The characteristics of the buffer also affect the
migration of proteins during electrophoresis. This is discussed
under Section 8.4.
After consideration of these factors, 0.05 mol/1 tris-
maleate buffer, pH 7.4 was selected for initial experiments and
produced good separation of protein zones.
The study is based on the principle that exogenous and
endogenous hormone are bound and behave similarly. This clearly can
only be the case if the amounts of radiolabel added are not
excessive. Serum proteins which bind iodothyronines at
physiological concentrations are not saturated at these
concentrations. Therefore, a mass of radiolabel must be used which
is sufficient to act as a marker during electrophoresis but which
does not displace the normal physiological equilibrium. In these
studies, a mass sufficient approximately to double the normal mean
hormone concentration was used.
General conclusions. These preliminary studies
established the following important methodological points:
(i) Feline serum proteins can be satisfactorily separated
by agarose gel el ectrophoresis at pH 7.4 in tris-maleate buffer.
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(ii) The distribution of iodothyronine binding can be
demonstrated by prior radiolabelling.
In the case of T4, this revealed the presence of binding in
two zones - albumin and alpha-l/alpha-2-globulin. Unfortunately, T4
in buffer only, also migrated in the more cathodal part of the latter
zone. Although the high percentage of label in serum in this zone,
and the slight difference in its mobility from free T4 suggested
that it was indeed protein bound, Farer, Robbins and Blumberg (1962)
using paper electrophoresis with a number of buffers, found that T4
could migrate as the unbound hormone when added to serum in which T4
binding proteins were weak or lacking. Consequently, further
experiments (described in Sections 8.4 to 8.6) were performed to try
to confirm the presence of T4-binding to this globulin fraction.
In the case of T3, there was apparent binding in the
alpha-1, alpha-2, beta and gamma-globulin fractions. This wide
distribution of binding is not seen in human serum and in order to
examine whether it was a feature of the particular electrophoresis
system selected, further experiments (described in Section 8.4) were
performed. T3 in buffer only migrated in significant quantities in
the area corresponding to gamma-globulin.
(iii) Autoradiography provided a convenient technique for
visualising the thyroid hormone binding proteins for T4 but not for
T3. This arose from constraints on the amount of labelled
iodothyronine that could be added without disturbing the
equilibrium.
(iv) Quantitative estimation of thyroid hormone binding by
the different proteins could be carried out by cutting and gamma
counting the zones or by scanning the autoradiograph
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densitometrically. The agreement between these techniques was
excellent. Although scanning the autoradiograph was more convenient
and less time-consuming, the cutting and counting technique offered
continuity between the T4 and T3 studies.
8.4 METHODOLOGICAL STUDIES OF IODOTHYRONINE BINDING TO PROTEINS
IN FELINE SERUM, (ii) EFFECT OF pH CHANGES AND BUFFER TYPE
ON ELECTROPHORESIS USING AGAROSE GEL
Introduction
In an attempt to resolve the bands corresponding to the
globulin bound and unbound T4 and whether or not multiple zone
binding of T3 was an artefact of the electrophoresis system, the
effects of varying the buffer type and pH were investigated.
Reagents and equipment
These were as described in Section 8.3, with the exception
of an additional buffer. This was 0.1 mol/1 diethylbarbiturate, pH
8.6 (Beckman B-2 buffer, Beckman Instruments). The prepared buffer
was stable for 60 days at room temperature.
Methods
Effect of changing pH of tris-maleate buffer on
thyroxine binding to serum proteins. 0.05 mol/1 tris-
maleate buffer was prepared as described previously. The pH of
aliquots of the buffer was adjusted to 6.8, 7.0, 7.2 and 7.4 by the
dropwise addition of 1.0 mol/1 sodium hydroxide. Sera from two
healthy cats and samples of buffer of each pH were incubated
with an(j subsequently electrophoresed at all four pHs
by the method described previously. The radiolabelled gels were
then autoradiographed for 48 hours.
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Effect of diethyl barbiturate buffer on thyroxine and
triiodothyronine binding to serum proteins. Sera from
two normal humans (kindly supplied by Dr. G.J. Beckett) and from three
healthy cats were used in these studies. Samples were radiolabeled
with the respective iodothyronines and electrophoresed on agarose
gel as described in Section 8.3 but using 0.1 mol/1
diethyl barbiturate buffer, pH 8.6. In each case, the corresponding
radiolabeled iodothyronine in buffer alone was also electrophoresed
on the same gel. The resulting gels were processed as described
previously with the exception that none of the studies was
autoradiographed.
Results
Effect of changing pH of tris-maleate buffer on
thyroxine binding to serum proteins. The resultant
autoradiographs are shown in Fig. 8.4. Sequential reductions in pH
from physiological failed to change the position of the T4 in
buffer relative to that in serum. Cutting and gamma counting of
the gels was not, therefore, carried out.
Effect of diethyl barbiturate buffer on thyroxine and
triiodothyronine binding to serum proteins
Serum protein separation. Typical stained
electrophoretograms of normal human and feline serum run in parallel
are shown in Fig. 8.5.
The proteins in feline serum were more mobile than those
in human serum, resulting in electrophoretograms which were ten per
cent longer with cat serum. There was little difference in the
definition of the protein bands.
Prealbumin fractions were not demonstrated with either
human or feline sera by this technique.
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Thyroxine binding to serum proteins. The results of
this study are presented in Table 8.5.
With feline serum, approximately equal amounts of
125
I-T4 were bound in albumin and alpha-l-globulin. Negligible
amounts of radiolabel were found in the three other fractions.
Unfortunately, an almost identical distribution was found when
the radiolabel was electrophoresed free in buffer and the resultant
gel cut according to a stained feline serum electrophoretogram.
The percentages of ^5j_j4 were si mil ar in human and
feline alpha-2-globulin, beta-globulin and gamma-globulin.
However, much higher amounts of radiolabel were found in the alpha-l-
gl obul in fraction in man than in the cat and there was a corresponding
reduction in the albumin zone. When 125i_j4 electrophoresed
free in buffer was cut according to a stained human serum protein
gel, almost all of the radioactivity was found in the area
corresponding to the albumin zone, with only a small percentage being
found in the other four areas.
Triiodothyronine binding to serum proteins. The
results of this study are presented in Table 8.6.
The pattern of protein binding was similar in both
feline and human sera with the major proportion being in the alpha-
1
globulin zone. Approximately twice the percentage of 1"I-T3 was
bound by human as by feline albumin. Significant amounts of
radiolabel were found in the beta-globulin in both species. The
majority of ^I-T3 el ectrophoresed free in buffer travelled in
areas corresponding to the alpha-2-globulin zone of both feline and
human serum. Significant amounts were also found in the area
corresponding to alpha-l-globulin of human serum.
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Piscussion
The characteristics of a buffer which affect the migration
of proteins during electrophoresis are its type, concentration, ionic
strength and pH.
The effects of buffer concentration arise because current is
carried by ions present in solution. The greater the number of
buffer ions present relative to other ions, the greater will be the
proportion of current they carry. The other ions will move more
slowly but this results in sharper definition of the protein
fractions.
As buffer ionic strength increases, heating within the
system increases although the resolution of the fractions is
enhanced (Smith, 1968). In practice, ionic strengths between 0.01
mol/1 and 0.10 mol/1 are commonly used.
Changes in buffer pH affect the distances travelled by
charged molecules during electrophoresis. Different molecules
carrying different amounts of charge should be affected to varying
degrees as described in Section 8.3.
Effect of changing the pH of tris-maleate buffer on
thyroxine binding to serum proteins. In this study, it
was hoped that a reduction in buffer pH would retard the travel of
free T4 more than that which was protein bound. The reasons why
this did not occur are not immediately obvious. It is possible that
the travel of the protein fractions and the free T4 were retarded
to the same degree, with the latter remaining in the same relative
position to the alpha-1 and alpha-2-globulin fractions. Indeed, the
resultant autoradiographs and those shown in Fig. 8.2 can be virtually
superimposed suggesting that this is the case. It may be that the
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free T4 and protein fractions could have been variably retarded if
the pH of the buffer had been reduced further. However Tata (1959)
found that there was an eight per cent increase in binding of T4 by
human TBG between pH 7.4 and 8.6. Such studies with cat serum have
not been carried out but it was felt that further reductions in pH
would create an unacceptable deviation from physiological
conditions.
Effect of diethylbarbiturate buffer on thyroxine and
triiodothyronine binding to serum proteins. Barbiturate
buffer, pH 8.6 has been the favoured buffer for studies on T4 and
T3 binding in human serum. The inclusion of samples of human serum
in this study, therefore, allowed comparison of the results with
those published by other workers.
Barbital buffers are monovalent and therefore they
contribute to the ionic strength to a lesser degree than polyvalent
ions. Ions of low valency interact minimally with proteins.
They are also very large and thus migrate slowly in the electrical
field so that the conductivity and, therefore, the Joule heat
effect can be kept to a minimum. However, pH 8.6 is not
physiological and barbiturate buffer blocks the binding of T4 to
TBPA (Ingbar, 1958; Farer et al., 1962).
There was little difference in the distribution of T4 in
cat serum in either barbiturate or tris-maleate buffer with the
majority of radiolabel being present in albumin and alpha-1-
globulin. Negligible amounts were found in the remaining protein
fractions. Similar findings using barbiturate buffer have been
reported by Robbins, Apter and Rail (1957), Robbins and Rail (1960),
Farer et al. (1962) and Scherzinger, Guzy and Lorcher (1972). In
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this study, unfortunately, an almost identical distribution occurred
when the radiolabel was electrophoresed in buffer alone, making it
impossible to differentiate between bound and free T4 in serum.
In contrast, there were marked differences in the
distribution of T3 in feline serum electrophoresed in tris-maleate
and barbiturate. Such differences due to buffer type have been well
documented in work with human serum. Without studies utilising
alternative techniques, it was not possible to decide which was
reflecting the situation in vivo.
Comparing the tracer distributions in feline and human
sera in barbiturate buffer, much higher percentages of T4 were found
in the alpha-l-globulin region of human than in feline serum with
resultant inverse findings with albumin. Because j_j4
electrophoresed in barbiturate alone travels at a point
corresponding to albumin, it was possible to confirm that human alpha-
l-globulin bound T4 in this system.
The pattern of T3 distribution in human and feline serum
with barbiturate buffer was similar. When electrophoresed free in
buffer, T3 travelled at a point corresponding to alpha-2-globulin in
both. Thus, it is only possible to report that both feline and
human albumin and alpha-l-globulins bind T3 in barbiturate.
Because there was less overlap between T3 electrophoresed
in serum and free in buffer, with tris-maleate than with barbiturate,
and because the tris-maleate was at physiological pH, further
studies were carried out with this buffer.
Unfortunately, this technique failed to separate TBPA from
sera of either species. TBPA does not appear to have been described
in the cat and it is therefore impossible to speculate whether
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this is a failure of the present technique or whether the protein is
lacking in this species. Tata (1959) suggested that in certain
buffer systems, TBPA was dissociated from an alpha-globulin and
that in barbiturate, TBPA migrated electrophoretically as an inter-
alpha-globulin. Other data, however, have been more easily
explained on the basis that TBPA is prevented from binding T4 in
barbiturate by some sort of competitive process (Robbins and Rail,
1960). It is interesting to speculate that, in the present studies
with human serum, TBPA may have migrated with alpha-globulin. If
such were the case, the results of the present study agree closely
with figures compiled from the literature for man by De Groot and
Stanbury (1975).
8.5 METHODOLOGICAL STUDIES OF IODOTHYRONINE BINDING TO PROTEINS
IN FELINE SERUM. (iii) RADIO IMMUNOELECTROPHORESIS
Introduction
In view of the difficulties in distinguishing reliably
between globulin bound and free T4 by the original technique and by
alterations in the buffer pH, radioimmunoelectrophoresis was carried
out to attempt to demonstrate the specific T4 binding proteins in
feline serum.
Immunoelectrophoresis was first described by Grabar and
Williams in 1953 and was modified to a micro technique by
Scheidegger (1955). The method is a combination of two techniques,
gel diffusion and immunodiffusion. It is capable of
differentiating the physicochemical and antigenic properties of
proteins. Radioimmunoelectrophoresis is a further modification of
the procedure in which specific protein fractions are made visible
autoradiographically after prior radiolabelling.
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Reagents
Support medium. The support medium was a commercially
available agarose gel (Beckman IEP Gels), containing
diethyl barbiturate as described below.
Buffer. The buffer was 0.1 mol/1 diethylbarbiturate,
pH 8.6 (Beckman B-2 buffer) as described previously.
Saline solution. 0.85 per cent saline solution was
prepared from reagent grade sodium chloride and deionised water.
Anti-cat serum. Goat anti-cat serum containing 0.1 per
cent sodium azide as preservative was supplied in liquid phase by
Miles-Yeda, Miles Laboratories, Stoke Poges, England. It was stored
in aliquots at -20°C.
Other reagents. All other reagents were as described in
Section 8.3.
Equipment
All equipment was as described in Section 8.3.
Method
The reagents and samples were allowed to come to room
temperature and each was mixed well before use.
Samples of serum from two healthy cats were incubated with
125
I-T4 for one hour as described in Section 8.3. Gels were
blotted gently with the gel blotter provided. Each gel could take
seven test samples. Electrophoresis runs were arranged with two
aliquots of the sample under test in lanes five and seven with
duplicate samples containing radiolabel in positions two and three.
Position four was purposely left free to facilitate cutting the gel.
Five ul samples were placed onto the gel via the sample
template provided and allowed to diffuse into the gel for ten
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minutes. Excess sample was removed by blotting with the template
blotter provided and the template removed.
Gels were electrophoresed for 20 minutes at a constant 100
volts. After removing the gel from the cell, the electrophoresed
samples were separated by cutting. One radiolabelled and one
unlabelled sample were then immunodiffused. Twenty ul of goat anti-
cat serum was applied to the antiserum troughs via the antiserum
template provided. After ten minutes, the antiserum template was
removed and the gel placed in a covered incubation tray for 24
hours on a gel blotter moistened with deionised water.
The remaining electrophoresed samples were immediately dried
at up to 90°C for five minutes. The unlabelled sample was then
stained as described in Section 8.3. The labelled sample was
covered in kitchen film and retained for 24 hours.
After 24 hours' immunodiffusion, the unlabelled sample was
stained as described in Section 8.3.
In the initial study, the radiolabeled, diffused sample was
soaked in saline for ten minutes and press-dried on blotting paper,
each on two occasions, and subsequently dried completely in the
drying oven, as per the manufacturer's instructions. This procedure
was found to cause dissociation of the bound T4 and subsequently the
saline washing and the press-drying were omitted.
After covering with kitchen film, the labelled, diffused
sample and the labelled, non-diffused sample were autoradiographed
for 48 hours as described in Section 8.3.
Results
The results of this study are presented in Fig. 8.6.
The stained electrophoretogram has a rocket-like appearance
with the leading edge of the albumin being pointed. The albumin and
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gamma-globulin zones are well-defined but other zones are more
difficult to distinguish. The corresponding autoradiograph shows
radiolabel present in the albumin zone moving back into the alpha-
globulin zone.
The immunoelectrophoresed sample shows seven areas, the
leading and most prominent one being albumin and the trailing one
being gamma-globulin. The corresponding autoradiograph shows a
wide, rocket-shaped distribution of radioactivity. There was no
evidence of areas corresponding to either albumin or any specific
globulin binding T4.
Piscussion
The principle of immunoelectrophoresis is based upon the
visualisation of specific proteins through the formation of antigen-
antibody precipitin lines following protein separation by
electrophoresis. The simultaneous diffusion of the separated
proteins in the sample and the antibody in the trough results in the
formation of precipitin areas, the shape and position of each being
determined by the nature and concentration of each protein present.
The areas represent the positions in the gel at which equivalence
between antigen and antibody concentrations exist. If a control
sample is available, direct comparisons of the precipitin areas can
be made.
If the protein sample is mixed with a radiolabel prior to
electrophoresis, any protein binding the radiolabel may be
demonstrated by autoradiography after the immunodiffusion phase.
In this study, excellent separation and visualisation of the
protein zones were achieved both by simple electrophoresis and by
immunoel ectrophoresis, although identification of specific
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constituent proteins was not possible because of the non-availability
of feline serum protein controls. Radioimmunoelectrophoresis was
unsatisfactory. When the manufacturer1s instructions with regard to
saline washing and press-drying were followed, autoradiographs were
not produced. This may have resulted from total dissociation of
125 i?c;
I-T4 from its binding proteins or J-"I-T4 may have
remained in the precipitin areas but in insufficient amounts for
autoradiography. The latter explanation is probably correct, as
when Bigler (1976a) used a similar technique, exposure times of
eight weeks were required to give satisfactory autoradiographs.
When the washing and press-drying stage was omitted,
125
I-T4 remained bound to proteins diffusely over the area of
electrophoresis. This may have been due to non-specific binding of
125
I-T4 to the anti-feline serum, which would normally have been
removed by the washing step.
Radioimmunoelectrophoresis has been successfully applied to
the visualisation of antigen-antibody reactions but was
unsatisfactory for the demonstration of T4 binding. This may have
been due to insufficient sensitivity of detection of the label, or the
relatively reversible nature of the TBG-T4 binding compared with that
of antigen-antibody binding, or a combination of these factors.
This experiment did not exclude the presence of a T4 binding
globulin and an alternative approach was adopted to investigate its
presence.
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8.6 METHODOLOGICAL STUDIES OF IODOTHYRONINE BINDING TO PROTEINS
IN FELINE SERUM, (iv) USE OF POLYACRYLAMIDE GEL
ELECTROPHORESIS
Introduction
Electrophoresis using agarose gel separates molecules mainly
according to charge. Support media such as polyacrylamide gel act
as molecular sieves, with small molecules progressing rapidly and
larger molecules more slowly. T4 is a relatively small molecule by
comparison with serum proteins. When ^5j_j4 -jn buffer alone is
electrophoresed in parallel with -^I-T4 -jn serum, the
radiolabel in the buffer should move more rapidly than the albumin
and is likely to pass completely through the gel during protein
separation.
The aim of this study was to demonstrate ^2^I-T4 binding
in the albumin and alpha-globulin regions of normal feline serum
electrophoresed on polyacrylamide gel, while showing that the
radiolabel was not present in corresponding areas of the gel when
electrophoresed in buffer alone.
Reagents
Radiolabelled thyroxine. ^25I-T4 was as described
in Section 5.2.
Acrylamide. Acrylamide used in the production of the
stacking and resolving gels was obtained from BDH Chemicals Ltd.,
Poole, Dorset, England.
Temed. The compound used to accelerate polymerisation
was N, N, Nl, N^ - tetramethylethylenediamine obtained as
Temed from BDH Chemicals Ltd.
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Buffers. Three buffers were used:
(i) 0.375 mol/1 tris-hydrochloride buffer, pH 6.8 was
used to prepare the stacking gel.
(ii) 1.0 mol/1 tris-hydrochloride buffer, pH 8.85 was
used to prepare the resolving gel.
(iii) The electrode buffer was 0.05 mol/1 tris-maleate
as described in Section 8.3.
All buffers were stored at 4°C.
Fixing solution. The electrophoresed proteins were
fixed using a solution containing 57.5g trichloracetic acid and
17.25g sulphosalicylic acid in 500 ml distilled water.
Protein stain. The protein stain was 0.2 per cent
Coumassie brilliant blue R in methyl alcohol: water: acetic acid
(50:50:7 by volume). The stain was stored at room temperature.
Acid-alcohol solution. Washing and destaining of the
gels was carried out using a solution of methyl alcohol: acetic
acid: distilled water (5:7:88 by volume).
Film. Fuji RX (Safety) 4 X-ray film, as described in
Section 8.3, was used for autoradiography.
Equipment
Electrophoresis system. Electrophoresis was carried out
using an LKB 2001 vertical electrophoresis unit obtained from LKB-
Wallac, Turku 10, Finland.
Other equipment. Additional equipment was as specified
in Section 8.3.
Methods
All reagents and samples were allowed to come to room
temperature and each was mixed well before use.
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Preparation of stock acrylamide solution. A 14 per cent
solution of acrylamide was prepared by dissolving 26.6g acrylamide
and 1.4g N-methylene bis-acrylamide in 200 ml distilled water. The
solution was stored at 4°C.
Preparation of resolving gel. An 8.7 per cent resolving
gel was prepared from 23 ml of the stock acrylamide, 30 ml of 1 mol/1
tris-hydrochloride buffer, pH 8.85, 26 ml distilled water, 0.1 ml
Temed and 0.1 ml freshly prepared ten per cent aqueous ammonium
persulphate solution.
While still liquid, the gel was poured into the
electrophoresis apparatus and a small amount of 100 per cent butanol
was added to produce a sharp surface. The gel was then allowed to
set and the top surface subsequently washed with distilled water.
Preparation of stacking gel. A 3.6 per cent stacking
gel was prepared from 3.6 ml of the stock acrylamide, 10.0 ml of
0.375 mol/1 tris-hydrochloride buffer, pH 6.8, 16 ml distilled
water, 0.1 ml Temed, and 0.1 ml freshly prepared ten per cent (w/v)
aqueous ammonium persulphate solution.
The stacking gel was added to the apparatus and the
plastic dividing inserts introduced. After allowing the gel to set,
the surface was washed with distilled water and the loose polymer
removed with a pasteur pipette.
Preparation of labelled sera and buffer. Samples
(50 ul) of sera from three healthy cats and electrode buffer were
incubated with 20 ml ^"I-T4 for one as described in detail
in Section 8.3. Subsequently, 10 ul of glycerol was mixed with the
labelled samples and with 50 ul of the corresponding unlabelled
sera. The glycerol caused the test samples to sink in the gel
wells.
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Electrophoresis. Ten ul of each sample was added to the
wells using a glass micropipette, and 10 ul of Coumassie blue was
added to one well to act as a marker. Gels were electrophoresed at a
constant 100 mA until the marker dye had traversed the stacking
gel. The current was then altered to 35 mA until the marker reached
the bottom of the gel. The gel was then removed from the apparatus
and divided through the position of the marker dye.
The unlabel!ed gels were placed in fixer for 45 minutes
and then in acid-alcohol solution for five minutes. After staining
with Coumassie blue for ten minutes, the gel was destained with
several changes of acid-alcohol solution until the background was
clear. Gels were stored in the short-term in the acid-alcohol
solution.
The labelled part of the gel was placed in a polythene bag
in direct contact with, but not clamped to, the X-ray film and
autoradiographed for 48 hours.
Results
Qualitative results of this study are shown in Fig. 8.7.
Serum protein separation is more complete than with the
agarose gel technique, with a number of protein components being
demonstrable. The corresponding autoradiograph shows two zones of
radiolabel in the serum samples corresponding to albumin and the
alpha-globulin fractions. The labelled buffer sample fails to show
a zone of radioactivity autoradiographically, indicating complete
passage of the *"l-T4 through the gel.
Piscussion
Polyacrylamide gel results from the polymerisation of
acrylamide monomer into long chains with cross-linking. The
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polymerisation is initiated by ammonium persulphate and accelerated
by Temed. The effective pore size of polyaery1 amide gels is greatly
influenced by the acrylamide concentration in the polymerisation
mixture, pore size decreasing as acrylamide concentration increases-
Gels with acrylamide concentrations of less than 2.5 per cent sieve
large molecules but are almost fluid, whereas those of more than 30
per cent will sieve molecular weights of only a few thousand. A
discontinuous or multiphase system (as employed here) employs a
large bore stacking gel, which concentrates the proteins into
extremely narrow zones prior to migration through the smaller bore
resolving gel. This aids the separation of proteins during
electrophoresis and their subsequent definition after staining.
In this study, a discontinuous system with a 3.6 per cent
stacking gel and an 8.7 per cent resolving gel gave excellent
protein separation and demonstration of the fractions binding the
125
I-T4. This early success was perhaps somewhat fortuitous
because, for the separation of any mixture of proteins, the choice
of acrylamide concentrations is critical.
Detailed accounts of polyacrylamide gel electrophoresis of
proteins in normal feline serum do not appear to have been described
previously. Thus, all the protein zones shown in the stained
electrophoretogram in Fig. 8.7 cannot be positively identified.
General conclusions. This study clearly established that:
(i) Feline serum proteins can be satisfactorily separated
by polyacrylamide gel electrophoresis at pH 7.4 in tris-maleate
buffer.
(ii) The presence of ^5j_j4 -jn buffer alone cannot be
demonstrated autoradiographically, indicating that it has passed
through the gel during electrophoresis.
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(iii) 125i_t4 can bg identified autoradiographically in
two distinct areas when electrophoresed in feline serum. These
result from binding of the radiolabel to albumin and a protein with
an alpha-globulin mobility.
These data confirm the results of the preliminary
electrophoresis studies using agarose gel (Section 8.3) and the
early reports of Farer et al. (1962) and Scherzinger, Guzy and
Lorcher (1972) using other electrophoresis systems (Section 3.6).
Although polyacrylamide gel electrophoresis gave a clearer
separation of feline proteins than agarose gel, it proved too complex
for routine use and was not amenable to quantitative work. Agarose
gel was therefore used in subsequent investigations.
8.7 BINDING OF THYROXINE AND TRIIODOTHYRONINE TO SERUM PROTEINS
IN HEALTHY CATS AND HUMANS - POPULATION STUDIES USING
AGAROSE GEL ELECTROPHORESIS
Introduction
The studies of serum T4 binding by polyacrylamide gel
electrophoresis strongly suggest that 125j_j4 found in the
alpha-l/alpha-2-globulin protein zones in the agarose gel system is
protein bound. The agarose gel system is also very satisfactory for
electrophoresis of labelled T3 in serum, as the mobility of protein
bound and free T3 differ substantially in this medium. It was
possible, therefore, to apply this technique, previously used in a
pilot study with four feline sera (Section 8.3), to serum T4 and T3
binding in a larger number of healthy cats. Results were compared
with corresponding data for humans.
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Methods
Serum samples from a total of 21 healthy cats (eight males,
seven females, two neutered males and four neutered females) aged
between five months and 11 years were selected randomly from
those previously used to determine the reference ranges for T4 and
T3. T4 binding studies were carried out on each sample and 20 of
the samples were used in the T3 studies. T4 and T3 binding was
also investigated in serum samples from two healthy humans.
Total serum protein concentrations were determined as
described in Section 4.4. Agarose gel electrophoresis was carried
out as described in detail in Section 8.3. With feline sera,
125
I-T4 binding was determined by autoradiography, by gamma
counting of the five major protein zones defined by comparison with
the stained, unlabelled electrophoretograms, and by densitometrically
scanning the autoradiographs. With human sera, quantitation
was by gamma counting of cut gel fractions only.
T3 binding was assessed similarly, with the exception that
autoradiography was not used.
Results
Serum protein separation. Typical stained
el ectrophoretograms of normal feline and human serum run in parallel
are shown in Fig. 8.8.
The feline serum proteins were more mobile than their human
counterparts, resulting in electrophoretograms that were 25 per cent
longer with cat serum. However the protein bands were more sharply
defined in the human samples. Prealbumin zones were not
demonstrated with serum from either species by this technique.
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The serum protein concentrations of the 21 feline samples
are shown in Table 8.7.
The majority of individual values fell within the range
published from this School by Keay (1982) using a different
commercially available agarose gel kit with diethylbarbiturate
buffer. Several values beyond the reference limits were noted,
particularly with gamma-globulin concentrations (ten cases),
which were also reflected in abnormal total serum protein
concentrations.
Serum protein concentrations were not determined for the
human samples.
Thyroxine binding to feline serum proteins. In all
cases, autoradiographs were similar and showed two distinct areas of
binding as shown in Fig. 8.1. The most anodal of these
corresponded to the albumin fraction. The leading edge of the
second zone corresponded to that of the alpha-l-globulin fraction
and this zone continued cathodally, merging with the leading edge of
the alpha-2-gl obul in fraction.
There was no significant difference between the two
quantitative methods of assessment of ^®I-T4 binding as
assessed by Student's paired t test (t = 0.03,104 d.f; P > 0.9)
and only the values obtained by gamma counting of the gel fractions
are presented (Tables 8.8 and 8.9).
The majority of the sera showed higher binding in the
alpha-l-globulin than in the albumin fraction with only three
showing the reverse trend. When the percentage bound in the alpha-1
and alpha-2-globulin fractions were taken together, only one sample
showed higher binding in the albumin fraction. Negligible amounts
of radiolabel were present in the beta and gamma-globulin fractions.
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Possible variations in binding according to sex were
investigated by the Mann-Whitney U-Test. Comparing females and
neutered females as one group with males and neutered males as the
other group, no significant difference could be demonstrated for
any protein fraction. The data failed to establish any relationship
between percentage T4 binding and age.
Thyroxine binding to human serum proteins. The results
of this study, together with the mean results of the feline study,
for comparison purposes, are presented in Table 8.10.
In human sera, a much higher percentage of ^-2^I-T4 is
bound in the alpha-l/alpha-2-globulin zone than in feline sera, with
inverse relationships for albumin binding. Negligible amounts of
radiolabel are found in the beta and gamma-globulin fractions.
Triiodothyronine binding to feline serum proteins. The
results of this study are presented in Tables 8.11 and 8.12.
There is minimal binding in the albumin fraction of all
sera. The four other serum fractions, in particular the alpha-2 and
beta-globulin zones appeared to bind significant quantities of T3.
Possible sex-related variations in binding were
investigated by the Mann-Whitney U-Test. Comparing females and
neutered females as one group with males and neutered males as the
other group, no significant difference could be demonstrated for any
protein fraction. The data failed to establish any relationship
between percentage T3 binding and age.
Triiodothyronine binding to human serum proteins. The
results of this study, together with the mean results of the feline
study for comparison purposes, are presented in Table 8.13.
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The majority of the radiolabel was carried in the alpha-
globulin zone with a slightly higher percentage being present in the
alpha-l-globulin fraction. By contrast, in the cat, the majority of
the label migrated in the alpha-2 and beta-globulin zones with a
small amount in the gamma-globulin. A mean of 22 per cent T3 was
found in the beta-globulin in humans. A small amount of T3 was
bound to human albumin but there was a negligible amount in the
gamma-globulin fraction.
Piscussion
Agarose gel electrophoresis was selected as the simplest
technique to study T4 and T3 protein binding because kits are
commercially available and the gels are simply managed,
autoradiographed and preserved. Unfortunately, TBPA was not
demonstrated in either human or feline sera by this method. With
human serum, this is presumably a feature of the support medium,
since Ingbar (1958) was able to demonstrate TBPA using paper
electrophoresis in tris-maleate buffer, although at pH 8.6 rather
than 7.4. The failure to demonstrate a feline TBPA may be due to
technique or because the protein does not occur in feline serum.
Prior to using the technique on a larger scale, it was
necessary to confirm that 12!>I-T4 -jn the alpha-globulin zone was
protein bound. This was achieved using the polyacrylamide gel
system. Further evidence for this was obtained in later studies
(see Section 9.3).
Although estimates vary according to technique, under normal
physiological conditions human TBG (an inter-alpha-l/alpha-2-
globulin) binds approximately 75 per cent of T4. The remainder is
bound to TBPA (15 per cent) and albumin (10 per cent) (De Groot and
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Stanbury, 1975). Other serum proteins may be involved in T4
transport but they carry very small amounts of the hormone (Marshall
and Levy, 1966).
All published studies agree that feline albumin binds T4.
However, there has been considerable debate over whether a T4
binding globulin exists in the cat, with Farer et al. (1962) and
Scherzinger, Guzy and Lorcher (1972) reporting a T4 binding alpha-
globulin, Tanabe, Ishii and Tamaki (1969) suggesting that this zone
was really post-albumin and Bigler (1976a) failing to identify a
TBG at al 1.
T3 binding in human serum has received less attention than
T4. Using paper electrophoresis with glycine acetate buffer, pH
8.6, 65 to 70 per cent of T3 was bound to TBG and the remainder to
albumin (Woeber, 1971). Investigations into feline T3 serum protein
binding have not been previously reported.
These studies clearly demonstrated the existence of a T4
binding globulin in all normal cat sera studied. Peak binding
occurred in the mid alpha-l-globulin zone and continued into the
leading edge of the alpha-2-globulin. Human TBG migrated in an
identical position in this system. However, although feline TBG
bound a lower percentage (mean 59 per cent) of T4 than human TBG (in
this study, mean 90 per cent), these data clearly do not support the
conclusions of Scherzinger, Guzy and Lorcher (1972), who suggested
that feline TBG had only a low capacity with most T4 being bound to
albumin at normal concentrations.
In the feline study, only a small percentage of T3 was bound
to albumin, approximately ten per cent to alpha-l-globulin, with
the majority being bound by the alpha-2 and beta-globulin fractions.
It is not possible, from these data, to decide whether the carriage
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in the alpha-2 and beta-globulin regions represents a single or
multiple protein because autoradiographic studies could not be
carried out using physiological concentrations of radiolabel.
Because ^5j_j3 electrophoresed in buffer alone ran in an area
corresponding to gamma-globulin, it was not possible to deduce
whether T3 in this zone in serum was protein bound or free.
Although the albumin binding of T3 in feline and human serum
was similar, a much higher proportion was bound to alpha-globulin in
man, due to increased alpha-1 carriage. A significant proportion
was also present in the beta-globulin fraction. The significance of
this observation is unknown.
In man, the concentration of the serum iodothyronine binding
proteins is essentially unaffected by age, although a small but
significant fall in TBPA, and increase in TBG concentrations, have
been reported in the elderly (Gregerman and Davis, 1978). No age-
related changes in T4 and T3 binding were noted in the present study
but only two cats were older than 9 years.
General conclusions. The following general conclusions
may be summarised from this study:
(i) Feline T4 is bound to albumin and a protein with a
mobility in the alpha-l-/alpha-2-globulin zone.
(ii) Feline T3 is bound mainly in the alpha-2 and beta-
globulin zones, with smaller proportions being present in albumin
and alpha-l-globulin. It is not possible to decide whether T3 in
the gamma-globulin zone is protein bound.
(iii) There are major differences in T4 and T3 binding
between cats and humans. While feline and human TBG migrate in an
identical position, feline TBG must be of lower affinity or capacity,
or present in smaller concentrations, than that of man.
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9. INVESTIGATIONS OF THYROID HORMONE BINDING BY SERUM PROTEINS
IN CATS WITH ABNORMAL TOTAL THYROXINE AND
TRIIODOTHYRONINE CONCENTRATIONS
9.1 GENERAL INTRODUCTION
The investigation of iodothyronine-protein interactions in
in serum is of interest because:
(i) variations in binding of thyroid hormones by serum
proteins may explain some of the features of abnormal thyroid
function, and
(ii) comparison of thyroid hormone binding in animals with and
without thyroid disease may give some insight into the physiological
roles of the various thyroid hormone binding proteins.
Extensive investigations have been carried out in this field in
man but no such studies have been reported in cats. This chapter
presents information on feline thyroid hormone protein binding in
naturally-occurring hyperthyroidism, experimentally-induced
hypothyroidism, and in apparent euthyroidism associated with
elevated or reduced concentrations of iodothyronines. In addition,
investigations were carried out into the T4 uptake test in naturally-
occurring hyperthyroidism and experimentally-induced hypothyroidism
in cats, and the role of serum free fatty acid concentrations in
alterations of T4 binding in feline thyrotoxicosis.
9.2 REAGENTS AND EQUIPMENT
Thyroxine and triiodothyronine uptake tests




The reagents and equipment used were as described in Section
8.3.
Non-esterified fatty acid determinations
A commercially available kit (Nefa C, Wako Pure Chemical
Industries Ltd., obtainable from Alpha Laboratories, 40 Parham
Drive, East Leigh, Hampshire, England) was used, the analyses being
run on a Cobas Bio centrifugal analyser.
9.3 BINDING OF THYROXINE AND TRIIODOTHYRONINE TO SERUM PROTEINS
IN FELINE HYPERTHYROIDISM
Introduction
The serum binding of T4 and T3 in human thyrotoxicosis has been
well-described. While the clinical aspects of feline
hyperthyroidism have been documented in detail, there are no
published reports of iodothyronine binding in unfractionated or
fractionated sera in this disorder.
The following studies describe the investigation of
iodothyronine binding in feline hyperthyroidism in unfractionated
serum using the T4 uptake test, and by agarose gel electrophoresis,
where possible comparing the results with post-treatment samples.
The results by electrophoresis are contrasted with those obtained
with normal feline serum in which T4 concentrations were
artificially elevated. Studies are reported which investigate
whether changes in serum non-esterified fatty acid concentrations
may be responsible for T4 binding changes observed in
thyrotoxicosis.
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Thyroxine binding to proteins in unfractionated sera in
feline hyperthyroidism
Methods
Clinical material. Sera from four cats taken before, and
from 12 to 20 weeks after, successful treatment of hyperthyroidism, were
used in this study. All had histories and physical findings
suggestive of the disorder and palpable goitre. All had elevated
total serum T4, and three had elevated total serum T3, concentrations.
Samples from three healthy cats, three healthy humans and buffer
alone were included for comparison.
Thyroxine uptake test. The T4 uptake test was performed as
described in detail in Section 8.2.
Results. Table 9.1 shows the T4 uptake expressed as the
number of counts per minute per 0.5 ml of supernatant fluid (i.e.
bound to serum proteins) for each of the test samples.
There were no significant differences between the results for
the healthy cats and for the untreated hyperthyroid cats, neither
were there significant differences within the hyperthyroid group
before and after surgery. As demonstrated in Section 8.2, the
binding in human serum was consistently higher than in any of the
cat samples.
Discussion. These data show that there are no differences
1 OC
in the gross protein binding of I-T4 between euthyroid,
hyperthyroid and successfully treated hyperthyroid cats. The T4
(and by interpolation, the T3) uptake test cannot, therefore, be
used as a diagnostic test for feline hyperthyroidism. This is
probably due to the much lower affinity of feline TBG for T4
compared with its human counterpart. It could, however, reflect a
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balanced increase in the TBG and T4 concentrations in hyperthyroid
feline serum, so that the number of free binding sites remained the
same as in the euthyroid individual.
In order to investigate possible changes in binding to
individual proteins in disease, studies were carried out using
agarose gel electrophoresis.
Binding of thyroxine and triiodothyronine to serum proteins
in feline hyperthyroidism. Agarose gel electrophoretic
studies
Methods
Clinical material. Investigations were carried out on sera
from 11 cats which satisfied the diagnostic criteria as stated in
the previous section. All were domestic short-haired individuals.
Five cats were female and six were male; all had been neutered.
Additional case data are presented in Table 9.4. In four cases,
before and after treatment sera were available for comparison. All
sera had been stored at -40°C prior to analysis.
Total serum protein determinations. The total serum protein
concentrations were determined by the biuret method as described in
Section 4.4.
Thyroxine binding to serum proteins. The distribution of
serum T4 binding was determined by agarose gel electrophoresis in
tris-maleate buffer, as described in Section 8.3. Serum protein
constituents were determined by densitometrically scanning gels
IOC
stained with Paragon blue. Binding of I-T4 was assessed by





Comparison between euthyroid and hyperthyroid cats.
Serum protein concentrations from the 11 cats are presented in
Table 9.2. Statistical comparison with the euthyroid range is shown
in Table 9.3.
Although the albumin concentrations of all pre-treatment
hyperthyroid cats studied fell within the normal range, the mean was
14.7 per cent lower than that of the euthyroid group. Beta-globulin
concentrations were a mean of 29.3 per cent higher in the
hyperthyroid than the euthyroid animals. No other significant
differences were demonstrated.
Comparison between hyperthyroid cats before and after
successful surgical treatment. Pre and post-treatment
concentrations of serum albumin and globulin were compared by means
of Student's paired t test. There was no significant difference
for either protein fraction (albumin: t = -0.54, 5 d.f., P = 0.61;
beta-globulin: t = 0.65, 5 d.f., P = 0.54).
Serum thyroxine binding. The distribution of ^^I-T4
binding in hyperthyroid cat sera is shown qualitatively in Fig. 9.1
and quantitatively in Table 9.4.
Comparison between euthyroid and hyperthyroid sera.
1 or
Autoradiographically, I-T4 distribution was similar in
euthyroid and hyperthyroid sera. In some autoradiographs, binding
in the alpha-globulin zone was assessed visually as higher, and in
the albumin zone as lower, than in healthy animals.
Table 9.5 presents the median, range and 25th to 75th percentiles
for the per cent T4 binding in euthyroid and hyperthyroid animals,
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and shows the reduced albumin and increased aipha-l/alpha-2-globulin
binding in the latter group.
The Mann-Whitney U-test was used to investigate these
differences statistically. Data are presented in Table 9.6. T4
binding to albumin, to alpha-l/alpha-2-globulins taken together and
to alpha-l-globulin alone was significantly different between the
two groups. There was no significant difference in binding in the
alpha-2-globulin zone between the two groups.
T4 binding: Differences between hyperthyroid cats before
and after successful surgical treatment. Table 9.5 presents
the median, range and 25th to 75th percentiles for the per cent
T4 binding in hyperthyroid animals before and after successful
surgical treatment, and shows apparently reduced albumin and
increased alpha-l/alpha-2-globulin binding in the former group.
However, when the Mann-Whitney U-test was used to investigate these
data (Table 9.7), no significant differences were found.
Serum triiodothyronine binding. The quantitative
distribution of ^I-T3 binding in hyperthyroid cat sera is
shown in Table 9.8.
Differences between euthyroid and hyperthyroid animals.
Table 9.9 presents the median, range and 25th to 75th percentiles for
the per cent T3 binding in euthyroid and hyperthyroid animals, and
shows an apparent decrease in albumin, alpha-l-globulin, and beta-
globulin binding and an increase in alpha-2-globulin binding.
The Mann-Whitney U-test was used to investigate these apparent
differences statistically. Data are presented in Table 9.10. Only
T3 binding to albumin and alpha-l-globulin was significantly
different between the two groups. A comparison of T3 binding to
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beta-globulin between the groups just failed to show significant
differences.
T3 binding: Differences between hyperthyroid animals
before and after successful surgical treatment. Table 9.9
presents the median, range and 25th to 75th percentiles for the
per cent T3 binding in hyperthyroid animals before and after
treatment and shows that, in all protein fractions except gamma¬
globulin, the median values for the post-treatment cases are between
those for the euthyroid animals and the pre-treatment thyrotoxic
individuals. In addition, the ranges of per cent T3 binding, in all
protein fractions except beta-globulin for the post-treatment
hyperthyroid cases, are between those of the euthyroid and pre-
treatment thyrotoxic individuals. However, when the Mann-Whitney li¬
test was used to investigate these data (Table 9.11) the differences
were not found to be significant.
Discussion
While there are a number of reports of iodothyronine binding in
thyrotoxicosis in man, using either direct or reverse flow
electrophoresis, no such studies have been carried out in cats. The
techniques are relatively simple and require no major alterations when
applied to feline sera, provided the mass of radiolabel used is not
sufficient to disturb physiological equilibrium.
There is some disagreement about the binding capacity of TBG in
human thyrotoxicosis. Robbins and Rail (1957, 1960) state that
there is no change in capacity, whereas Werner (1978b) reported that
it may be reduced. Both of these observations may be correct
because Inada and Sterling (1967), using reverse flow, paper
electrophoresis with glycine buffer at pH 8.6 in 23 hyperthyroid
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subjects, found that 17 showed reduced and six normal TBG capacity
for T4. Richards, Dowling and Ingbar (1959) reported that the
capacity of TBPA is usually decreased in untreated hyperthyroid
subjects but described a similar defect in subjects with other
diseases. Inada and Sterling (1967) confirmed that TPBA capacity
fell in all 23 hyperthyroid patients they studied. It is
interesting that reduction of the capacity of these proteins in
thyrotoxicosis is in a direction which would tend to exaggerate the
di sorder.
The present study clearly demonstrates a reduction in the
proportion of T4 bound by albumin and an increase in the proportion
bound by alpha-globulin in hyperthyroid cats. There is, of course,
a reciprocal relationship between the two and a fall in one must be
accompanied by a rise in the other. It is possible, therefore, that
the change may be in either the albumin or the alpha-globulin
binding.
In human thyrotoxicosis, the serum albumin concentration was
found to fall by 15 per cent (Lewis and McCullagh, 1944), but the
reason for this change was unexplained. It is of considerable
interest that, in hyperthyroid cats, the mean albumin concentration
was also 15 per cent lower than for euthyroid animals. This may
either result from a reduced rate of formation or an increased rate
of degradation. It is possible that the hepatic damage which is a
feature of feline and human hyperthyroidism may result in reduced
albumin synthesis. An elevated rate of catabolism such as occurs in
hyperthyroidism could result in increased albumin breakdown.
Robbins and Rail (1957) felt that a 15 per cent fall in human
albumin concentration would not affect its binding capacity
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significantly. However, it is interesting to speculate that in
cats, where the affinity of serum proteins for T4 is much lower than
in man, a reduction in albumin concentration may alter the binding
equilibrium so that alpha-globulin plays a relatively larger role in
T4 carriage.
It is possible that a factor present in the serum of
hyperthyroid cats may inhibit T4 binding to albumin but these
studies provide no information on this hypothesis.
An alternative explanation for the relative increase in alpha-
globulin T4 binding in feline hyperthyroidism is an increase in
this protein's capacity. This could result from either an increase
in its affinity or in its serum concentration. Because a binding
protein's affinity is generally genetically determined, any change
in alpha-globulin capacity must result from a change in its serum
concentration. Unfortunately, measurement of the concentration of
the specific globulin of cats which binds T4 was not possible as its
physicochemical and immunological characteristics remain unknown. It
would appear from the T4 uptake test, however, that the overall
binding of T4 in hyperthyroidism remains unchanged, and that the
change is simply restricted to a shift from albumin to alpha-
globulin binding.
In human thyrotoxicosis, the TBG capacity does not change after
successful treatment (Robbins and Rail, 1957). In this study, the
1
protein binding of I-T4 by both albumin and alpha-globulin in
hyperthyroid animals tended to revert towards the normal ranges with
successful treatment, although the results were not quite
statistically significant.
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With regard to T3, only binding to albumin and alpha-l-globulin
was significantly different in hyperthyroid and euthyroid cats.
The effect of hyperthyroidism on albumin concentrations has been
referred to previously. However, only small percentages of T3 are
bound by these two proteins in the cat and these changes are
unlikely to be important in vivo.
The changes in T3 binding by beta-globulin in hyperthyroid
cats just failed to show statistical significance. It is
interesting, however, that the beta-globulin concentration of
hyperthyroid cats was significantly higher than the normal range.
Speaking of domestic animals in general, Kaneko (1980b) stated that
increases in beta-globulins alone are infrequent and are found only
in association with active liver disease, suppurative dermatopathies
and occasionally the nephrotic syndrome. The hyperthyroid
individuals in this series had neither infected skin lesions nor the
nephrotic syndrome but did show alterations in indices of liver
function (see Chapter 10). The hepatopathy of feline hyperthyroidism
has been referred to previously. It is interesting to speculate
that this resulted in the production of a beta-globulin with
abnormal T3 binding capacity, causing the lowered T3 binding in this
fraction. While the differences were not statistically significant,
the changes in T3 binding tended to revert towards the euthyroid
range with successful surgical treatment.
Three cats (FT/HE/11/83, FT/HE/26/83 and FT/HE/27/83) showed
different serum T3 binding patterns from the remainder, with much
higher binding in the beta and gamma-globulin fractions with a
consequent reduction in the alpha-2-globulin. One of these
(FT/HE/26/83) was the only hyperthyroid cat to show higher T4
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binding in the albumin than in the alpha-globulin fraction. It is
possible that a larger study may reveal other patterns of change in
iodothyronine binding than those described in detail here and
further work in this area is required.
Thyroxine binding in normal feline serum. Effects of
increments of added thyroxine
Introduction
The previous section demonstrated that there is increased alpha-
1/alpha-2-globulin binding and decreased albumin binding in
thyrotoxic cats and suggested possible reasons for this
abnormality. This study was carried out to confirm that this change
was not simply a result of increased T4 concentrations per se
but reflected alterations in T4 binding proteins.
Method. Known amounts of T4 were added to aliquots of a
sample of normal feline serum to give concentrations in the range of
95 nmol/1 to 440 nmol/1. The T4 was added as a 20 ul volume to 0.48
ml aliquots of serum, the T4 solutions (concentrations approximately
2.5 umol/1, 5.0 umol/1, 7.5 umol/1, 10.0 umol/1, 12.5 umol/1 and 15
umol/1) being prepared in diluent. The resultant solutions were
assayed for T4 as described in Section 6.1 to determine the actual
concentrations.
Serum thyroxine binding for each concentration was determined
as described in Section 8.3 using agarose gel electrophoresis with
tris-maleate buffer. The results were assessed qualitatively by
autoradiography and quantitatively by cutting and gamma counting the
electrophoresed gels.
Results. Qualitative results of autoradiographic studies are
presented in Fig. 9.2 and show distribution of the radio!abel in
the albumin and alpha-l/alpha-2-globulin zones.
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Quantitative results are presented in Table 9.12.
Increasing the T4 concentration more than ten fold above the
basal concentration of 29 nmol/1 failed to reproduce the
distribution of binding seen in hyperthyroid cats. There was an
increase in the proportion of T4 bound to albumin at 440 nmol/1 and
a decrease in the proportion bound to alpha-l/alpha-2-globulin,
changes which were the converse of those seen in naturally-occurring
hyperthyroidism. No changes in the percentages of labelled T4 found
in other globulin fractions were detected.
Piscussion
This study was carried out to determine whether the increased
alpha-l/alpha-2-globulin binding and reduced albumin binding in
feline hyperthyroidism might be a function of hyperthyroxinaemia
per se. The results clearly exclude this possibility, the
changes seen at the highest concentration of T4 examined being, in
fact, the converse of those seen in naturally-occurring
hyperthyroidism. At lower T4 concentrations, no significant
changes in distribution were found.
In human serum, the addition of increasing quantities of T4
results in a decreasing proportion of labelled T4 bound by TBG and
an increasing proportion bound by albumin (Woeber, 1971). The
proportion bound by TBPA initially increases and then declines.
Tanabe, Ishii and Tamaki (1969) investigated the effects of
added T4 on the protein association of radiothyroxine after
cellulose acetate electrophoresis of serum from healthy cats. They
found that the radioactivity in the area immediately cathodal to
albumin did not disappear or decrease when T4 was added and
suggested that this band was therefore post-albumin and not TBG.
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However, these finding were probably due to very poor separation of
albumin and alpha-l/alpha-2-globulin in their studies.
The results reported here support the hypothesis that the
changes in distribution of labelled T4 in hyperthyroidism are due to
changes in the binding capacity of albumin or the alpha-l/alpha-2-
globulins, and are not simply a feature of raised T4 concentrations.
Parenthetically, these observations provide additional evidence that
T4 migrating in the alpha-l/alpha-2-globulin zone is not free T4.
If this were the case, there would have been an increasing fraction
in the alpha-l/alpha-2 zone and a decreasing fraction in the albumin
zone with increasing exogenous T4, reflecting the progressive
saturation of binding proteins and increasing free T4 concentration.
Changes in binding capacity may be due to inhibition of T4
binding. One such group of inhibitors is non-esterified fatty acids
(NEFA) (Tabachnick, 1964) and experiments were performed to
investigate this possibility.
Are increases in serum non-esterified fatty acids responsible
for changes in thyroxine protein binding in feline
hyperthyroidism?
Introduction. Non-esterified fatty acids are capable
of displacing T4 from binding sites on human albumin. In man, the
concentration of NEFA in serum is significantly increased in
thyrotoxicosis. Investigations were therefore carried out to
determine whether there might be a similar increase in NEFA in feline
hyperthyroidism which might result in displacement of binding from
albumin and increased binding to alpha-l/alpha-2-globulin.
Method
Clinical material. Sera from three hyperthyroid cats
were used in this study. All had histories and physical findings
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suggestive of the disorder and palpable goitre. All had elevated
total serum T4 and T3 concentrations and elevated percentage alpha-
1/alpha-2-globulin T4 binding. In one case, a sample taken 13 weeks
after successful surgical treatment was also tested. Samples from
nine healthy cats were included for comparison. All animals had
been fasted for 12 hours and were conscious when bled.
Non-esterified fatty acid determinations. Serum NEFA were
measured by courtesy of Dr. R. A. Riemersma using a commercially
available enzymatic kit method. The technique relies on the
acylation of coenzyme A (CoA) by fatty acids in the presence of
added acyl CoA synthetase. The acyl CoA thus produced is oxidised
by added acyl CoA oxidase with generation of hydrogen peroxide. In
the presence of peroxidase, this permits the oxidative condensation
of 3-methyl-N-enthyl-N-(beta-hydroxyethyl)-aniline with 4-
aminoantipyrine to form a purple coloured adduct which is measured
colorimetrically at 550 nm.
The coefficient of variation of the method was seven per cent.
Results. Clinical data on the animals studied and the
results of biochemical investigations are presented in Table 9.13.
There is no obvious difference between the NEFA concentrations
of euthyroid and hyperthyroid animals. In the single animal in
which samples were checked before and after surgery, there was a
fall in the NEFA concentration with successful treatment but it is
not possible to draw a firm conclusion from this single observation.
Discussion. Many methods of NEFA determination require their
prior extraction from serum. These approaches are time-consuming,
potentially hazardous and not easily automated. In this study, an
enzymatic method was used which was accurate, precise and rapid.
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Blood for analysis must be collected after an overnight fast
because the concentration of circulating NEFA is increased by the
ingestion of food. Blood collected in heparinised containers is not
suitable for the test, as heparin is known to stimulate the activity
of lipoprotein lipase. Some anaesthetics also interfere with the
method and blood should be collected from conscious patients.
The effect of various anionic compounds in inhibiting the
binding of T4 by human serum albumin is well-known. Thus, according
to decreasing effectiveness, the following compounds are capable of
displacing T4 from its binding sites to albumin: oleate, linoleate,
dodecyl sulphate, palmitate, laurate, octanoate and salicylate
(Tabachnick, 1964). For example, oleate at a molar ratio to
albumin of 3.1:1 causes a reduction of approximately 70 per cent
in the ability of the protein to bind T4. Conversely, defatted
albumin has an increased affinity for T4 (Tabachnick, 1964).
The ability of various anions to displace T4 from binding
sites on albumin may be of physiological significance. In human
hyperthyroidism, the concentrations of NEFA in blood rise from one
to two moles fatty acid per mole of albumin (Rich, Bierman and
Schwartz, 1959). This may lead to increased removal of T4 from
binding sites on plasma albumin and be one of the factors involved
in producing the acceleration in the rate of disappearance of T4
from the circulation that occurs in human thyrotoxicosis
(Tabachnick, 1964; Koppers and Palumbo, 1972).
In this study, NEFA were measured in thyrotoxic feline sera to
see whether this might explain the decreased albumin binding. There
were no obvious differences in the results between the hyperthyroid
and euthyroid animals. However, NEFA were only measured in three
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hyperthyroid sera and this hypothesis warrants further
investigation.
General conclusions on iodothyronine binding in feline
hyperthyroidism
These studies allow the following general conclusions to be
made about iodothyronine binding in feline hyperthyroidism:
(i) There is no change from normal in the percentage of T4
bound in whole serum, as judged from the results of the T4 uptake
test. This test is therefore of no value in the diagnosis of
feline hyperthyroidism.
(ii) The percentage T4 bound to albumin is decreased and the
percentage T4 bound to alpha-globulin is increased. However, the
percentage binding to one protein is inversely proportional to the
other. Thus, these changes may reflect the decrease in serum
albumin concentrations which occur in hyperthyroidism, inhibition
of T4 binding to albumin or an increased TBG concentration. They
are not the result of hyperthyroxinaemia per se, nor, in the
small number of cases studied, were they due to blockage of binding
of T4 to albumin by NEFA.
(iii) The percentage of T3 bound to albumin and alpha-1-
globulin is significantly decreased but these changes are unlikely
to be important in vivo. Although not quite statistically
significant, the percentage binding of T3 to beta-globulin is
reduced, which may reflect an increased synthesis of beta-globulin
with abnormal binding properties.
(iv) After successful surgical treatment of feline
thyrotoxicosis, T4 and T3 binding tends to revert to that seen in
euthyroid animals, although these changes do not reach statistical
significance.
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9.4 BINDING OF THYROXINE AND TRIIODOTHYRONINE TO SERUM PROTEINS
IN EXPERIMENTALLY-INDUCED FELINE HYPOTHYROIDISM
Introduction
There have been a number of reports describing the serum
protein binding of T4 and T3 in human hypothyroidism. Such studies
have not been carried out in cats because no cases of confirmed,
naturally-occurring, acquired, feline hypothyroidism have been
documented.
This section reports on the serum protein binding of T4 in
unfractionated serum, and T4 and T3 after agarose gel electrophoresis,
in two cats in which hypothyroidism was produced experimentally.
Methods
Clinical material. Sera from two five-year-old, adult
female, domestic short-haired cats, taken before and 30 weeks after
successful thyroid ablation with *^1, were used in this study.
Hypothyroidism was confirmed by the absence of T4 and T3 in post-
treatment serum samples and subsequently by the failure to produce
a serum T4 or T3 response by TSH stimulation. Details of these
experimental procedures are presented in Chapters 11 and 13. All
sera were stored at -40°C prior to analysis.
Thyroxine uptake test. The T4 uptake test was performed,
as described in Section 8.2, on paired sera from each cat before and
after thyroid ablation. Samples from three healthy cats, three
healthy humans and buffer alone were included for comparison.
Results. Table 9.14 shows the number of counts per minute
per 0.5 ml of supernatant fluid (i.e. bound to serum proteins) for
each of the test samples. There were no obvious differences between
the results for the normal cats and the experimental cats before
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treatment or between the experimental cats before or after thyroid
ablation. As shown in Section 8.2, the T4 binding in human serum
was consistently higher than in any of the cat samples.
Piscussion. The data presented clearly show that the T4 (and
by interpolation, the T3) uptake test cannot be used for the
diagnosis of feline hypothyroidism. An essential requirement for the
use of the test is a high-affinity, serum iodothyronine binding
protein, and the lack of change after induction of hypothyroidism in
these cases probably reflects the much lower affinity that feline
TBG has for T4 than its human counterpart. It could, however,
reflect a balanced decrease in the TBG and T4 concentrations in
hypothyroid cat sera, so that the number of free binding sites
remained the same as in the euthyroid individual.
In order to investigate possible changes in binding to
individual proteins, studies were carried out using agarose gel
electrophoresis.
Agarose gel electrophoretic studies
Methods
Clinical material. The clinical material was as described
in the previous study.
Total serum protein determinations. The total serum
protein concentrations were determined by the biuret method as
described in Section 4.4.
Thyroxine binding to serum proteins. The distribution of
serum T4 binding was determined by agarose gel electrophoresis in
tris-maleate buffer, as described in Section 8.3. Serum protein
constituents were determined by densitometrically scanning gels
stained with Paragon blue. Binding of ■^I-T4 was assessed by
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autoradiography and by gamma counting of protein fractions cut from
the gel plates.
Triiodothyronine binding to serum proteins. This study was
performed as above and as described in detail in Section 8.3. The
distribution of the radiolabel was determined by cutting and gamma
counting the electrophoresed gels according to their protein
fractions.
Results
Serum protein concentrations. Data on serum protein
concentrations of the samples used in the studies are presented in
Table 9.15.
The gamma-globulin concentration rose after thyroid ablation
such that in cat 1, it was above the upper limit of the reference
range.
Thyroxine binding to serum proteins. Fig. 9.3 shows
autoradiographs of sera from the two animals before and after
thyroid ablation and illustrates that there are no qualitative
differences due to induced hypothyroidism.
Table 9.16 provides quantitative data on the 125I-T4
binding in the same samples. There are no obvious differences
before and after ablation and values for each of the fractions
binding T4 lie within one sd of the mean of the euthyroid group.
Triiodothyronine binding to serum proteins. Table 9.17
1 O C
presents data on -L/:-31-T3 binding in serum samples taken before
and after thyroid ablation.
There are no obvious differences between the pre and post-




There is some disagreement about the capacity of thyroid
hormone binding proteins in human hypothyroidism. In an early
study, Albright, Larson and Deiss (1955) found that there was no
change in the T4 capacity of what they termed "thyroxine binding
proteins" (TBP, now called TBG) in hypothyroidism, although the
proteins were relatively unsaturated with respect to T4. However,
Robbins and Rail (1957, 1960) found that the TBP concentration was
slightly but significantly elevated in all seven hypothyroid
patients studied. Bellabarba, Inada, Varsano-Aharon and Sterling
(1968) and Oppenheimer (1968) found that the TBG concentration was
increased by ten to 30 per cent in hypothyroid subjects. Inada and
Sterling (1967) showed that both situations may apply. Using
reverse flow paper electrophoresis with glycine acetate buffer at pH
8.6, five of 16 hypothyroid subjects had normal, and 11 of 16
increased, TBG capacity for T4. The TBPA capacity was normal in all
subjects studied. An increase in TBG capacity is in a direction
which would tend to exaggerate the change in free hormone
concentrations in the disorder.
Robbins and Rail (1957) showed that successful treatment of
hypothyroidism in two patients produced a fall in TBP to normal
concentrations. This occurred with T3 therapy (which could not have
increased the serum T4 concentrations) as well as with T4 therapy.
No attempt was made to reverse the hypothyroid state in the cats in
this study.
Both cats showed an increase in their serum gamma-globulin
concentrations after thyroid ablation. Such changes have also been
demonstrated in Hashimoto's disease in man (Roitt, Doniach, Campbell
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and Vaughan Hudson, 1956) and experimental thyroidectomy in the rat
(Levin and Leathern, 1942) and will be discussed further in Chapter
11.
As no cases of naturally-occurring, acquired, feline
hypothyroidism have been definitively diagnosed, this study of T4
and T3 binding in two cases of the experimentally-induced condition
is the first to be published. No significant binding changes
were documented. However, it is possible that investigations on a
much larger number of cases would reveal subtle changes not
demonstrated here.
9.5 BINDING OF THYROXINE AND TRIIODOTHYRONINE TO SERUM PROTEINS
IN HEALTHY EUTHYROID CATS WITH HYPERTHYROXINAEMIA AND/OR
HYPERTRIIODOTHYRONINAEMIA
Introduction
Euthyroid hyperthyroxinaemia and hypertriiodothyroninaemia
have been well-documented in man. The conditions have not been
previously reported in cats.
In Chapter 7, details were given of two apparently healthy,
euthyroid cats, one of which had grossly elevated T4 and T3 and one
normal T4 but grossly elevated T3 concentrations. This section
describes investigations into the serum protein binding of
iodothyronines in these animals.
Methods
Clinical material. Detailed information on these two
animals was presented in Chapter 7 and is summarised in Table 7.9.
Sera were stored at -40°C until tested. In each case, the abnormal
iodothyronine concentrations were confirmed by repeating the RIAs.
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Total serum protein determinations. The total serum
protein concentrations were determined by the biuret method as
described in Section 4.4.
Thyroxine binding to serum proteins. The distribution of
T4 binding was determined by agarose gel electrophoresis in tris-
maleate buffer at pH 7.4 as described in Section 8.3. Serum protein
constituents were determined by densitometrically scanning gels
stained with Paragon blue. Binding of ^I-T4 was assessed by
autoradiography and by gamma counting of protein fractions cut from
the gel plates.
Triiodothyronine binding to serum proteins. This study
was performed as above and as described in detail in Section 8.3.
The distribution of the radiolabel was determined by cutting and
gamma counting the labelled, electrophoresed gels.
Results
Serum protein concentrations. The serum protein
concentrations of the two cats are presented in Table 9.18.
The total serum protein concentrations of both cats were
elevated. With cat FT/NC/9/82, this was due, in the main, to a
gross increase in the gamma-globulin concentration, although the beta-
globulin concentration was also elevated. With cat FT/NC/3/82, only
the beta-globulin fraction was elevated.
Thyroxine binding to serum proteins. Fig. 9.4 shows the
autoradiographs obtained with the two test sera and compares them to
a normal autoradiograph and electrophoretogram. Table 9.19 provides
quantitative data on T4 binding in the two sera.
(i) FT/NC/9/82. Both qualitatively and quantitatively, the
serum from this cat showed relatively little albumin binding of
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125i_t4# Almost all of the T4 was carried in the alpha-1 and
alpha-2-globulin zones, although the beta and gamma-globulin
fractions also carried elevated amounts of radiolabel.
(ii) FT/NC/3/82. Both qualitatively and quantitatively,
the serum from this cat showed reduced albumin binding of 125j_
T4. Qualitatively, no other abnormalities were demonstrated but
quantitatively there was elevated binding in the alpha-l-globulin
with normal percentage binding in the alpha-2-globulin zones.
Minimal amounts of radiolabel were found in the other protein zones.
Triiodothyronine binding to serum proteins. Table 9.20
presents data on T3 binding in the two sera.
(i) FT/NC/9/82. T3 carriage in the alpha-1 and alphas-
globulin zones was marginally and markedly reduced respectively.
This was accompanied by a gross elevation in T3 carriage in the
gamma-globulin fraction.
(ii) FT/NC/3/82. T3 carriage in the alpha-l-globulin
fraction was marginally reduced but this was probably not significant.
No other abnormalities were noted.
Piscussion
Euthyroid hyperthyroxinaemia, with or without
hypertriiodothyroninaemia has been wel 1-documented in man (reviewed
by Borst, Eil and Burman, 1983). The numerous causes have been
reviewed in Section 7.4. The condition has not been recorded
previously in the cat. Euthyroid hypertriiodothyroninaemia, with
normal T4 concentrations, has not been recorded in either man or the
cat. The causes of the states in these two animals are difficult to
explain with the relatively small amount of data available.
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FT/NC/9/82. Attempts to explain the binding changes seen
in this cat may be considered under three headings:
(i) Interference with methodologies. The elevated gamma¬
globulin concentration in this animal, together with the increased
T3 binding in this region, suggest that thyroid hormone binding
immunoglobulins may be in some way responsible for the binding
abnormalities seen. Such immunoglobulins have been reported in the
serum of human patients with autoimmune thyroid disease
(Premachandra and Blumenthal, 1967; Staeheli, Vallotton and Burger,
1975; Jorgensen, Skovsted and Jensen, 1979). They cause
interference in the direct RIA of T4 and T3 and thus produce
incorrect values. The type of interference produced depends on the
separation method involved in the assay (Beckett, Todd, Hughes and
Campbell, 1983). The double antibody system, as employed in these
studies, does not precipitate human gamma-globulin and thus the
tracer fraction bound to it is not measured. This produces
spuriously high thyroid hormone concentrations (Wu and Green, 1976;
Ginsberg, Segal, Erlich and Walfish, 1978).
In the case under discussion, no T4 binding was demonstrated
in the gamma-globulin region after serum electrophoresis. The
presence of antibodies against T3 (anti-T3) alone, as has been
described in man (Wu and Green, 1976), would neither explain the
elevated T4 concentration nor its increased binding in the alpha-
1/alpha-2-globulin region, unless antibodies to T4 (anti-T4), which
migrated for some unexplained reasons in this protein fraction on
electrophoresis, were also present.
(ii) Changes in serum protein concentrations. In human
subjects, changes in the concentrations of various serum proteins may
produce profound alterations in thyroid hormone binding patterns.
262
An inherited increase in TBG concentration was the first
recognised cause for alterations in human serum iodothyronine
binding (Beierwaltes and Robbins, 1959). Because the protein binds
both T4 and T3, affected people have elevated TBG binding and
elevated serum concentrations of both iodothyronines (Borst, Eil and
Burman, 1983). In the cat under discussion, the serum T4 and T3
were both elevated and the alpha-globulin binding of T4 was markedly
increased. However, T3 binding in the alpha-globulin fraction was
actually decreased, with a marked increase in the gamma-globulin
zone.
A further inherited thyroid hormone binding protein
abnormality which has been described in man is increased TBPA
concentrations. TBPA was not demonstrated in any cat in the studies
in Chapter 8, but it is not known whether this was a feature of the
separation systems used or whether the protein does not occur in the
cat. As observed previously, Tata (1959) suggested that in certain
buffer systems, human TBPA migrated electrophoretically as an inter-
alpha-globulin. If this were the case in cat serum, with the system
used, increased TBPA would explain the T4 binding changes noted in
this patient. However, because human TBPA does not bind T3,
individuals with excess TBPA have normal T3 concentrations (Moses,
Lawlor, Haddow and Jackson, 1982) whereas they were elevated in the
cat under discussion.
Analbuminaemia is a rare serum protein variant in man
(Stockigt, Stevens, White and Barlow, 1983). A corresponding
abnormality in the cat under discussion would explain the T4 binding
changes seen but is not supported by the results of serum protein
electrophoresis.
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(iii) Changes in the iodothyronine binding affinity of
serum proteins. The iodothyronine binding changes
seen in this cat might, in part, be explained by abnormalities in the
binding affinity of its serum proteins. An abnormal albumin variant
which failed to bind T4 would explain the reduced albumin binding
and the relative increase in alpha-l/alpha-2-globulin binding in
this case. However, the reduction in the overall number of binding
sites would tend to result in a lowered total T4 whereas in this
case it was increased. Such an abnormal variant of albumin has not
been described in man and would still fail to explain the altered T3
binding seen in this case.
Circulating inhibitors of serum T4 and T3 binding resulting
in a raised FT4 would also increase the free ^^I-T4 and
125
I-T3 concentrations and produce the binding abnormalities
noted. The possible influence of elevated serum NEFA concentrations
on the inhibition of iodothyronine binding in this animal is
discussed in Section 9.6.
An inhibitor of thyroid hormone binding to serum proteins
in the serum of some human patients with non-thyroidal illness has
been described (see Section 9.6). However, the cat under discussion
was apparently healthy and remained so over a follow-up period of
three years and it is unlikely that this could account for the
changes seen.
FT/NC/3/82. The abnormalities in this case are also
extremely difficult to explain with the data available. It is
interesting that while the T3 concentration is grossly elevated,
there are minimal T3 binding changes, while there are obvious T4
binding abnormalities despite a normal T4 concentration.
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(i) Interference with methodologies. The elevated T3
concentration without a concomitant increase in T4 could be
explained by anti-T3 interference in the separation stage of the
assay in the absence of anti-T4. However, the percentage of T3
found in the gamma-globulin zone on electrophoresis was within the
normal range.
(ii) Changes in serum protein concentrations. As
discussed earlier in this chapter, the iodothyronine serum protein
binding changes seen in hyperthyroidism may reflect changes in serum
protein concentrations. In the cat under discussion, the decreased
albumin and increased alpha-globulin binding of T4, the decreased
T3 binding by alpha-l-globulin and the elevated beta-globulin
concentration are all suggestive of hyperthyroidism due to T3
toxicosis. For the reasons discussed in Section 7.4, this is an
unlikely explanation of the changes noted.
(iii) Changes in the iodothyronine binding affinity of
serum proteins. As described in detail in Section
7.3, this cat had been involved in a road traffic accident three
weeks before sampling but, apart from thiopentone sodium anaesthesia
for mandibular symphysis repair immediately after the accident, no
other drugs had been given and the cat had been clinically normal
for two weeks. As will be discussed in detail in the following
section, inhibitors of thyroid hormone binding to serum proteins
may be present in nonthyroidal illnesses and may also result from
soft tissue injury. However, it is difficult to explain how the
earlier road traffic accident and associated anaesthesia might have
produced apparent hypertriiodothyroninaemia.
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The specific reasons for the binding changes seen in these
cats cannot be determined from the data available. Unfortunately,
neither owner would allow further blood samples to be taken from
his animal. Further information on serum T4 and T3 binding by
the T4 or T3 uptake tests, quantitative determination of TBG
concentrations and the measurement of FT4 and FT3 concentrations
would have added much to the understanding of these cases but
largely await the development and validation of suitable
methodologies for use with cat serum.
9.6 BINDING OF THYROXINE AND TRIIODOTHYRONINE TO SERUM PROTEINS
IN SELECTED CATS WITH EUTHYROID PATHOLOGICAL STATES
Introduction
The thyroxine binding proteins of human serum have been
examined in a variety of pathological situations. Apart from their
general interest, such studies have been used to evaluate the
physiological importance of the thyroxine-protein interactions. No
corresponding investigations have been carried out in cats.
During the studies described in Chapter 7, two cats with
definitively diagnosed disease were found to have grossly subnormal
T4 concentrations. One also had hypertriiodothyroninaemia. This
section describes investigations into the serum protein binding of
iodothyronines in these animals.
Methods
Clinical material. The case details of the two cats are
presented in Table 9.21. In each case, the abnormal serum
iodothyronine concentrations were confirmed by repeating the RIAs.
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Case number 124550 was sampled on two occasions (124550a and
124550b respectively) six months apart. On the second occasion, the
presenting complaints were weight loss and decreased activity.
Physical examination confirmed slight weight loss and flea
infestation but no further abnormalities were noted. The cat died
suddently eight weeks later but post-mortem examination was not
permitted.
All sera were stored at -40°C prior to analysis.
Total serum protein determinations. The total serum
protein concentrations were determined by the biuret method as
described in Section 4.4. Sample 124550b was not tested.
Thyroxine binding to serum proteins. The distribution of
serum T4 binding was determined by agarose gel electrophoresis in
tris-maleate buffer as described in Section 8.3. Serum protein
constituents were determined by densitometrically scanning gels
stained with Paragon blue. Binding of ^£>I-T4 was assessed by
autoradiography and by gamma counting of protein fractions cut from
the gel plates. Sample 124550b was not tested.
Triiodothyronine binding to serum proteins. This study was
performed as above and as described in detail in Section 8.3. The
distribution of the radiolabel was determined by cutting and gamma
counting the electrophoresed gels. Sample 124550b was not tested.
Results
Serum protein concentrations. These data are presented in
Table 9.22.
All values for sample 124550a were within the normal
reference ranges. The serum from cat FT/NC/5/82 was markedly
lipaemic resulting in an incorrectly elevated total protein
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concentration. The serum protein concentration reverted to normal
after delipidation by ether extraction.
Thyroxine binding to serum proteins. Fig. 9.5 shows
autoradiographs obtained with the two test sera and compares them to
a normal autoradiograph and electrophoretogram. Table 9.23 provides
quantitative data on T4 binding in the two sera.
(i) FT/NC/5/82. Both qualitatively and quantitatively,
this serum showed minimal albumin binding of ^^5j_y4. Almost all
of the radioactivity was carried in the alpha-1 and alpha-2-globulin
zones. However, within these zones, the distribution was changed
from that seen in healthy cats. From the autoradiograph, it could
be seen that the binding of the radiolabel had been shifted cathodally,
with little 12J>I-T4 being present in the leading half of the
alpha-l-globulin. The total radiolabel in this zone remained within
the normal range but there was a significant increase in the
percentage present in alpha-2-globulin. A slightly higher
IOC
percentage of ii3I-T4 was also found in the beta-globulin,
probably reflecting this cathodal shift of binding.
(ii) 124550a. This serum showed normal albumin binding of
T4. Autoradiographically, binding was diffuse throughout the alpha-
globulin zone. This resulted in the percentage binding in the alpha-
l-globul in being toward the low end of the normal range, with a
corresponding increase in the alpha-2-globulin.
Triiodothyronine binding to serum proteins. Table 9.24
presents these data.
(i) FT/NC/5/82. This serum showed reduced alphas-
globulin and increased gamma-globulin binding of ^^I-T3.
Binding in the other protein fractions was within the appropriate
reference ranges.
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(ii) 124550a. No abnormalities of T3 binding were noted
in this cat.
Piscussion
FT/NC/5/82. This cat sustained a fractured pelvis in a
road traffic accident five days before sampling. It was treated
conservatively and required no medication. Serum samples were
grossly lipaemic. In man, lipaemia may occur in starvation (Rogers,
1977). As this cat had not eaten since the accident, the lipaemia
probably reflected fat mobilisation in an anorectic animal. Both
thyroid hormone RIA and protein binding studies were carried out on
whole serum that had not been ether extracted.
(i) Thyroid hormone concentrations. Drug therapy may
reduce total T4 concentrations (reviewed in Section 3.6) but as no
drugs had been administered, may be discounted as a cause of the low
T4 concentration in this animal.
The lipaemia noted reflected elevated NEFA concentrations.
However, it is unlikely that this resulted in the low T4
concentration because, in human serum, total T4 RIA is not
influenced by NEFA concentrations (Rootwelt, 1975).
It is possible that the low serum T4 concentration resulted
from hypothyroidism. In man, a normal serum T3 concentration may be
preserved at the expense of T4 in the early stages of the disease
(Seth, Toft and Irvine, 1976). However, no cases of naturally-
occurring, acquired hypothyroidism in cats have been described and
this animal was healthy prior to the road traffic accident.
Hypothyroidism is, therefore, an unlikely diagnosis in this case.
The low T4 concentration of this animal probably resulted from
a condition analagous to the low T4 state of medical illness of man.
This is a specific category of the euthyroid sick syndrome
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(reviewed in Section 3.6). In part, it may result from the
inhibition of binding of T4 to serum proteins by either an IgM
antibody, an immune complex with IgM, or a substance that shares with
IgM several physicochemical and antigenic characteristics (Chopra et
al., 1979), as well as from increased T4 disposal.
The T3 concentration of the cat under discussion was within
the normal range. In man, the low T4 state of medical illness is
usually accompanied by a low total T3 concentration. A group of
dogs with a variety of medical illnesses in an intensive care unit
had subnormal total T4 concentrations (Ferguson, 1984), but their
T3 concentrations were not reported. No such studies have been
carried out in cats.
(ii) Changes in the iodothyronine binding affinity of
serum proteins. It is possible that the reduced
albumin binding of T4 in this case was induced by elevated NEFA
concentrations in the lipaemic serum, as may be seen in man
(Section 9.3). The subsequent addition of ^I-T4 would result
in an increased free concentration of the radiolabel which would
migrate in the position shown in Table 9.5.
The T4 and T3 binding changes seen in cat FT/NC/9/82,
(discussed in the previous section), were very similar to those seen
in this case and it is interesting to speculate that there may have
been a common cause. Both animals showed elevated total protein
concentrations. The serum from FT/NC/9/82 was slightly lipaemic,
although this was not considered to be sufficient to require ether
extraction. In retrospect, it is possible that this gave an
artificially high, total protein concentration, which was reflected
in elevations of the individual protein fractions. A concurrently
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elevated serum NEFA might have resulted in the binding changes
observed. A cause for the slight lipaemia in this case is not
obvious from the history.
Considerable soft tissue damage resulted from the fractured
pelvis sustained by cat FT/NC/5/82. Chopra, Solomon, Chua Teco
and Eisenberg (1982) reported that extrathyroidal tissue of man and
the rat contained a potent inhibitor of the binding of thyroid
hormones to serum proteins which acted by reducing the binding
affinity of thyroid hormones to serum proteins and not by reducing
the number of binding sites. The tissue inhibitor was similar to
that described previously in the serum of some critically ill
patients (Chopra et al., 1979; Oppenheimer, Schwartz, Mariash and
Kaiser, 1982) and they suggested that tissue damage might result in
its leakage into the circulation.
In man, serious illness is accompanied by a sharp fall in
serum TBPA concentration but as TBPA has a relatively minor role in
T4 transport, this is not thought to be of clinical significance
(Oppenheimer, 1968). For reasons discussed in Chapter 8, the
importance of this observation with respect to cats is unknown.
An abnormal albumin variant which failed to bind T4 might
result in the changes seen in this case. As discussed in Section
9.5, such an abnormal variant has not been described in man and
would not explain the altered T3 binding in this case.
In summary, the most likely causes of the laboratory changes
seen in cat FT/NC/5/82 are the low T4 state of medical illness,
together with lipaemia resulting from anorexia. It would have been




(i) Thyroid hormone concentrations. This cat initially
showed low serum total T4 and elevated serum total T3 concentrations
(124550a). However, a repeat blood sample six months later,
shortly before the animal died, revealed normal T4 and T3
concentrations (124550b). It is unlikely that the results obtained
with the first sample were methodological in origin as they were
confirmed on repeat analysis.
Treatment with exogenous T3 would result in the abnormalities
seen in 124550a, but such treatment can be excluded in this case.
T3 toxicosis would cause high serum T3 and low serum T4
concentrations but this state has not been described in the cat and
compatible physical signs were not present when the animal was first
examined.
It is interesting to speculate that the normal T3 concentration
in the second sample was due to the reduction of a naturally-
occurring, high T3 concentration as the result of terminal disease in
this cat. An analagous situation occurs in the so-called
hypermetabolic state of "T4 toxicosis" in man, in which the serum
total T3 concentration is artificially decreased in hyperthyroidism
because of concomitant fasting or systemic illness (Turner, Brownlie
and Sadler, 1975; Joasoo, 1975; Birkhauser, Burer, Busset and
Burger, 1977; Engler, Donalson, Stockigt and Taft, 1978). In this
syndrome, the previously normal serum T3 concentration enters the
thyrotoxic range during a patient's convalescence from serious, non-
thyroidal disease. While this is a possible explanation for the
discrepancy in the total T3 concentration in the two sera, it does
not explain the low T4 concentrations found on each occasion.
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Although the cat had skin and ear pathology when initially
sampled, this was not severe enough to have resulted in a low T4
concentration, and the euthyroid sick syndrome would have caused a
low, rather than an elevated, serum total T3 concentration.
As discussed in Section 9.5, T3 antibodies may cause spuriously
high T3 concentrations when measured by RIA. It is possible that
these may have disappeared from the serum six months later.
However, this would not explain the low serum total T4 concentration
in sample 124550a.
In man, familial decrease in TBG concentration results in
reduced serum total T4 and T3 concentrations (Refetoff and Selenkow,
1968). However, a comparable abnormality in the cat discussed here
would not explain the initial elevated T3 concentration, nor the
return to the normal range in the second sample.
(ii) Changes in the iodothyronine binding affinity of
serum proteins. The only abnormality noted was a
diffuse binding of T4 throughout the alpha-globulin zone. Such a
change could result from acquired or inherited TBG excess.
However, as discussed in Section 9.5, such abnormalities in man
result in elevations in both T4 and T3 concentrations, whereas T3
alone was elevated in this case.
It is possible that elevated NEFA concentrations might
increase the percentage T4 bound to alpha-globulin while inhibiting
its binding to albumin. However, qualitative and quantitative
albumin binding of T4 was normal in this case.
It would have been of interest to determine the serum protein
concentrations and the distribution of iodothyronine binding in
serum taken from this animal at the second visit (124550b).
Unfortunately, insufficient sample remained to carry out these tests.
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In human medicine, there is now a large body of literature on
thyroid function in non-thyroidal illness. This interesting field




Until 1979, no cases of naturally-occurring feline
hyperthyroidism had been definitively diagnosed. Currently,
thyrotoxicosis is recognised as a common disease of older cats
(Peterson 1984) but it is unclear whether there has been a real
increase in the prevalence of the disease or whether clinical
awareness and the availability of thyroid hormone RIA has led to an
increase in the diagnosis of the condition.
Only three major independent series of cases of feline
hyperthyroidism have been described in detail: ten cases by
Holzworth et al. (1980), 24 cases by Hoenig et al. (1982) and 131
cases by Peterson et al. (1983b). This chapter describes a further
series of 74 cases.
10.2 METHODS
Clinical material
The case material comprised cats presenting by referral to
the author or directly to veterinary surgeons in private practice who
agreed to take part in the study. A tentative diagnosis was made on
the basis of historical and clinical features. Subsequently, blood
samples were collected from conscious animals by jugular or cephalic
venepuncture after a minimum of 12 hours' starvation. Potassium EDTA
tubes were used for samples for routine haematological examination
and plain tubes for samples for biochemistry.
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With the exception of thyroid hormone determinations, all other
measurements were made within 24 hours of sampling. Serum was
stored at -40°C if it was not possible to assay for T4 and T3
within this period.
Haematological tests
The total RBC count was carried out using a one to 50,000
dilution of whole blood in Isoton II, (obtainable from Coulter
Electronics Ltd., Cold Harbour Lane, Harpenden, Hertfordshire,
England). The total RBCs were counted electronically using a
Coulter Electronic Particle Counter, Model ZF6, (obtainable from
Coulter Electronics Ltd.), each reported result being the mean of
duplicates.
The PCV was determined by the microhaematocrit method using
plain capillary tubes and a microhaematocrit centrifuge obtainable
from Hawksley & Sons Ltd., 12 Peter Road, Lancing, Sussex, England.
The haemoglobin concentration was measured directly after
conversion to cyanmethaemoglobin using a 3.3 mg/ml solution of
potassium cyanide (Zap-O-Globin, obtainable from Coulter
Electronics Ltd.) and read directly in a haemoglobinometer, also
obtained from Coulter Electronics.
Total white blood cell counts were performed on the Coulter
Counter previously described. Whole blood samples were diluted one
to 5,000 with isotonic saline and RBCs were lysed with Zap-0-Globin.
For the differential white cell count, blood films were fixed with
eosin methylene blue compound (Leishman staining solution,
obtainable from BDH Chemicals, Poole, Dorset, England) and 200 cells
counted under oil immersion microscopy.
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The thrombocyte count was determined by the pre-dilution
technique. Whole blood was diluted one to ten with isotonic saline
and centrifuged using a Coulter Thrombofuge. The thrombocyte-
containing supernatant was then diluted one to 200 with Isoton and
counted by a Coulter Thrombocounter C.
Biochemical tests
The serum T4 and T3 concentrations were measured as described
in Chapter 6.
Serum AP, ALT, cholesterol, urea and inorganic phosphate
concentrations were all measured with the aid of a Shimadzu CL-720
clinical analyser.
The serum AP concentrations were determined at 30°C by a
commercially available kit method (Gilchem Single Vial Reagent
System ALP, obtainable from McQuilkin & Co., 21 Polmadie Avenue,
Glasgow, Scotland). The technique involves the hydrolysis of p-
nitrophenylphosphate to p-nitrophenol and inorganic phosphate by the
AP in the test sample. The rate of p-nitrophenol formation is
directly proportional to AP activity and is determined by measuring
the rate of change of absorbance at 405 nm. At low, medium and high
levels of AP activity, the within-assay cvs were 7.4, 3.2 and 2.1
per cent and the corresponding figures for between-assay cvs were
7.4, 7.7 and 9.3 per cent respectively.
The serum ALT concentrations were determined at 30°C by a
commercially available kit method (Gilchem Single Vial Reagent
System ALT), obtained as described previously. ALT in the sample
catalyses the combination of alpha-oxoglutarate and L-alanine to L-
glutamate and pyruvate. The latter subsequently oxidises
nicotinamide adenine dinucleotide (reduced) (NIADH) to nicotinamide
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adenine dinucleotide (NAD) with the formation of L-lactate. Lactate
dehydrogenase is included in the reagent to prevent interference
from endogenous pyruvate which is normally present in serum samples
at low concentrations. Oxidation of NADH causes a decrease in
absorbance at 340 nm and the rate of change of absorbance is
directly proportional to the ALT activity in the serum. At low and
high levels of ALT activity, the within-assay cvs were 8.9 and 1.6
per cent and the corresponding figures for between-assay cvs were
10.3 and 3.2 per cent respectively.
The serum total cholesterol concentrations were determined by a
commercially available kit method (Gilchem Single Vial Reagent
System Cholesterol), obtainable as described previously. The
technique involves the hydrolysis of cholesterol esters in the serum
into free cholesterol and fatty acids, by means of cholesterol
esterase. The free cholesterol is then oxidised to cholesten-3-one
and hydrogen peroxide in the presence of cholesterol oxidase. 2-4
Dichlorophenol and 4-aminoantipyrine then combine with the hydrogen
peroxide in the presence of peroxidase to produce red quinoneimine.
The intensity of the colour thus produced measured
spectrophotometrically at 500 nm is directly proportional to the
total cholesterol concentration of the sample. For low and high
concentration controls, the mean within-assay cvs were 1.5 per cent
and 0.9 per cent, with the corresponding between-assay cvs being 1.5
per cent and 1.2 per cent respectively.
The serum urea concentrations were determined at 30°C using a
modification of a commercially available kit method for blood urea
nitrogen (BUN) (Gilchem Single Vial Reagent System BUN), obtainable
as described previously. The technique involves the hydrolysis of
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urea in the sample to ammonia and water, catalysed by urease. The
ammonia thus produced combines with 2-oxoglutarate in the presence
of NADH during the glutamate dehydrogenase catalysed synthetic
reaction, to yield glutamate. An equimolar quantity of NADH
undergoes oxidation during the reaction and thus the decrease in
absorbance at 340 nm is directly proportional to the blood urea in
the sample, when the BUN standards supplied are replaced by pure urea
standards. Using serum urea controls, at low and high
concentrations of urea activity, the within-assay cvs were 2.6 and
4.5 per cent and the corresponding figures for between-assay cvs
were 8.0 and 3.2 per cent respectively.
The serum inorganic phosphorus concentrations were determined
by a commercially available kit method (Gilchem Diagnostics
Inorganic Phosphorus), obtained as described previously. The
technique involves the reaction of inorganic phosphorous in the
sample with ammonium molybdate in an acid medium to form a
phosphomolybdate complex which absorbs light at 360 nm. This
absorbance is directly proportional to the amount of inorganic
phosphorus present in the sample. At low and high inorganic
phosphorus concentrations, the within-assay cvs were 5.1 per cent
and 6.4 per cent and the corresponding figures for between-assay cvs
were 4.5 per cent and 1.8 per cent respectively.
The serum calcium concentrations were determined by atomic
absorption spectroscopy using an IL 357 Atomic Absorption
Spectrometer, supplied by Allied Instrumentation Laboratory, Kelvin
Close, Birchwood Science Park, Warrington, Lancashire, England.
Samples were diluted with 0.1 per cent calcium chloride and compared
with calcium nitrate standards. Within and between-assay cvs were
not available for the technique.
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Total and individual serum protein concentrations were
determined by the biuret method and by agarose gel electrophoresis
as described in Section 4.4.
Radiography
Lateral and dorsoventral thoracic radiographs of conscious
patients were taken using a Siemens Heliophos 4E X-ray machine
supplied by Siemens Ltd., Wheatfield House, 6 Wheatfield Street,
Edinburgh, Scotland. They were recorded on Kodak Ortho G X-ray film
(Kodak Ltd., P.O. Box 10, Dallimore Road, Manchester, England).
Processing was carried out automatically in a Cronex X-ray Film
Processor, (Du Pont (UK) Hawkesden Road, St. Neots, Huntingdon,
Cambridgeshire, England) at a developer temperature of 32°C and a
dryer temperature of 30°C.
Electrocardiography
Recordings from the six basic limb leads (I, II, III, aVR, aVL
and aVF) were recorded from conscious individuals using a Cardiofax
3-channel ECG recorder, manufactured by Nlihon Kohden and supplied by
by Hoi star Instruments Ltd., Haywards Heath, Sussex, England.
Treatment
Confirmation of the diagnosis was by the demonstration of
elevated serum concentrations of total T3 and/or T4. Unless the
owners refused, treatment of all cases was by surgical thyroidectomy.
Pre-operative treatment. All cases were treated three
times daily for a minimum of one week with 10 mg aqueous
potassium iodide solution (10 mg/ml) in an attempt to reduce the
circulating T4 and T3 concentrations and the vascularity of the
thyroid gland. This solution was readily taken by most cats when
mixed with food. Inappetent or anorexic animals were drenched with
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the solution using a syringe. Excessive salivation was not noted as
a result of either route of administration. In addition,
propranolol (Inderal, Imperial Chemical Industries) was administered
at a dosage of 2.5 mg three times daily to reduce the heart rate.
This dosage was increased to 5 mg three times daily if the heart
rate remained above 200 beats per minute after three days'
treatment.
In some animals during this period, serum samples were
collected as described previously to monitor T4 and T3
concentrations.
Anaesthesia. All cats were premedicated with acetyl promazine
(ACP injection 2 mg/ml, C-Vet) at a dose of 0.05 mg/kg bodyweight.
Anaesthesia was induced using intravenous ketamine hydrochloride
(Parke, Davis) at a dose of 25 mg/kg bodyweight, and maintained with
a halothane (Fluothane, Imperial Chemical Industries) and nitrous
oxide mixture administered via an Ayres T piece and cuffed
endotracheal tube in a non-rebreathing system, using high flow rates
(three times the minute volume).
Surgical technique. The patients were placed in dorsal
recumbency, with the neck extended and the legs pulled caudally. A
ventral, midline skin incision was made from the larynx to the
manubrium. After blunt dissection of subcutaneous fascia, the
sternohyoideus and sternothyroideus muscles were separated in the
midline.
The thyroid lobes and cranial parathyroid glands were
identified and inspected. As pre-operative thyroid scanning
facilities were not available, the decision as to whether to perform
a unilateral or bilateral thyroidectomy was a clinical one based on
281
the size and appearance of the thyroid lobes. In all but one case
(110989) thyroidectomy was by the extracapsular technique, although
efforts were always made to preserve the cranial parathyroid gland
of affected lobes whether there was unilateral or bilateral
involvement. The caudal thyroid vasculature was identified and
ligated using three metric chromic catgut. The cranial parathyroid
gland was dissected free of the thyroid lobe using fine scissors,
taking care to avoid damaging its vasculature. The cranial thyroid
vessels were ligated with three metric chromic catgut and the gland
subsequently removed by blunt dissection. Throughout the
procedure, it was necessary to maintain meticulous haemostasis to
allow visualisation of the cranial parathyroid gland. The incision
was then closed routinely.
Where involvement of the other thyroid lobe was obvious, the
above procedure was repeated.
In one case of bilateral lobe involvement, intracapsular
thyroidectomy was carried out. After exposing the thyroparathyroid
glands and ligation of the caudal thyroid vein of one abnormal lobe
as described above, a small nick incision was made in an avascular
area of the ventrocaudal aspect of the thyroid capsule. The
incision was extended cranially using small scissors. The thyroid
parenchyma was bluntly dissected off the thyroid capsule using
sterile cotton buds taking care not to place any tension on the
cranial thyroid vessels. Where thyroid tissue fragments were left
attached to the capsule, these were carefully removed even if this
required partial capsulectomy. Otherwise, the capsule and the
cranial parathyroid gland were left intact. The procedure was then
repeated for the other thyroid lobe.
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In cases in which thyroid antibody studies were to be carried
out, excised lobes were divided. One piece was snap-frozen in liquid
nitrogen (see Chapter 14). The rest of the excised tissue was
preserved in ten per cent formal saline, prior to histological
examination. In the remainder of the cases, the lobes were placed
entire into the formol saline.
After formalin fixation, excised thyroid tissue was processed
to paraffin and 4u to 5u sections were routinely stained with
haematoxylin and eosin.
In cases where both thyroid lobes had been removed, serum
calcium and phosphate concentrations were measured 16 hours after
completion of surgery and subsequently daily for a further four
days. Cases were discharged from the hospital between the fourth
and the seventh day post-surgery.
Cases were reassessed at intervals as required after surgery.
Initially, owners of unilaterally thyroidectomised animals were
warned of the possibility of subsequent involvement of the remaining
lobe with recurrence of thyrotoxicosis. With recurrence of the
condition in a small number of bilaterally thyroidectomised animals,
this warning was extended to all cases.
Medical management. The remaining cases were treated
medically using PTU (Propylthiouracil B.P.). The drug was
administered at a dose of 50 mg three times daily for three weeks
and then reduced to 50 mg twice daily.
10.3 RESULTS
The study comprised 74 cats.
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Pre-treatment data
Breed, sex and age. These data are presented in Table
10.1.
There were no pedigree cats in the series. There were more
females than males but there was no significant difference in the
mean age at presentation between the sexes. The two cats in the
series under nine years of age when presented (six years and 7.5
years) were both neutered females.
Historical and clinical features. Fifty-three owners were
able to report reasonably accurately the duration of symptoms in
their animals before first presentation. This ranged from two weeks
to 1.5 years with a mean of 4.0 months. However, many owners
reported the onset of signs to be insidious and gauged the time of
their first impression of them retrospectively. In five cases, no
systemic signs had been noted, these having been presented for
annual vaccination, annual health check, feline leukaemia virus
testing, an ingrowing claw and oral haemorrhage (one case each).
Table 10.2 lists the frequency of the major historical and
clinical features of the disease in the series. Weight loss
together with a ravenous appetite were the most common signs. A
typical case is shown in Fig. 10.1. Twenty-five per cent of the
cats vomited occasionally, usually after eating. One cat vomited
regularly each evening after feeding and one vomited hair
occasionally. Almost half of the cats had diarrhoea, the faeces
varying in consistency from liquid to pale and pasty with
macroscopic evidence of steatorrhoea. One animal was faecally
incontinent.
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Polyuria and polydipsia were present in three quarters of all
cases. Three owners had noticed haematuria and two cats were
actually presented with this as the primary complaint. One third of
the cats showed some respiratory abnormality, usually tachypnoea and
panting but two cats were dyspnoeic and two showed episodes of
sneezing.
Dermatological signs were also present in one third of the
cats. Mats (Fig. 10.2) and local or regional asymmetrical alopecia
were the commonest lesions. However, two cats had symmetrical
alopecia affecting the caudal thighs and hocks (Fig. 10.3) and the
ventral abdomen (Fig. 10.4) in a distribution resembling FEA (see
Chapter 12). The remaining haircoat could be more easily epilated
in some cases. Some cats had hyperaemia of the skin of the pinnae,
possibly reflecting hypertension. An example is shown in Fig. 10.5.
Approximately one half of all cats showed tachycardia (heart
rate greater than 240 beats per minute) at rest. Other
cardiovascular signs were present in just over one quarter of cats
examined. Three cats were presented in congestive cardiac failure,
with pleural effusions and muffling of heart sounds. These animals
were lethargic and inappetent rather than hyperactive and
polyphagic. Three other cats exhibited lethargy and inappetence
making a total of six cases (eight per cent) with signs comparable
to apathetic hyperthyroidism of man.
Palpable goitre was present in 71 of the 74 cats (96 per
cent). Of these, 46 cases (64.8 per cent) were judged to be
unilateral and 25 cases (35.2 per cent) bilateral. Of the animals
with unilateral goitre, 58.6 per cent affected the left lobe and
41.4 per cent the right lobe. A case of left-sided thyroid goitre
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is shown in Fig. 10.6. Thyroid enlargement could not be palpated in
three of the 74 cases (four per cent).
In most animals, the enlarged lobes were easily mobile,
often between the larynx and the thoracic inlet. Sometimes, lobes
became retrotracheal making careful palpation essential if goitre
was not to be missed.
Radiography. Thoracic radiography was carried out on ten
cases. The summary of results reported here is provided courtesy of
A.H.M. van den Broek.
Cardiac size was assessed on lateral radiographs by
measurements of the maximum apicobasilar length (ABL) at the level
of the carina of the trachea and the maximum craniocaudal width
(CCW) at right angles to the ABL. A typical lateral thoracic
radiograph from a hyperthyroid cat and the position of these
measurements is shown in Fig. 10.7a. The results were compared to
those obtained from 30 healthy cats using Student's unpaired t test
and are summarised in Table 10.3.
Nine of the ten cases had ABL and CCW values which were
greater than the respective means of the healthy cats. The ABL was
significantly and the CCW was highly significantly increased in
hyperthyroid compared with healthy cats.
Electrocardiography. Pre-treatment electrocardiographic
data for ten cats are presented in Table 10.4.
The commonest abnormality was an increase in the R wave
amplitude in lead II which occurred in eight cases (80 per cent).
An example is shown in Fig. 10.8a. Three cats (30 per cent) had
tachycardia at rest. Four cats (40 per cent) had marked notching of
the QRS complex, suggestive of cardiac enlargement. Four cats had
increased P wave voltages in lead II.
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Conduction disturbances included two cats (20 per cent) with
left anterior fascicular block and one (ten per cent) with
ventricular premature beats (Fig. 10.8a).
Serum thyroid hormone concentrations. Serum total T4
concentrations were determined in all cases but were reported simply
as greater than 200 nmol/1 in two individuals. Serum total T3
concentrations were determined in 71 cases.
The zero, 25th, 50th, 75th and 100th sample percentiles for
these analytes are presented in Table 10.5. The T4 concentrations
were greater than three sds from the mean of the reference range in
all cases. Serum T3 concentrations were normal in six individuals
(mean 1.08 nmol/1, range 0.90 to 1.27 nmol/1). In none of these
cats did the serum T4 concentration exceed 80 nmol/1 (mean value
70.0 nmol/1, range 63.0 to 80 nmol/1).
Individual T4 and T3 values were highly significantly
correlated (Kendall rank correlation,= 0.68, P<0.001). This
relationship is shown in Fig. 10.9.
Haematological tests. Pre-treatment haematological
parameters were measured in 12 cases. These data are presented in
Table 10.6.
The RBC count was normal in all cats. The PCV and
haemoglobin concentrations were elevated in one (8.3 per cent) and
two cases (16.7 per cent) respectively, in one case concurrently.
Eight cats had a leucocytosis, which was always due to a
neutrophilia. In three cases, this could be explained by pathology
unrelated to the hyperthyroidism (one case each of mural
endocarditis, periodontal disease and infected end-stage kidney
disease). There was a lymphopenia in one case (possibly due to
287
stress) and a monocytosis and eosinophilia in four and three cases
respectively.
Non-specific biochemical tests. Pre-treatment biochemical
parameters other than T4 and T3 concentrations were measured in 12
cases. These data are presented in Table 10.7.
Seven cases (58 per cent) showed elevated serum AP
concentrations while five (42 per cent) were within the normal
range. Serum ALT concentrations were raised in 11 cases (92 per
cent) and normal in one case (eight per cent). The serum urea
concentration was measured in ten cases, being elevated in seven (70
per cent). The serum cholesterol, calcium and inorganic phosphate
concentrations were within the respective normal ranges in all cases
tested. The serum protein concentrations showed no obvious trends.
Treatment data. Four cats died before treatment could be
undertaken. Six cats were euthanased at the owner's request. Three
animals were lost to follow-up after the initial diagnosis and two
owners elected not to have their animals treated. Fifty-five
animals were treated surgically and four medically.
Of the three cases in which thyroid enlargement was not
palpable, one died before surgery could be carried out, one was
treated medically and one was lost to follow-up.
Of the cats with apathetic hyperthyroidism, two were
euthanased at the owner's request, two were treated surgically and
two were treated medically but were lost to follow-up.
Surgical management
Pre-operative management. All cats undergoing surgery were
treated for at least seven days prior to surgery with potassium
iodide and propranolol as described in Section 10.2. Serum total T4
288
and T3 concentrations were sequentially monitored during this period
in six cases. These data are presented in Table 10.8.
Using potassium iodide and propranolol, in only one case
(134562) were serum T4 and T3 concentrations reduced to the
euthyroid range. In one other (131335), the T3 concentration
returned to the euthyroid range but the T4 concentration remained
marginally elevated. Both the T4 and T3 concentrations fell from
their initial values in one cat (113897) but still remained
grossly elevated. In two cases (127281 and 137264) there was an
initial marginal decrease in both T4 and T3 concentrations but these
began to rise again before surgery. Thyroid hormone concentrations
remained unaffected in case 134770.
In all cats, the thyroid gland became palpably firmer and the
heart rates decreased during this period.
Surgery. Affected thyroid lobes varied in size from 1.5
cm to 3.5 cm in length and were often irregular in contour. They
ranged in colour from yellow to yellow-green, through tan to dark
brown. A typical gland from a case of unilateral disease is shown
in Fig. 10.10. Small cysts were frequently present on the surface
of the glands, extending into the deeper tissue. The cut surface
of a typical gland is shown in Fig. 10.11.
In cases of unilateral lobe involvement, the contralateral
lobe appeared atrophic.
Of the 55 animals treated surgically, 39 (70.9 per cent)
underwent unilateral and 16 (29.1 per cent) bilateral thyroidectomy.
All animals survived the operative procedure. Two died immediately
afterwards, probably as a result of cardiac arrhythmias. Both of
these had had unilateral lobe removal.
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Post-operative management. No further potassium iodide was
given post-surgery but propranolol was continued at a dose of 2.5 mg
three times daily for a further three days. T4 was not routinely
administered post-operatively to either unilaterally or bilaterally
thyroidectomised cases.
In the majority of cases from which both thyroid lobes had
been removed, the serum calcium concentration fell on the second day
post-operatively to values of between 1.8 nmol/1 and 2.0 nmol/1. No
treatment was administered unless such individuals showed physical
signs of hypocalcaemia (muscle tremors, weakness, tetanic spasms,
convulsions), when 1.5 ml/kg ten per cent calcium borogluconate
(diluted from Calcium Borogluconate 20%, Crown Chemicals) was
administered intravenously. Subsequently, intravenous or
subcutaneous therapy was given to effect, together with daily
maintenance doses of 0.2 g dihydrotachysterol (A.T. 10, Sterling
Research Laboratories) or tablets containing calcium lactate (300
mg), calcium phosphate (150 mg) and calciferol (0.0125 mg) (Calcium
with Vitamin D Tablets, B.P. (Vet), Veterinary Drug Co.).
Signs of hypocalcaemia developed in seven cats which had
undergone bilateral thyroidectomy. In all cases, this occurred
between the first and the third day post-operatively. Despite the
treatment outlined above, six of the affected animals died, one on
the first, two on the second, one on the third, one on the sixth and
one on the seventh days post-operatively. Two of these cases were
the most severely cachectic in the series. The remaining animal was
maintained on Calcium with Vitamin D tablets (one twice daily) for
three weeks and remained normocalcaemic when these were subsequently
withdrawn.
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No other post-operative complications were noted. Thus, 37
of the 39 cases (95 per cent) of unilateral lobe involvement and ten
of the 16 cases (63 per cent) of bilateral lobe involvement were
treated successfully by surgery.
In order to determine how quickly serum thyroid hormone
concentrations returned to normal after surgery, blood samples were
collected at varying intervals post-operatively in six cats. The
results of this study are shown in Table 10.8.
In four of the six cases, the serum total T4 concentration
was within the normal range by the day following surgery and in all
cases by the second post-operative day. The serum total T3
concentration was in the normal range in all cases by the day
following surgery.
Thyroid histology. Excised thyroid tissue from 54 cases
was examined.
In all cases, the histological appearance was compatible with
a diagnosis of follicular adenomatous hyperplasia with varying
degrees of cystic formation or colloid accumulation. Fig. 10.12 is
an example of normal feline thyroid tissue. A typical example of
adenomatous hyperplasia is shown in Fig. 10.13. No attempt was made
to distinguish between this and true adenoma formation. The degree of
replacement of normal thyroid tissue varied from mild to severe.
Varying degrees of encapsulation of abnormal tissue were noted
(Fig. 10.14).
Lymphocytic infiltrates were observed in 22 cases (41.5 per
cent) (Fig. 10.15). While they were found in equal numbers of
unilateral and bilateral goitre (11 cases each), bilateral cases of
goitre made up only 33 per cent (18 cases) from which thyroid tissue
291
was examined histologically. Lymphocytes tended to be distributed
either paravascularly (Fig. 10.16) or adjacent to relatively normal
peripheral thyroidal acini (Figs. 10.17(a) and (b)).
Post-mortem examinations. Post-mortem examinations were
carried out on three cases, all of which died before treatment could
be carried out.
All three cats were thin. One (140802) had 90 ml of fluid
with the characteristics of a modified transudate in the thoracic
cavity and 100 ml of the same type of fluid were present in the
abdominal cavity. The heart of this cat showed left auricular and
ventricular dilatations. The heart of one of the other cats
(135619) was flaccid and showed dilatation of the left ventricle
while that of the third (109404) had a left ventricular mural
endocarditis which on culture yielded occasional colonies of
Pasteurella multocida. In the latter, infected emboli were
present in the brain, kidney and liver. This cat had pulmonary
oedema and the other two, pulmonary congestion.
One cat (135619) had a pale liver with cystic foci.
Histologically, there were areas of telangiectasis and an unusual,
portal-bridging, fatty, degenerative change.
Two cats had firm, irregular kidneys. Histologically, one
(135619) had widespread glomerulonephropathy with protein deposits
within the Bowman's capsule and early thickening of the glomerular
tufts, and in one kidney, localised pyelitis. This cat had a serum
urea concentration of 74.8 mmol/1. The other (140802) had
histological evidence of low-grade interstitial nephritis and a
blood urea concentration of 32.8 mmol/1.
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The stomach of cat 135619 was contracted and apparently
atrophic with no obvious rugae. There were multiple, cream, nodular
formations around the cardia and some larger, solitary nodules in
the body region. Histological sections of these areas confirmed
that they consisted of non-neoplastic, lymphoid infiltrations. This
cat had enlarged adrenal glands. Histologically, all layers of the
adrenal cortex were hyperplastic but this change was most marked in
the zona reticularis.
The cat showing bacterial endocarditis also had macroscopic
and histological evidence of chronic pancreatitis.
Post-operative follow-up
Clinical findings. Post-operatively, the signs of
hyperthyroidism resolved in all cases successfully treated.
Hyperactivity ceased within four days. Some animals
subsequently became mildly to moderately lethargic for up to eight
weeks following surgery, while others, according to their owners,
were normally active. One (110989) slept continually, apart from
feeding periods, from two weeks following bilateral thyroidectomy.
This animal developed the same bilaterally symmetrical pinnal
changes (alopecia, hyperpigmentation) as did two experimental
hypothyroid cats, (discussed in detail in Chapter 11). Pinnal
changes were first obvious 17 weeks post-surgery. T4 and T3
determinations confirmed persistent hypothyroidism (Table 10.9).
The ear lesions, together with the lethargy, resolved on
introduction of T4 therapy (Eltroxin, Glaxo) at a dose of 50 ug
twice daily.
Polyphagia tended to persist until normal weight was
re-established, when the appetite reverted to normal. The time
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required to re-establish normal weight varied from four to 12 weeks
in mildly and severely affected animals respectively. One 16-year-
old cat increased in bodyweight from 1.8 kg pre-operatively to 4.8
kg within six weeks.
Diarrhoea (but not vomition) continued in a number of cats
for up to 12 weeks and appeared to be related to the persistence of
polyphagia, resolving when the animals' appetites reverted to
normal.
Radiography. Thoracic radiography was carried out in seven
cats between seven and 11 weeks (mean ten weeks) after successful
surgical treatment of hyperthyroidism. Cardiac size was measured as
reported previously. These data are presented and compared with
pre-treatment values in Table 10.3 using Student's paired t test.
There were no significant differences between the groups.
However, in some cases, reductions in cardiac size were obvious
radiographically. An example is shown in Fig. 10.7(b).
Electrocardiography. Post-treatment ECGs were available
for six cats, measured between three and 18 weeks (mean 11.3 weeks)
after thyroidectomy. These data are presented in Table 10.4. In
one cat (140363), clinical and biochemical evidence of
hyperthyroidism recurred rapidly after surgery and its ECG
parameters did not alter or worsened in the eight weeks between the
two measurements. This animal is therefore disregarded when
considering ECG alterations after successful therapy.
Of the four animals which had elevated pre-treatment R wave
voltages, three (75 per cent) reverted to normal after
thyroidectomy. There was no significant change in the fourth
despite resolution of the thyrotoxicosis. The notching of the QRS
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complex, the left anterior fascicular block and the ventricular
premature beats resolved in all affected cats.
Fig. 10.8(b) shows a post-treatment ECG and compares it to a
pre-treatment ECG from the same animal (Fig. 10.8(a)).
Serum thyroid hormone concentrations. Serum total T4 and
T3 concentrations were monitored serially post-operatively in eight
cats. Five of these had had unilateral and three bilateral thyroid
lobe excisions. These data are presented in Table 10.8.
The T4 and T3 concentrations of animals with unilateral lobe
involvement returned to their normal respective ranges within two to
eight weeks post-operatively. In one (140363) the T4 was again
elevated five weeks post-surgery, and this cat subsequently
developed recurrence of symptoms and signs of hyperthyroidism. Two
of the three cases of bilateral lobe involvement also showed a
return of T4 and T3 concentrations to their normal respective ranges
but this took longer than with the unilateral cases. The third
(110989) continued to have non-demonstrable serum total T4 and T3
concentrations 18 weeks after thyroidectomy and received T4
supplementation. Its T4 and T3 concentrations returned to their
normal respective ranges and its symptoms and signs of
hypothyroidism as previously discussed, subsequently resolved. No
other animal in the series of 74 cases required thyroid hormone
therapy post-operatively.
Other biochemical and haematological tests. These were not
monitored post-operatively.
Recurrence of hyperthyroidism. During a follow-up period
of from two to 40 months, hyperthyroidism recurred in four cases
in this series. Three of these are discussed in more detail in
Chapter 14.
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The fourth case (140363) was judged to have unilateral lobe
involvement at surgery and was treated by unilateral thyroidectomy.
While T4 and T3 concentrations were below the detection limits of
the respective assays one week post-surgery, after a further four
weeks the T4 concentration was above the upper limit of the
reference range (49 nmol/1) although the T3 concentration remained
within the normal range (0.9 nmol/1). The cat continued to be
restless, extremely aggressive and failed to increase in weight.
After a further 11 weeks, the T4 concentration (78 nmol/1) was
greater than three sds from the mean of the reference range as
determined in Chapter 7 although the T3 concentration (1.2 nmol/1)
was at the upper end of the reference range. Further monitoring
and prospective surgery were arranged with the owners but the cat
was lost to follow-up.
Medical management. Four owners refused surgical treatment
on the grounds of cost. Medical treatment was begun using PTU at a
dose of 50 mg three times daily. Regrettably, serial monitoring of
serum T4 and T3 concentrations together with haematological and
biochemical examinations to check for side-effects of drug therapy
were also refused because of expense or inconvenience. Treatment
was therefore empirical and the maintenance dosage of PTU was 50 mg
twice daily.
In all cases, the animals became less restless. While they
remained polyphagic, further weight loss ceased but no significant
weight gain ensued.




While a considerable amount of information has been published
on feline hyperthyroidism since its first description in 1979, only
three independent series of ten or more cases have been reported.
The study described here is the second largest to be presented.
Pre-treatment data
Breed, sex and age. No pedigree cats were represented in
this series. Whether this indicates a reduced incidence of the
condition in pedigree cats is unknown as cases have been recorded
previously in Siamese, Persians and a Russian blue (Hoenig et al.,
1982; Peterson et al., 1982; Peterson et al., 1983b).
Fifty-five per cent of the present series were females but the
significance, if any, of this observation is unknown. Other authors
have reported that feline hyperthyroidism has no sex predisposition
(Peterson, 1982; Hoenig, 1983; Peterson and Becker, 1984). In
human medicine, 90 per cent of cases of hyperthyroidism are due to
Graves' disease, toxic multinodular goitre or a toxic solitary
thyroid nodule and each of these is seen more commonly in females
than in males (Toft, Campbell and Seth, 1981). For example, Graves'
disease and toxic solitary thyroid nodule are seen approximately
seven and six times more commonly respectively in females than in
males (Toft, Campbell and Seth, 1981). The slight increase in
females to males in the present series is obviously not comparable
with such figures.
The mean age at onset in this series was 12.7 years,
comparing well with mean ages of 11.8 years for a series of 24 cases
(Hoenig et al., 1982), and 12.8 years for a series of 131 cases
297
(Peterson et al., 1983b). The age range at onset for the present
series was six to 18 years. The youngest cases previously recorded
were also six years of age (Hoenig et al., 1982; Peterson et
al., 1983b). While the mean age at onset of females compared with
males in this series was not significantly different, the range was
greater for females (six to 18 years) compared with males (nine to
16 years). Previous studies have not subdivided the age at onset
of feline thyrotoxicosis according to sex and the significance of
these observations is unknown.
Historical and clinical features. The historical and
clinical features of the cats in the present series (Table 10.2)
compare well with those described in previous reports (Table 3.11).
In each, the major symptom was weight loss despite polyphagia.
Heat intolerance and intermittent fever were also important
features. Thyroid hormones regulate carbohydrate, protein and lipid
metabolism and heat production in virtually all body tissues.
Increased energy metabolism and heat production from excess thyroid
hormone secretion result in the increased appetite, weight loss,
muscle wasting, weakness and moderate temperature elevation of
thyrotoxicosis (Ingbar and Woeber, 1981).
Hyperexcitability with nervousness and aggressive behaviour
are commonly seen in hyperthyroid cats (Holzworth et al., 1980;
Hoenig et al., 1982; Peterson et al., 1983b). Thyroid hormones
interact with the nervous system producing overall increased
sympathetic drive resulting in these symptoms (Rockey and Griep,
1980; Ingbar and Woeber, 1981).
Gastrointestinal symptoms (vomition, diarrhoea, bulky faeces
and increased frequency of defaecation) were important features of
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this and previous series of hyperthyroid cats. In human
thyrotoxicosis, vomiting is a rare but well-documented symptom. The
mechanism is unclear but may result from direct action of thyroid
hormones on the chemoreceptor trigger zone (Rosenthal, Jones and
Lewis, 1976). Rapid overeating in the hyperthyroid cat may also
contribute to vomiting (Peterson et al.,1983bD.Thyrotoxic people
commonly develop intestinal hypermotility resulting in increased
frequency of defaecation and diarrhoea (Middleton and Morrow, 1971).
Malabsorption with increased faecal fat excretion, also develops in
approximately 25 per cent of human hyperthyroid patients (Thomas,
Caldwell and Greenberger, 1973). The exact causes of the steatorrhoea
are unknown but appear to include reduction in pancreatic trypsin
secretion (Wiley, Lavigne, Liu and MacGregor, 1978) and excess fat
intake due to polyphagia (Kasper, 1970; Thomas, Caldwell and
Greenberger, 1973). Pancreatic enzyme and absorption tests and
faecal fat analyses were not carried out in the present study.
Polyuria and polydipsia occurred in 75 per cent of cases in
the present and in previous series of feline hyperthyroidism. While
some cats had concurrent evidence of primary renal disease, most cats
with polyuria and polydipsia did not. Similar signs are seen in
human thyrotoxicosis but the exact cause is unknown. In some cases,
a primary polyuria with secondary polydipsia appears to result from
decrease in renal medullary solute concentration (medullary
"washout") due to increased total renal blood flow (Cutler, Glatte
and Dowling, 1967). Other humans with thyrotoxicosis have normal
renal concentrating ability and primary polydipsia appears to result
from a hypothalamic disturbance associated with the thyroid disease
process (Evered, Hayter and Surveyor, 1972).
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In the present series, two cats had haematuria as the primary
complaint and another owner reported haematuria as one of
several symptoms shown by her animal. Although it is possible that
this finding was coincidental, haematuria has been reported in two
previous hyperthyroid cats (Jones and Johnstone, 1981; Watson et
al., 1981). Bleeding tendencies in untreated human thyrotoxicosis
are uncommon. However, an associated thrombocytopenia, reversible
by thyroidectomy, has been described (Woodruff, 1940). Prothrombin
deficiency may rarely result from hyperthyroid hepatopathy
(Bechgaard, 1946). In addition, thyrotoxicosis may lead to
depressed activity of several coagulation factors (II, VII, IX and
X) although the effects are not usually apparent clinically (Ikkala,
Eisalo and Heinivaara, 1962).
No other signs of bleeding tendencies were seen in the cats
in the present series. Further investigations into their haematuria
were not carried out and the symptom did not recur after successful
surgical therapy.
Respiratory abnormalities, chiefly tachypnoea and dyspnoea at
rest were seen in 33 per cent of cats. Hoenig et al. (1982)
reported respiratory abnormalities in the same percentage of 24
cases and Peterson (1983b) in 25 per cent of 131 cases. In man,
thyrotoxicosis produces a decreased vital capacity, decreased
pulmonary compliance and increased minute ventilation (Ingbar and
Woeber, 1981). These abnormalities in respiratory function probably
result from a combination of respiratory muscle weakness and
increased carbon dioxide production (Peterson, 1984). Congestive
cardiac failure may contribute to the signs in some cats (Peterson,
1984).
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Dermatological abnormalities were found in 32 per cent of
cases in the present series. Most abnormalities affected the hair
(alopecia, mats, harsh, dry coat, increased ease of epilation) and
were probably associated with behavioural changes resulting in
decreased or increased grooming, together with direct effects of
excessive concentrations of thyroid hormones. One cat was presented
for an ingrowing claw. Similar changes have been reported in other
hyperthyroid cats (Holzworth et al., 1980; Hoenig et al., 1982;
Peterson et al., 1983b). Changes in hair texture, partial hair loss
and increased nail growth are also common features of human
thyrotoxicosis (Freedburg, 1978a).
Tachycardia was present in more than half of the cats in the
present series and other cardiac abnormalities (powerful apex beat,
murmur, gallop rhythm and arrhythmias) occurred in 28 per cent of
cases. Four per cent of cases had congestive cardiac failure.
Cardiomegaly was confirmed in a study of ten cats by comparison with
30 healthy animals. This results from hypertrophic cardiomyopathy
(Liu, Peterson and Fox, 1984). Electrocardiographic changes
included tachycardia, increased R wave amplitude in lead II,
ventricular arrhythmias and intraventricular conduction disturbances.
These electrocardiographic changes have been reported previously in
feline hyperthyroidism (Peterson et al., 1982; Peterson et al.,
1983b; Liu, Peterson and Fox, 1984).
The exact pathogenesis of the cardiac abnormalities
associated with hyperthyroidism is unclear but appears to involve a
combination of direct action of thyroid hormones on the heart,
interactions between thyroid hormones and the sympathetic nervous
system and cardiac changes that compensate for altered peripheral
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tissue function caused by thyrotoxicosis (Ingbar and Woeber, 1981;
Peterson et al., 1982).
In this series, signs compatible with the state of apathetic
(masked) hyperthyroidism were seen in six cases (eight per cent).
This is close to the figure of "approximately ten per cent" of 131
cases reported by Peterson et al. (1983b). Severe cardiac
abnormalities (arrhythmias, congestive cardiac failure) were seen in
four of these cases. Cardiac abnormalities have been reported
previously to be common in cases of apathetic hyperthyroidism
(Peterson, 1984).
Palpable thyroid enlargement was present in 71 of the 74 cats
(96 per cent) in the present series. In the remaining three cases,
the site of the hyperfunctional thyroid tissue was never identified
as one case died before surgery could be carried out and post-mortem
examination was not allowed, one was treated medically with PTU and
one was lost to follow-up.
Of the cases of unilateral goitre, 58.6 per cent affected the
left and 41.4 per cent the right lobe. These figures are virtually
identical to those published by Peterson et al., (1983b) who found
the left lobe affected in 58 per cent and the right in 42 per cent
of 36 cases.
Biochemical tests. As in previous series (e.g. Peterson et
al., 1983b), serum T4 concentrations were elevated in all cats. In
addition, all T4 values were greater than three sds from the
reference mean, a value which has been suggested by Turrel et al.
(1984) as useful in differentiating hyperthyroid animals from those
healthy individuals with T4 concentrations outside the reference
range. The maximum T4 concentration determined was 688 nmol/1,
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which is about 15 times the upper value of the reference range.
These figures compare closely with those of Peterson et al. (1983b)
who, in a series of 131 cases, reported the maximum T4 concentration
as 696 nmol/1, 14 times the upper limit of their reference range.
The serum T3 concentration was elevated in 65 of the 71 cases
in which it was measured, with a maximum value of 10.30 nmol/1, which
is about eight times the upper limit of the reference range. These
figures are lower than those of Peterson et al. (1983b), who reported
a maximum T3 concentration in 131 hyperthyroid cats of 15.4 nmol/1,
which was 17 times the upper limit of their reference range.
Six of the hyperthyroid cats in this series had normal serum
T3 concentrations. The T4 concentration in each was only marginally
raised. One cat died of Pasteurel1 a endocarditis before surgery and
one was euthanased because of congestive cardiac failure. A third
cat died on the second day post-surgery. Peterson (1982, 1983),
Peterson et al. (1983b) and Peterson (1984) have suggested that
hyperthyroid cats with normal T3 concentrations are only mildly
affected and that such concentrations would increase into the
thyrotoxic range if the disorder were allowed to progress. This
may indeed be the case in some cats. However, the results of the
present study suggest that some affected animals may be manifesting
a condition analagous to the state of "T4 toxicosis" in man, in
which the serum total T3 concentration is artificially decreased in
hyperthyroidism because of concomitant systemic illness. T4
toxicosis has been discussed in detail in Section 9.6.
In the present series, individual T4 and T3 values were, as
in euthyroid animals, highly significantly correlated. Such a
relationship might have been anticipated but has not been reported
previously.
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Elevations in serum ALT, AP and urea were the commonest non¬
specific biochemical abnormalities seen, occurring in 92 per cent,
58 per cent and 70 per cent of cases respectively. Previous reports
have discussed the frequency with which ALT and AP are elevated in
feline hyperthyroidism (e.g. Peterson, 1983b and fully reviewed in
Section 3.11). In human thyrotoxicosis, similar enzyme increases
are frequent and are usually attributed to hepatic dysfunction
(Dooner, Parada, Aliaga and Hoyl, 1967). The causes of hepatic
damage in thyrotoxicosis are unclear and may include malnutrition,
congestive cardiac failure, infections, hepatic anoxia and direct
toxic effects of thyroid hormones on the liver (Dooner et al.,
1967). In human thyrotoxicosis, serum concentrations of the bone
isoenzyme of AP are commonly increased (Dooner et al., 1967) and
this may result from increased bone turnover.
Elevated serum blood urea concentrations were found in 70
per cent of the cases studied in the present series. This is
considerably higher than the 25 per cent of cases reported by
Peterson et al. (1983b). The reasons for this discrepancy are
unci ear.
The serum cholesterol concentration was within the normal
range in all cats tested. Similar results have been reported by
Holzworth et al. (1980) and Peterson et al. (1983b).
The pre-treatment serum inorganic phosphate concentration
was measured in only three cases in the present series but was
normal in each. Peterson et al. (1983b) reported that 20 per cent
of 131 hyperthyroid cats had increased serum phosphate
concentrations. This may result from renal insufficiency. In
addition, thyroid hormones stimulate bone resorption directly,
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resulting in elevations in serum calcium with concomitant decreases
in serum parathyroid hormone concentrations. This causes increased
tubular resorption of phosphate, which together with the increased
phosphate loads from bone resorption and muscle catabolism, result in
hyperphosphataemia (Mosekilde and Christensen, 1977; Parfitt and
Kleerekoper, 1980).
Haematological tests. In the present study, there were
minimal changes in the red cell series of 12 cats studied, with
elevations of PCV and haemoglobin in one and two cases respectively.
None of the cats was anaemic. In a series of 131 cases, Peterson et
al. (1983b) reported increases in PCV, RBC and haemoglobin
concentration in 45 per cent, 14 per cent and 14 per cent
respectively. In addition "a small number" of cats with severe
thyrotoxicosis developed mild anaemia.
The erythrocytosis of hyperthyroidism appears to result from
the direct effect of thyroid hormones, via beta-adrenergic receptors,
on erythroid marrow as well as by increased production of
erythropoietin (Das, Mukherjee, Sarkar, Dash and Rastogi, 1975;
Popovic, Brown and Adamson, 1977). By increasing the rate of RBC
differentiation and decreasing total RBC maturation time,
erythropoietin excess may cause release of macrocytes into the
circulation (Peschle, 1980). Anaemia is also encountered
occasionally in human thyrotoxic patients but the cause is unknown
(Rivlin and Wagner, 1969).
Treatment data
Surgical management
Pre-operative management. All cats were treated prior
to surgery with a combination of propranolol and potassium iodide.
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This treatment was effective in slowing the elevated heart rates
but, in all but two cases, ineffective in lowering serum thyroid
hormone concentrations to the euthyroid range.
Propranolol slows heart rate by beta-adrenergic blockade
(Peterson, 1982; Hoenig, 1983; Peterson, 1983). It is generally
considered to have no effect on serum thyroid hormone
concentrations of either hyperthyroid people (Toft, Campbell and
Seth, 1981) or cats (Peterson, 1982; Hoenig, 1983; Peterson,
1983). However, in human medicine, several clinical investigations
conducted in euthyroid, hyperthyroid and T4-treated hypothyroid
people have shown a decrease in the serum T3 concentrations with a
concurrent increase in the serum rT3 concentrations during
propranolol treatment, which was reversible when such therapy was
withdrawn (Lotti, Delitala and Devilla, 1977; Wiersinga and Touber,
1977). The thyroid hormone metabolism of euthyroid dogs is not
altered by propranolol (Center, Mitchell, Nachreiner, Concannon and
Reimers, 1984).
Large doses of stable iodine are reported to block T4 and T3
release from the human thyroid gland and to lower serum thyroid
hormone concentrations (McKenzie, Zakarija and Bonnyns, 1979;
Ingbar and Woeber, 1981). However, other authors report that serum
thyroid hormone concentrations are not affected by iodine (Toft,
Campbell and Seth, 1981).
Recently, the combination of propranolol and potassium
iodide, unlike the use of either drug alone, has been reported to
cause a fall in plasma total T4 and T3 to the normal range in most
human hyperthyroid patients (Feek, Sawyers, Irvine, Beckett,
Ratcliffe and Toft, 1980). Similar changes in plasma thyroid
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hormone concentrations do not appear to occur in most hyperthyroid
cats.
The thyroid lobes of cats treated with potassium iodide were
palpably firmer than prior to therapy. In human medicine, potassium
iodide is used routinely for ten days prior to thyroidectomy to
reduce the size and vascularity of the thyroid gland (Toft, Campbell
and Seth, 1981). Pre-operative potassium iodide therapy of
hyperthyroid cats is, therefore, of benefit even in the absence of a
reduction in plasma thyroid hormone concentrations.
While Hoenig (1983) has recommended the administration of
saturated potassium iodide solution to hyperthyroid cats, it is
known that concentrated solutions may result in vomition due to
gastric irritation (Thoday, 1986). Potassium iodide was therefore
administered to these cats as a 10 mg/ml aqueous solution. Black
and Peterson (1983) have reported that potassium iodide has a brassy
taste which may result in partial to complete anorexia in some cats.
No such difficulties were encountered in the present series.
Indeed, the author can vouch for the fact that the preparation used
was completely tasteless.
Anaesthesia and surgical technique. In the present
series, cats were premedicated with acetyl promazine. Atropine was
not used as it is known to cause sinus tachycardia or to enhance
anaesthetic-induced cardiac arrhythmias (Black and Peterson, 1983).
Anaesthesia was induced using ketamine hydrochloride and maintained
with a halothane and nitrous oxide mixture. This anaesthetic regime
has been recommended for use in hyperthyroid cats (Birchard,
Peterson and Jacobson, 1984).
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In this series, 70.9 per cent of cases were, on macroscopic
examination at surgery, judged to have unilateral thyroid lobe
involvement and 29.1 per cent bilateral lobe involvement. This is
the reverse of a series of 131 cases reported by Peterson et al.
(1983b) who, with the aid of thyroid imaging techniques, found
unilateral lobe involvement in 29 per cent of cases and bilateral
involvement in 71 per cent of cases. Hoenig et al. (1982), also
aided by thyroid imaging studies, reported bilateral lobe
involvement in 79 per cent of affected cats.
The reason for such a marked difference in these series is
not clear. While it is tempting to speculate that thyroid imaging
in the present series would have led to the diagnosis of a greater
number of cases of bilateral lobe involvement, this is unlikely as
recurrence of hyperthyroidism took place in only two of the
unilaterally thyroidectomised cases. At the time of writing, the
period of follow-up in these cases has varied from two to 40 months.
It is, of course, possible that recurrence may still follow in some
of the unilateral cases in due course. The possible reasons for
recurrence in bilaterally thyroidectomised cases are discussed in
Chapter 14.
With the exception of one case, all thyroidal excisions were
by the extracapsular technique. This method was used to prevent
small fragments of thyroid tissue remaining attached to the
capsule because of the resultant risk of recurrence of
hyperthyroidism due to continued hyperplasia (see Chapter 14).
However, the technique carries a moderate risk of damage to the
cranial parathyroid gland or to its blood supply with resultant
hypercalcaemia in cases of bilateral lobe excision (Peterson,
Birchard and Mehlhaff, 1984).
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In the present series, hypocalcaemia developed in seven of
the bilaterally thyroidectomised cats. Despite intensive therapy,
six of these animals died. Intracapsular excision is likely to
have reduced the number of deaths due to hypocalcaemia but
increased the cases of recurrent hyperthyroidism. In human
medicine, further surgery for recurrent hyperthyroidism combines
technical difficulties and unacceptable morbidity (Toft, Campbell
and Seth, 1981) and may cause technical difficulties in cats.
Facilities for radioiodine therapy were not available to the
author. Medical therapy using PTU may result in mild to serious
drug associated reactions (Peterson, 1981, 1982; Peterson, Cavanagh
and Hurvitz, 1983; Peterson et al., 1984). In addition, in this
series, owner compliance with PTU therapy was poor with all four
such treated cases being lost to follow-up within 14 weeks of
beginning therapy.
One possible way of circumventing the problems outlined
above is to carry out intracapsular thyroidectomy followed by
subsequent excision of the caudal two thirds of the thyroid capsule.
This would remove the majority of thyroid remnants without
disturbing the vasculature to the cranial parathyroid gland. This
approach has been used in a small number of cases of hyperthyroidism
(not reported here) and results are encouraging.
Thyroid histology. The histological findings in this
series are in general agreement with other reports (Peterson et al.,
1982; Peterson et al., 1983b; Birchard, Peterson and Jacobson,
1984; Peterson, 1984; Peterson and Becker, 1984). However, there
have been no previous reports of lymphocytic infiltrates in
hyperfunctional thyroid tissue. Such infiltrates are closely
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correlated with the presence of serum thyroid autoantibodies in
human thyroid disease (Schade, Owen, Smart and Hall, 1960) and
investigations into autoantibody production in feline
hyperthyroidism were subsequently carried out. The results are
reported in Chapter 14.
No cases of functional thyroid carcinoma were identified in
the present series. However, this would not be unexpected in a
series of 54 thyroid histological examinations, as Peterson et al.
(1983b) reported that the prevalence of functional thyroid carcinoma
in cats is only one to two per cent.
Post-mortem examinations. The pathological changes found
at post-mortem examination of three of the cats in this series are
consistent with those reported previously.
One cat had congestive cardiac failure and the remaining two
had cardiac changes similar to those reported previously (Jacobs,
Hutson, Dougherty and Kirmayer, 1986). There is clinical and
experimental evidence in man and dogs that hyperthyroidism may
result in congestive heart failure in the absence of antecedent
cardiovascular disease (Paitnek-Leinissen and Olsen, 1967; Shapiro,
Steier and Dimich, 1975). One cat had left ventricular mural
endocarditis with widespread infected emboli formation. This change
has not been reported previously in feline hyperthyroidism.
Hepatic fatty change occurred in one cat. This has been
reported previously in feline thyrotoxicosis (Jones and Johnstone,
1981).
One cat had diffuse adrenocortical hyperplasia. Liu, Fox
and Peterson (1984) reported that eight of 23 hyperthyroid cats
showed nodular hyperplasia and three, diffuse hyperplasia of zones
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of the adrenal cortex. However, these involved the zona
glomerulosa and the zona fasciculata while the most marked changes
in the present case were found in the zona reticularis.
Adrenocortical hyperplasia is an uncommon finding in cats (Liu, Fox
and Peterson, 1984). In human patients with thyrotoxicosis, thyroid
hormone excess increases the metabolic clearance rates of Cortisol
and aldosterone, which in turn lead to an increase in their
secretion rates (Peterson, 1958). Adrenocortical hyperplasia in
hyperthyroidism may represent a compensatory response to maintain
circulating concentrations of adrenocortical steroids within their
normal ranges (Peterson, 1958), although it is possible that it is
simply the end result of a chronic response to stress produced by
the disease.
One cat had widespread glomerulonephropathy, and gastric
atrophy with prominent gastric lymphoid infiltrations. Because
these changes may be commensurate with altered immune status or
autoimmune disease, it would have been interesting to carry out
serum thyroid antibody and ANA determinations in this cat but,
regrettably, no serum samples remained to be included in the study
reported in Chapter 14.
Post-operative follow-up
Clinical findings. In all cases treated successfully, the
signs of hyperthyroidism resolved. Hyperactivity was the first sign
to disappear and this correlated with the rapid return to normal of
serum thyroid hormone concentrations. Some cats subsequently became
lethargic while others remained normally active. This appeared to
correlate well with the rate at which thyroid hormone concentrations
returned to the normal range (discussed below).
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It is interesting that polyphagia tended to persist until
animals regained their normal bodyweight and then resolved. This
mechanism is obviously independent of serum thyroid hormone
concentrations. The persistence of post-operative diarrhoea was
linked to that of polyphagia, suggesting that the latter was the
cause of the former.
Radiographic and electrocardiographic changes. While
significant reductions in cardiac size were not recorded on
statistical comparison of pre- and post-treatment radiographic
measurements of seven hyperthyroid cats, some individual cases
showed obvious improvements post-surgery. Follow-up radiographs
were taken between seven and 11 weeks after surgery and it is
possible that if this period had been extended, significant
reductions in cardiac size might have been noted. ECG abnormalities
also improved or resolved in successfully treated cases. Previous
authors have noted that effective therapy of feline hyperthyroidism
may produce resolution of the ECG changes (Peterson et al., 1982)
and cardiomyopathy (Liu, Peterson and Fox, 1984) commonly associated
with the disease.
Serum thyroid hormone concentrations. In all of the six
cases in which T3 and T4 concentrations were monitored serially post¬
operatively, these values returned to their normal ranges within 24
and 48 hours respectively. These findings agree with those of
Peterson, Becker and Hurley (1980), Peterson (1982, 1983) and
Birchard, Peterson and Jacobson (1984).
The serum thyroid hormone concentrations of eight cats
treated by surgical thyroidectomy were monitored serially for
between five and 32 weeks post-surgery. In all cases which had
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undergone unilateral thyroidectomy, the remaining thyroid lobe
returned to normal function within eight weeks. Of the three cases
of bilateral thyroidectomy, two had serum T4 concentrations in the
normal range within 14 weeks. Similar findings have been reported
by Peterson (1982), Black and Peterson (1983), Hoenig (1983) and
Peterson (1983).
Theran and Holzworth (1980), 01 sen (1982) and Martin and
Capen (1983) have reported that bilateral thyroidectomy in
hyperthyroid cats results in permanent hypothyroidism. This is
clearly incorrect. Hoenig et al. (1982) and Birchard, Peterson and
Jacobson (1984) reported a return to normal thyroid hormone
concentrations between six weeks and six months after bilateral
thyroidectomy in hyperthyroid cats. All authors recommend
beginning exogenous thyroid hormone supplementation within 24 to 48
hours of bilateral thyroidectomy. This would seem to be contra-
indicated as exogenous thyroid hormones tend to suppress endogenous
thyroid hormone production, delaying a return to T4 and T3 self-
sufficiency. For this reason, T4 supplementation was not used in
this series until clinical and biochemical signs of persistent
hypothyroidism were noted. This occurred in only one case. The
possible sources of endogenous thyroid hormone production after
bilateral thyroidectomy are discussed in detail in Section 3.11 and
Chapter 14.
Other biochemical and the haematological changes found in
hyperthyroidism return to normal after successful treatment of the
condition (Peterson et al., 1983b). Post-operative studies of these
parameters were not carried out in this series.
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Medical management. Medical treatment with PTU was only
used in this study where owners refused surgery on the grounds of
cost. The cases were managed empirically on the same grounds.
Peterson (1982, 1984) discussed the problems of owner compliance
when feline hyperthyroidism is managed medically. These problems,
perhaps caused by the potential expense of necessary haematological
and biochemical monitoring, resulted in all four cases being lost
to follow-up within 14 weeks of beginning therapy.
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11. EXPERIMENTAL PRODUCTION OF FELINE HYPOTHYROIDISM
11.1 INTRODUCTION
No naturally-occurring cases of acquired, feline hypothyroidism
have been reported in the veterinary literature. Attempts have
been made to induce the condition experimentally, but the clinical
and biochemical changes that ensued were not monitored in detail
(reviewed in Section 3.12).
This chapter describes the production of feline hypothyroidism
in two cats and monitors the clinical and laboratory changes that
resulted over a period of 91 weeks.
11.2 EXPERIMENTAL ANIMALS
Two five-year-old, female, domestic short-haired cats (ex-
breeding queens) were supplied by the Centre for Laboratory Animals,
University of Edinburgh. Immediately on receipt, they were given a
detailed physical examination and found to be healthy. They were
then vaccinated against feline panleucopenia and feline upper
respiratory disease (calici and herpes viruses) using Katavac P and
Katavac CH nasal, both supplied by Duphar Veterinary Ltd.,
Southampton, England.
11.3 ANIMAL ACCOMMODATION
The two cats were accommodated in separate steel cages
in the same room. The walls and floor of the room were covered in
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heavy grade polythene to guard against contamination by spilled
excreta or aerosols. The unit was self-contained with the
exception of a central area for preparation of food. Protective
clothing (coats, hats, rubber gloves and boots), together with
disposable face-masks, were worn by animal attendants until
radioactivity levels were judged to have fallen to safe levels
(considered to be five per cent of each administered dose). Radiation
exposure to staff was monitored by individual thermo-1uminescent





I was obtained as sodium iodide (1311) for injection
B.P., with specific activity of 185 MBq (5 mCi) per microgram of
iodine at the date and hour stated on the label, and containing
sodium thiosulphate as reducing agent. The preparation was obtained
from the Radiochemical Centre, Amersham, England. Dilutions were
made into sterile, isotonic saline.
Thyroid stimulating hormone
Bovine TSH was obtained in 10 iu vials as Thyrotropar from the
Armour Pharmaceutical Company, Hampden Park, Eastbourne, Sussex,
England, and donated by courtesy of Berk Pharmaceuticals. The
diluent was aqueous sodium chloride solution containing 9 mg sodium
chloride/ml without preservative.
11.5 METHODS
Preparation of animals and induction of hypothyroidism
For the first five weeks, the cats were fed on fresh bovine
316
heart supplied ad 1ibiturn and deionised water was given to
drink. They were totally deprived of food for a period of three
days before and three days after the administration of radioiodine.
Subsequently they were fed on a commercially available tinned food
(Whiskas, Pedigree Petfoods, Melton Mowbray, England) given ad
1ibiturn, and water from the mains supply.
Twenty-four hours and again four hours before the
administration of radioiodine, each cat was injected intramuscularly
with 10 iu TSH.
To minimise risks to people handling the cats, 1^1 was
administered under light anaesthesia. This was induced using a dose
of 33 mg/kg ketamine hydrochloride (Parke, Davis), administered
intramuscularly. 1 mCi/kg Na l^lj jn a total volume of 5 ml was
injected into a cephalic vein using a lead-shielded syringe, cat 1
receiving a total dose of 3.8 mCi and cat 2, 3.2 mCi
The cages were cleaned daily and cleaning cloths, litter and
excreta were collected and incinerated. The cats were examined
with a Geiger-Muller counter at weekly intervals to estimate
131
I retention. Physical examinations and blood sampling were
begun 23 days after Na 131 j administration.
Monitoring of physical and laboratory parameters
Physical and laboratory parameters were monitored for a five
week period (weeks 1-5) prior to thyroid ablation. Apart from a
1
four week period after the administration of I, when the cats
were deemed to be too radioactive to handle, other physical and the
haematological and biochemical parameters were assessed weekly
for 23 weeks (9-34) and then at approximately monthly intervals.
Although detailed monitoring then ceased, further investigations
were carried out intermittently. Full physical examinations were
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carried out at each inspection. Blood samples were collected after
24 hours' starvation from conscious animals by jugular venepuncture
into potassium EDTA (for cytology) and into tubes without
anticoagulant for harvesting serum (for biochemistry).
With the exception of thyroid hormone determinations, all other
measurements were made within 24 hours of sampling. Serum was
stored at -40°C for the T4 and T3 assays which were carried out in
batch mode.
Assessment of physical parameters
Demeanour and appetite were assessed daily and the
observations meaned to give a weekly result. The cats were fed
once daily at 14.00 hours. In an attempt to minimise subjectivity,
these observations were scored as shown:
General demeanour score: 1 - Lethargy
2 - Quiet: reduced activity
3 - Normally active
4 - Restless: unwilling to settle
for more than short periods
of time
5 - Continually hyperactive
Appetite score: 1 - Anorexia
2 - Inappetent: significant quantity
of food left daily
3 - Reduced appetite: consuming most
food over 24 hours
4 - Normal appetite: all food eaten
within three hours




The RBC count, PCV and haemoglobin concentrations were
determined as described in Chapter 10.
The erythrocyte sedimentation rate (ESR) was determined as mm
per hour after allowing blood to stand in a Wintrobe haematocrit
tube.
To determine the reticulocyte count, five drops of blood were
incubated with 2 ml brilliant cresyl blue stain (containing 0.4 g
brilliant cresyl blue in an aqueous solution of 20 ml of three per
cent sodium citrate solution and 80 ml of 0.85 per cent sodium
chloride solution) in a waterbath at 37°C for one hour.
Subsequently, the incubate was spun gently in a Clandon T52.1
centrifuge (obtainable from Clandon Scientific Ltd., Lysons Ave.,
Ash Vale, Aldershot, Hampshire, England), the supernatant stain
decanted and smears prepared. One thousand RBCs were counted under
oil immersion microscopy and the number of reticulocytes expressed
as a percentage of the total.
Biochemical tests
Serum total T4 and T3 concentrations were determined as
described in Chapter 6.
The serum cholesterol concentration was determined using the
Gilchem single vial reagent system, as described in Chapter 10.
Creatinine kinase (CK) was measured at 30°C by a commercially
available kit method (Gilchem single vial reagent system CK,
obtainable from McQuilkin and Co., as described previously). CK
catalyses the phosphorylation of adenine diphosphate (ADP) in the
presence of creatinine phosphate to form adenine triphosphate (ATP)
and creatinine. The auxiliary enzyme hexokinase catalyses the
phosphorylation of glucose by the ATP formed to produce ADP and
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glucose-6-phosphate (G-6-P). The G-6-P is oxidised to
phosphogluconate with the concomitant production of NADH. The rate
of NADH formation, measured spectrophotometrically at 340 nm is
directly proportional to the CK activity in the serum sample. The
mean within-assay and between-assay cvs by this technique were 3.8
per cent and 5.6 per cent respectively.
Total and individual serum protein concentrations were
determined as described in Chapter 4.
Skin biopsy
Skin biopsies were taken from each cat during week 119.
The cats were premedicated with atropine sulphate (Atropine
Sulphate Injection B.P., Veterinary Drug Company), administered
subcutaneously. General anaesthesia was induced with five per cent
thiopentone sodium (Intraval Sodium, May and Baker) administered
intravenously, and maintained by halothane (Fluothane, Imperial
Chemical Industries) via a cuffed endotracheal tube. Biopsy sites
were the dorsal muzzle, frontal region, right pinna, dorsal mid-
thorax, right lateral thorax, right lateral abdomen, dorsal mid-
lumbar area, dorsal tail-base, xyphysternum and the left lateral
carpus. Hair was removed over these areas using electric clippers
but the skin was not cleaned. Full thickness, punch biopsies were
taken from all sites using 6 mm, disposable, sterile biopsy punches
obtainable from Stiefel Laboratories (UK) Ltd., Well croft Road,
Slough, England.
Specimens were blotted gently on a dry swab, placed subcutis
down on a piece of card and immersed immediately and individually
in ten per cent formol saline. Samples were embedded in agar,
processed to paraffin and 4 u to 5 u sections cut and stained with
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haematoxylin and eosin, Marti us scarlet blue, PAS reagent,
Alcian blue and Verhoeff's haematoxylin.
Electrocardiography
Recordings from the six basic limb leads (I, II, III, aVR, aVL
and aVF) were taken from conscious individuals during week 163 using
a Cardiofax 3-channel ECG recorder, obtained as described in Chapter
10.
11.6 RESULTS
In this section, weeks 1-5 refer to the period when the cats
were on an iodine-deficient diet, week 6 the time of administration
of radioiodine, and week 9 the time of recommencing the physical and
laboratory observations.
Physical parameters
Skin. Figs. 11.1 and 11.2 show the cats prior to
treatment with Na^I.
By week 9, the coat of cat 2 appeared raised, particularly over
the dorsum (Fig. 11.3). Mild thinning of the hair was evident over
the trunk in both animals by week 15 but this did not progress to
alopecia. By week 23, cat 1 showed mild and cat 2 marked, non¬
pruritic seborrhoea sicca characterised by variably-sized, bran-like
scales, which were particularly obvious over the dorsal trunk (Fig.
11.4). This gradually became more extensive and severe during the
remainder of the observation period (Figs. 11.5 and 11.6). By
week 29, hair over the dorsal trunk in both animals could be more
easily epilated than in normal individuals.
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Pinnal changes were first observed in week 62 (cat 2)
and week 67 (cat 1) (Figs. 11.7 and 11.8) and gradually worsened
subsequently. The lesions were bilaterally symmetrical and
consisted of alopecia which began around the ear borders, but which
rapidly spread to involve the whole of the lateral and medial,
distal halves of the pinnae. By weeks 67 (cat 2) and 79 (cat 1), the
skin over these areas was brownish-black and had the texture of
emery paper (Figs. 11.9 and 11.10). Small pieces of this
hyperkeratotic material could be removed with difficulty to leave
shiny but dry epidermis.
Cat 1 showed reduced and cat 2, total absence of grooming
behaviour from week 17. By week 79, both animals were matted over
the dorsum but this only became severe in cat 2 (Fig. 11.11).
Focal areas of alopecia developed over the cranio-1ateral
aspects of both carpi (Figs. 11.12 and 11.13) (cats 1 and 2), the
caudal hocks (Fig. 11.14) (cat 2) and the dorsal and lateral tail-
base (cat 1) (Fig. 11.15) by week 111. Thick, bran-like scales were
obvious over the tail-base of cat 2. No other pressure points were
affected.
Skin changes were always more severe in cat 2 than in cat 1.
In both animals, hair removed by electric clippers on a number of
occasions from various sites regrew normally.
Both cats developed apparent shortening and broadening of the
muzzle after thyroid ablation (Fig. 11.16).
General demeanour. The means of the daily observations are
illustrated on a weekly basis in Fig. 11.17 and show that the
changes in both cats were very similar. Normal activity was
maintained for between five and six weeks after administration of
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radioiodine but then decreased rapidly to lethargy by weeks 16 to 17.
This continued until week 40 when both cats reverted to normal
activity and this was continued unchanged until the end of the
observation period.
Appetite. The means of the daily observations are illustrated
in Fig. 11.18 and show obvious differences between the two animals.
Cat 1 showed a reduction in appetite from week 11 to week 28 but
then reverted to normal. The appetite of cat 2 remained unchanged
throughout the experiment.
Bodyweight. The results of these observations are illustrated
in Fig. 11.19.
Cat 1 showed some weight increase until administration of the
radioiodine. Subsequently there was a gradual fall in weight with
some recovery towards the end of the study. No significant weight
changes were noted for cat 2.
Respiratory rate. The results of these observations are
shown in Fig. 11.20.
Although the respiratory rate was always assessed before the
animals were removed from their cages, it fluctuated greatly in
both animals from week to week. Nevertheless, with cat 1, the trend
was for a slower rate after thyroid ablation, possibly as a result
of its being less nervous when approached. There were no obvious
differences with cat 2. No abnormalities were noted on auscultation
of the lungs at any stage during the study.
Heart rate. The results of these observations are shown in
Fig. 11.21.
With both cats, the trend was for the heart rate to be slower
after ablation, the rates usually falling below the commonly quoted
323
mean of 197 beats per minute (Tilley, 1985). Both animals showed
actual, although marginal bradycardia (less than 160 beats per
minute) after treatment, with the first occasion being as early as
week 11 in cat 2.
Rectal temperature. The rectal temperatures of the two cats
are illustrated in Fig. 11.22.
Both animals showed the same trends. From week 18,
temperatures within the normal range were recorded on only two
occasions from each animal.
Other systems. Neither cat showed signs of gastrointestinal
abnormalities during the period of study.
Although both animals were ex-breeding queens, no oestrous
behaviour was noted during the experimental period.
Haematological tests
Red blood cells. These data are presented in Fig. 11.23.
Although the RBC counts of both cats remained in the normal
range throughout the experiment, they were consistently below the
individual pre-treatment values from week 12 in both animals. No
abnormalities of the red cells were detected.
Packed cell volume. These data are presented in Fig.
11.24.
The PCV of both cats also remained in the normal range for
the duration of the study. However, from weeks 9 (cat 2) and 15
(cat 1), the values obtained were consistently below those found
before treatment.
Haemoglobin concentration. These data are presented in
Fig. 11.25.
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Although the haemoglobin concentration of both animals
remained in the normal range throughout the study, from weeks 9
(cat 2) and 16 (cat 1), the values were consistently lower than
those obtained before treatment. Cat 1 appeared to be most
severely affected but showed some increase in haemoglobin
concentration towards the end of the experimental period.
Erythrocyte sedimentation rate. These data are
presented in Fig. 11.26.
Prior to thyroid ablation, the ESR of each cat was low and
relatively constant. After treatment with radioiodine, the ESRs of
both animals fluctuated dramatically and were frequently above the
upper limit of normal. These fluctuations became less in the later
part of the study, although abnormal values were still recorded for
both animals.
Reticulocyte counts. These data are presented in Fig.
11.27.
Prior to administration of radioiodine, the reticulocyte
count was in the normal range in both animals. Contrary to what
might have been expected, elevated counts were recorded on a small
number of occasions after thyroid ablation.
Biochemical tests
Serum thyroxine concentrations. These data are presented in
Fig. 11.28.
For both cats, the serum total T4 concentrations were
consistently below the detection limits of the assay (<1.3 nmol/1)
from the time of first sampling after administration of Na^I
(week 9). From weeks 16 (cat 1) and 18 (cat 2), the per cent binding
of tracer in the samples was greater than that in the RIA zero
standard.
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Serum triiodothyronine concentrations. These data are
presented in Fig. 11.29.
For both cats, the serum total T3 concentrations were
consistently below the detection limits of the assay (0.1 nmol/1),
with the per cent binding of tracer in the samples being greater
than that in the RIA zero standard, from the time of first sampling
after administration of the radioiodine.
Choiesterol. These data are presented in Fig. 11.30.
The serum cholesterol concentrations of both cats were within
the normal range both before and after thyroid ablation. There was
no tendency for the serum cholesterol concentration to rise during
monitoring of the hypothyroid state.
Creatinine kinase. These data are presented in Fig. 11.31.
Values above the normal reference range were seen both before
and after thyroid ablation in both cats and no trends were obvious
for this analyte.
Serum protein concentrations. These data are presented in
Figs. 11.32 and 11.33 and Table 11.1.
Total serum protein. The total serum protein
concentrations of both cats were found to increase after thyroid
ablation, such that from weeks 12 (cat 2) and 22 (cat 1) they were
consistently elevated.
Serum albumin. The serum albumin concentration of both
cats tended to decrease after administration of radioiodine. With
cat 1, between weeks 16 and 25, and cat 2, between weeks 16 and 38,
the values were consistently below the reference range. The
concentrations were never low enough to precipitate ascites or
oedema.
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Serum alpha-l-globulin. No trends were obvious with this
protein fraction in either cat.
Serum alpha-2-globulin. No general trends were obvious
with this protein fraction. In cat 1, the concentration decreased
(although remained in the normal range) between weeks 14 and 22 but
similar changes were not observed in cat 2.
Serum beta-globulin. No general trends were obvious with
this protein fraction.
Serum gamma-globulin. In cats 2 and 1, the concentrations
of gamma-globulin became elevated from weeks 11 and 12 respectively.
Although there was some degree of fluctuation between samples, the
general trend was for the concentrations to increase steadily with
time, such that the final serum samples showed gamma-globulin
concentrations of greater than twice the upper limit of the normal
reference range.
Skin biopsy
The thickness of the viable epidermis varied depending on the
site. Biopsies from the lateral thorax, lateral abdomen,
xyphysternum and the dorsal mid-thorax (both cats) and the anterior
carpus (cat 1) showed a single layer of nucleated epidermal cells.
The epidermis of the inner and outer surfaces of the pinnae of both
cats was acanthotic with up to six layers of nucleated cells (Fig.
11.34). In this site, melanin could be found throughout the
epidermis. Hyperkeratosis (Fig. 11.34) was evident in all biopsies
except those from the muzzle and the dorsal mid-thorax.
Increased dermal mucin was present in a number of sites. It
was most obvious in the pinnae of both cats, in the deep dermis on
both sides of the cartilage (Fig. 11.35). It was also seen in
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connective tissue deep to cutaneous muscle in the muzzle and around
the hair follicle units and in the frontal region and the
lateral thorax (both cats), the dorsal mid-thorax (cat 1) and the
tail-base (cat 2). Collagen fibres appeared normal in all sites
with the exception of the pinnae where, in both cats, they were
smaller, fragmented, less eosinophilic with haematoxylin and eosin,
and showed reduced numbers of nuclei (Fig. 11.36). This change was
most marked in the deep rather than the superficial dermis,
especially in cat 1. No abnormalities of elastic fibres were
detected.
In the dermis of the outer surface of the pinnae (both cats)
and in the anterior carpus (cat 2), there was pigmentary incontinence
with dermal melanophages.
Hair follicles contained hairs, even in sites which were
macroscopically alopecic (Figs. 11.37 and 11.38). Follicular
hyperkeratosis was absent but there was a light, mononuclear cell
infiltrate around the hair follicle units. No abnormalities of
arrector pilae muscles were identified.
No abnormalities of sebaceous glands were seen. In contrast,
apocrine gland changes were noted in sections from all sites except
the muzzle and the pinnae in one or both cats. These abnormalities
ranged from a reduction in number (cat 1, dorsal mid-thorax; cat 2,
lateral thorax, lateral abdomen), partial atrophy and shortening
with a lining of flattened cells (cat 1, frontal region, dorsal
lumbar area; cat 2, lateral abdomen), to their complete absence. In
only one site (the anterior carpus), were apocrine glands normal in
one animal and absent in the other (cats 1 and 2 respectively).
328
El echocardiography
Post-ablation ECGs from the two cats are shown in Figs. 11.39 and
11.40. The data are quantified in Table 11.2.
For both cats, the majority of values were within the normal
respective limits as published by Tilley (1985). P.G.G. Darke (personal
communication) considered all the values to be within the normal
respective ranges for cats.
11.7 DISCUSSION
Preparation of animals and induction of hypothyroidism
Hypothyroidism can be induced surgically, medically or with
radioiodine.
Because of the frequency with which accessory thyroid tissue
is found in dogs, surgical thyroidectomy is not universally
successful in producing hypothyroidism (DiScala, Lippe and
Segal, 1971). Accessory thyroid tissue is equally common in cats
(see Section 3.4), and the outcome of surgical ablation is,
therefore, likely to be similar. Indeed, bilateral surgical
thyroidectomy for feline hyperthyroidism does not usually
necessitate thyroid hormone replacement therapy (see Chapter 10),
suggesting that accessory thyroid tissue quickly becomes functional
after removal of the thyroid glands.
Goitrogens such as the thiouracils have been used in the cat to
induce reported (although unconfirmed) hypothyroidism (Pascalov-
Stoenescu and Sterescu, 1971) but mild to severe side-effects of
such therapy occur frequently in cats (Peterson, 1981; Peterson et
a!., 1984). Consequently, the safest and most effective agent for
the experimental induction of feline hyperthyroidism is radioiodine.
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In the dog, doses of up to 3 mCi/kg 1311 have been used
without causing total thyroid ablation (Goldberg and Chaikoff,
1952). Varying, although considerably smaller doses have been
reported to result in hypothyroidism in cats, an apparently
effective dose being 1 mCi/kg (see Section 3.12). Consequently this
dose was used in the present study. However, a number of other
procedures were employed to ensure maximal thyroidal uptake of the
radioisotope.
The cats were fed on an iodine-deficient diet (fresh bovine
heart) for five weeks prior to administration of the radioisotope,
to deplete body stores of iodine. Bovine heart contains negligible
amounts of iodine (Scott, Greaves and Scott, 1961). In addition,
heart also has a very low calcium content and the same authors
showed that the feline thyroid concentrated 2.5 times the quantity
of *^I when animals were fed on raw heart alone, compared
with those fed raw heart supplemented with calcium gluconate at
2.5g/100g wet diet (Scott, Greaves and Scott, 1961).
Deionised water was supplied during this period and for three
days after the administration of the radioiodine. In addition,
animals were starved for three days before and three days after
dosing. It was hoped that this would markedly reduce the urinary
1 Ol
excretion of I and thereby increase its thyroidal uptake.
This effect was expected from the report by Riggs (1949) who noted a
marked dependence of iodide clearance on chloride excretion in dogs,
with prolonged retention of iodide by animals whose kidneys were
conserving salt. Lippincott, Lewallen and Shellabarger (1957)
confirmed this effect during their studies on canine thyroid
ablation using 131i. Starvation appeared to cause no untoward
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effects in the two cats in this experiment. Indeed, Anderson and
Lewis (1980) found that dogs undergoing total calorie restriction
exhibited less hunger after the first few days than dogs with
partial calorie restriction, and no significant clinical or
biochemical changes were detected in periods of total starvation
ranging from 24 to 42 days.
In addition, TSH was given 24 and four hours before
administration of the Na131I. TSH increases thyroidal trapping
of iodide after several hours (Belshaw, 1983) and has been used to
increase 33^I uptake during the production of experimental
hypothyroidism in dogs (DiScala, Lippe and Segal, 1971).
Monitoring of the hypothyroid state
Confirmation by determination of serum thyroxine and
triiodothyronine concentrations. Prior to administration
of radioiodine, the mean total T4 and T3 concentrations of sera
taken on four occasions from the cats in this study were
37.7 nmol/1 and 0.31 nmol/1 (cat 1) and 46.2 nmol/1 and 0.56 nmol/1
(cat 2). In some samples, T4 concentrations were above the
normal range as determined in Chapter 7. The reasons for this are
unclear. From the first sampling four weeks after the
administration of radioiodine, the serum T4 and T3 concentrations of
both animals were consistently below the detection limit of the
respective assays, confirming them to be hypothyroid. The finding
that the per cent binding of tracer in the samples was greater than
that in the zero standard suggests that there was little, if any,
thyroid hormone in these sera.
Physical parameters
General demeanour. Both cats in this study were lethargic
between weeks 17 and 38 and slept for long periods of the day.
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Hypothyroid humans show similar signs and may lapse into stupor
or even coma (Weiner, 1978). The reasons for these changes are
complex. Thyroid hormones appear to interact with the nervous
system. Scheinberg, Stead, Brannon and Warren (1950), in a study of
eight hypothyroid patients, found reductions in cerebral blood flow
and oxygen and glucose consumption and increased cerebral vascular
resistance, suggesting a correlation between disturbances in brain
metabolism and mental status.
From week 40, both cats reverted to normal activity despite
continued physical and biochemical evidence of severe
hypothyroidism. The reasons for this are unclear as such
improvements in untreated humans do not occur.
Appetite, weight and rectal temperature. Apart from a
period of inappetence from weeks 14 to 27, the appetite of both
animals remained unchanged during the period of study. The weight
of cat 2 was unaltered, although cat 1 lost weight during the middle
part of the study. The reasons for the latter observation are
unclear.
The rectal temperatures of both animals were subnormal almost
constantly from week 18.
In human hypothyroidism, there is a slowing of a vast number
of energy-requiring reactions, which is reflected in a decreased rate
of oxygen consumption per unit of body surface area and a decrease
in the rate of heat production (Du Bois, 1936). The decreased rate
of energy utilisation and heat production are shown clinically as a
fall in basal metabolic rate, a decrease in body temperature and
cold intolerance. There is mild weight gain, despite a reduction in
appetite, in approximately half of hypothyroid humans
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(Watanakuakorn, Hodges and Evans, 1965), although obesity is rare
(Loeb, 1978). Obesity or weight loss, decreased or increased
appetite and a low body temperature may be associated with canine
hypothyroidism (Muller, Kirk and Scott, 1983).
Respiratory system. The respiratory rate of cat 1 tended to
decrease after thyroid ablation although there was no obvious
change with cat 2. No abnormalities were detected on auscultation
at any stage with either animal. No other studies of respiratory
function were carried out. In man, development of severe
hypothyroidism does not give rise to consistent significant changes
in lung volume, airway conductance or blood gas composition. In
severe myxoedema, however, there is evidence of alveolar
hypoventilation with hypercapnia and hypoxia that may be severe
enough to induce coma (Turino, 1978).
Cardiovascular system. In both cats, the trend was for a
slower heart rate in the hypothyroid compared with the euthyroid
state. Bradycardia was occasionally seen in both animals.
Bradycardia is a common feature of human hypothyroidism. It
appears to be due to the effect of lack of thyroid hormone on the
electrophysiological properties of sinoatrial cells. Decreased
sympathoadrenal stimulation may also be contributory (Skelton and
Sonnenblick, 1978).
No significant alterations were seen on ECGs from either cat.
In human hypothyroids, the ECG may also be normal, but characteristic
though non-diagnostic changes (sinus bradycardia, flattening or
inversion of the T wave and low P, QRS and T wave amplitudes), are
usually seen (Douglas and Samuel, 1960). Both the direct myocardial
effects of thyroid hormone deficiency and pericardial effusion are
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important in the genesis of the ECG changes seen (Skelton and
Sonnenblick, 1978). No tests were carried out to detect possible
pericardial effusions in the present study.
Skin changes. Skin changes were seen in both cats in this
study and are common in both human and canine hypothyroidism
(Roberts and Rook, 1979; Belshaw and Rijnberk, 1980). Although the
same types of changes occurred in both animals, they began earlier
and were always more severe in cat 2. Variations in the
dermatological manifestations of canine hypothyroidism have been
reported to be enormous and frequent (Muller, Kirk and Scott, 1983).
The earliest change seen in both cats was diffuse thinning of
hair over the trunk. Thyroid hormones have a number of effects on
hair growth, initiating or advancing anagen and increasing growth
rate (Amoroso and Ebling, 1966). Although coat changes do not occur
universally in hypothyroid dogs, in many, hair follicles remain in
telogen and there is failure of hair growth (Muller, Kirk and Scott,
1983). Thinning of hair first develops over areas such as the neck,
the dorsal aspect of the nose, the pinnae, the trunk and the tail,
where friction tends to dislodge telogen hairs (Martin and Capen,
1979), but may progress to generalised, bilaterally symmetrical
alopecia. Widespread hair loss did not develop in the cats in this
study and alopecia was confined to the pinnae, the carpi (both cats)
and the tail-base (cat 1). Widespread alopecia did not occur in a
congenitally hypothyroid kitten (Arnold et al., 1984) nor in other
cats in which the thyroids were ablated using ^*1 (Crawford,
1961). Hair loss is reported to occur in up to 49 per cent of
hypothyroid humans (Saito, Hou and Kurebayaski, 1976). Typically,
there is loss of the lateral third of the eyebrows and sometimes the
334
sexual hair and beard. Hairs in these areas grow only slowly (Lang,
1978) and it is interesting that, in the present study, the most
severe hair loss was over the pinnae, an area where hair is short
and growth is slow.
In human hypothyroid patients, there is a decrease in numbers
of anagen hairs only in those patients with clinical hair loss
(Smith, Weinstein and Burr, 1959). In the cats in the present
study, widespread alopecia did not develop and hair repeatedly
removed by clipping in multiple sites, regrew. Although plucked
hairs were not examined to determine anagen: telogen ratios, these
results suggest that no major change followed as a consequence of
the hypothyroid state.
Both cats had dry and brittle coats. The hair of hypothyroid
humans and dogs is also dull, coarse and brittle (Lang, 1978;
Muller, Kirk and Scott, 1983).
Both cats developed abnormal keratinisation reflected as
varying degrees of dry scale. Similar changes have been reported
previously in experimental feline hypothyroidism (Randall and
Parsons, 1970). Hypothyroidism in man and dogs results in abnormal
keratinisation due to decreased protein synthesis, mitotic activity
and oxygen consumption (Holt, Lazarus and Marks, 1976; Martin and
Capen, 1979). In hypothyroid people, decreased activity of eccrine
(merocrine) sweat glands and sebaceous glands also contributes to dry
skin (Warin, 1973). Eccrine sweat glands are found only in the
footpads of cats (Strickland and Calhoun, 1963) and effects of
hypothyroidism on them could not, therefore, have contributed to the
dry skin seen in the cats in the present study.
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Hyperkeratosis and hyperpigmentation of the pinnae developed in
both cats. Identical macroscopic changes were seen in a cat
with clinical and biochemical signs of hypothyroidism subsequent to
bilateral thyroidectomy for hyperthyroidism (see Chapter 10).
Hyperpigmentation may occur in hypothyroid humans and dogs (Muller,
Kirk and Scott, 1983).
In human hypothyroidism, myxoedema is most obvious over the
face, producing a broad, flat nose (Freinkel and Freinkel, 1971) and
hypertelorism (Adams and Reed, 1971). Both cats in the present
study developed apparent shortening and broadening of the muzzle
which may have been due to myxoedema. Similar changes were reported
in a case of goitrous primary hypothyroidism in a kitten (Arnold et
al ., 1984).
A number of other skin changes occur in hypothyroid humans and
dogs. The skin may be cold due to vasoconstriction. There may be
poor wound healing, capillary fragility and easy bruising (Lang,
1978; Muller, Kirk and Scott, 1983). Lack of thyroid hormones may
also affect resistance to infection in man (Lang, 1978) and pyoderma
is a common complication of the condition in dogs (Muller, Kirk and
Scott, 1983). Comedo formation is seen frequently in canine
hypothyroidism (Scott, 1982a). None of these changes was seen in the
cats in this study.
A number of histological abnormalities were seen in skin
biopsies from these cats. Hyperkeratosis was identified in
specimens from most sites. This finding must be carefully evaluated,
as the processing and subsequent staining of sections of normal
feline skin alter the structure of the stratum corneum from a
compact to a loose formation (Baker, 1974a). In this study,
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biopsies were processed in agar which prevents loss of keratin even
if it is loose. In the present report, the term hyperkeratosis is
used to describe a stratum corneum of thickness equal to or greater
than a four cell thickness of the stratum spinosum.
The epidermis of these cats was one to six nucleated cells
thick, depending on the site. Epidermal atrophy has been reported in
some cases of canine hypothyroidism (Rojko, Hoover and Martin,
1978). The epidermis of normal feline hairy skin is two to three
nucleated cells thick (Baker, 1974a) and in cats, the term epidermal
atrophy can therefore only be ascribed to areas where there is a
single layer of basal epidermal cells. This occurred over the
dorsal mid-thorax, lateral thorax, xyphysternum and lateral abdomen
(both cats) and the anterior carpus of cat 1.
Although Baker (1974a) stated that the stratum spinosum was not
present in normal, feline, hairy skin, most other workers (e.g.
Strickland and Calhoun, 1963; Scott, 1980) disagree, stating it to
be one or two cells in thickness. Acanthosis (a stratum spinosum
of more than three cells thick) was identified at the inner and
outer pinnal surfaces of both cats. In these sites, melanin could be
found throughout the epidermis. In cats, melanocytes are found in
the germinal layer of only a few specialised, relatively hairless,
skin areas: the prepuce, scrotum and teats (Strickland and Calhoun,
1963), the circumanal area, the pinnae and the umbilical skin of the
foetus (Baker, 1974a). Epidermal melanosis may occur in hypothyroid
humans and dogs but the pathomechanism is unclear (Muller, Kirk and
Scott, 1983).
The major dermal abnormalities seen were increased dermal
mucin and swollen, fragmented collagen fibres. Mucin is a mixture
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of acid mucopolysaccharides, particularly hyaluronic acid and
chondroitin sulphate. Hyaluronic acid has a high affinity for
water and its deposition results in puffy, non-pitting skin
(Freedburg, 1978b). Originally, it was felt that the increase in
dermal mucopolysaccharides resulted from high circulating TSH
concentrations (Dyrbye, Ahlquist and Wegelius, 1959). However, the
same deposits are found in secondary hypothyroidism and it is
unlikely that TSH is important in the process. Thyroid hormone
deficiency probably accounts for mucin accumulation (Asboe-Hansen,
1966).
It is generally considered that the dermal mucin of both human
and canine hypothyroidism is not readily visualised with the
haematoxylin and eosin technique (Lang, 1978; Martin and Capen,
1979), and special stains such as Alcian blue or PAS must be used to
demonstrate the material adequately (Milne, 1972). However, in this
study, haematoxylin and eosin were equally as effective in
demonstrating myxoedema as the more specialised stains.
In human hypothyroid patients, mucin is found predominantly in
the papillary dermis. However, because of a lack of rete ridges and
dermal papillae, there is no clear-cut division into a papillary and
reticular dermis in cat skin and the terms superficial and deep
dermis are preferred (Scott, 1980). Myxoedema was found around the
hair follicle units and in the deep dermis, particularly in the skin
of the muzzle and the pinnae.
Swollen, fragmented collagen fibres were seen in the skin of the
pinnae of both cats. Such changes are a feature of some cases of
human and canine hypothyroidism (Percival, Montgomery and Dodds,
1962; Martin and Capen, 1979). The physical compression of
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collagen by mucin is thought to contribute to these changes (Martin
and Capen, 1979). In experimentally-induced hypothyroidism in
various animal species, it has been shown that the rates of collagen
synthesis and degradation are decreased (Fink, Ferguson and Smiley,
1967; Kivirikko, Laitinen, Aer and Hal me, 1967) and this may also
contribute to the changes seen in the naturally-occurring condition.
Histologically, there was no obvious change in the anagen:
telogen ratio of hair follicles from either cat except over the
distal halves of the pinnae where telogen follicles predominated.
In this area, there was, in addition, a light, mononuclear cell
infiltrate. Appendagocentric inflammatory infiltrates have been
described in canine hypothyroidism (Scott, 1982a).
Abnormalities of sebaceous glands were not identified in the
present study. Decreased activity of sebaceous glands (Lang, 1978)
and sebaceous gland atrophy (Scott, 1982a) are common in human and
canine hypothyroidism respectively.
Changes in the appearance and number of apocrine sweat glands
were seen in many of the biopsies. Although Langham and Schirmer
(1968) observed cystic changes in, and Anderson (1979) reported
atrophy of, apocrine glands in canine hypothyroidism, Scott (1982a)
found no evidence of such changes in skin biopsies from 137
confirmed hypothyroid dogs.
Eccrine sweat glands are found only in the footpads of cats
(Strickland and Calhoun, 1963) and biopsies from these areas were
not examined in the present study. Specific cytological changes
have been reported in the eccrine sweat glands of human hypothyroid
patients (Means and Dobson, 1963).
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A large number of other histological abnormalities have
been reported in skin from hypothyroid dogs (Scott, 1982a) but were
not identified in the present study.
Other systems. Abnormalities may be seen in a number of
other systems in human hypothyroid!'sm. Intestinal motility
disturbances are the major and most frequent gastrointestinal
effects of the disease, with patients complaining of distention,
flatulence and constipation (Javitt, 1978). No evidence of
gastrointestinal abnormalities was detected in the two cats under
discussion.
Amenorrhoea is common in hypothyroid women (Hembree and Vande
Wiele, 1978). Neither of the two experimental cats showed evidence
of oestrous behaviour. Enlarged mammary glands and galactorrhoea
may also be seen in human and canine primary hypothyroidism (Hembree
and Vande Wiele, 1978; Chastain and Schmidt, 1980). It is thought
that these result from increased TRH secretion which stimulates
increased prolactin release. No such changes were seen in the two
experimental cats.
Haematological tests. The RBC counts, PCVs and haemoglobin
concentrations of both cats were consistently lower after thyroid
ablation than before treatment, although no subnormal values were
recorded. The reticulocyte counts remained in the normal range
apart from on a small number of occasions. As the lower limit of the
reticulocyte range in healthy cats is zero in the author's
laboratory, it is not possible to draw any conclusions about the
effect of thyroid ablation on this parameter. Certainly, there were
no major changes and elevated counts were actually recorded on a
number of occasions.
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In human medicine, approximately one third of all patients with
hypothyroidism have anaemia which has a primary and sometimes a
secondary component (Tudhope and Wilson, 1960). The primary
component, which is dominant in fifty per cent of patients, results
in a physiological, hypoplastic (normocytic, normochromic) anaemia
as an adaptive response to decreased tissue oxygen requirements.
It is responsive to thyroid hormone alone. Superimposed on this,
there may be a secondary nutritional anaemia due to deficiency of
iron, vitamin B12 or folate, or any combination of these. These
deficiencies may arise from poor appetite, intestinal malabsorption
or as a result of autoimmune disease (pernicious anaemia). If iron
deficiency anaemia (responsive to iron alone) is dominant, the red
cells are hypochromic and microcytic. If vitamin B12 (responsive to
vitamin B12 alone) or folate deficiency is dominant, the red cells
are macroovalocytic.
In the present study, the red cells appeared normal and their
reduced numbers appeared to correspond to the hypoplastic situation
in man. Cline and Berlin (1963), in investigations on
erythropoiesis and red cell survival in experimentally-induced
hypothyroidism in dogs, reported similar findings. Parenteral iron
or parenteral vitamin B12 administration had no effect on the
haematocrit or reticulocyte count of these dogs. Leptocytes,
reflecting increased membrane cholesterol loading, may be seen in
canine hypothyroidism (Feldman and Feldman, 1977) but were not seen
in blood samples from cats in this study (see subsequently).
The ESR of both animals was frequently elevated after thyroid
ablation. Elevations of ESR are common in human myxoedema
(McAlpine, 1955) and in canine hypothyroidism (Bush, 1978).
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Elevations of the ESR may result from concurrent increases in plasma
concentrations of fibrinogen and, to a lesser extent, alpha and
gamma-globulins (Zilva and Pannall, 1975). The plasma gamma¬
globulin concentrations of both these cats increased
progressively after treatment with radioiodine. While this may have
been contributory to the raised ESR, it could not have been the sole
cause as higher ESRs were seen in the earlier, and gamma-globulin
concentrations in the later, part of the study. ESR also increases
with tissue injury and haemodilution (Schappes, 1937), and the high
rates seen in the earlier part of the study may have resulted from
thyroidal damage by the radioiodine and the fall in RBC numbers
which was most severe at this time.
Non-specific biochemical tests
Choiesterol. There was no trend for increases in the serum
cholesterol concentration after thyroid ablation in these animals.
In man, hypercholesterolaemia has been seen in up to 80 per cent of
hypothyroid patients (Watanakuakorn, Hodges and Evans, 1965).
Cholesterol biosynthesis is decreased in such patients (Loeb, 1978)
but its degradation is decreased to a greater extent (Koppers and
Palumbo, 1972). There is a three-fold increase in the plasma
concentration of low-density, cholesterol-carrying apolipoproteins,
reflecting decreased cholesterol catabolism and turnover (Walton,
Scott, Dykes and Davies, 1965). These combined effects appear to
account for the hypercholesterolaemia in human hypothyroidism.
Approximately 33 per cent of hypothyroid dogs show an elevation of
serum cholesterol concentrations (Muller, Kirk and Scott, 1983).
Experimental feline hypothyroidism does not appear to be
accompanied by significant increases in serum cholesterol. This may
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account for the absence of leptocytes on haematological examination
(already described).
Creatinine kinase. Values for this analyte were above the
normal reference range in both animals before and after thyroid
ablation and no trends are obvious from these data.
In man, hypothyroidism is associated with a wide spectrum of
muscle symptoms and signs (McKeran, Slavin, Ward, Paul and Mair,
1980). The muscle enzyme of CK is elevated in up to 80 per cent of
human hypothyroids (Fleisher, McConaley and Pankow, 1965).
Serum proteins. After thyroid ablation, there were a number
of alterations in serum protein parameters. Albumin concentrations
tended to fall. In human hypothyroidism, similar findings have been
described (Lewis and McCullagh, 1944; Skillern, Crile, McCullagh,
Hazard, Lewis and Brown, 1956), although other workers have reported
that, despite a reduction in the synthesis of albumin, there is a
proportionately greater decrease in its degradation resulting in a
rise in the total miscible albumin pool (Schwartz, 1955; Lewallen,
Rail and Berman, 1959).
No trends were obvious for the alpha or beta-globulin
fractions. The increased serum cholesterol of some human hypothyroid
patients is reflected on electrophoresis by an elevation of the
beta-1ipoproteins, either alone or in association with elevations
in pre-beta-1ipoproteins (Jones, Cohen and Corbus, 1955).
Similarly, in lipaemic hypothyroid dogs, there may be intense
electrophoretic bands at the origin, the beta-1-1ipoprotein and the
alpha-2-1ipoprotein positions (Rogers, 1977). Specific lipoprotein
electrophoresis was not carried out on samples from the cats under
discussion. However, large increases in serum lipids may be obvious
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on serum protein electrophoresis. No such changes were observed in
the two experimental cats, the serum samples were not lipaemic, nor
were there increases in serum cholesterol concentrations after
thyroid ablation.
In both cats, the serum gamma-globulin concentrations increased
markedly and progressively after thyroid ablation. The increases in
this serum protein fraction were responsible for the increases in
the total serum protein concentrations.
Levin and Leathern (1942) showed that surgical thyroidectomy in
rats increased the serum gamma-globulin concentration and that
treatment with T4 prevented this change. Hypergammaglobulinaemia
has been known, for a considerable period of time, to occur in
Hashimoto's disease in man (Luxton and Cooke, 1956), and Skillern et
al. (1956) felt that this was due entirely to deficiency of thyroid
hormones. However, Roitt et al. (1956) showed that, at a time when
Hashimoto's disease was still being treated by thyroidectomy, the
gamma-globulin concentrations returned to normal after surgery.
Lindsay, Dai ley and Jones (1954) reported that thyroidal
histological patterns indistinguishable from those in Hashimoto's
disease were observed after therapeutic doses of 1^11 in humans.
As thyroglobulin is released after radioiodine therapy, Doniach and
Vaughan Hudson (1957) suggested that the immune response in
Hashimoto's disease represented an immune response to antigen
released by the thyroid. The possible role of thyroid
autoantibodies as a source of the hypergammaglobulinaemia in the two
cats under discussion was investigated subsequently and the results
are reported in Chapter 14.
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11.8 ATTEMPTS TO MEASURE SERUM THYROID STIMULATING
HORMONE CONCENTRATIONS IN CATS
Introduction
The value of measurements of plasma basal TSH in the diagnosis
of human hypothyroidism has been discussed in Section 3.7. TSH is a
species specific polypeptide. Attempts to measure canine TSH using
different human TSH RIA kits have been variably reported as
unsuccessful (Chastain, 1978) or reliable (Nachreiner, 1981a).
Feline TSH has not been purified and there are no reports of
attempts to determine its serum concentration using heterologous
RIAs. This section describes attempts to assay feline serum TSH
using human and canine TSH assay procedures.
Methods
Radioimmunoassay for human thyroid stimulating
hormone. Sera were assayed courtesy of Dr. J. Seth, in a
double antibody RIA using a sheep anti-human TSH (obtained from
SAPU) as first antibody and ^I-human as radiolabel. The
assay was standardised against the international reference
preparation (IRP) of human TSH (80/558). Between-assay precision
was approximately eight per cent cv at concentrations of 2mu/l or
above, and the sensitivity was 0.9 mu/1.
Sera from two healthy pet cats, two experimental cats before
and 17 weeks after thyroid ablation using radioiodine, and two
animals with FEA (one before and 43 weeks after beginning treatment
with 100 ug T3 daily) were examined.
Radioimmunoassay for canine thyroid stimulating
hormone. The kit used was a double antibody RIA employing
rabbit anti-canine TSH as first antibody and -^I-canine jsh as
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radiolabel, (cTSH, obtainable from Associate Biolabs Ltd., The
Novo Centre, 9-11 London Lane, London, England). Within and between-
assay precision were approximately seven and eight per cent cv
respectively at concentrations of 5.2 ng/ml or above. The
sensitivity of the assay was not stated. All samples were tested in
duplicate.
Sera from six healthy pet cats, two experimental cats before
and on three occasions after thyroid ablation using radioiodine, and
eight cats with FEA prior to and two during T3 therapy were tested.
In addition, canine sera from two cases of primary and two cases of
secondary hypothyroidism, confirmed by the measurement of T4 before
and after TSH stimulation testing, and in one case, at post-mortem
examination (139943) were included to act as controls.
Radioimmunoassay for thyroxine and triiodothyronine.
Feline sera were assayed for T4 and T3 as described in Chapter 6.
T4 and T3 concentrations in canine sera were determined by a
commercial laboratory using an RIA method optimised and validated
for dogs (Serono Laboratories (UK) Ltd., 2 Tewin Court, Welwyn
Garden City, Hertfordshire, England.)
For all techniques, sera were stored at -40°C prior to testing.
ResuVts
Radioimmunoassay for human thyroid stimulating hormone. These
results are summarised in Table 11.3.
All TSH concentrations were at, or marginally above, the
detection limit of the assay, even in the thyroid ablated animals in
which high concentrations would have been anticipated. The slight
differences in TSH concentrations that were seen in these cats pre
and post-ablation and in the treated FEA cat, were not judged to be
of any significance.
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Radioimmunoassay for canine thyroid stimulating hormone. These
results are summarised in Table 11.4.
Both dogs with primary hypothyroidism showed elevated TSH
concentrations whereas those with secondary hypothyroidism showed
concentrations below the assay detection limit, suggesting probable
satisfactory performance of the technique. Both healthy dogs also
showed TSH values which were below the assay detection limit.
In the experimental cats, TSH concentrations were below the
detection limit of the assay, both before and after thyroid
ablation. Measurable concentrations were recorded in the FEA cats,
but these did not differ significantly from healthy animals when
compared by the Mann-Whitney U-test. Paradoxically, an apparent
increase in TSH concentrations was recorded in two FEA cats treated
with T3.
Piscussion
In the absence of an established assay for feline TSH, the
purpose of these experiments was to determine whether there might be
sufficient cross-reactivity between feline TSH and human or canine
TSH, to allow the use of these heterologous assays in the assessment
of feline thyroid function. The failure of both assays to detect
raised concentrations in the thyroid ablated cats was taken as
clear evidence that no significant degree of cross-reactivity
existed. This is in agreement with current concepts on the species
specificity of TSH (Ferguson, 1984).
Although slight differences in apparent TSH concentrations were
seen in the thyroid ablated cats in the human assay, and measurable
concentrations were recorded in the FEA animals in the canine assay,
these probably reflected non-specific responses in the RIAs. Such
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responses may arise owing to the different serum matrix found in cat
serum and the sera for which the assays are designed.
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12. THYROID FUNCTION IN FELINE ENDOCRINE ALOPECIA
12.1 INTRODUCTION
The aetiology of FEA is unknown (see Section 3.13). While
Martin and Capen (1975) have equated FEA with hypothyroidism, most
other authors have stated that affected cats are not hypothyroid
(Baker, 1974a; Scott, 1975b; Doering, 1976; Scott, 1976; Kirk,
1980; Scott, 1980, 1981). However, only Scott (1975b) has presented
data to support this view.
Many cases of FEA respond to treatment with thyroid hormones
(see Section 3.13). The present study was carried out to determine
whether any cases of FEA may result from hypothyroidism.
12.2 METHODS
The case material comprised 51 consecutive cats referred with
a tentative diagnosis of FEA. After a detailed history and physical
examination, a number of laboratory tests were carried out.
Examinations for dermatophytes
All cats were screened for evidence of fluorescence with an
ultra-violet (Wood's) light. The lamp used contained two ultra¬
violet sources and a magnifying lens and was obtained from The
Burton Manufacturing Company, Santa Monica, USA.
Samples for microscopic examination for fungal elements were
obtained by superficial dry skin scraping and by epilating hairs in
affected areas by means of epilation forceps. Material was examined
after warming in ten per cent potassium hydroxide solution. Fungal
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culture was performed by aerobic incubation of small amounts of hair
and skin scales on Sabouraud's glucose agar containing 0.4mg/ml
chloramphenicol and 0.5mg/ml actidione (cyclohexamide), and nutrient
agar (obtainable from Oxoid Ltd.), containing the same concentration
of the above antibacterial and antifungal agents.
Examinations for ectoparasites
After close clipping of the hair with electric clippers, and
moistening the skin with five per cent potassium hydroxide solution,
deep scrapings producing capillary ooze were taken for examination
for ectoparasites. The material was warmed with ten per cent
potassium hydroxide and subsequently aliquoted into small amounts
prior to microscopic examination.
Examinations for endoparasites
Faecal samples for examination for endoparasite eggs were
obtained by manual removal per rectum or, where this was impossible,
were collected by the owners. Subsequently, 2g faeces were
macerated through a small sieve into an evaporating dish using 30ml
saturated sodium chloride solution. The residue in the sieve was
then washed with a further 30ml of the saturated saline.
Two chambers of a McMaster counting slide were filled with the
faecal suspension and examined microscopically.
Haematological and biochemical examinations
Blood samples were collected from conscious animals by jugular
venepuncture after a minimum of 12 hours' starvation. Potassium EDTA
tubes were used for samples for routine haematological examination
and plain tubes for samples for biochemistry.
T4 and T3 concentrations were determined as described in
Chapter 6 and haematological parameters and cholesterol
concentrations as in Chapters 10 and 11.
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Treatment
All cases were initially treated for fleas, at weekly intervals
for six weeks, with a combination of topical dichlorvos (0.2 per cent
w/w) and fenitrothion (0.8 per cent w/w) (Nuvan Top, Ciba-Geigy),
together with routine vacuum-cleaning of the environment. Animals
which had responded to this treatment after six weeks were diagnosed
as flea infestation or probable flea infestation (see later)
and blood sampling was repeated as described above. A definitive
diagnosis of FEA was based on the history, physical examination,
absence of ectoparasites macro or microscopically, negative ultra¬
violet light examination and failure to demonstrate dermatophytes
microscopically or on culture, and no response to flea-control
measures. In these cases, blood sampling was repeated 12 weeks
after beginning T3 therapy and was carried out three hours after
administering T3.
All cases of FEA were treated with liothyronine sodium (L-T3,
Tertroxin, Glaxovet) at an initial dose of 20ug/cat twice daily,
increasing by lOug twice daily every third day, to a maximum of 50ug
twice daily. Cats were reinspected three, eight and 12 weeks after
beginning T3 treatment and intermittently thereafter, and the
response subsequently classified as total (hair regrowth complete),
partial (incomplete regrowth of hair) or no response (no change in
the condition). Treatment of some cases in the last two groups was
by:
(i) L-thyroxine sodium (L-T4, Eltroxin, Glaxo) at an oral
dosage of 50ug twice daily and subsequently lOOug twice
daily.
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(ii) depot injections of a preparation containing a combination
of four testosterone esters (Durateston, Intervet
Laboratories). Each intramuscular injection consisted of
testosterone propionate (3mg), testosterone
phenyl propionate (6mg), testosterone isocaproate (6mg)
and testosterone decanoate (lOmg), administered initially
at monthly intervals.
(iii) megestrol acetate (Ovarid, Glaxovet) at an initial oral
dosage of 5mg every third day, reducing after three weeks to
2.5mg every third day and subsequently to the lowest
possible maintenance dosage (approximately 2.5mg once or
twice weekly).
12.3 RESULTS
Wood's light examination, direct microscopy and culture for
dermatophytes, examination of skin scrapings for ectoparasites and
faecal examinations for endoparasite eggs were negative in all 51
cats.
Feline endocrine alopecia
Feline endocrine alopecia was diagnosed in 26 cats.
Historical data. Historical data for the FEA cats are
presented in Table 12.1.
Twenty-four of the animals were domestic short-haired cats with
two cross-breeds. There were ten neutered males (38.5 per cent),
15 neutered females (57.8 per cent) and one entire male (3.7 per
cent). The age at onset ranged from one to 11 years with a mean of
4.5 years. Of the 23 neutered animals where the age of surgery
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was accurately known, only one had been neutered above nine months
of age. The latent period between neutering and the onset of FEA
ranged from six months to 10.5 years with a mean of 4.1 years.
The duration of physical signs before referral ranged from two
weeks to seven years.
No significant variation of onset of alopecia between the
months was identified using the Chi-Square test.
Seven animals (26.9 per cent) showed symptoms of involvement
of other systems in addition to the skin. These were lethargy (four
cases), vomiting of hair (three), and obesity and inappetence (one
each).
Seventeen of the cats had received some form of treatment
before being referred. In 14 of these, there had been no
improvement of the condition. Three cases had responded to a number
of drugs but had relapsed at varying intervals after the cessation
of treatment.
Physical and laboratory findings. The physical and
laboratory findings for the 26 cats before and after treatment with
T3 are presented in Table 12.2.
Pre-treatment data
Dermatological changes. The hair changes seen were as
described in the literature and reviewed in Section 3.13. Generally,
there was diffuse thinning in affected areas, rather than complete
alopecia, although this varied considerably. The remaining primary
hairs could be easily epilated. In some cases, secondary hairs
could also be easily removed but, in others, epilation could only
be achieved with difficulty.
353
The distribution of alopecia was very variable. Of the 26
cases, the ventral abdomen and medial hind legs as far as the
stifles were affected in 25 (96.2 per cent), the lateral hind legs
in 15 (57.7 per cent), the caudal hind legs in 13 (50 per cent), the
fore-legs from elbow to carpus in 12 (46.2 per cent), the anogenital
region and the lateral abdominal area in five each (19.2 per cent),
the ventral thorax in three (11.5 per cent) and the axillae and
lateral thorax in two each (7.7 per cent). Examples of alopecia
distribution are shown in Figs. 12.1 to 12.8. In general, animals
in which the problem was long-standing tended to be more severely
affected but this was by no means universal, e.g. case 134590 had had
lesions confined to the ventral abdomen and medial thighs for four
years.
Heart rate. Data on heart rate were available for 12 cases.
Six (50 per cent) had values below the normally accepted reference
range. No animal had an elevated heart rate.
Rectal temperature. Data on rectal temperature were
available for 13 cases. Three (23.1 per cent) had values below and
one (7.7 per cent) above the normally accepted reference range.
Thyroid hormones. Serum thyroxine and triiodothyronine
concentrations were measured in all cases. For T4, one (3.9 per
cent) was below and three (11.5 per cent) above the reference range.
T3 concentrations of all cases were within the reference range.
Choiesterol. Serum cholesterol concentrations were measured
in 22 cases. Four (18.2 per cent) of these had values above the
reference range. No animal had a cholesterol concentration below
the reference range.
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Red blood cell count. Data on RBC count were available for
17 cases. Sixteen animals (94.1 per cent) had values within the
reference range. One animal had an RBC count which was marginally
above the normal range.
Packed cell volume. Data on PCV were available for 17 cases.
No values were below the normal range but three (17.7 per cent)
were above the upper limit of the reference range.
Erythrocyte sedimentation rate. Data on ESR were available
for 14 cases. Two animals (14.3 per cent) had values above the
upper limit of the normal range.
Reticulocytes. Data on reticulocyte count were available for
15 cases. One animal (6.7 per cent) had a value above the
reference range prior to treatment, while no sub-normal values
were recorded.
Eosinophil count. Data on the eosinophil count were
available for 17 cases. Only one value (5.9 per cent) was above the
upper limit of the reference range.
Post-treatment data. Retrospectively, the 26 FEA cases could
be divided into three groups according to their response to T3
therapy.
Historical data for these three groups are compared in Table
12.3 and show no obvious difference in the age at onset between
them. Both the pedigree cats were T3 totally responsive. While
there were equal numbers of neutered males and neutered females in
the T3 totally responsive group, neutered females accounted for
75 per cent and 100 per cent of the partially and T3 non-responsive
groups respectively.
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Liothyronine totally responsive group. Data on treatment of
these 19 cases are presented in Table 12.4.
In 13 cats, hair growth was obvious at the first reinspection
after beginning T3 therapy (three weeks), although it was delayed as
long as ten weeks in one cat. Complete regrowth of hair over
affected areas had occurred by 22 weeks in all but one case. In
black cats, the first signs of regrowth were multiple, discreet
islands of black hair in affected areas. Examples of two cases in
this group before and during T3 therapy are shown in Figs. 12.9
to 12.12.
Other symptoms associated with FEA resolved in three cats,
and one other owner (of cat 131369) reported that the appetite and
activity of her cat had improved although she had not initially
reported these as being abnormal.
A Grade II (of V) soft, systolic, cardiac murmur with a split
second sound developed in cat 134278 after three weeks of T3 therapy.
The heart rate was 188/minute. No evidence of cardiac enlargement
was seen radiographically but the ECG revealed evidence of left
anterior fascicular block and ventricular premature beats (Fig.
12.13a). The dose of T3 was reduced to 40ug daily but the
abnormalities were still present one week later. T3 therapy was
stopped. On re-examination two weeks later, the murmur was absent
at rest although a grade III systolic murmur could be heard when the
heart rate increased due to excitement. On electrocardiography,
there was no left anterior fascicular block although occasional
ventricular ectopic beats persisted. Treatment was changed to
monthly injections of depot testosterone. Three months later, hair
was growing well and no cardiac abnormalities could be detected. An
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ECG taken at this time is shown in Fig. 12.13(b). The cat was
subsequently maintained with depot testosterone injections as
required.
In the first three animals treated long-term with T3, the dose
was reduced every four weeks by 20ug daily. In two, hair loss
became evident at a dose of 80ug daily and in one at 40ug daily.
The condition resolved once the T3 was increased to lOOug daily. In
all but three subsequent cases, the lowest effective maintenance
dose of T3 was determined. In three animals, T3 was reduced as
described and eventually discontinued without recurrence of
alopecia. Two animals (130196 and 131365) did not require
subsequent treatment. One (108276) was treated at a dose of lOOug
T3 daily when relapses occurred.
Liothyronine partially responsive group. Data on the
treatment of these four cases are presented in Table 12.5.
In two animals the response was acceptable to the owners and
the cats were maintained on lOOug T3 daily. Response to other
treatments in two was complete.
Liothyronine non-responsive group. Data on the treatment of
these three cases are presented in Table 12.6.
One cat also failed to respond to T4 and was lost fo follow-up.
Another was euthanased at the owner's request. The third animal
failed to respond to T4 and treatment was discontinued for eight
weeks. A thyroid biopsy was then carried out and the sections
processed and stained as described in Chapter 10. No abnormality
was noted. The animal subsequently responded completely to depot
testosterone.
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Comparison of the pre-treatment physical and laboratory
findings according to response to liothyronine sodium. There
were no obvious differences between the cutaneous lesions in the
three groups of FEA cats. Other clinical and the laboratory data
were compared using the Kruskal-Wall is test for group differences.
The results of these comparisons are presented in Table 12.7.
Only the T4 concentration was significantly different between
the groups, the inference from the test being that the more T3
responsive an FEA cat is, the lower is its basal T4 concentration.
Comparison of pre and post-treatment clinical and
laboratory data for the liothyronine totally responsive
group. Clinical and laboratory values for this group were
compared before and 12 weeks after beginning T3 treatment, by means
of Student's paired t test. The results are presented in Table
12.8.
The serum T4 and cholesterol concentrations were significantly
lower and the serum T3 concentrations significantly higher 12 weeks
after, compared with before, beginning T3 therapy. No other
parameters studied were significantly altered.
Comparison of pre and post-treatment physical and
laboratory findings for the liothyronine partially and
non-responsive groups considered together. Because of the
small numbers in each, these two groups were considered together.
Data were compared before and 12 weeks after beginning T3 treatment,
by means of Student's paired t test. The results are presented in
Table 12.8.
The serum T4 concentration was significantly lower during T3
treatment. No other parameter was significantly altered.
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Cases resembling feline endocrine alopecia
An alternative diagnosis to FEA was made in 24 of the 51
referred cases. One animal was lost to follow-up and was
undiagnosed.
Historical data. Historical data of the 25 cases are
presented in Table 12.9.
All were domestic short-haired cats. There was one entire male
(4 per cent), three entire females (12 per cent), eight neutered
males (32 per cent) and 13 neutered females (52 per cent). The age
at onset ranged from less than one year to 12 years with a mean of
5.1 years. The duration of physical signs before referral ranged
from one week to four years.
No significant variation of onset of alopecia between the
months was identified using the Chi-Square test. In eight cases,
pruritus had never been a feature of the problem, 11 had been
pruritic (usually manifested by licking) from the onset and in five
others, pruritus had been variable.
Fifteen animals had received some form of treatment before
referral. In four of these, there had been no change in the
condition. In 11, there had been temporary improvement with
relapse on cessation of drug administration.
Physical and laboratory findings. Physical and laboratory
data for the 25 cats at the first consultation are presented in
Table 12.10.
Dermatological changes. In 19 animals, the distribution of
the coat changes was very similar to FEA. In six cases, additional
areas to FEA sites were affected. The per cent alopecia
distribution of the group as a whole, and also of those animals in
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which lesions were confined to FEA sites, are compared to the FEA
cases in Table 12.11. This shows the very similar distribution of
lesions in all three groups.
In 14 cases (56 per cent), hairs appeared to have been epilated
rather than fractured. Fifteen cases (60 per cent) showed hair
loss unaccompanied by skin changes.
Haematological and biochemical changes. Because a number of
conditions were represented in this group, the haematological and
biochemical changes within it were not compared.
The most pronounced abnormal laboratory finding was the number
of blood eosinophils. Eleven animals showed an elevated (greater
than 1.5 x 10^/1) and three a high normal (greater than
1.1 x 10^/1) total eosinophil count.
Diagnosis, treatment and outcome of the non-FEA group. These
data are presented in Table 12.12.
Fleas or their faeces were found on nine animals. Topical
treatment with a spray combination of dichlorvos and fenitrothion at
weekly intervals for six weeks, together with vacuum-cleaning of the
environment, produced remission of signs in all cases. One of these
animals had kittened six weeks before treatment was begun and was
diagnosed as having concurrent telogen defluxion.
In ten animals in which there was no evidence of fleas or their
faeces on physical examination, flea treatment as described above
resulted in remission of signs. An example of such a case is shown
in Figs. 12.14(a) and 12.14(b). Five of these had elevated (greater
than 1.5 x 10^/1) and three high normal (greater than 1.1 x
10^/1) total eosinophil counts on first presentation. These
were diagnosed as probable flea infestation, and flea control
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treatment as described above was carried out at weekly intervals.
One cat had miliary dermatitis with eosinophilia. This was
diagnosed as probable flea infestation but was lost to follow-up.
The diagnoses, treatment and outcome of the remaining cases are
shown in Table 12.12.
Comparison of blood eosinophil counts before and six weeks
after beginning treatment. In 14 cases, blood eosinophil
counts were available before and six weeks after beginning
treatment. In all cases, the post-treatment value was lower than
the pre-treatment value. However, when these were compared using
Student's paired t test, the results just failed to be statistically
significant (t = 1.91; P >0.05).
Comparison of historical, physical and laboratory parameters
of the feline endocrine alopecia and non-feline endocrine
alopecia groups
Table 12.13 compares the data for the month of onset of
alopecia in the two groups.
Using the Chi-Square test, while there was no significant
variation in frequency of onset of alopecia between the months for
either group alone, such a variation was identified when the groups
were considered together (P <0.05). The onset of symptoms was
greatest in the months March to May and October to December
inclusive. Of the 43 cases in which the month of onset was known
accurately, 35 (81.4 per cent) began during these six months.
In an attempt to identify an effective test for differentiating
between FEA and clinically similar conditions, the clinical and
laboratory data of the two groups were compared by the Wilcoxon Rank
Sum test. The results are presented in Table 12.14 and show
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significant differences between the two groups for the serum
cholesterol concentration, the red blood cell count, the packed
cell volume and a highly significant difference for the total
eosinophil count.
Table 12.15 compares the eosinophil counts of the FEA animals
and those clinically resembling FEA. The range in the FEA cats
approximates to, and in the non-FEA cats is much greater than, the
normal range. The median of the eosinophil count of cats with
conditions resembling FEA is more than twice that of the FEA
animals. The predictive values of the total eosinophil count in
differentiating FEA from clinically similar conditions is shown in
Table 12.16.
12.4 DISCUSSION
Although a number of workers have stated that FEA is not a
manifestation of hypothyroidism, only one has presented supportive
data (Scott, 1975b). However, the condition is frequently responsive
to treatment with thyroid hormones (see Section 3.13). Accordingly,
the aim of the present study was to determine whether, in some cases,
FEA may result from thyroid hypofunction.
The parameters monitored were those used to assess thyroid
function in the experimental study in Chapter 11. The clinical and
laboratory changes occurring in hypothyroidism and the reasons for
these changes were discussed in detail in that chapter and will not
be considered further here. Because demodicosis (Scott, 1984) and
dermatophytosis (Thoday, 1986) may present with similar lesions to
FEA, screening tests to eliminate these conditions were carried out
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on all cases at first presentation. They were negative in all 51
cats in this study. Preliminary observations suggested that the
total eosinophil count might be useful in differentiating FEA from
clinically similar conditions and it was therefore monitored in all
cases. Because endoparasites may cause a circulating eosinophilia
(Schalm, Jain and Carroll, 1975a), faecal samples from all animals
were examined but parasite eggs were not identified in any.
Fleas are the most important cause of skin disease in cats
(Thoday, 1985) and the clinical signs of infestation vary between
individuals (Thoday, 1981). All cats were therefore treated with a
parasiticide, and their environment by vacuum-cleaning, to exclude
flea infestation as a cause of the presenting signs. Because there
is no definitive test for FEA, this diagnosis had to be made on the
history, results of physical examination, negative laboratory
results for diseases with similar presenting signs and failure to
respond to flea control measures.
Historical data in feline endocrine alopecia. FEA was not
diagnosed in a pedigree cat in this study although two cross-bred
cats were affected. Although Conroy (1964) stated that the condition
was more common in the Siamese breed, and Kirk (1980), in a review
of 34 cases, reported one further case in a Siamese cat, there are no
other reports of the condition in pure-bred animals, although it has
been described previously in cross-breeds (Scott, 1975b; Thoday,
1985).
Only one entire cat was affected in this series. Most other
authors agree that the condition is more common in neutered
individuals (reviewed in Section 3.13), although Kirk (1980)
reported a relatively even distribution between entire and neutered
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animals. As suggested by Thoday (1986), because the majority of
mature cats seen at veterinary clinics are neutered, this
predisposition may be apparent rather than real.
In the present study, 58 per cent of cases were neutered
females and 39 per cent neutered males. No author has reported an
apparent female predisposition for the disease. Indeed, Scott
(1975b), in a series of 20 cases, found that 90 per cent were
neutered males.
The age at onset of the condition in this series ranged from
one to 11 years with a mean of 4.5 years. This is in good agreement
with most other reports, although FEA is clearly not a disease of
old cats as reported by Thornton (1963), Anon. (1966), Daykin (1971)
and Joshua (1979).
In the current series, all but one animal had been neutered
before nine months of age. Premature neutering has been suggested as
a cause of the disease (Scott, 1981). However, feline castration
and ovariohysterectomy is routinely carried out at approximately six
months of age in the UK. Krai (1959) and Krai and Schwartzman
(1964) suggested that affected animals might produce insufficient
androgens and/or oestrogens from their adrenal cortices, but no data
were presented.
In the present series, there was a latent period between
neutering and the onset of FEA, of between six months and 10.5 years,
with a mean of 4.1 years. These data are in close agreement with
those of Scott (1975b) who reported a range of one to nine years,
with a mean of five years, in a series of 20 animals.
No significant variation in the frequency of month of onset of
alopecia in the FEA group was identified in the present series.
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However, the peak seasonal incidence was between November and May.
This agrees with the findings of Kirk (1980) who found a "rough
seasonal incidence" of the onset of FEA, although he did not
analyse his data statistically. Although his cases were presented
throughout the year, except for a higher concentration in November,
the largest number of cases was seen between January and June,
coinciding with the peak cat breeding season. These findings might
have been expected from the studies of Baker (1974a) in Eire, who
reported that in entire and neutered housed and unconfined cats, the
hair roots showed minimum activity from December to May. Ryder
(1976) in Australia, found that peak follicle inactivity was in
August, corresponding closely to the results of Baker (1974a)
in the northern hemisphere.
Seventeen animals had received a wide variety of drugs prior
to referral. Most of the agents used have been recommended in the
literature for the treatment of FEA (see Section 3.13). However,
response in all but three cases had been unsatisfactory. In many
cases, this may have been a dose-related problem because dosages were
not specified by most referring veterinary surgeons. However, the
failure rate with the progestogen megestrol acetate, a commonly
recommended therapy for FEA, was very high.
Physical and laboratory findings in feline endocrine
alopecia. The distribution of hair loss in this series was
in general agreement with literature reports of FEA. However, while
the majority of authors have reported that the condition begins over
the anogenital region, this was not the case in the present study
where this area was affected in only 19 per cent of cases. Figures
for the distribution of FEA have not been published previously.
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Three animals were reported to vomit hairballs as a result of
grooming in FEA. This is in agreement with the observations of
Kunkle (1984).
While three animals were lethargic and one obese in association
with the condition, systemic signs suggestive of hypothyroidism were
absent in the remainder.
The pre-treatment laboratory data did not suggest hypothyroidism
as the cause of FEA. The serum T4 concentration was below the
reference range in only one animal . The T3 concentration was normal
in all animals studied. No trends can be deduced from the non¬
specific tests of thyroid function.
Treatment of feline endocrine alopecia. While T4 is
currently the therapy of choice for the treatment of naturally-
occurring hypothyroidism in man (Toft, Campbell and Seth, 1981),
dogs (Rosychuk, 1982) and iatrogenic hypothyroidism in cats
(Holzworth et al., 1980), all cases of FEA in this series were
treated with T3 because in a preliminary study, the clinical
impression gained was that the response to T3 was better than to T4.
An increasing dosage regime was used to prevent possible cardiac or
thyrotoxic problems being brought about by initial slow metabolism
of the hormonal supplement or rapid changes in cellular
metabolism. Such regimes have been used in human medicine
(Rosychuk, 1982). Despite this, one cat developed cardiac signs
compatible with iatrogenic thyrotoxicosis during treatment with T3.
These signs resolved completely when T3 was withdrawn.
A maximum total daily dose of lOOug T3 per cat was used. This
is higher than the commonly quoted dose for cats of 13,2ug/kg/day
(Rosychuk, 1982), but appeared to be necessary because a number of
cats developed recurrence of alopecia at lower dosages.
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In dogs, the half-life of T3 is considerably shorter than T4
(see Section 3.6) and as a result, Nachreiner (1981b), cited by
Rosychuk (1982), has recommended administering T3 on a three-times-
daily regime. However, Rosychuk (1982) has reported successful
maintenance of hypothyroid dogs by twice-daily administration of T3.
Reducing the frequency of drug administration is likely to increase
owner compliance and in the present series, a twice-daily regime was
found to be satisfactory in the majority of cases.
All FEA cases were treated with T3 for 12 weeks before taking
further blood samples to monitor progress. This allowed the
establishment of a steady state situation for thyroid hormones and a
clinical assessment of the response to therapy. No figures are
available for cats for the length of time which should elapse before
biochemical re-evaluation, following the institution of thyroid
hormone therapy, but Rogers, Donovan and Kociba (1975) have suggested
a minimum of four to six weeks in dogs. Muller, Kirk and Scott
(1983) have recommended that the treatment of canine hypothyroidism
should be maintained for a minimum of 12 weeks before making a
clinical assessment of its effectiveness.
The serum thyroid hormone concentrations during treatment were
assessed from blood samples taken three hours after the
administration of half the daily dose of T3. While no figures are
available for cats, this regime has been recommended for therapeutic
monitoring of hypothyroid dogs treated with T3 (Rosychuk, 1982).
Retrospectively, the FEA cases could be divided according to
their response to T3. There was no obvious difference in the age at
onset between the groups. However, while equal numbers of neutered
females and neutered males were present in the T3 totally responsive
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group, neutered females predominated in the other two, comprising 75
per cent and 100 per cent of the T3 partially and non-responsive
groups respectively. The significance of these observations is
unknown.
In the T3 totally responsive group, the response to treatment
was rapid with some hair growth being evident after a mean of four
weeks. By comparison, a mean of ten weeks was required for the T3
partially responsive group to show signs of hair regrowth.
A maintenance dose of between 60ug and lOOug T3 was required to
prevent thinning of the coat in all but three animals. One of these
(108276) was treated when the alopecia recurred (approximately every
six months) with lOOug T3 daily until regrowth of hair was complete.
Two other cases did not require continuous T3 therapy. One of
these (case 130196) had had symptoms for 11 months prior to referral
which were unresponsive to dessicated thyroid (dose unspecified).
After treatment with lOOug T3 daily for four months, the dose was
gradually reduced and subsequently discontinued after a further
seven months. In a follow-up period of four years, there was no
recurrence of alopecia. In the second case (131365), FEA of five
months' duration was treated with T3 for four months. Subsequently,
no further treatment was required in a follow-up period of two
years. The explanation for these interesting responses is unknown.
Two of the T3 partially responsive cases showed an improvement
which was satisfactory to their owners and alternative therapy was
not attempted. One other responded totally to depot testosterone.
The remaining cat subsequently responded well to oral megestrol
acetate therapy.
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Two of the T3 non-responsive group were treated with T4 but
also failed to respond. Of these, one was subsequently lost to
follow-up while one responded completely to depot testosterone. The
owner requested euthanasia in the third animal and would not allow
a post-mortem examination.
Comparison of physical and laboratory findings in the three
groups of feline endocrine alopecia. When the basal physical
and laboratory findings of the three groups were compared, the only
significant difference noted was between the T4 concentrations. The
results suggest that the more T3 responsive an FEA cat is, the
lower is its T4 concentration. A similar trend was noted for T3
but this was not statistically significant.
When the laboratory findings 12 weeks after beginning T3
treatment were compared, interesting differences were noted between
the T3 totally responsive and the T3 partially and non-responsive
groups taken together. The T3 and T4 concentrations were
significantly higher and lower respectively during treatment with T3
in the T3 totally responsive group. The low serum T4 concentration
would be expected due to the negative feedback of T3 on TSH
production. For the T3 partially and non-responsive groups taken
together, only the T4 concentration was significantly different
before and after treatment. Thus, in this latter group, while the
exogenous T3 was at a high enough dose to cause suppression of
endogenous T4 production, it was not sufficient to produce a
statistical difference between pre and during-treatment T3
concentrations.
Similarly, while the serum cholesterol concentration of the T3
totally responsive group during treatment was significantly lower
369
compared with the pre-treatment values, such a difference was not
noted for the T3 partially responsive and non-responsive groups
taken together. Thyroid hormones are known to lower the serum
cholesterol concentrations of hypothyroid and euthyroid humans
(Anon., 1951; Kritchevsky, 1958) and successive falls in the serum
cholesterol concentration of hypothyroid dogs during thyroid hormone
therapy is a good prognostic sign (Bush, 1984).
The biochemical differences between the T3 totally responsive
group and the T3 partially and non-responsive groups taken together
may have a number of explanations. It is possible that T3
absorption was poorer in the latter group and that with a higher T3
dosage a more satisfactory clinical response would have been
obtained. The results do not necessarily imply that the condition
in either group was the result of hypothyroidism, as Gunaratnam
(1986) reported that T4 increases the number of hair follicles
entering the anagen phase of the hair cycle in healthy dogs when
administered orally or topically.
Alternatively, it is possible that the aetiology of FEA is
multifactorial, with the alopecia in the T3 totally responsive group
being a manifestation of low thyroid reserve, and in the T3 non-
responsive group (and possibly the partially responsive group also),
a reflection of extrathyroidal disease. A thyroid biopsy from cat
130985 showed no histological abnormality which suggests that
primary hypothyroidism was not the cause of the condition in this
animal. Thyroid biopsies were not carried out on any of the animals
in the T3 totally responsive group.
Further investigation of the thyroid function of cats with FEA
was subsequently carried out by means of the TSH stimulation test
(see Chapter 13).
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Cases resembling feline endocrine alopecia
The physical signs of FEA are common to a number of diseases.
As there is, at present, no definitive diagnostic test for FEA,
careful elimination of other diseases must be made prior to
beginning hormonal therapy.
Historical and physical parameters. Sixteen per cent of the
non-FEA cats seen were entire compared to only 3.7 per cent of the
FEA animals. The age at onset was similar in both groups.
No significant variation in the frequency of month of onset of
alopecia in the non-FEA group was identified. However, the monthly
distribution of onset of the condition in this group was similar to
the FEA group and corresponded approximately to the period of
minimum hair root activity in cats in the northern hemisphere. The
telogen hair root is poorly anchored (Ihrke, 1982). Thus, it might
be expected that hair loss would be more severe in any skin
condition during this stage of the hair cycle.
Although six of the 25 animals showed lesions of areas other
than FEA predilection sites, the lesion distribution in the
remainder was very similar to the FEA group. However, 56 per cent
of the non-FEA cats showed fractured hairs and 40 per cent
accompanying skin changes, whereas these changes were rare in FEA.
Pruritus was present at some stage in the disease process in 64 per
cent of this group compared with only 3.9 per cent of the FEA
cases. However, the degree of pruritus was very variable and
frequently the presence of the symptom was only detectable from the
history and not on physical examination.
Differential diagnosis of feline endocrine alopecia. In this
series, fleas or their faeces were found on nine cats and these
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cases responded within six weeks to weekly sprays with a
dichlorvos/fenitrothion combination and environmental flea control.
Four of these animals had elevated (greater than 1.5 x 10^/1)
blood eosinophil counts. In addition, ten cats with no macroscopic
evidence of flea infestation responded completely to the same
therapy. Of these, five had elevated and three high normal (greater
than 1.1 x 10^/1) blood eosinophil counts. As all were negative
for ectoparasites on skin scrapings, and for endoparasites on faecal
examination, and as neither dichlorvos nor fenitrothion have known
stimulatory action on hair growth, it was concluded that these
dermatoses were associated with flea infestation. One animal had
miliary dermatitis with eosinophilia. This was diagnosed as
probable flea infestation but was lost to follow-up.
One cat with flea infestation also showed telogen defluxion
which in this and one other case occurred post-partum (Figs.
12.15(a), 12.15(b) and 12.15(c)). Telogen defluxion (also termed
telogen effluvium or telogen defluvium) occurs in situations in
which the anagen phase of the hair cycle is shortened, resulting in
large numbers of hairs entering the resting phase synchronously.
The condition may occur at times of physiological stress such as
gestation or lactation, in numerous disease states and with certain
drug treatments (Thoday, 1986). Affected hairs are easily epilated
both by friction and by normal grooming. Specific treatment for the
hair loss is not required.
In this series there was a single case each of psychogenic
alopecia, pediculosis and mastocytosis.
The case of psychogenic alopecia occurred in a domestic short-
haired cat and no initiating cause was identified. Although the
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distribution of hair loss was the same as in FEA, remaining hairs
in affected areas were fractured and could not be easily epilated.
Scott (1980), reviewing the literature on psychogenic alopecia,
reported that any breed might be affected but pedigree cats appeared
to be predisposed. Stress factors often appeared to precipitate
the condition which might have a similar distribution to FEA.
However, in psychogenic alopecia, hairs do not epilate easily and
appear broken off when examined microscopically (Muller, Kirk and
Scott, 1983).
The case of pediculosis (133477) had a similar distribution to
FEA (Figs. 12.16(a) and 12.16(b)). Hairs over the trunk were not
fractured but there was hyperaemia and self-inflicted injury around
the base of the pinnae. Louse infestation in the cat, with lesions
compatible with a diagnosis of FEA, does not appear to have been
reported previously.
The case of multiple mast cell tumours showed a similar
distribution to FEA but the median raphe of the upper lip was also
involved. There was diffuse partial alopecia over affected areas
but, in addition, there were multiple areas of dry scale,
hyperpigmentation and, subsequently, small, variably-sized (2mm to
4mm) papules which distinguished the case from FEA.
Other conditions, not seen in the present study, which may have
a similar distribution pattern and lesions to FEA include megestrol
acetate-induced diabetes mellitus (Moise and Reimers, 1983),
demodicosis (Scott, 1984) and dermatophytosis (Thoday, 1986).
Blakemore (1975), cited by Kirk (1980), reported that cats in
oestrus may shed their hair easily, particularly in the groin. It
is likely that this is merely a manifestation of telogen defluxion.
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Comparison of laboratory findings in feline endocrine
alopecia and clinically similar conditions
A number of significant differences in laboratory parameters
were identified between the FEA and non-FEA groups. The
significance of the lower RBC count and PCV in the non-FEA groups is
unknown because this is the converse of what might have been
expected if FEA is due to hypothyroidism. A higher serum
cholesterol in FEA cats compared to non-FEA animals would be
consistent with a tendency towards mild hypothyroidism in the former
group, but this is a relatively non-specific feature. In dogs,
hypercholesterolaemia may result from feeding high fat diets,
hepatopathies, the nephrotic syndrome, acute pancreatitis, diabetes
mellitus and hyperadrenocortical ism, in addition to hypothyroidism
(Rogers, 1977). Indeed, only four cats in the FEA group were
actually hypercholesterolaemic.
The most significant laboratory difference between the two
groups was the elevation of the total eosinophil count in the non-
FEA group. Eosinophilia may occur in a number of conditions
represented in this group. Between 13 and 20 per cent of dogs and
cats with flea allergy dermatitis are reported to have blood
eosinophilia (Baker, 1974d; Kristensen and Kieffer, 1978; Kieffer
and Kristensen, 1979). However, while flea infestation was
confirmed or suspected in the present series, affected animals did
not exhibit the wel 1-recognised distribution and signs of flea-bite
hypersensitivity and the percentage of cases with blood eosinophilia
was much higher than that quoted above.
The single case of multiple mast cell tumours had a marked
blood eosinophilia. This might have been expected as blood
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eosinophilia occurs in a number of diseases involving degranulation
of mast cells (Schalm, Jain and Carroll, 1975a).
It follows from the data presented here that, at present, the
most useful screening test for the differentiation of FEA and
clinically similar conditions is the total blood eosinophil count.
Assuming that the prevalence of FEA and non-FEA conditions in this
study is the same as in the general population, a raised eosinophil
count is highly reliable in excluding FEA. A normal result is of
little value in making the diagnosis and is equally probable in FEA
and non-FEA conditions.
375
13. THE THYROID STIMULATING HORMONE STIMULATION TEST
IN THE ASSESSMENT OF FELINE THYROID FUNCTION
13.1 GENERAL INTRODUCTION
The TSH stimulation test has been used in the investigation of
suspected hypothyroidism in both man and the dog. Various regimes
have been reported to give satisfactory responses in healthy cats
(see Section 3.9) but there are only a small number of reports of
the use of the test in specific diseases in cats (Scott, 1975b,
1980; Peterson, 1982; Peterson et al., 1983b.,Arnol d et al., 1984;
Peterson, 1984).
This chapter details the optimisation of the TSH stimulation
test in healthy cats and its subsequent application to the further




Bovine TSH was as described in Section 11.4.
13.3 EQUIPMENT
Equipment used in the RIA of T4 and T3 was as described in
Section 5.3.
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13.4 PRELIMINARY INVESTIGATIONS INTO TSH STIMULATION TESTING IN
HEALTHY CATS, (i) DETERMINATION OF THE CHANGE IN SERUM
IODOTHYRONINE CONCENTRATIONS WITH RESPECT TO TIME
Methods
Three domestic short-haired cats were used in this experiment.
Each was classified as healthy on the basis of a detailed physical
examination. Samples were collected from conscious animals by
jugular venepuncture at 08.50 hours after starvation from 21.00 hours
the previous evening. At 09.00 hours, 5 iu TSH were injected into a
cephalic vein. Blood was subsequently collected by jugular
venepuncture at one, two, four, six, eight, ten, 12, 16 and 24 hours
after TSH administration. After clot retraction, blood was
centrifuged and the serum transferred to clean tubes for storage at
-40°C. T4 and T3 were assayed on each specimen as described in
Chapter 6.
Results
The results of this study are presented in Table 13.1.
Thyroxine concentrations. T4 concentrations showed no
significant increases until four hours. In all three cats, the peak
T4 concentration was found at eight hours after TSH administration
although each had doubled the basal concentration at six hours. At
24 hours, T4 concentrations in cats A and TSH/NC/1/84 approached the
basal concentration but remained elevated in cat B.
Triiodothyronine concentrations. As with T4, T3
concentrations showed no appreciable rise until four hours. Peak
concentrations were obtained at eight hours after TSH




When the present study was carried out, there were no published
reports comparing the serum T4 response in cats to varying doses of
TSH. However, a number of authors (eg. Scott, 1981) have reported
that in healthy dogs, irrespective of weight, 5 iu of TSH
administered intravenously causes more than a doubling of basal T4
concentrations four hours after administration. This dose of TSH
was therefore selected for initial studies in cats.
As a consequence of this dosage regime, there was considerable
variation in the number of units of TSH/kg administered, such
that cat A received more than twice the number of units with respect
to weight than cat TSH/NC/1/84. However, although both cats' basal
T4 concentrations were similar, a much greater increase in serum T4
was seen in cat TSH/NC/1/84, suggesting that the response to TSH is
not simply a function of the administered dose.
In contrast to the response in dogs, none of the three cats
showed a doubling of their basal T4 concentrations until six hours
after TSH administration. The maximal response was seen after eight
hours.
Scott (1975b, 1980) also used 5 iu TSH to carry out the TSH
stimulation test in healthy cats. Although he administered it
subcutaneously and collected his second sample at 12 hours, the
degree of response was the same as in the present study. Reimers
(1982) and cited by Randolph and Jorgensen (1984) also used 5 iu TSH
subcutaneously, but from the data reported, it is difficult to
compare his results with the present study.
The changes in serum T3 concentration after TSH stimulation
were similar to those described for T4 with maximal concentrations
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being seen after eight hours. However, cat TSH/NC/1/84 failed to
double its basal T3 concentration. There are no previous reports of
the serum T3 response to TSH in cats.
13.5 PRELIMINARY INVESTIGATIONS INTO TSH STIMULATION TESTING IN
HEALTHY CATS, (ii) DETERMINATION OF THE OPTIMUM DOSE
Introduction
Dosages of TSH that have been reported to give a satisfactory
rise in serum T4 concentrations in healthy cats range from 1.0 iu
per cat (Taurog, Porter and Thio, 1964) to 1.0 iu/0.45 kg (Ling,
Lowenstine and Kaneko, 1974). However, Morris and Garcia (1983)
and Held and Oliver (1984) have demonstrated that 5 iu TSH is
sufficient to elicit a satisfactory increase in T4 concentrations in
healthy horses, suggesting that much lower doses than have been used
previously might be satisfactory in cats. Because TSH is relatively
expensive, there has been some reluctance on the part of British
veterinary surgeons to use the TSH stimulation test for the
diagnosis of canine hypothyroidism. The following study was carried
out to determine the optimum dose of TSH for use in the TSH
stimulation test in cats.
Methods
The study was carried out as described in Section 13.4 with the
exception that the dose of TSH used was 1 iu per cat and that
sampling was carried out prior to, and six, eight and ten hours after,
TSH administration. To assist in comparing the results, the




The results of this study are presented in Table 13.2 and
compared with the previous experiment in Tables 13.3, 13.4 and 13.5.
Thyroxine concentrations. Two of the cats showed peak T4
concentrations at six and one at eight hours after TSH
administration. All three animals showed a doubling of basal T4
concentrations at six hours.
Triiodothyronine concentrations. In contrast to the results
with T4, one of the cats showed peak T3 concentration at six, and two
at eight, hours after TSH administration. Cats A and B showed a
doubling of basal T3 concentrations at six hours whereas cat
TSH/NC/1/84 just failed to do so. The T3 response to TSH appeared
to be more sustained than the corresponding T4 response.
Comparison of the two dosage regimes
Thyroxine concentrations. The T4 responses with respect to
time were very similar for the two dosage regimes. However, in all
cats, the post-TSH T4 concentration was slightly lower with 1 iu
than with 5 iu TSH, but this might have resulted from the lower basal
T4 concentrations in two of the cats in the 1 iu study. Using 1 iu
TSH, the absolute increase in T4 concentration at six hours was
either equal to, or lower than, when using 5 iu. Although samples
were only taken up to ten hours after TSH dosing with the 1 iu
regime, it appeared that the response with 5 iu was more sustained
than with 1 iu.
Triiodothyronine concentrations. The results of the two
studies were similar although, surprisingly, there was a tendency for
a greater absolute increase in T3 with the lower TSH dosage.
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The post-stimulation T4/T3 ratio varied with the TSH dose and
the time elapsed after administration.
Discussion
The administration of 1 iu TSH to cats in this study resulted
in a dose of between 0.15 iu/kg and 0.34 iu/kg. This produced a
satisfactory rise in both serum T4 and T3. Two of the three animals
showed peak T4 concentrations at six hours and one at eight hours
whereas the reverse was true for T3. Using similar dosage regimes,
Hoenig and Ferguson (1983) obtained comparable results for T4,
although all six cats they studied with TSH doses of greater than
0.05 iu/kg showed peak concentrations at six hours.
The T3 response of cat A at eight hours was unexpectedly high.
When retested, the sample gave the same result. The reasons for
this are unclear.
A comparison of the two TSH dosage regimes shows a marginally
better T4 response with 5 iu/kg, but the difference is relatively
small compared with the five times increase in the amount of TSH
used. However, the absolute increase in T3 concentration at six
hours with the 1 iu/cat dose was equal to or greater than that seen
with 5 iu/cat (equivalent to between 0.78 iu/kg and 1.72 iu/kg).
There is no obvious explanation for a poorer response of serum T3
being obtained with a higher dose of TSH. It is probable that a
maximal response was obtained with the lower dose and that the
difference between the two merely reflects test variables. No
previous studies have been published describing the serum T3
response to TSH in healthy cats. However, Faber, Friis,
Kirkegaard, Lauridsen, Nerup, Rogowski and Siersbaek-Nielsen (1976)
reported that, in man, the maximum response of serum T4 and T3 was
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obtained with 0.1 iu/kg TSH, a figure comparable to the 1 iu per
cat dose used in the present study.
Analysis of data showed no correlation between the T4/T3 ratio
6 hours after TSH stimulation and the TSH dose, in disagreement with
the findings of Faber et al. (1976) in man, who reported that this
ratio remained unaltered with increasing doses of TSH.
The data presented here demonstrate that a satisfactory T4 and
T3 response can be produced in normal cats at six or eight hours
with a dose of 1 iu TSH per cat (equivalent to 0.15 to 0.34 iu/kg).
However, as Einhorn and Larsson (1959) commented with respect to man,
the results obtained in subjects without thyroid disease should not,
without extensive clinical trials, be applied to patients with
thyroidal disorders. From the results of the present study, a more
satisfactory dose would be 0.35 iu/kg as this produced more than a
doubling of the basal T4 concentration in all cats studied.
However, this is a difficult figure to compute for injection and a
dose of 0.5 iu/kg was selected for further studies. This is half
the figure suggested by Hoenig and Ferguson (1983) and is therefore
cheaper and consequently more applicable to use in veterinary
practice. Using this regime, resampling could be carried out at six
or eight hours with satisfactory results. In a clinical situation,
sampling at zero and six hours is more convenient and this protocol
was used in subsequent investigations.
13.6 THYROID STIMULATING HORMONE TESTING IN HEALTHY CATS -
POPULATION STUDIES
Introduction
The pilot studies carried out as described in the previous
sections of this chapter suggested a suitable regime for the feline
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TSH stimulation test. This study describes the use of the test
in healthy cats.
Methods
Sixteen pet cats were used in this study. Prior to
selection, each was classified as healthy on the basis of a detailed
history and physical examination.
Animals were starved from 21.00 hours the evening before
testing. Blood was obtained from conscious animals by venepuncture
at 08.50 hours and 0.5 iu/kg TSH solution was injected into a
cephalic vein at 09.00 hours. Animals were resampled six hours
later by jugular venepuncture. Serum was subsequently collected and
stored as described in Section 13.4 and assayed for T4 and T3 as
described in Chapter 6.
Results
The results of this study are presented in Table 13.6.
Thyroxine concentrations. The basal T4 concentrations were
within the 95 per cent range for healthy cats established previously
(see Chapter 7).
All cats showed an obvious T4 response to TSH, with the mean
T4 increment being approximately three times the basal
concentration. Only one cat (TSH/NC/13/84) failed to double its
basal serum T4 concentration six hours after dosing. Linear
regression analysis failed to establish a relationship between the
increment in serum T4 concentration after TSH administration and the
basal T4 concentration (r = 0.183, 14 d.f.).
Triiodothyronine concentrations. The basal T3
concentrations were within the 95 per cent range for healthy cats
established previously (see Chapter 7).
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The T3 response to TSH was much more variable than with T4,
ranging from a fall in serum T3 concentration to an almost five-fold
increase after six hours. The mean T3 concentration showed an
increase of approximately two-fold over basal concentrations.
Linear regression analysis failed to establish a relationship
between the increment in serum T3 concentration after TSH
administration and the basal T3 concentration (r = -0.035, 14 d.f.).
Discussion
The development of reliable assay techniques for the
determination of thyroid hormone concentrations has simplified the
evaluation of thyroid function in veterinary medicine. However, the
measurement of basal T4 and T3 concentrations may not always
accurately reflect thyroid status in the face of chronic disease,
other hormonal abnormalities, drug administration and starvation
(reviewed in Section 3.6). The TSH stimulation test has therefore
been used in both man and animals to supplement the information
available from serum T4 and T3 determinations.
With the regime described here, the minimum total T4
concentration six hours after TSH administration was 56.8 nmol/1
with a minimum T4 increment of 21.6 nmol/1. Hoenig and Ferguson
(1983) reported that these parameters correlated more closely with
the logarithm of the TSH dose than did the ratio of post-TSH serum
T4 concentration with baseline T4 concentration. Using the same
regime as in the present study but twice the TSH dose, their
results (51.5 nmol/1 and 32.3 nmol/1 respectively) were closely
comparable to those found in this study.
The serum total T3 response to TSH was considerably less
uniform than the T4 response. One cat showed a marginal fall in
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serum T3 concentration after stimulation and three others showed a
rise of 0.1 nmol/1 or less. This poor response was not related to
the basal T3 concentration. There are no previous reports of T3
response to TSH in healthy cats. However, in dogs, T3 responses to
TSH are not a reliable index of thyroid function (Nesbitt, 1983),
and this is probably because 37 per cent to 60 per cent of T3 is
derived from extra-thyroidal mono-de-iodination of T4 (Belshaw et
al., 1974). Therefore, the wide variation in T3 response to TSH in
this study was not surprising.
The cat showing the lowest T4 response to TSH also showed the
poorest T3 response. This animal, a 12-year-old cat, was the oldest
in the study. In a follow-up period of 18 months, the animal has
remained well and it is interesting to speculate that its poor
thyroid reserve was simply associated with ageing.
Of the sixteen animals used in this study, only one showed
evidence of toxic reactions to TSH administration. This cat
(TSH/NC/1/84) was used in each study. No side-effects were noted
during the first two stimulation tests but on the third occasion,
the cat became depressed within 30 minutes of TSH injection, and
remained so for 48 hours. The animal was anorexic for 24 hours and
inappetant for a further 24 hours but returned to normal
subsequently. Toxic effects of TSH have not been recorded
previously in cats. However, in dogs, repeated intravenous
injections of TSH have been reported to produce anaphylaxis (Scott,
1982b) and Muller, Kirk and Scott (1983) advise against the
intravenous route if repeated injections have to be given.
In the present study, this was not possible and treatment for the
reaction in the cat under discussion was not necessary. Taunton,
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McDaniel and Pittman (1965) reported the toxic reactions to TSH in
87 human euthyroid patients to be nausea and vomiting (9 patients),
tachycardia, nervousness and increased excitability (2), acute pain
and tenderness of the neck over the thyroid (3), urticaria (2) and
local soreness at the injection site (87). No comparable reactions
were seen in the cats under discussion.
Changes in serum thyroid hormone binding proteins can alter
baseline and post-TSH T4 concentrations (Hoenig and Ferguson, 1983).
Thyroid hormone protein binding studies were not carried out on the
sera from animals in this study but all had T4 and T3 concentrations
within the respective reference ranges.
The data indicate that, in euthyroid cats, intravenous
administration of TSH at a dose of 0.5 iu/kg bodyweight should
lead to a T4 concentration of greater than 55 nmol/I at six hours
after administration, or to an increment in the serum T4 of greater
than 20 nmol/1. The changes in serum T3 concentration in response
to TSH are not consistent enough to be used in a clinical situation.
13.7 THE THYROID STIMULATING HORMONE STIMULATION TEST IN FELINE
ENDOCRINE ALOPECIA
Introduction
A number of authors have stated that FEA is either a
manifestation of hypothyroidism or responds to treatment with
thyroid hormones (see Chapter 12). However, Scott (1975b), in the
only study of FEA to include TSH stimulation testing, reported that
this and other parameters of thyroid function were normal in all
animals investigated. In the previous chapter, no definitive
laboratory evidence of thyroid abnormalities was found in 26 cases
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of FEA investigated in detail. However, 70 per cent of affected
animals showed a total response to T3 supplementation.
In order to investigate these apparently contradictory results
and reports, the TSH stimulation test was used to assess the thyroid
functional reserve in a number of cases of FEA.
Methods
The TSH stimulation test was carried out on six cats which
fulfilled the criteria for the diagnosis of FEA as described in
Chapter 12. Three cases were totally, and two partially, responsive
and one was non-responsive to treatment with T3. Prior to carrying
out the tests, in cases receiving thyroid hormone replacement
therapy, T3 was discontinued for two months and serum thyroid
hormone concentrations were determined to ensure there was no
residual therapeutic suppression and elevation of serum T4 and T3
concentrations respectively.
The TSH stimulation test was carried out and the sera harvested
and stored as described in Section 13.6. Serum total T4 and T3
concentrations were determined as described in Chapter 6.
Results
The results of this study are presented in Table 13.7.
Thyroxine concentrations. The basal T4 concentrations of the
six FEA cats were within the normal range established for healthy
cats in Chapter 7 but four were below the range of the 16 healthy
cats used in the TSH stimulation tests. The serum T4 concentration
and the absolute increase in serum T4 concentration, after TSH
administration, were all below the mean values for normal cats
(Section 13.6). One cat had a T4 concentration post-TSH marginally
below the range found in the normal group. When these parameters
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were compared for FEA and healthy animals using the Mann-Whitney Li¬
test, significant differences were identified (Table 13.8). The
ratio of post-TSH serum T4 concentration to basal serum T4
concentration was not significantly different between the two
groups.
Triiodothyronine concentrations. The basal T3 concentrations
of the FEA cats were also within the normal range as established in
Chapter 7 but one cat showed a basal T3 lower than the range
established for the 16 healthy cats used in the TSH stimulation
test.
Using the Mann-Whitney U-test, no significant differences
between healthy and FEA cats were identified for basal T3
concentrations, post-TSH T3 concentrations, the absolute increase in
serum T3 concentrations after TSH administration and the ratio of
post-TSH serum T3 concentrations to basal T3 concentrations (Table
13.8).
Piscussion
The basal T4 concentrations of all six FEA cats used in this
study fell into the reference range derived from observations in 318
animals (see Chapter 7). However, when compared to the basal T4
concentrations of the 16 animals used for the optimisation of
the TSH test in healthy cats (Section 13.6), four FEA cats had
subnormal basal T4 concentrations. It is possible that this
resulted from the smaller sample size of healthy animals used for
the TSH study. Between-assay variation in the T4 and T3 assays may
also have contributed to the observed pattern of results.
Scott (1975b) is the only person to have reported the results of
TSH testing in FEA. Five affected cats showed a normal response to
388
TSH, (defined as a doubling or tripling of the basal T4
concentration), 12 hours after the subcutaneous administration of
5 iu TSH. Detailed statistical analysis of the results was not
reported.
The serum T3 response to TSH in cats has not been reported
previously. In this study, there were no significant differences
between the FEA and the healthy cats in any of the TSH stimulation
test parameters for T3 measured. As was discussed in Section 13.6,
the serum T3 response to TSH is not a reliable indicator of thyroid
function and the present findings were anticipated.
Although a more extensive study is required before any definite
conclusions can be drawn, the present data suggest the possibility
that FEA in some cats may be a manifestation of low thyroid
reserve. This term was originally used by Jefferies et al. (1953)
to describe a condition of man characterised by a normal three-hour
thyroidal uptake of ^lj and serum PBI concentration but a
failure of either to respond to stimulation with TSH. They
attributed the condition to the presence of a remnant of thyroid
tissue which was being stimulated maximally by endogenous TSH and
hence could not respond further to the exogenous hormone
administered in the test. Subsequently, Levy, Kelly and Jefferies
1
(1954) observed that in some circumstances I uptake would rise
following administration of TSH but the serum PBI concentration
would not, whereas in others the reverse occurred. Low thyroid
reserve in humans may be a transient phenomenon or may persist
indefinitely, as may FEA.
Low thyroid reserve was observed more frequently in patients
who had had l^lj therapy or subtotal thyroidectomy, but was also
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seen following thyroiditis and within three to eight weeks of
cessation of prolonged thyroid hormone medication. In the present
study, T3 therapy was discontinued for a minimum of eight weeks
prior to TSH testing in all cats. Four had had no other drug
treatments in that time. One had received diazepam from the
referring veterinary surgeon for its FEA. There appear to have been
no reports of diazepam causing decreases in serum thyroid hormone
concentrations or response to TSH. One animal had received a depot
injectable preparation of testosterone esters, (Durateston, Intervet
Laboratories, duration of action of one month), two months before
testing, as it was non-responsive to T3. Androgens have been
reported to lower T4 and T3 concentrations in dogs but in such
cases, the T4 response to TSH parallels that seen in untreated,
healthy individuals (Ferguson, 1984). However, this is unlikely to
have influenced the test results in the case in question as therapy
was effectively discontinued one month before testing.
1 01
Because XJ1I uptake studies were not carried out, it is not
possible to suggest whether the cats in the present study might be
classified into similar sub-groupings of low thyroid reserve as
described in man. Indeed, it is interesting to speculate that,
because cases of FEA may be subdivided retrospectively according to
response to T3, the syndrome may represent a number of thyroidal and
non-thyroidal states. Further studies using a combination of
131
I uptake and TSH stimulation are warranted in FEA to
determine more clearly whether the condition in some animals may be
a manifestation of low thyroid reserve.
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13.8 THE THYROID STIMULATING HORMONE STIMULATION TEST IN
EXPERIMENTAL FELINE HYPOTHYROIDISM
Introduction
Although attempts have been made to induce hypothyroidism
experimentally in cats on a number of occasions (see Chapter 11), TSH
stimulation testing has never been employed to confirm the
hypothyroid state. This section describes the use of the TSH
stimulation test in two cats in which the thyroid glands had
previously been ablated with radioiodine.
Methods
The two cats used were those described in detail in Chapter
11. One hundred and ten weeks after the administration of
radioiodine, the TSH stimulation test was carried out as described
in Section 13.6. Serum was subsequently collected and stored as
described in Section 13.4 and assayed for T4 and T3 as detailed in
Chapter 6.
Results
The results of this study are presented in Table 13.9.
Serum T4 and T3 were undetectable (<1.3 nmol/1 and <0.10 nmol/1
respectively) both before and after administration of TSH. In
addition, in all test samples, the per cent radioisotope bound was
greater than that in the corresponding zero standard for that assay.
Discussion
These experimental cats had shown serum T4 and T3
concentrations consistently below the detection limits of the
respective assays for 107 weeks prior to TSH stimulation testing.
The lack of any obvious T4 or T3 response to TSH provides clear
confirmation that thyroid ablation in these animals had been
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successful. Repeated TSH administration is not required for the
demonstration of primary hypothyroidism by thyroid hormone assay.
There are no previous reports of the confirmation of
experimental feline hypothyroidism by TSH testing. Arnold et al .
(1984) are the only workers to have substantiated a diagnosis of
naturally-occurring feline hypothyroidism by TSH stimulation. They
measured serum T4 concentrations before and ten hours after the last
of three, consecutive, daily, intramuscular injections of 5 iu bovine
TSH to a 14-week-old kitten with suspected goitrous hypothyroidism
and dwarfism. The T4 concentration was below the detection limit of
the assay (0.4 nmol/1) on both occasions.
A case of naturally-occurring, acquired, feline hypothyroidism
has yet to be definitively diagnosed. The present study illustrates
the potential value of the TSH stimulation test in the investigation
of possible cases.
13.9 THE THYROID STIMULATING HORMONE STIMULATION TEST IN FELINE
HYPERTHYROIDISM
Introduction
Hyperthyroidism is a multisystemic disorder, resulting from
excessive circulating concentrations of T4 and T3. Although a TSH
stimulation test is not required for the diagnosis of
hyperthyroidism in most affected cats, it has been suggested that it
might be of value when resting thyroid hormone concentrations are
borderline or only slightly increased (Peterson, 1982; Peterson et
al . 1983b; Peterson, 1984). This section reports on the use of the
TSH stimulation test in a single case of feline hyperthyroidism.
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Methods
Case details of the patient are presented in Table 13.10.
When 12 years old, the cat was presented with a history and
clinical signs suggestive of hyperthyroidism and the diagnosis was
confirmed by the demonstration of elevated serum total T4 and T3
concentrations. Bilateral thyroidectomy resulted in total remission
of clinical signs and laboratory tests returned to normal.
Histopathological examination of the thyroid revealed bilateral
adenomatous hyperplasia. Both glands were infiltrated with
lymphocytes. A serum sample taken on initial presentation was
scored as ++ for thyroid microsomal antibodies (see Chapter 14).
Ninety-two weeks after surgery, the cat was represented with a
recurrence of clinical signs and hyperthyroidism was confirmed by
the demonstration of elevated serum total T4 and T3 concentrations.
TSH stimulation testing was carried out at this stage, as described
in Section 13.6. Serum was subsequently collected and stored as
described in Section 13.4 and assayed for T4 and T3 as detailed in
Chapter 6.
Results
The results of the TSH stimulation test are presented in
Table 13.10.
The absolute increase in serum T4 concentration after TSH
administration and the ratio of post-TSH serum T4 concentration to
basal serum T4 concentration were within the respective ranges for
normal cats. The absolute increase in serum T3 concentration after
TSH administration was above the normal range, but the ratio of the
post-stimulation to basal concentrations was normal.
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Discussion
The normal responses to TSH stimulation found here in a single
animal do not support the conclusions of Peterson (1982), Peterson
et al. (1983b) and Peterson (1984) who suggested that the lack of
serum T4 response to TSH might be helpful where a diagnosis of
feline hyperthyroidism is equivocal. They showed that four hours
after the intravenous administration of 1 iu/kg TSH, the mean serum
T4 concentration of 11 hyperthyroid cats (144.1 nmol/1) was not
significantly higher than the mean basal T4 concentration (127.1
nmol/1). T4 concentrations increased by more than 19.3 nmol/1 above
baseline concentrations in only three cats, with the highest increase
being 87.5 nmol/1 (Peterson et al. 1983b). The authors suggested
that either the thyroid glands of thyrotoxic cats secreted thyroid
hormones independently of TSH control, or that T4 and T3 were already
being produced at a maximal rate. These alterations would
correspond to human toxic multinodular or nodular goitre and Graves'
disease.
Although only one animal was studied in the present report, it
is clear that the lack of serum T4 response to TSH has limitations
for the diagnosis of feline hyperthyroidism. A sub-normal T4
response may indicate thyrotoxicosis but a normal increase in T4
concentration does not exclude the diagnosis.
There are no previous reports of changes in serum T3
concentrations in response to TSH in feline hyperthyroidism. In the
present study, the absolute increase in serum T3 concentration after
TSH administration was greater than that seen in any healthy animal
studied. As discussed for healthy animals in Section 13.6, the
response of serum T3 to TSH is unlikely to be a reliable test of
feline thyroid function.
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14. AUTOANTIBODY STUDIES IN FELINE NATURALLY-OCCURRING
HYPERTHYROIDISM AND RAD 10IODINE-INDUCED HYPOTHYROIDISM
14.1 INTRODUCTION
Circulating autoantibodies to various thyroid components have
been identified in human hyperthyroidism, both prior to treatment
and after thyroid ablation using l^I. Thyroid autoantibodies
have also been induced in euthyroid humans by radioiodine therapy
(reviewed in Section 3.14). Similar immunological investigations
have not been carried out in cats.
This section describes autoantibody studies in cases of
naturally-occurring feline hyperthyroidism, and in two cats in which
hypothyroidism was induced experimentally using radioiodine.
14.2 REAGENTS
Anti-cat immunoglobulin
Goat anti-cat IgG conjugated with fluorescein isothiocyanate
(Miles-Yeda) was obtained from Miles Scientific, Stoke Court, Stoke
Poges, England.
Thyroid stimulating hormone receptor assay
Measurement of TSH receptor antibodies was attempted using a
kit technique (TSH Receptor Antibody Assay Kit, R.S.R. Ltd., St.
Nicholas, Cardiff, South Wales).
14.3 EQUIPMENT
The ultra-violet microscope was a Leitz Ortholux II, obtainable
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from E. Leitz (Instruments), Luton, England, and fitted with a Wild
MPS 51 camera attachment.
Other equipment was as described in previous chapters.
14.4 METHODS
Examinations for thyroid microsomal, antinuclear and TSH
receptor antibodies were carried out in collaboration with Dr.
R.L. Kennedy.
Thyroid microsomal and antinuclear antibodies
Thyroid microsomal antibodies and ANA were measured by indirect
immunofluorescence on normal cat thyroid.
Thyroid tissue was removed from a healthy cat immediately after
euthanasia by intravenous injection of 20 per cent w/v
pentobarbitone sodium solution (Euthatal, May and Baker), and frozen
in liquid nitrogen.
Sera were diluted 1:4 with phosphate buffered saline (PBS),
pH 7.2, and applied to 5u sections of healthy feline thyroid for 30
minutes at room temperature. The sections were then washed in PBS
for 30 minutes with two changes of buffer. Goat anti-cat IgG
conjugated with fluorescein isothiocyanate was then applied at a
dilution of 1:8 for 30 minutes and the slides were subsequently
washed for two hours with several changes of buffer.
The sections were coded and read blindly under ultraviolet
light and were scored as follows:
0 - No fluorescence
+_ - Borderline fluorescence (not counted as positive)
+ - Definite positive
++ - Strong positive
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The non-organ specific nature of the ANA detected in some cats
was confirmed by repeating the experiment using rat kidney as
substrate.
Thyroid stimulating hormone receptor antibodies
TSH receptor antibodies were sought in undiluted serum using a
kit radioreceptor assay based on the method of Southgate, Creagh,
Teece, Kingswood and Rees Smith (1984).
The technique depends on the serum antibody's ability to
inhibit ^-^5j_iabeiqecj j$h binding to a detergent solubilised
preparation of thyroid TSH receptors. Between-assay precision was
approximately 12 per cent, two per cent and 2.5 per cent cv at mean
inhibition of TSH binding values of 11, 53 and 79 respectively.
Thyroxine and triiodothyronine determinations
Serum total T4 and T3 concentrations were determined as
described in Chapter 6.
Histological examinations
Thyroid lobes excised from cases of feline hyperthyroidism were
preserved in ten per cent formol saline and processed and examined
as described in Chapter 10.
14.5 NATURALLY-OCCURRING FELINE HYPERTHYROIDISM
Clinical material
This study comprised 29 consecutive cases of feline
hyperthyroidism. The tentative diagnosis was made on the basis of
history and clinical findings and confirmed by the presence of
elevated total serum thyroid hormone concentrations.
Serum samples were collected by jugular venepuncture, stored at
-40°C and tested in batch mode. Indirect immunofluorescence
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testing was carried out on sera from all 29 cats and from 15 healthy
cats of a wide age range to act as controls. TSH receptor antibody
assay was carried out on sera from 12 of the thyrotoxic cats and
from 12 healthy controls.
Two affected cats died soon after the diagnosis was made.
Euthanasia was requested by the owners in two further cases. One
cat was treated medically with PTU.
The remaining 24 cases were treated surgically by unilateral or
bilateral thyroidectomy as described in Chapter 10. Thyroid tissue
was preserved for immunological studies by snap-freezing in liquid
nitrogen and was subsequently stored at -40°C.
Two cats died within two days of surgery. One case was lost to
follow-up. Twenty-one cases were followed up intermittently after
surgery.
Results
There were 28 domestic short-haired cats and one domestic
long-haired cat in the study. Thirteen (45 per cent) were male
(one entire and 12 castrated) and lb (55 per cent) were female
(three entire and 13 ovariohysterectomised). The mean age was 12.8
years with a range of six to 17 years. The historical and clinical
features were largely in agreement with those of the more extensive
series described in Chapter 10 and those published by other workers
and are summarised in Table 14.1. Twenty-eight cats had a palpable
goitre, with 16 being unilateral and 12 bilateral.
The serum T4 concentration was elevated in all cats but the
serum T3 concentration was within the normal range in one animal.
In two cats, the serum T4 concentration was not precisely quantified
and was reported as greater than 200 nmol/1. In the remainder, the
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range for serum T4 concentration was 65.1 nmol/1 to 654.0 nmol/1
(mean 197.9 nmol/1) and for T3 was 1.06 nmol/1 to 10.3 nmol/1 (mean
3.87 nmol/I).
Thyroid microsomal and antinuclear antibodies. Thyroid
autoantibodies were detected in ten cases, five of which were
strongly positive. ANA was identified in another four cats. Serum
from all 15 control cats was negative for thyroid autoantibodies and
ANA.
Clinical and laboratory data from the 15 hyperthyroid antibody
negative cats are shown in Table 14.2, from the ten thyroid antibody
positive cats in Table 14.3 and from the four ANA positive cats in
Table 14.4.
Thyroid antibodies. Cat thyroid incubated with serum from a
healthy cat and serum strongly positive for thyroid autoantibodies
is shown in Figs. 14.1 and 14.2 respectively. Thyroid tissue from
the thyrotoxic cats was also satisfactory for detection of thyroid
antibodies.
The ten thyroid antibody positive cats consisted of six
neutered males and four neutered females. There was no significant
difference between the ages at diagnosis between the thyroid
antibody positive cats (mean of 13.3 years) and the 17 antibody
negative cats (mean of 12.5 years) as analysed by Student's unpaired
t test.
The mean serum total T4 and T3 concentrations in the thyroid
antibody positive cats was 166.0 nmol/1 and 3.93 nmol/1 respectively
compared with 213.8 nmol/1 and 3.84 nmol/1 in the thyroid antibody
negative cats. Because two of the high T4 concentrations were not
precisely quantified, the Wilcoxon Rank Sum test was used to
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compare these data whereas Student's unpaired t test was used for
the T3 concentrations. None of the differences was significant.
Of the five cats scored ++ for thyroid antibodies, four had
bilateral goitres compared with only five of the other 22 cats.
Lymphocytic infiltrates were found in four of the five thyroids but
only in five of the 22 thyroids examined from the rest of the cats.
Using Fisher's exact test, these variables were found to be
significantly different (P <0.05 in both cases).
Antinuclear antibodies. Cat thyroid incubated with serum
positive for ANA is shown in Fig. 14.3.
All four cats positive for ANA had unilateral goitres and two
affected thyroid glands contained lymphocytic infiltrates. The two
youngest cats in the series, aged six and 7.5 years, were in this
group.
The serum total T4 (mean 132.3 nmol/1) and T3 (mean 3.24 nmol/I )
concentrations of the ANA positive cats did not differ from those of
the other hyperthyroid cats as analysed by the Wilcoxon Rank Sum
test and Student's unpaired t test respectively.
Thyroid stimulating hormone receptor antibodies. TSH
receptor antibodies were not detected in sera from any of the 12
hyperthyroid or the 12 healthy cats.
Follow-up of cats treated surgically. It was possible to
follow up 21 cats after surgery, over a range of three to 40 months,
with a mean of 11.1 months. During this time, recurrence of
hyperthyroidism was confirmed in three cats (113897, FT/HE/17/83 and
FT/HE/15/82) after twenty-one months, seven months and an
unspecified period respectively.
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Two of these cats (113897 and FT/HE/17/83) had shown strongly
positive reactions for serum thyroid antibodies and bilateral goitre
at initial diagnosis. After bilateral extracapsular thyroidectomy,
lymphocytic infiltrates were found in excised thyroid glands. The
third cat (FT/HE/15/82) had shown a strongly positive reaction for
serum ANA and unilateral goitre. This cat had been treated by
unilateral extracapsular thyroidectomy and lymphocytic infiltrates
were found in excised tissue. Recurrence in this case had involved
the side on which surgery had already been performed.
FT/HE/17/83 and FT/HE/15/82 responded totally to further
surgery and there was no recurrence of the condition. With 113897,
a second bilateral thyroidectomy produced remission of clinical
signs and lymphocytic infiltrates were again found in the excised
thyroid tissue. After a further five months, the cat became
thyrotoxic once more. Treatment with PTU controlled the symptoms
and signs of the condition but had to be withdrawn after six months
because of severe although asymptomatic thrombocytopenia. Further
surgery recovered cystic thyroid tissue but clinical and
biochemical hyperthyroidism persisted and no further treatment was
given.
Piscussion
The 29 hyperthyroid cats in this report presented consecutively
but were not selected for autoantibody studies by any other
criteria. Using normal cat thyroid as tissue substrate,
circulating autoantibodies were detected by indirect
immunofluorescence in 14 of these cats (48 per cent). Ten showed
thyroid antibodies with a staining pattern similar to that of the
microsomal antibody found in human thyroid diseases and four had
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ANA. The non-organ specific nature of the ANA was demonstrated by
incubating the positive sera with rat kidney.
The five sera with strong reactions for microsomal antibody
included four cats with bilateral goitre, and four of the five
thyroids removed contained lymphocytic infiltrates. Such
infiltrates were found in only five of the other 22 thyroids
examined, and sera from two of these five affected cats were
positive for ANA. The correlation between lymphocytic infiltration
of the thyroid gland and circulating antibodies to the thyroid is
well-recognised in human thyroid disorders (Schade et al., 1960).
Despite surgical therapy using the technique of extracapsular
thyroidectomy, thyrotoxicosis recurred in three cats. Two of these
had bilateral goitres with lymphocytic infiltrates at initial
presentation and their serum was strongly positive for thyroid
antibodies. The third cat had a unilateral goitre but there was
lymphocytic infiltration and its serum was positive for ANA.
Autoantibodies may therefore have prognostic significance in feline
hyperthyroidism as they do in human Graves' disease (Irvine, Gray,
Morris and Ting, 1977; McGregor, Rees Smith, Hall, Petersen, Miller
and Dewar, 1980).
Recurrence of feline thyrotoxicosis after bilateral
thyroidectomy has been recorded previously (Peterson, Birchard and
Mehlhaff, 1984). Proposed or proven causes include continued
hyperplasia of remnants of thyroid tissue left with the thyroid
capsule after intracapsular thyroidectomy (Birchard, Peterson, and
Jacobson, 1984; Peterson, 1984), local regrowth of, or distant
metastasis from, a thyroid adenocarcinoma (Cotter, 1979; Hoenig et
al., 1982; Olsen, 1982, 1983) and involvement of accessory or
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ectopic thyroid tissue in the disease process (Holzworth et al.,
1980; 01 sen, 1982, 1983).
In the three cases under discussion, the thyroid was excised
within its capsule. In the cases of bilateral thyroidectomy, it is
possible that remnants of thyroid tissue may have remained with the
cranial parathyroid glands which were carefully dissected free of
the cranial thyroid capsule and preserved. However, the cranial
parathyroid gland is situated in an extracapsular position (Section
3.3) and this is therefore unlikely. This cannot be the explanation
for the recurrence on the same side of the neck in the unilateral
case, as here a unilateral thyroparathyroidectomy was carried out.
Neither can recurrence in any of the cases be due to malignancy as
this was excluded on histological examination of excised tissue in
each.
It is tempting to speculate that recurrence of thyrotoxicosis
in these cases was due to involvement of accessory or ectopic
thyroid tissue in the disease processes. Alternatively, because
hyperfunctional thyroid tissue frequently contains numbers of cysts
of varying size, it is possible that spillage of cystic fluid
together with viable thyroid cells, resulted in eventual recurrence
of hyperthyroidism in these three cats.
In healthy cats, serum ANA has been variously reported as rare
(Scott, Haupt, Knowlton and Lewis, 1979) and occurring in low titres
(between 1:2 and 1:10) in ten per cent of normal cats (Pedersen,
1982). In a series of 100 healthy cats, ANA was identified in
only two, at a titre of 1:5 (D.W. Scott, personal communication).
In the present study, sera from all 15 healthy controls were negative
for ANA.
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Positive serum ANA may occur in cats with systemic lupus
erythematosus (Scott et al., 1979; Pedersen, 1982; D.W. Scott, 1984),
pemphigus erythematosus (Scott, Miller, Lewis, Manning and Smith,
1980); cholangiohepatitis, leukaemia virus infection and infectious
peritonitis (Pedersen, 1982) and fibrosarcoma, (D.W. Scott, personal
communication). In addition, as discussed previously, Peterson et
al. (1984) identified serum ANA as a consequence of PTU therapy in
five hyperthyroid cats. The four cats which were positive for ANA
in the present series did not show signs of other diseases and had
not been treated with PTU and it is likely that their ANA titres
were related to their thyrotoxicosis rather than to other disease
states.
In this series, two of the ANA positive cats (aged six and 7.5
years) are among the youngest cases of feline hyperthyroidism yet
reported (see Section 3.11). If thyroid autoantibody production is
secondary to thyroid damage rather than part of a primary
immunological disturbance, the formation of non-organ specific
autoantibodies would not be surprising although ANA may also be
found in human autoimmune thyroid disease (Hijmans, Doniach, Roitt
and Hoiborow, 1961).
Circulating TSH receptor antibodies were not identified in any
animal in this series. This is not surprising as the assay used in
this study has been developed for use with human serum.
Histological examination of excised thyroid glands from these
cats, as in the larger series reported in Chapter 10, revealed
adenomatous hyperplasia in all cases. Feline hyperthyroidism has an
equal sex incidence, unlike the female predominance in Graves'
disease, and is a disease of older cats (see Chapter 10). The
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condition, therefore, has many similarities to human toxic nodular
goitre.
Thyroid antibodies are frequently found in cases of human toxic
nodular goitre (Codaccioni et al., 1971) and, although it is
possible that they may simply reflect tissue damage, a variety of
other immunological disturbances have been described (Kiy et al.,
1982; Smyth, Neylan and 0'Donovan, 1983). An autoimmune aetiology
is not, therefore, excluded by the finding of toxic nodular goitre.
The immunological aspects of feline hyperthyroidism have not
been studied previously. Many cases have serum autoantibodies
although their pathogenic role, if any, remains to be clarified.
The aetiology of the condition requires further investigation. Such
work may be of relevance, not only to veterinary, but also to medical
practice, in an area in which animal models are sadly lacking.
14.6 RAD 10IODINE-INDUCED FELINE HYPOTHYROIDISM
Clinical material
Serum samples from two experimental cats (see Chapter 11)
before (week 1) and on two occasions after (weeks 18 and 67) thyroid
ablation with radioiodine were studied. Samples were collected and
stored as described in Chapter 11. Sera were examined by indirect
immunofluorescence testing as described in Section 14.4 but TSH
receptor antibodies were not assayed.
Results
Clinical and laboratory details of the two cats at the time
of sampling, together with the results of direct immunofluorescence
testing are given in Table 14.5.
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Thyroid antibodies and ANA were not identified in any of the
sera tested.
Discussion
Neither thyroid microsomal antibody nor ANA were induced in
either cat as a result of thyroid ablation with radioiodine. These
results are not surprising because, although microsomal and
thyroglobulin antibodies have been induced in low titres in
euthyroid humans as a result of 131 j therapy, this occurred in
only ten and eight patients respectively of 28 studied (Einhorn,
Fagraeus and Jonsson, 1966).
Thus, microsomal autoantibody or ANA formation was not
contributory to the progressive elevations of gamma-globulin
concentrations in the cats in the present study (see Chapter 11).
Other thyroid antibodies that have been demonstrated in human
thyroid diseases include antithyroglobulin antibody and a second
antibody against a colloid antigen distinct from thyroglobulin
(Ingbar, 1985). Detection of these antibodies requires techniques
which were not carried out in this study. It is unlikely that the
degree of increase in gamma-globulin concentrations observed in
these cats (approximately 2.5 times the basal concentrations) could
be due merely to thyroid autoantibody formation. Similar increases
in serum gamma-globulin concentrations occur in human Hashimoto's
disease, but these are not due simply to thyroid antibody formation
and the exact mechanism is unknown (A.D. Toft, personal
communication). Human B cells may be activated by a large number of
triggering signals to produce a polyclonal response resulting in
elevated gamma-globulin concentrations (Fauci, 1980, 1983). It is
interesting to speculate that such B cell stimulation may be the end
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ABSTRACT
Double antibody radioimmunoassays for thyroxine (T4) and triiodothy¬
ronine (T3) were established for use in cats, using standards in T4- and
T3-free, normal cat serum. The assay working ranges were 5-200 nmol/1
for T4 and 0-125-10 nmol/1 for T3. Recovery of added hormone was 106
per cent ± 5-9 for T4 and 104 per cent ± 8-5 for T3 (mean ± 1 s.d.). Mean
between-assay coefficients of variation (c.v.) were 6-6 per cent for T4 and
12-1 per cent for T3.
Serum total T4 levels of 318 and total T3 levels of 299 healthy cats aged
4 months to 13 years were measured. Mean + 1 s.d. values were 26-1 ±
10-1 nmol/1 for T4 and 0-69 ± 0-29 nmol/1 for T3. T4 and T3 con¬
centrations within individual animals were highly correlated. T4 levels in
both sexes tended to decrease until approximately 5 years of age and then
rise again. A similar, though less pronounced effect, was found for T3,
concentrations for older cats levelling out rather than rising.
For any given age, females and neutered females tended to have
significantly higher T4 values than males and neutered males, but such
effects were not significant for T3. When other effects were accounted
for, the effects of neutering were not significant for levels of either hormone.
Pedigree animals tended to have higher levels of T3 at any given age than
domestic short- and long-haired cats taken as one group. Animals living in
the same environment had significantly similar T4 levels and T3 levels. For
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T3, this appeared to be due to a definite genetic component, but it was not
possible to differentiate between environmental and genetic effects for T4.
INTRODUCTION
Thyroid function of cats has been little studied in comparison with that of the dog.
This may have resulted, in part, from an apparent lack of thyroid-related disease
states in the former. However, with the recent recognition of hyperthyroidism as an
important condition of older cats (Peterson, Johnson & Andrews, 1979; Holzworth
et al., 1980) and further definition of feline endocrine alopecia as a thyroid
hormone-responsive dermatosis (Thoday, 1983), a more detailed understanding of
the cat's thyroid physiology is urgently required.
Many of the reported studies of feline thyroid function have used methods which
have been superseded in studies on humans because of poor specificity, sensitivity
or both. Thus, early studies using serum protein-bound iodine (e.g. Bustad &
Fuller, 1970; Kaneko, 1970), triiodothyronine (T3) uptake (e.g. Kallfelz & Erali,
1973; Ling, Lowenstine & Kaneko, 1974), competitive protein binding (CPB) (e.g.
Scherzinger & Grosser, 1972; Scherzinger, Guzy & Lorcher, 1972; Kallfelz &
Erali, 1973; Ling, Lowenstine & Kaneko, 1974; Bigler, 1976a) and free thyroxine
(T4) index (Kallfelz & Erali, 1973) were valuable but failed to provide the accurate
information on circulating T4 and T3 levels which may be obtained using
radioimmunoassay (RIA) methods now available.
Two studies have reported details of total thyroid hormone levels in normal cats
measured by RIA. Reap, Cass & Hightower (1978) measured total T4 and T3 and
Anderson & Brown (1979) total T4 and T3 uptake values. The only other reports
using RIA have referred to normal ranges without giving information about the
numbers and types of animals studied, in clinical papers on feline hyperthyroidism
or in review articles. (Peterson, Johnson & Andrews, 1979; Holzworth et al., 1980;
Peterson, Becker & Hurley, 1980; Theran & Holzworth, 1980; Jones & Johnstone,
1981; McMillan & Scherding, 1981; Nesbitt, 1981 (quoted in Rosychuk, 1982);
Peterson, 1981; Peterson, 1981 (quoted in Pvosychuk, 1982); Peterson et al., 1981;
Theran, 1981; Watson et al., 1981; Hoenig et al., 1982; Peterson et al., 1982;
Reimers, 1982; Belshaw, 1983; Kirk, 1983; Noxon et al., 1983; Peterson et al.,
1983; Peterson and Yoshioka, 1983; Peterson & Becker, 1984.)
There is, therefore, a need for a more detailed study of serum thyroid hormone
levels in normal cats using specific and accurate techniques and examining possible




Sheep anti-T4 and sheep anti-T3 sera were obtained from the Scottish Antibody
Production Unit (SAPU), Carluke, Lanarkshire, Scotland. Donkey anti-sheep
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serum (DAS) for use as a precipitating antiserum and normal sheep serum (NSS)
were obtained from the same source. T4 sodium salt and T3 free acid for use as
standards, and 8-anilinonaphthalene-1-sulphonic acid (ANS) were obtained from
the Sigma Chemical Company. 125I labelled T4, of specific activity > 34-5
MBq/nmol, and 125I-labelled T3, of specific activity > 28-9 MBq/nmol were
obtained from the Radiochemical Centre, Amersham, Bucks., England.
T4 and T3 standards
Standards were prepared in hormone-free cat serum to minimize the errors that
arise if protein concentrations in standard and sample incubates are unequal.
Pooled serum from normal cats was stripped of endogenous hormones by stirring
with Dowex 2 — X8 (CI ) anion exchange resin (Salter, 1979). The resin-treated
serum was separated by filtration rather than decanting to increase the yield. This
procedure removed more than 99 per cent of T4 and T3, as measured from the
recovery of 1251-labelled hormones. Sodium azide (0-01 per cent) was added to the
stripped serum as a bacteriostat.
Stock solutions of T4 and T3 were prepared in alkaline propylene glycol and
concentrations were confirmed spectrophotometrically. Appropriate dilutions of
the stock solutions in assay diluent were added to hormone-free serum to give
standards of 0, 5, 10, 20, 40, 60, 80, 120, 160 and 200 nmol/1 for T4 and 0, 0-125,
0-25, 0-5 1, 1-5, 2, 3, 4, 5 and 10 nmol/1 for T3. The standards were stored in
aliquots at —40°C.
Radioimmunoassay methods
Serum T4 and T3 were measured by radioimmunoassays based on the double
antibody methods described by Ratcliffe, Challand & Ratcliffe (1974) and
modified for use with feline serum. The dilutions of anti-T4 and anti-T3 sera were
adjusted to give the maximum response over the concentrations anticipated in
feline serum. Concentrations of NSS and DAS were optimized by the procedures
of Hunter (1978). All determinations were performed in duplicate in polystyrene
tubes (12 x 75 mm). The assay diluent was 0-05 mol/1 sodium barbiturate buffer,
pH 8-6, containing 0-1 per cent bovine serum albumin and 0-01 per cent sodium
azide. The reagents and procedure are summarized in Table 1.
ClinicalMaterial
Blood was obtained from 319 cats (122 males, 141 females, 35 neutered males
and 21 neutered females) aged between 4 months and 13 years. All were classified
as healthy on the basis of detailed history and physical examination. Pregnancy
checks were carried out on all entire females by ballottement and those considered
to be positive were excluded from the study. The majority of the animals were
either domestic short- or long-haired, but 23 pedigree animals of several breeds
were also represented. Samples were collected from conscious animals by
venepuncture, usually from the jugular vein but also from the cephalic vein. After
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Table 1. Constituents of assays and procedures
T4 radioimmunoassay T3 radioimmunoassay
Serum Serum
(standard or sample) 25 p\ (standard or sample) 504
Reagent 1 Reagent 1
125I-T4 125I-T3
approx. 35,000 c.p.m./tube 600 4 approx. 30,000 c.p.m./tube 4004
DAS (1:73) DAS (1:29)
Reagent 2 Reagent 2
ANS (290 /rg/tube) ANS (90 /rg/tube)
Sheep anti-T4 (1 :4,850) 200 4 Sheep anti-T3 (1 :8,400) 5604
NSS (1:1,360) NSS (1:680)
Total volume 825 4 Total volume 1,050 //I
Procedure
1. Using an automatic diluter, pick up standard or sample and dispense together with Reagent 1.
Dispense reagent 2. Vortex mix.
2. Incubate for 36 hours at 4°C.
3. Centrifuge at 3,000 r.p.m. for 30 minutes at 4°C.
4. Decant supernatant to waste. Blot tube tops dry on absorbent paper.
5. Determine antibody-bound 125I in tubes by counting in a gamma counter.
6. Enter count results on paper tape via Hewlett Packard tape reader (Model 9883A) and calculator
(Model 9821 A) into computer (Hewlett Packard 9871A) for calculation of results using 4
parameter logit-log model for the standard curve.
clot retraction, blood was centrifuged and the serum transferred to a clean tube for
storage at —40°C. Where the volume of sample allowed, T4 and T3 were assayed
on each specimen giving 298 paired observations. Twenty samples were assayed
for T4 alone and one for T3 alone.
RESULTS
Validation ofassay procedures
(a) Elimination ofserum interference. ANS was included in the RIA incubate to
block binding of thyroid hormones by serum proteins which would otherwise
interfere in the assay. The optimum concentrations were determined by varying the
amount of ANS per tube between 0 and 1,500 pg and selecting the concentration
which yielded the minimum difference in binding between incubates containing
diluent only and diluent plus hormone-free serum. For T4, the ANS concentration
required was 290 ^g/tube. For T3, a lower concentration of ANS was required,
possibly reflecting the lower affinity of T3 for serum proteins, 90 ^g/tube being
effective.
(b) Accuracy. Accuracy was assessed by determining the recovery of known
amounts of T4 or T3 added to normal feline sera to give concentrations in the
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Table 2. Between assay precision for T4 and T3 radioimmunoassays
T4 radioimmunoassay T3 radioimmunoassay
Mean T4
concentration
Pool (nmol/1) sd c.v. (%)
Mean T3
concentration
Pool (nmol/1) sd c.v. (%)
Low 18-08 1-31 7-2
Medium 37-10 2-86 7-7
High 116-19 5-61 4-8
Low 0-29 0-05 17-2
Medium 0-47 0-06 12-7
High 2-80 0-18 6-4
Mean c.v. 6-6 Mean c.v. 12-1
T4 data derived from 14 assays. T3 data derived from 12 assays.
range of 18-1 to 69 nmol/1 for T4 and 1 to 2 nmol/1 for T3. In both assays,
recovery was excellent, mean ± 1 s.d. (number of observations) being 106-0 ± 5-9
(n = 11) for T4 and 104-4 ± 8-5 (n = 9) for T3.
(c) Precision and drift. Precision was assessed by the inclusion of low, medium
and high pools in each assay. The medium pool was prepared from normal feline
serum and the low and high pools from this by dilution with hormone-free
serum, and by addition of known amounts of T4 and T3 respectively. There was no
evidence of drift as assessed by Student's paired t test on results from pools placed
at the beginning and end of the assays (T4: t = 0-03, 16 d.f.; T3: t = 0-50, 25 d.f.).
Within-assay c.v. for low, medium and high pools respectively were 5 per cent, 4
per cent and 2 per cent for T4 and 12 per cent, 5 per cent and 5 per cent for T3.
Between-assay precision was excellent; the results are given in Table 2.
(d) Detection limit (sensitivity) and working range. Using the 4 parameter
logit-log model for curve fitting, the calculated standard curve agreed with the
observed standard points over the whole concentration range. The working range
was therefore taken as being between the lowest and highest standards (T4, 5-200
nmol/1; T3, 0-125-10 nmol/1.
Serum total thyroid hormone concentrations in healthy cats
(a) Distribution of values in healthy population (all ages and both sexes). Both
T4 and T3 values were found to fit a normal distribution (chi-squared
goodness-of-fit tests on grouped data were not significant). Table 3 summarizes
the data in terms of mean, s.d., range and 95 per cent range (2-5 per cent and 97-5
per cent sample percentiles).
(b) Relationship between T4 and T3 levels (all ages and both sexes). Individual
T4 and T3 values were highly significantly correlated (r = 0-46, P < 0-001).
(c) Effects of age, sex and breed on hormone levels. Multiple regression was
used to investigate the relationship of T4 and T3 levels to age, sex and breed. This
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Table 3. Total serum T4 and T3 concentrations in healthy cats
Range (nmol/1)
No. of Mean ± 1 sd
Hormone Observations (nmol/1) Actual 95%
T4 318 26-1 ± 10-1 <5-54-1 8-5-46-2
T3 299 0-69 ± 0-29 <0-13-1-48 0-13-1-27
Table 4. Multiple regression of age, sex and breed on total T4 and T3 levels in healthy cats.
Results shown are t-statistics, testing significance of each factor for given levels of the others
Results Interpretation
Test T4 T3 T4 T3
Do total T4 or T3 t = 3-74 t = 4-14 Highly significant Highly significant
concentrations (P < 0-001) (P < 0-001) relationship to relationship to
change with age? age age
Do total T4 or T3 t = 3-51 t = 2-70 Highly significant Significant
concentrations (P < 0-001) (P <0-01) quadratic change quadratic




Do total T4 or T3 t = 2-57 t = 0-34 Females show No significant
concentrations of (P < 0-05) (NS) significantly difference
animals of a given higher levels between the
age differ than males at a sexes
according to given age
original sex?
Does castration or t = 0-62 t = 0-47 No significant effect No significant
ovarohysterectomy (NS) (NS) when age is effect when age
influence total accounted for is accounted for
T4 or T3
concentrations?
Does breed influence t = 1-17 t = 3-53 No significant Pedigree cats have





NS = not significant
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method tests whether or not mean hormone levels are significantly affected by each
factor when the effect of all the others is taken into account. A quadratic term for
age was included to test whether any relationship with age was linear. In view of the
small numbers of pedigree cats, the analysis compared all pedigree to all domestic
breeds. The former comprised 10 Siamese, 7 Burmese, 3 British blues, 2 Devon rex
and 1 Persian, while there were 254 domestic short-haired and 24 domestic
long-haired cats.
The results of the analyses as applied separately to T4 and T3 are summarised in
Table 4. In the case of T4, both the linear and quadratic effects of age were highly
significant and there was also a significant difference in T4 levels between the
original sexes. Fig. 1 illustrates mean values (with standard error bars) for T4 for
each sex and in five age groups, and shows that T4 levels in both sexes tended to
decrease with age up to about 5 years and then to rise again. Female cats of a given
age tended to have higher T4 values than male cats. The effects of neutering and
breed were not significant for a given age and original sex.
For T3, a similar, though less pronounced, age effect was found, with the initial
decrease with age being followed by a levelling out rather than an appreciable rise.
The effects of original sex and neutering on T3 were not significant, but pedigree
cats tended to have higher levels of the hormone at any given age than domestic
cats (Table 4). Fig. 2 illustrates the differences in mean serum T3 concentrations of















1 2 3 4 5
(4-6 months) (> 6-12 months) (> 12-60 months) (> 60-1 08 months) (>108 months)
Age group
Fig. 1. Effects of sex and age on serum total T4 concentrations in healthy cats. The mean
values (±1 s.e.m.) are shown. The figures in parentheses are the number of observations in
each group.
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4
( > 60-1 80 months)
Age group
Fig. 2. Comparison of serum total T3 concentrations in pedigree and domestic cats
according to age. The mean values (+1 s.e.m.) are shown. The figures in parentheses are
the number of observations in each group.
considered separately from other pedigree cats differ significantly from domestic
long-haired cats for given levels of the other significant factors (see discussion).
(d) Influence of heredity and environment on hormone levels. If environmental
effects influence T4 and T3 levels, it would be expected that cats reared in the same
environment would show less variation in hormone levels than those reared in
different environments. Similarly, a genetic component in hormone levels would
lead to related cats varying less than unrelated ones. To examine these possibilities,
hormone levels were measured in 13 unrelated cats grouped in five environments
and in 18 related cats grouped in nine environments. Nested random-effect analysis
of covariance was used to test for significant between-environment and
between-family effects while correcting for the previously established effect of age
on T4 and T3 levels.
The results of these analyses are shown in Table 5 together with their
interpretation. The significant excess variation between environmental groups for
the related cats suggests that hereditary and/or environmental influences exist on
both T4 and T3, but it is not clear which component predominates for T4. For T3,
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Table 5. Influence of environment and heredity on total T4 and T3 levels in healthy cats
Results
Test T4 T3 Interpretation
Are there significant differences
in T4 and T3 values of
related cats in the same,
compared with different








Are there significant differences
in T4 and T3 values of
unrelated cats in the same,
compared with different,
environments? (4 and 4 d.f.)




unrelated and related cats
(4 and 9 d.f.)
F = 2-17 F = 4-01
(P < 0-05)
For T3 only, related cats in
the same environment have
significantly less variable
values than unrelated
animals, i.e. evidence for
an hereditary effect
there appears to be a definite hereditary component, but these results on small
numbers of animals clearly need to be confirmed by further studies.
DISCUSSION
Measurements of the circulating total T4 and total T3 by RIA are now widely used
in the investigation of thyroid disease in man. Such techniques are applicable to the
cat provided the methods are modified to allow for the much lower levels of
circulating total T4 and T3 in this species compared with man.
Reap, Cass & Hightower (1978) and Anderson & Brown (1979) appear to be
the only workers to have reported details of the RIA methods they used to
determine plasma total T4 and total T3 levels in normal cats. The former workers
measured total T4 and T3 in only 10 animals, whereas the latter evaluated total T4
but not T3 in 92. Both groups used commercially produced RIA kits which were
designed for use with human serum. Both groups recognized the particular
problems in using these kits to assay the low levels of thyroid hormones found and
attempted to circumvent them by doubling the volume of serum used and halving
the results to give the correct hormone concentration. Neither assay was optimized
for the cat and standards were prepared in buffer. In a report on electrocardio¬
graphic changes in hyperthyroid cats, Peterson et al. (1982) employed a double
antibody technique for T4 and T3 modified by using charcoal-extracted, pooled
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serum from normal cats to produce T4 and T3 depleted serum for addition to
control and standard tubes. Further details were not reported.
The assays described here were specifically designed for use with cat serum. The
dilutions of anti-T4 and anti-T3 sera were adjusted to permit measurement of the
relatively low concentrations of the hormone in cat serum. Correct standardization
of the assays is essential and for this reason standards were prepared in
resin-stripped cat serum which equalizes protein concentrations in standard and
sample tubes and compensates for residual protein interference not eliminated by
ANS. The stripping method adopted has been recommended for use with human
serum as it does not affect the major thyroid hormone-binding protein
concentrations (C. R. Salter, personal communication), whereas charcoal stripping
as used by Peterson et al. (1982) tends to remove a proportion of such proteins.
When used with cat serum, the technique showed no definite trends. Albumin levels
were sometimes lowered but alpha-1 and alpha-2 globulin levels were not (human
thyroxine-binding globulin migrates in the inter orl/or2 zone on electrophoresis).
The procedure was efficient, removing greater than 99 per cent of T4 and T3, while
providing a yield of approximately 70 per cent. It is generally accepted for man,
that serum is satisfactory for standard production if greater than 95 per cent of the
hormones have been removed.
The inclusion of the protein-binding inhibitor ANS in the incubates was found to
be necessary despite reports in the literature that high affinity binding proteins for
thyroid hormones could not be demonstrated in cat serum (Tanabe, Ishii & Tamaki,
1969; Scherzinger, Guzy & Lorcher, 1972; Bigler, 1976b). As barbital contributes
to the blocking of the binding of thyroid hormones to their carrier proteins, it
was thought that it might be possible to omit ANS from the incubate, particularly
in the T3 assay. However, in the absence of ANS, T3 levels were consistently and
incorrectly 20 per cent lower, and ANS was therefore included in both assays.
Data on within and between assay precision and on accuracy is essential if
values for normal ranges are to be considered reliable. Reimers et al. (1981) are the
only workers to have described validation of radioimmunoassays for T4 and T3 in
cats, but normal ranges were not reported. They investigated solid phase kits
designed for use with human serum and produced additional standards to allow
measurement of the lower levels of the hormones found in normal cats. In the
present study, within-assay precision for T4 and T3 and between-assay precision
for T4 were excellent. Between assay precision was less good for T3 but compared
well with that of similar assays and reflected the low concentrations of T3
measured.
This study, based on 318 T4 estimations and 299 T3 estimations is more
comprehensive than any previously described (Table 6). The values reported here
can be considered reliable as they were obtained with well validated methods on a
large population. Although the mean T4 and T3 levels found here are in good
agreement with previously reported values, it is evident that some euthyroid levels
found in other series would be in the hyperthyroid range on the basis of the present
data.
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Three of the T4 and 10 of the T3 estimations (0-94 per cent and 3-35 per cent
respectively) gave values that were less than the lowest standards of the assays. In
each case, however, the paired T3 or T4 concentration was within the 95 per cent
confidence limits for the respective assay. The assays were designed for the
diagnosis of thyroid hypo and hyper-function and inevitably there will be some
normal animals which will have hormone concentrations outwith the 95 per cent
range. To have re-optimized the assays to measure the lowest levels of T4 and T3
found would have meant a loss in sensitivity at the higher end of the range. In
addition, the values of the 2-5 per cent sample percentiles were greater than the
lowest standard for each assay.
In this study, the serum T3 concentration was found to be highly significantly
related to the serum total T4 concentration. While the methods of T3 production in
the cat have not been established, such a relationship would be expected if its
derivation is similar to that in man where only a small proportion of circulating T3
is secreted by the thyroid, approximately 80 per cent of it being produced from
extra-thyroidal mono-de-iodination of T4 (Braverman & Vagenakis, 1979).
Both RIA and CPB techniques have been used to evaluate age differences in
feline total T4 levels. Using RIA, Anderson & Brown (1979) found no significant
age effects in 92 cats varying between 5 months and 15 years, but the actual
numbers in each group were not stated. Using CPB methods, no age effects were
noted by Ling, Lowenstine & Kaneko (1974) who evaluated 39 animals, but none
was older than 5 years. Bigler (1976a), using a CPB technique, reported T4 levels
in 110 cats. However, 92 were between 8-5 months and 1 -5 years and only 4 were
older than 4 years and the author was therefore unable to comment about age
differences. Kallfelz & Erali (1973) evaluated the T4 levels of 5 cats aged 10 weeks,
4 aged 1 year and 5 that were more than 1 year old. There was a trend towards
decreasing concentrations with increasing age but the results were not statistically
significant.
In this study, total T4 levels were found to vary highly significantly with age in a
non-linear manner, mean levels decreasing in both males and females until > 12-60
months and increasing thereafter. T3 levels also showed this non-linear decrease
with age but tended to level out rather than increase at very high ages. Such data on
T3 have not been previously reported. It would be expected that T3 changes would
parallel those for T4 in view of the findings that T4 and T3 concentrations were
highly correlated. In man, thyroid hormone levels decrease with increasing age in
hospital patients, but not in the healthy elderly; that is, the decrease appears to be a
consequence of illness rather than age per se (Olsen, Laurberg & Weike, 1978).
Cats for inclusion in this study were taken from a healthy rather than a hospital
population but, nevertheless, the rise of total serum T4 levels in older animals was
not expected.
Sex differences in total T4 levels have been evaluated by both RIA and CPB
techniques but total T3 levels only by RIA. Using RIA, Reap, Cass & Hightower
(1978) found that there were no sex differences in total T4 and T3 levels but did not
state whether any animals had been neutered. Anderson & Brown (1979) found no
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Reported levels of total T4 and T3 by radioimmunoassay techniques in healthy cats
No. T4 (nmol/1) T3 (nmol/1)
Reference Method cats Range Mean ± 1 sd Range Mean ± 1 sd
Reap, Cass &
Hightower (1978)
NR 10 15-2-38-0 26-0 ± 7-9 0-60-1-73 1-00 ± 0-32
Anderson & Brown
(1979)
Solid phase 92 18-0-83-7 39-8 ± 24-5 ND ND
Peterson, Johnson
& Andrews (1979)





NR NR 19-3-64-4 NR 0-92-3-08 NR
Peterson, Becker &
Hurley (1980)
Peterson et al. (1981)






NR 30-0-50-0 NR ND ND
Peterson (1981) NR NR 12-9-38-7 NR 0-39-1-54 NR
McMillan &
Scherding (1981)








NR NR ND ND NR 0-49 ± 0-22
Theran (1981) NR NR 12-9-51-5 NR 0-92-3-08 NR
Watson et al. (1981) NR 3 23-0-38-0 NR ND ND









NR 16-7-42-5 NR 0-23-0-77 NR





T4 (nmol/1) T3 (nmol/1)
Reference Method Range Mean 4: 1 sd Range Mean ± 1 sd
Reimers (1982) NR NR 9-7-56-3 NR 0-23-1-23 NR
Belshaw (1983) NR NR 19-3-45-1 NR 0-77-2-31 NR
Kirk (1983) NR NR 14-1-48-9 NR NR NR












135 10-3-48-9 27-0 ± 15-0 0-23-1-60 0-81 ± 0-32
Peterson &
Yoshioka (1983)
NS NS 19-3-64-4 NR 0-92-3-08 NR




NR = not reported. ND = not determined
significant differences between T4 levels of male and female cats but entire females
had significantly higher levels than those that had been ovarohysterectomised.
Using CPB, Ling. Lowenstine & Kaneko (1974) also found that the sex of cats did
not affect circulating total T4 levels. Bigler (1976a). however, reported that female
cats had significantly higher T4 levels than males. In man, thyroid hormone levels
have been reported to be slightly higher in females than in males, but there is no
universal agreement on this. Indeed, the tendency to higher levels in females may
have been due to the inadvertent inclusion of some pregnant women in the series
(Robbins & Rail, 1979).
In this study, an attempt was made to exclude pregnant animals by physical
examination. For any given age. female and neutered female cats taken as one
group, tended to have significantly higher T4 levels than males and neutered males.
No such effect was seen with T3. When age was accounted for, the effects of
castration or ovarohysterectomy were not significant for either T4 or T3.
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In the only report on breed differences in thyroid hormone levels, Ling,
Lowenstine & Kaneko (1974), using CPB, found a significantly higher level of total
T4 in Siamese (n = 11) compared with domestic long-haired cats (n = 7) but no
difference between T4 in either of these breeds and domestic short-haired cats (n =
10). Because our study only included 23 pure-bred cats, data were pooled and
compared with those for domestic short- and long-haired animals taken together.
No significant differences in total T4 levels were found but the total T3 values were
significantly higher for any given age in the pedigree breeds. When the Siamese
breed was compared separately with domestic long-haired cats, T4 and T3 levels
did not differ significantly.
There was an apparent similarity in both T4 and T3 values respectively of
animals kept in the same environment and this was proven statistically. However,
when the animals were separated into related and non-related groups, it was not
possible to show which component predominated for T4. For T3 there appeared to
be a definite genetic component. Such findings have not been reported previously
but they require further studies in larger numbers of animals.
This paper describes the first RIA specifically designed for measurement of
thyroid hormones in cat serum and details the steps required for its optimization. It
is the largest study so far conducted and presents data not previously reported on
possible variables which, it is hoped, will be of use to both clinicians and research
workers.
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